Document:

exv10w36

 

Exhibit 10.36

AGREEMENT REGARDING DISTRIBUTION OF ASSETS

     This AGREEMENT REGARDING DISTRIBUTION OF ASSETS (this “Agreement”) is made as of September 4 , 2007, by and between United Country Brands, LLC (“UCB”), its parent organization, CHS Inc.
(“CHS”) and Winfield Solutions, LLC (“WS”), and its parent organization, Land O’Lakes, Inc.
(“LOL”).

RECITALS

     WHEREAS, UCB and LOL are the member owners of Agriliance LLC (Agriliance LLC and its
subsidiaries referred to herein collectively as “Agriliance”), with each of them holding fifty
percent governance and financial interests. Agriliance is engaged in the wholesale distribution
and marketing of crop nutrient products, crop protection products, seed and related technical
services to farmers and ranchers through local cooperatives and independent dealers in North
America and the sale of products and services through retail locations.

     WHEREAS, to enhance operating efficiencies, UCB, CHS, WS and LOL have agreed to more closely
align certain of the business segments of Agriliance with each parent entity. The parties have
agreed that the crop nutrient business segment of Agriliance (“CN Business”) will be aligned with
CHS and the crop protection products business segment (“CPP Business”) will be aligned with LOL.
These objectives will be met by causing a distribution of the CN Business Assets (as defined
hereinafter) to CHS, as directed by UCB, and a distribution of the CPP Business Assets (as defined
hereinafter) to WS, as directed by LOL, all in accordance with the provisions set forth herein.
Agriliance will continue to own and operate its remaining assets.

     NOW, THEREFORE, in consideration of the Recitals set forth above which are contractual in
nature and part of this Agreement, and the other agreements set forth herein, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties further agree as follows:

I. DEFINITIONS

     1.1 Definitions. The following capitalized terms used in this Agreement have
the meanings set forth below:

     “Affiliate” means any person or entity which controls, is controlled by or under common
control with another person or entity. For purposes of this Agreement, “control” means, in the
case of a privately held person or entity, the ownership of greater than tenty-five percent (25%)
of the voting interests of the person or entity, or the right to appoint fifty percent (50%) or
more of the members of the governing body of the person or entity and in the case of a publicly
traded person or entity, ownership of greater than five percent (5%) of the outstanding voting
securities of such person or entity.

     “Bank Debt” means the Private Placement Notes, the Revolving Credit Agreement, and the
Securitization Agreement.

     “Business Day” means any day excluding Saturday, Sunday or any day which the Federal Reserve
Bank of Minneapolis is closed.

     “CN Inventories” means all raw materials, ingredients, supplies, materials, work-in -
progress, semi-finished goods, finished goods, components, spare parts and packaging materials
used in the CN Business.

     “CN Site Contamination” means the presence of any Material of Environmental Concern in soil,
groundwater or surface water at any CN Owned Real Property or CN Leased Real Property.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Contract” means a contract, agreement, commitment or binding understanding that is in effect
as of the date of this Agreement or any time after the date of this Agreement, including, but not
limited to, leases for the CPP Leased Real Property and CN Leased Real Property
(including all amendments, modifications, schedules, addenda, exhibits and attachments thereto).

 

 

     “CPP Inventories” means all raw materials, ingredients, supplies, materials, work-in -
progress, semi-finished goods, finished goods, components, spare parts and packaging materials
used in the CPP Business.

     “CPP Site Contamination” means the presence of any Material of Environmental Concern in soil,
groundwater or surface water at any CPP Owned Real Property or CPP Leased Real Property.

     “Distribution Date” means September 4, 2007, which is the date upon which the distributions
contemplated hereunder will occur.

     “Effective Time” means 12:01 a.m. on September 1, 2007.

     “Encumbrance” means any mortgage, deed of trust, lien, option, pledge, security interest,
right of first refusal, easement, right of way, title imperfection, restriction, zoning ordinance
or similar restriction of any kind.

     “Environmental Claim” means any actual or threatened claim, action, cause of action or
investigation by any Person other than UCB, CHS, LOL, and WS, alleging liability (including,
without limitation, liability for investigatory costs, cleanup costs, governmental response costs,
natural resources damages, property damages, personal injuries, or penalties) arising out of,
based on or resulting from (a) the presence, or release into the environment, of any Material of
Environmental Concern at any location, whether or not owned or operated by Agriliance or (b)
circumstances forming the basis of any violation of any Environmental Law.

     “Environmental, Health and Safety Requirements” means all Laws concerning public health and
safety, worker health and safety related to Materials of Environmental Concern, and/or pollution
or protection of the environment, including without limitation all those relating to the presence,
use, production, generation, handling, transportation, treatment, storage, emissions, disposal,
distribution, labeling, testing, processing, discharge, release, threatened release, control, or
cleanup of any Materials of Environmental Concern.

     “Environmental Law” means all Laws relating to pollution or protection of the environment,
including Laws relating to releases of Materials of Environmental Concern or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Materials of Environmental Concern, including without limitation the federal
Comprehensive Environmental Response, Compensation and Liability Act, as amended, the federal
Resource Conservation and Recovery Act, as amended, the federal Clean Water Act as amended, the
federal Toxic Substances Control Act as amended, and the federal Clean Air Act, as amended, and
regulations promulgated thereunder.

     “Environmental Response Action” means any action undertaken to remediate soil, groundwater or
surface water to applicable standards, including standards that are based on reasonable projections
concerning the property’s future use (often known as risk-based remediation standards), or
undertaken in lieu of, or in addition to, remediation in order to prevent or minimize harm to human
health or the environment from the presence of any Material of Environmental Concern in soil,
groundwater or surface water. This definition shall include any actions or measures taken, even if
there is no legal obligation to take such action or measures, and even if no legal liability will
result from not taking such action or measures, if in the exercise of commercially reasonable
discretion, the party taking such actions or measures believes such will avoid or reduce future
Liabilities.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the rules
and regulations thereunder.

     “Governmental Authorization” means any approval, consent, license, permit, waiver,
registration or other authorization issued, granted, given, made available or otherwise required
by any Governmental Entity or pursuant to Law.

     “Governmental Entity” means any federal, state or local entity or authority exercising
executive, legislative,

2

 

judicial, regulatory, administrative or taxing functions of or pertaining to government.

     “Governmental Order” means any judgment, injunction, writ, order, ruling, award or decree by
any Governmental Entity or arbitrator.

     “Intellectual Property Rights” means patents and patent applications; trademarks, trade
names, and the trade dress related to such trademarks and trade names; designations of origin;
works of authorship; copyrights; copyrightable works; technical research; product formulations,
product specifications, software, manuals, source codes documentation, configuration,
architecture, know-how, inventions (whether patented, patentable or unpatentable); methods;
information; data; domain names; confidential information; trade secrets; and any other
intellectual or proprietary rights (including without limitation Contracts relating to any of the
foregoing).

     “Law” means any constitution, law (including principle of common law), ordinance, regulation,
statute, treaty, ruling, determination, order or legally binding directive of any Governmental
Entity.

     “Liability” means any liability or obligation whether accrued, absolute, contingent, whether
due or to become due and regardless of when asserted.

     “Litigation” means any claim, action, arbitration, mediation, proceeding, agency complaint,
litigation or suit (whether civil, criminal, administrative or investigative) commenced, brought,
conducted or heard by or before any Governmental Entity or arbitrator or mediator.

     “Loss” means any damage, deficiency, penalty, fine, cost, amount paid in settlement, monetary
loss, expense or fee, including court costs and reasonable attorneys’ fees and expenses.

     “Materials of Environmental Concern” means all substances and materials listed, defined in or
in any way regulated by, or for which liability may be incurred under, any Environmental, Health
and Safety Requirement or Environmental Law, including, without limitation, pollutants,
contaminants, wastes, toxic substances, radioactive materials, asbestos, petroleum and petroleum
products.

     “Permitted Encumbrances” means (a) Encumbrances for Taxes and other governmental charges and
assessments that are not yet due and payable or which are being contested in good faith by
appropriate proceedings, (b) easements, rights of way, title imperfections and restrictions,
zoning ordinances and other similar encumbrances affecting the CN Owned Real Property or the CPP
Owned Real Property and which do not materially interfere with the use or title thereof in the
ordinary course of business.

     “Person” means any individual, corporation (including any non-profit corporation), general or
limited partnership, limited liability company, joint venture, Governmental Entity or other
entity.

     “Private Placement Notes” means the following notes issued by Agriliance pursuant to that
certain Note Agreement, dated as of December 4, 2003, as amended: $42,000,000 of 5.66% Series A-1
Senior Secured Notes due December 4, 2008, $6,000,000 of Floating Rate Series A-2 Senior Secured
Notes due December 4, 2008, $47,000,000 of 6.31% Series B-1 Senior Secured Notes due December 4,
2010, and $5,000,000 of Floating Rate Series B-2 Senior Secured Notes due December 4, 2010

     “Responsibility” means responsibility under the various Environmental Laws for contamination,
or for conducting Environmental Response Action or other remedial measures. This definition shall
include any actions or measures taken, even if there is no legal obligation to take such action or
measures, and even if no legal liability will result from not taking such action or measures, if in
the exercise of commercially reasonable discretion, the party taking such actions or measures
believes such will avoid or reduce future Liabilities.

     “Revolving Credit Agreement” means, as amended, that certain $325 Million Third Amended and
Restated Revolving Credit Facility, dated as of December 20, 2005, among Agriliance, Agro
Distribution, LLC, as borrowers, the lenders party thereto, CoBank, ACB, as administrative agent,
and General Electric Capital Corporation as collateral agent.

     “Securitization Agreement” means, as amended, the Amended and Restated Receivables Purchase

3

 

Agreement, dated as of November 16, 2005, by and among Agriliance SPV, LLC, as seller,
Agriliance LLC, as initial servicer and originator, CoBank, ACB and the other purchasers from time
to time party thereto, and CoBank, ACB, as administrator.

     “Taxes” means all taxes, charges, fees, levies or other assessments, including all net
income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits,
license, withholding, payroll, employment, social security, unemployment, excise, estimated,
severance, stamp, occupation, property or other taxes, customs duties, fees, assessments or
charges of any kind whatsoever, including all interest and penalties thereon, and additions to tax
or additional amounts imposed by any Governmental Entity.

     “Third Party Licenses” means license agreements or arrangements between either LOL or
Agriliance and a third party software provider which may or may not contain terms and conditions
prohibiting the transfer of Intellectual Property to either CHS or LOL. The parties agree that
should such prohibitive terms exist in the license agreements the Intellectual Property associated
with such license agreements may not be transferred to the relevant party. This definition is not
intended to diminish or eliminate the obligations of the parties to assist each other in the
transfer of an Third Party License to the other party as further described in Section 9.2.
below:

1.2 Other Defined Terms. The following terms are defined in the sections indicated

	 	 	 
	Term	 	Section
	Active Employees

	 	7.4
	Controlling Party

	 	8.3
	CN Business

	 	Preamble
	CN Business Assets

	 	3.1
	CN Contracts

	 	3.1(d)
	CN Equity Interests

	 	3.1(h)
	CN Employees

	 	7.1
	CN Intellectual Property

	 	3.1(g)
	CN Leased Real Property

	 	3.1(b)
	CN Obligations

	 	3.2
	CN Owned Real Property

	 	3.1(a)
	CN Prepaid Customer Accounts

	 	3.2(a)
	CN Prepaid Supplier Accounts

	 	3.1(i)CN 
	Product Registrations

	 	3.1(j)CN
	Site Contamination

	 	3.2(b)
	CN Supplier Rebate Accruals

	 	3.1(n)
	CN Tangible Personal Property

	 	3.1(c)
	Collateral Source

	 	12.7
	CPP Business

	 	Preamble
	CPP Business Assets

	 	4.1
	CPP Contracts

	 	4.1(e)
	CPP Employees

	 	7.2
	CPP Equity Interests

	 	4.1(d)
	CPP Intellectual Property

	 	4.1(h)
	CPP Leased Real Property

	 	4.1(b)
	CPP Obligations

	 	4.2
	CPP Owned Real Property

	 	4.1(a)
	CPP Prepaid Customer Accounts

	 	4.2(a)
	CPP Prepaid Supplier Accounts

	 	4.1(j)
	CPP Product Registrations

	 	4.1(k)
	CPP Site Contamination

	 	4.2(b)
	CPP Supplier Rebate Accruals

	 	4.1(m)
	CPP Tangible Personal Property

	 	4.1(c)
	Estimated Inventories

	 	6.5(b)
	Final Balance Sheet

	 	6.2
	Hired CN Employees

	 	7.1
	Hired CPP Employees

	 	7.2

4

 

	 	 	 
	Term	 	Section
	Indemnified Party

	 	12.5
	Indemnifying Party

	 	12.5
	Interim Balance Sheet

	 	6.2
	Post Transfer Period

	 	9.1(c)
	Pre-Transfer Period

	 	9.1(c)
	Property Taxes

	 	9.1(c)
	Retained Environmental Liabilities

	 	8.1
	Title Commitment

	 	9.1(a)
	Title Company

	 	9.1(a)
	Third Party Action

	 	12.6

II. GENERAL OVERVIEW OF DISTRIBUTION PROCESS

     To clarify the intent of the parties, a general overview of the distribution process is as
follows:

     2.1 Retire Portions of Bank Debt of Agriliance; Additional Payment to CHS. The
parties recognize that the assets to be distributed hereunder constitute collateral for the Bank
Debt. Further, the parties recognize and agree that the value attributed to the CPP Business
Assets exceeds the value attributed to the CN Business Assets. Because the parties intend to
maintain their current membership interests in Agriliance after the distribution of assets
hereunder, the parties agree that LOL shall, on the Distribution Date, make those payments against
the Bank Debt on behalf of Agriliance as set forth in that certain Agreement to Pay Debt dated
September 4, 2007, by and between LOL and Agriliance, a copy of which is attached hereto as
Exhibit A. To the extent additional funds are necessary to bring into equal balance the value
received by each party, LOL shall pay the requisite cash directly to CHS on the Distribution Date.

     2.2 Distribution of Assets; Assumption of Certain Liabilities. On the
Distribution
Date, the parties shall cause the following to occur:

     (a) Agriliance shall distribute the CN Business Assets to CHS and CHS shall assume the
CN Business Obligations; and,

     (b) Agriliance shall distribute the CPP Business Assets to WS and WS shall assume the
CPP Business Obligations.

     2.3 Timing. The parties recognize that the Distribution Date will be September 4,
2007, and that September 1 through September 3, 2007, are not Business Days. For purposes of
allocating responsibility for ordinary income gained and ordinary expenses incurred from the
conduct of the CN Business and the CPP Business in the ordinary course, and except as otherwise
provided for herein, the parties agree that such responsibility shall be treated as if the
distribution occurred as of September 1, 2007. The parties recognize that the distributions
contemplated by Sections III and IV of this Agreement and the cash equalization payment from LOL to
CHS contemplated by paragraph 2.1 of the Agreement are all scheduled to occur essentially
simultaneously. The parties also recognize that for tax purposes, these transactions (i.e., the
distributions of the businesses and the cash equalization payment) will have to be reported as
occurring in sequence which will have tax implications. Therefore, the parties agree to report the
transaction consistently in an order to be determined by the parties so as to minimize the tax
liabilities of the parties.

     2.4 Agriliance Continues Operations. Agriliance will continue its operations as a
limited liability company in which LOL and UCB each will continue to have fifty percent financial
and governance rights.

III. DISTRIBUTION OF CN BUSINESS ASSETS TO CHS;

ASSUMPTION OF CERTAIN CN BUSINESS OBLIGATIONS

     3.1 Distribution of CN Business Assets. On the Distribution Date UCB and LOL
shall cause Agriliance to distribute to CHS all of Agriliance’s right, title and interest in and
to the following assets and property of Agriliance, free and clear of all encumbrances other than
the Permitted Encumbrances (collectively, the “CN Business Assets”):

     (a) all of the real property owned by Agriliance described on Schedule 3.1(a) (the “CN
Owned

5

 

Real Property”), including all improvements and fixtures thereon and all rights and
easements appurtenant thereto;

     (b) leasehold interests in all of the real property leased by Agriliance and described
on Schedule 3.1(b) (the “CN Leased Real Property”), including all Agriliance’s rights in the
improvements and fixtures thereon and all rights and easements appurtenant thereto;

     (c) all machinery, equipment, tools, furniture, office equipment, computer hardware,
computer software used on such computer hardware (excluding, however, such items of
Intellectual Property which are otherwise provided for in this Agreement and subject to
Third Party Licenses) supplies, materials, vehicles and other items of tangible personal
property of every kind owned, leased, or subleased by Agriliance and used in the operation
of the CN Business and located at the CN Owned Real Property or the CN Leased Real Property,
and those additional items described on Schedule 3.1(c) (the “CN Tangible Personal
Property”).

     (d) all Contracts primarily related to the operation of the CN Business to which
Agriliance is a party or a third party beneficiary, including any lease agreements
pertaining to the CN Leased Real Property or the CN Personal Tangible Property, and the
Contracts listed on Schedule 3.1(d) (the “CN Contracts”);

     (e) to the extent legally transferable, all Governmental Authorizations held by
Agriliance and utilized to own, lease or operate the CN Business Assets or to conduct the CN
Business as presently operated.

     (f) all written materials, data and records of Agriliance related exclusively to the
operation of the CN Business, including (i) client, customer, prospect, supplier, dealer and
distributor lists and records, (ii) service catalogs and brochures, (iii) sales and
marketing, advertising and promotional materials, (iv) research and development materials,
reports, and records, (v) maintenance records and other documents relating to the CN
Tangible Personal Property, (vi) purchase orders and invoices, (vii) sales orders and sales
order log books, (viii) correspondence, (ix) books, records, journals and ledgers, (x)
product ideas and developments, and, (xi) all data to support the CN Product Registrations;

     (g) subject to Third Party Licenses, all of Agriliance’s rights in the Intellectual
Property Rights that are owned by Agriliance or licensed to Agriliance, used in connection
with the conduct of the CN Business and are listed on Schedule 3.1(g) (the “CN Intellectual
Property”);

     (h) the equity interests held by Agriliance in the following entities (the “CN
Equity Interests”):

Northwest Iowa Agronomy LLC

Southwest Crop Nutrients, LLC

Loomis Crop Nutrients LLC Cooperative Agronomy Services Plains Partners, LLC

     (i)
those deposits or prepaid accounts to suppliers set forth on Schedule 3.1(i) (the “CN Prepaid Supplier Accounts”);

     (j) the CN Inventories set forth on Schedule 3.1(j);

     (k) to the extent legally transferable, those state and federal registrations as set
forth on Schedule 3.1(k) (the “CN Product Registrations”) and associated assets, including
(i) confidential statements of formulations, (ii) data files/packages for each product,
(iii) trade secrets, know-how, specifications, technical processes, and information used in
the manufacture of each product, (iv) any task force memberships not regarded as a CN Equity
Interest, and (v) all other related data;

     (l) all storage tanks for the storage of ammonia products commonly referred to in the
industry as “ammonia bullets” or “NH3 tanks” owned or leased by Agriliance, wherever
located;

     (m) assets supporting accrued benefits under Agriliance non-qualified benefit plans for
Hired CN Employees, as described on Schedule 3.1(m);

     (n) accruals for CN supplier rebates as set forth on Schedule 3.1(n) (the “CN Supplier
Rebate Accruals”); and,

6

 

     (o) the goodwill associated with the CN Business.

     3.2 Assignment and Assumption of Certain CN Obligations. Agriliance shall assign,
and CHS shall assume, pursuant to an Assignment and Assumption of Certain CN Obligations Agreement
attached hereto in the form of Exhibit B, the following, and only the following, obligations and
Liabilities of Agriliance (the “CN Obligations”):

     (a) Contract Obligations; CN Prepaid Customer Accounts; CN Equity Interests. The
obligations of Agriliance under the CN Contracts arising after the Effective Time; provided,
however, that CHS shall not assume any obligations arising as a result of Agriliance’s
breach of, or failure to pay in the ordinary course in accordance with the terms of any CN
Contract prior to the Effective Time, which such responsibility shall remain with
Agriliance; and, all Liabilities for delivery of prepaid products or services of the CN
prepaid accounts listed on Schedule 3.2(a) (the “CN Prepaid Customer Accounts”); and, the
obligations of Agriliance under the CN Equity Interests arising after the Effective Time;
CHS shall not assume any obligations of Agriliance under the CN Equity Interests to the
extent arising prior to the Effective Time, which such responsibility shall remain with
Agriliance.

     (b) Environmental Contamination at CN Properties. Except as provided in Article VIII,
the Responsibility and Liability of Agriliance for any Environmental Response Action at any
CN Owned Real Property or any CN Leased Real Property

     (c) Other Environmental Conditions. The Responsibility and Liability of Agriliance for
any physical and operational features not in compliance with any Environmental Law at any CN
Owned Real Property or any CN Leased Real Property, excluding CN Site Contamination;
provided, however, that to the extent a fine or penalty for such non-compliant features is
allocated or attributed in any part to ownership or operation by Agriliance prior to the
Effective Time, then Agriliance’s allocable share shall be retained by Agriliance; and

     (d) Non-Qualified Plan Liabilities. Liabilities to Hired CN Employees for benefits
accrued under Agriliance non-qualified benefit plans.

IV. DISTRIBUTION OF CPP BUSINESS ASSETS TO WS;

ASSUMPTION OF CERTAIN CPP BUSINESS OBLIGATIONS

     4.1 Distribution of CPP Business Assets. On the Distribution Date, and as of the
Effective Time, UCB and LOL shall cause Agriliance to distribute to WS (or, with respect to
certain items, distribute to LOL as LOL may direct) all of Agriliance’s right, title and interest
in and to the following assets and property of Agriliance, free and clear of all encumbrances
other than the Permitted Encumbrances (collectively, the “CPP Business Assets”):

     (a) all of the real property owned by Agriliance described on Schedule 4.1(a)
(the “CPP Owned Real Property”), including all improvements and fixtures thereon and all
rights and easements appurtenant thereto;

     (b) leasehold interests in all of the real property leased by Agriliance and described
on Schedule 4.1(b) (the “CPP Leased Real Property”), including all Agriliance’s rights in
the improvements and fixtures thereon and all rights and easements appurtenant thereto;

     (c) all machinery, equipment, tools, furniture, office equipment, computer hardware,
computer software used on such computer hardware (excluding, however, such items of
Intellectual Property which are otherwise provided for in this Agreement and subject to
Third Party Licenses) supplies, materials, vehicles and other items of tangible personal
property of every kind owned, leased or subleased by Agriliance and used in the operation of
the CPP Business and located at the CPP Owned Real Property or the CPP Leased Real Property
and those additional items described on Schedule 4.1(c) (the “CPP Tangible Personal Property”);

7

 

     (d) all of the equity interests owned by Agriliance in each of the following entities
(the “CPP Equity Interests”):

Impec Services, LLC

GHB Services, LLC

Farm Kan, LLC;

Spray Drift Task Force, LLC;

Outdoor Residential Exposure Task Force LLC; and

Agriculture Re-Entry Task Force LLC.

     (e) all Contracts primarily related to the operation of the CPP Business to which
Agriliance is a party or a third party beneficiary, including any lease agreements
pertaining to the CPP Leased Real Property or the CPP Tangible Personal Property, and all of
the Contracts listed on Schedule 4.1(e) (the “CPP Contracts”);

     (f) to the extent legally transferable, all Governmental Authorizations held by
Agriliance and utilized to own, lease or operate the CPP Business Assets or to conduct the
CPP Business as presently operated;

     (g) all written materials, data and records of Agriliance related exclusively to the
operation of the CPP Business, including (i) client, customer, prospect, supplier, dealer
and distributor lists and records, (ii)service catalogs and brochures, (iii) sales and
marketing, advertising and promotional materials, (iv) research and development materials,
reports and records, (v) maintenance records and other documents relating to the CPP
Tangible Personal Property, (vii) purchase orders and invoices, (vi) sales orders and sales
order log books, (vii) correspondence, (viii) books, records, journals and ledgers, (ix)
product ideas and developments; and, (x) all data to support CPP Product Registrations.

     (h) subject to Third Party Licenses, all of Agriliance’s rights in the Intellectual
Property Rights owned or licensed by it and used in connection with the conduct of the CPP
Business, and any others listed on Schedule 4.1(h) (the “CPP Intellectual Property”) The
parties agree that certain of these Intellectual Property Rights may be distributed to LOL
instead of WS, all as directed by LOL;

     (i) the CPP Inventories listed on Schedule 4.1(i);

          (j) those deposits or prepaid accounts to suppliers listed on Schedule 4.1(j)
(the “CPP Prepaid Supplier Accounts”);

     (k) to the extent legally transferable, those state and federal product registrations
and registrations in Mexico as set forth on Schedule 4.1(k) (the “CPP Product
Registrations”)and associated assets including, (i) confidential statements of formulations,
(ii) data files/packages for each product, (iii) trade secrets, know-how, specifications,
technical processes, and information used in the manufacture of each product, (iv) any task
force memberships not regarded as a CPP Equity Interest, and (v) all other related data;

     (l) assets supporting accrued benefits under Agriliance non-qualified benefit plans for
Hired CPP Employees as described on Schedule 4.1(l);

     (m) accruals for CPP supplier rebates as set forth on Schedule 4.1(m) (the
“CPP Supplier Rebate Accruals”); and,

     (n) the goodwill associated with the CPP Business.

     4.2 Assignment and Assumption of Certain CPP Obligations. Agriliance shall assign,
and WS shall assume, pursuant to an Assignment and Assumption of Certain CPP Obligations Agreement
attached hereto in the form of Exhibit C, the following, and only the following, obligations and
Liabilities of Agriliance (the “CPP Obligations”):

     (a) Contract Obligations; CPP Prepaid Customer Accounts; CPP Equity Interests. The
obligations of Agriliance under the CPP Contracts arising after the Effective Time;
provided, however, that

8

 

WS shall not assume any obligations arising as a result of Agriliance’s breach of, or
failure to pay in the ordinary course in accordance with the terms of any CPP Contract prior
to the Effective Time, which such responsibility shall remain with Agriliance; and, all
Liabilities for delivery of prepaid products or services of the CPP prepaid customer
accounts listed on Schedule 4.2(a) (the “CPP Prepaid Customer Accounts”); and, the
obligations of Agriliance under the CPP Equity Interests arising after the Effective Time;
WS shall not assume any obligations of Agriliance under the CPP Equity Interests to the
extent arising prior to the Effective Time, which such responsibility shall remain with
Agriliance.

     (b) Environmental Contamination at CPP Properties. Except as provided in Article VIII,
the Responsibility and Liability of Agriliance for any Environmental Response Action at any
CPP Owned Real Property or any CPP Leased Real Property

     (c) Other Environmental Conditions. The Responsibility and Liability of Agriliance for
any physical and operational features not in compliance with any Environmental Law at any
CPP Owned Real Property or any CPP Leased Real Property, excluding CPP Site Contamination;
provided, however, that to the extent a fine or penalty for such non-compliant features is
allocated or attributed in any part to ownership or operation by Agriliance prior to the
Effective Time, then Agriliance’s allocable share shall be retained by Agriliance; and

     (d) Non-Qualified Plan Liabilities. Liabilities to Hired CPP Employees for benefits
accrued under Agriliance non-qualified benefit plans.

V. ASSETS RETAINED BY AGRILIANCE; OBLIGATIONS RETAINED BY AGRILIANCE

     5.1 Assets Retained by Agriliance. The parties recognize and agree that Agriliance
is not distributing, but is retaining, all of its assets not specifically identified as
distributed hereunder, including, but not limited to the following:

     (a) Equity Interests. Agriliance’s equity interests in Agro Distribution, LLC,
Agriliance SPV, LLC, Agriliance AFC, LLC, Wilco-Agriliance, LLC, Westco Agronomy Company,
LLC, Vision Ag LLC, Valley Agronomics, LLC, Wisconsin River Agronomy, LLC, North Plains
Fertilizer & Chemical, L.L.C., RSA Microtech, Agriliance de Mexico, S.A and.,Templeton Crop
Nutrients, LLC.

     (b) Idle Properties. The following real properties owned by Agriliance but not
currently active in the conduct of Agriliance’s business:

     Shenandoah, IA Albert Lea, MN Janesville, MN

     (c) Cash. All of Agriliance’s cash and cash equivalents (including marketable
securities and short-term investments);

     (d) Accounts Receivable. Except for the CN Prepaid Supplier Accounts, the CN Supplier
Rebate Accruals, the CPP Prepaid Supplier Accounts, and the CPP Supplier Rebate Accruals,
all of Agriliance’s (i) accounts receivable and other rights to payment from customers of
Agriliance arising prior to the Effective Time and the full benefit of all security for such
accounts receivable or rights to payment, (ii) other accounts or notes receivable of
Agriliance and the full benefit of all security for such accounts or notes and (iii)
Agriliance’s rights related to any of the foregoing; and,

     (e) Retail Assets. Those assets generally described by the parties as the retail north
and retail south assets.

     5.2 Retention of Obligations by Agriliance The parties agree that neither CHS nor WS
is assuming or intending to assume or agreeing to pay, discharge, perform or fulfill any
obligations or Responsibility or Liability not specifically assumed by them in accordance with
Sections 3.2 and 4.2 hereunder, all of which such obligations and Liabilities shall remain with
Agriliance, including, but not limited to, the following:

9

 

     (a) Retained Assets: Any obligations of Agriliance relating to the assets retained by
Agriliance;

     (b) Tax Liability: Except as provided in Section 9.1(c), neither CHS nor WS is
assuming any Tax Liability of any kind of Agriliance, including Tax liabilities arising,
imposed or assessed in respect of Agriliance’s operation of either the CN Business or the
CPP Business or its ownership of either the CN Business Assets or the CPP Business Assets
for or applicable to periods of time ending on or before the Effective Time (such as Taxes
on or measured by net worth, sales and use Taxes, property Taxes, liabilities for withheld
federal and state income Taxes and employee or employer Federal Insurance Contribution Act
Taxes and tonnage Taxes);

     (c) Employees. Any obligations for Agriliance employees who are not Hired CN Employees
or Hired CPP Employees. Agriliance shall also retain any obligations arising before
September 1, 2007 with respect to Hired CN Employees or Hired CPP Employees, including but
not limited to obligations for personal, sick and vacation time accruals, workers’
compensation accruals, any liability arising out of or relating to an employee claim or
grievance, liabilities and obligations to any employee under any welfare benefit plan,
obligations to pay wages or incentives, bonuses or variable compensation, and post -
retirement welfare benefit obligations. Further, Agriliance shall retain and neither CHS or
WS is assuming any obligations for severance pay, termination benefits, or retention
payments of any kind whatsoever, including COBRA obligations, for any employees who do not
accept employment with either CHS or WS and for those LOL or Hired CPP Employees identified
in Schedule 5.2(c), regardless of whether such termination occurs before or after the
Effective Time; provided, however, that such termination occurs on or before the termination
of the last transition services agreement related to Agriliance or any purchaser of
Agriliance assets.

     (d) Debt. Any obligations for any indebtedness for borrowed money;

     (e) Warranties and Returns: Any obligations or liabilities with respect to product
returns or product warranty claims relating to the operation of the businesses prior to the
Effective Time;

     (f) Accounts Payable. Except for CN Prepaid Accounts or CPP Prepaid Accounts, any
obligations for any accounts payable arising from the conduct of business prior to the
Effective Time;

     (g) Liability; Litigation. Except as specifically assigned and assumed under Sections
3.2 and 4.2, any Responsibility, Liability or Litigation to the extent pertaining to the
time period prior to the Effective Time, including without limitation, any (i) Liability or
Litigation pertaining to noncompliance prior to the Effective Time with any Laws,
Governmental Order, or Governmental Authorization ; and (ii) Liability for any Environmental
Claim arising our of or associated with ownership or operation by Agriliance of any CN Owned
Real Property, CN Leased Real Property, CPP Owned Real Property, CPP Leased Real Property or
any other property; and (iii) Responsibility and Liability for Environmental Response
Actions at any property other than the CN Owned Real Property, CN Leased Real Property, CPP
Owned Real Property and CPP Leased Real Property; and

     (h) Retained Cleanup Responsibilities under Article VIII below.

VI. VALUATION

     6.1 Maintenance of Membership Interests. UCB and LOL intend that after the retirement
of the Bank Debt and payment by LOL to CHS described in Section 2.1, the completion of the
distribution of the CN Business Assets to UCB and the CPP Business Assets to WS, and the true-up
procedures referenced herein, each of them shall maintain their fifty percent governance and
financial interests in Agriliance. Therefore, UCB and LOL agree as follows:

     6.2 Value Distributed to CHS and WS. The actual value attributed to the CN
Business Assets and the CPP Business Assets will be based on the August 31, 2007 audited balance
sheet of Agriliance (the “Final Balance Sheet”); with adjustments made to inventory valuations as
set forth in Section 6.3, and with adjustments made for supplier rebates as set forth in Section
6.4 and with adjustments made for prepays for CPP and CN product by Agriliance retail facilities
allocated to WS and CHS.

10

 

     The parties shall utilize the unaudited balance sheet of Agriliance as of July 31, 2007 (the
“Interim Balance Sheet”), for purposes of determining the amount of cash necessary to address the
Bank Debt and the payment by LOL to CHS as referenced in Section 2.1 and to maintain their equal
membership interests in Agriliance as of the Distribution Date. Upon receipt of the Final Balance
Sheet, the parties shall reconcile any differences from the action taken on the Distribution Date.
The calculation of value of the distributions to CHS and WS based on the Interim Balance Sheet is
attached hereto as Schedule 6.2. The same calculations contained in Schedule 6.2 shall be
utilized to determine any differences between the Interim Balance Sheet and the Final Balance
Sheet, subject to Sections 6.3 and 6.4, to determine the actual value distributed.

     The difference between the “adjusted value at closing” line for each of CPP and CN based on
the Interim Balance Sheet (Schedule 6.2) and the “adjusted values at closing” line for each of CPP
and CN based on the Final Balance Sheet, if positive, will be paid to Agriliance by the respective
party. If such difference is negative, then such difference shall be paid by Agriliance to the
respective party. Payments received pursuant to this calculation by Agriliance will be distributed
to LOL and UCB on an equal basis. Similarly, any payments required by Agriliance pursuant to this
calculation will be funded equally by LOL and UCB.

     6.3 Calculation of Value of Inventories. The value of the CN Inventories and the CPP
Inventories shall be calculated as set forth in Schedule 6.2, modified as follows:

     (a) Quantity; Reconciliation. As of the Effective Time, the value of the
respective inventories distributed to each party hereunder, shall be based on the quantities
as then reflected on the Interim Balance Sheet (“Estimated Inventories”). As soon as
practical,, the parties shall cause to be prepared a final balance sheet with respect to
both the CN Inventories and the CPP Inventories as of August 31, 2007, prepared on a basis
consistent with the preparation of the financial statements of Agriliance, along with a
detailed explanation of any differences between the Estimated Inventories and the final CN
and CPP Inventories. The parties have agreed to retain the accounting firm of KPMG, L.L.P.
(“KPMG”) to audit these Inventories numbers, including physical audits of the locations
housing such inventories. The determination of KPMG of the final Inventories numbers will
be set forth in writing and be conclusive and binding on the parties. The cost of KPMG will
be borne by Agriliance. The results of such audits shall be part of the true up referenced
below.

     (b) Merchantable. The parties agree that only Inventories which are usable in the
ordinary course of business and are not obsolete, damaged or defective as of the Effective
Time shall be utilized in making the calculations herein. The cost to dispose of any
Inventories not meeting these requirements shall be borne by Agriliance.

     (c) Ordinary Course of Business. The valuations performed hereunder assume inventory
movements in the ordinary course of business, consistent with past practice. The economic
effect of any unusual inventory movements prior to the Effective Time will be taken into
account by the parties in determining value distributed hereunder.

     6.4 Subsequent True Up; Rebates. As referenced above, the parties shall reconcile
any differences between the calculation made on Schedule 6.2 (which is based on the Interim Balance
Sheet) and the Final Balance Sheet, with Inventories finally valued as set forth in Section 6.3.
Any payments mandated by such reconciliation shall be made within three Business Days of receipt of
the Final Balance Sheet.

          Further, the parties agree that the accruals for CN product rebates and incentives and CPP
product rebates and incentives may not equal the actual cash ultimately received. The parties
will compare the actual cash received from suppliers as rebates or incentives for all sales of CN
products and CPP products prior to the Effective Time against the CN Supplier Rebate Accruals and
the CPP Supplier Rebate Accruals. If the actual amount received exceeds the relevant accrual, then
such difference shall be remitted to Agriliance. If the actual amount received is less than the
relevant accrual, then Agriliance shall pay such difference to the appropriate party. Provided,
however, any such rebates or incentives targeted for distribution to an existing customer of
Agriliance, such as a CPP Equity Interest or a CN Equity Interest shall be directed to such party
holding such equity interest (Agriliance, WS or CHS), prior to making the calculation set forth
herein.

     Such calculation will be based on the total dollar sales of each specific item of CN products
and CPP products during the relevant rebate or incentive period, including both prior to and after
the Effective Time. It is the

11

 

intent of the parties that any volume or similarly based rebates or incentives which may be
triggered by sales after the Effective Time will be spread evenly by dollar sales over the entire
rebate or incentive period for purposes of making this calculation. The parties expect the rebate
calculations to be completed by March 1, 2008. Any payments required under this Section 6.4 shall
be made within three Business Days of the date of such calculation.

VII. EMPLOYEES AND EMPLOYEE MATTERS

     7.1 CN Employees. As set forth in Section 7.4, CHS shall offer employment to
Agriliance’s employees principally engaged in the CN Business along with certain employees in
shared services; a current list of such employees is attached hereto as Schedule 7.1 (“CN
Employees”). All of the CN Employees who accept employment with CHS shall be referred to as
“Hired CN Employees”. (The parties acknowledge that included in the CN Assigned Contracts is the
Labor Union Agreement at Indianapolis, Indiana.). If CHS does not offer employment to CN
Employee, CHS shall be solely responsible for any and all severance costs paid by CHS or
Agriliance.

     7.2 CPP Employees. As set forth in Section 7.4, LOL shall offer employment to
Agriliance’s employees principally engaged in the CPP Business along with certain employees in
shared services (such as Finance, IS, HR), a current list of such employees is attached hereto as
Schedule 7.2 (“CPP Employees”). All of the CPP Employees who accept employment with LOL shall be
referred to as the “Hired CPP Employees”. If LOL does not offer employment to a CPP Employee, LOL
shall be solely responsible for any and all severance costs paid by LOL or Agriliance.

     7.3 Schedule Information. Schedules 7.1 and 7.2 indicate whether each such
employee is full-time, part-time, or temporary, and whether each such employee is subject to any
employment agreements (other than the standard non-competition and employee non-solicitation
agreement signed by each employee of Agriliance), or other Contracts relating to employment,
severance or changes in control.

     Schedules 7.1 and 7.2 also show for each such employee his/her date of employment, location
and position.

     7.4 Offers of Employment. As soon as administratively practicable after the
execution of this Agreement, but in no event later than September 4, 2007, CHS shall make an offer
of employment to all CN Employees, and LOL shall make an offer of employment to CPP Employees.
The terms CN Employees and CPP Employees shall mean all Agriliance employees listed on Schedules
7.1 and 7.2 but shall not include employees that would otherwise be CN Employees and CPP
Employees except that they are currently on family medical leave, military leave, temporary
disability or sick leave, workers’ compensation leave (unless in a rehabilitation or light duty
role) or long-term disability leave (collectively, “Leave Status”). CN Employees and CPP
Employees who are on Leave Status as of September 4, 2007 will remain employees of Agriliance
until they are removed from Leave Status. Once an employee of Agriliance is removed from Leave
Status and is ready to work, and has been designated as on FMLA leave or Military leave on
Schedule 7.4, either CHS or LOL shall offer employment to the employee and the employee shall
become a Hired CN Employee or Hired CPP Employee if employment is accepted. Once an employee of
Agriliance is removed from Leave Status and is ready to work and that employee has been designated
in a leave category other than FMLA leave or Military leave on Schedule 7.4, either CHS or LOL may
offer employment to the employee and such employee shall become a Hired CN Employee or a Hired CPP
Employee if employment is accepted. If the respective future employer does not offer employment
to the employee removed from Leave Status and is ready to work, that employer shall be solely
responsible for all severance costs and liabilities associated with such decision not to hire.
All employees that are on Leave Status are listed on Schedule 7.4. Schedule 7.4 will also show
the employee’s allocation, current status, type of leave, date of employment, location and
position. Nothing in this Agreement will be construed to create a right in any Agriliance employee
to employment with either CHS or LOL. Subject to all applicable Laws, CHS and LOL will have
reasonable access to the personnel records (including performance appraisals, disciplinary
actions, and grievances) of the Agriliance employees for the purpose of preparing for and
conducting employment interviews. Except as set forth herein with respect to those on Leave
Status as of September 4, 2007, CHS’s and LOL’s employment of the CN Hired Employees and the CPP
Hired Employees shall be deemed to commence as of September 4, 2007.

     7.5 Recognition of Years of Service. CHS and LOL each agree that with respect to any
Hired CN Employee or any Hired CPP Employee, it shall recognize for purposes of
participation, eligibility and vesting (but not for purposes of benefit accrual and compensation
arrangements) under its employee benefit plans including paid time off (PTO), the Agriliance
service credit date of any Hired CN Employee or any Hired CPP Employee with Agriliance prior to
the Effective Time. Notwithstanding the foregoing, neither CHS nor LOL

12

 

will recognize Agriliance service for purposes of eligibility for retiree medical subsidy
for any CPP Hired Employee or CNN Hired Employee; however, if such employee was eligible for a
retiree medical subsidy from Agriliance as of September 1, 2007, such employee will retain
eligibility for retiree medical subsidy under the CHS or LOL plans, as the case may be.

     7.6 Welfare Plans.

     (i) CHS and LOL each agree that with respect to any Hired CN Employee or any Hired CPP
Employee, it shall waive pre-existing condition requirements, evidence of insurability
provisions, waiting period requirements or any similar provisions under any welfare employee
benefit plan or compensation arrangements maintained or sponsored by such party after the
Effective Time, but only to the extent such Hired CN Employee or Hired CPP Employee had
satisfied such requirements under the appropriate provisions of Agriliance’s plans as of the
Effective Time, so that the employee shall be in at least as good a position with respect to
such matters under CHS’s or LOL’s employee benefit plans as under Agriliance’s plans.

     (ii) CHS and LOL each agree that with respect to any Hired CN Employee or any Hired CPP
Employee, it shall apply toward any deductible requirements and out-of- pocket maximum
limits under its employee welfare benefit plans any amounts paid by each Hired CN Employee
or Hired CPP Employee that qualified as such under Agriliance’s employee welfare benefit
plans during the current plan year in which the Effective Time occurs.

     7.7 Qualified Defined Benefit Retirement Plans. After the Distribution Date, LOL and
CHS will mutually agree upon the treatment of the qualified defined benefit plans of Agriliance
with respect to the Hired CN Employees and Hired CPP Employees including, without limitation,
possible transfer of the assets and liabilities of the Agriliance retirement plan to the respective
defined benefit plans sponsored by LOL or CHS, to be effective as of a date to be determined by
Agriliance and LOL and CHS. CHS and LOL shall share equally in the responsibility to fund any
asset shortfall that may arise related to benefits accrued under the Agriliance defined benefit
plan prior to the Effective Time. The amount of the asset shortfall shall be based upon a
valuation mutually agreed upon between LOL and CHS.

     7.8 Qualified Defined Contribution Plans. Agriliance will cause its qualified
defined contribution plan to transfer assets to the qualified defined contribution plans of CHS or
LOL at such time as CHS and LOL may jointly direct through the Agriliance benefit committee for the
account of any Hired CN Employees or Hired CPP Employees.

     7.9 Non-Qualified Deferred Compensation Plans. With respect to the transfer of
employment of the Hired CN Employees from Agriliance to CHS, and the transfer of the Hired CPP
Employees from Agriliance to LOL in connection with this Agreement, , Agriliance, CHS and LOL
agree that such transfer shall not be treated as a “termination of employment” or “separation from
service” that would be a distributable event under Agriliance’s non-qualified deferred compensation
plans.

VIII. EXISTING ENVIRONMENTAL CONTAMINATION

     8.1 Agriliance to Retain Certain Responsibility. Except with respect to those
Properties identified on Schedule 8.1 for which a longer period of time shall be in effect as
described in Section 8.7 below, for a period of three (3) years after the Effective Time (the
“Retained Responsibility Period”), Agriliance shall retain all Responsibility and Liability for
Environmental Response Actions at all CN Owned Real Property, CN Leased Real Property, CPP Owned
Real Property and CPP Leased Real Property (collectively the “Properties”), to the extent arising
out of or associated with CN Site Contamination or CPP Site Contamination existing prior to the
Effective Time ( “Retained Cleanup Responsibilities”), provided that notice of the Environmental
Response Action has been given pursuant to Section 8.2 or the Environmental Response Action
pertains to matters listed on Schedule 8.6. The burden of proof to show that the CN Site
Contamination or CPP Site Contamination existed prior to the Effective Time shall be on the
Controlling Party. Upon expiration of the applicable Retained Responsibility Period and payment of
the Anticipated Costs (as defined below), Agriliance shall have no further Responsibility or
Liability for Environmental Response Actions at any of the Properties.

     8.2 Notice Within 3 Year Period. In addition to the known matters set forth on
Schedule 8.6, in order

13

 

for any Responsibility or Liability for any Environmental Response Action pertaining to the
Properties to be considered a Retained Cleanup Responsibility of Agriliance, the party seeking to
so designate it must provide Agriliance and the other party with written notice of such matter on
or before the three (3) year anniversary of the Effective Time. Such notice shall include a
description of the Environmental Response Action and an estimation of the anticipated costs
associated therewith based on such information as the party giving notice has at that time.

     8.3 Costs. To the extent a party undertakes any environmental site assessment or
other environmental investigation in order to determine whether there is any existing CN Site
Contamination or CPP Site Contamination, and without any legal requirement or request by a
governmental authority, such cost shall not be considered part of the Retained Cleanup
Responsibility. In addition, only out-of-pocket costs actually incurred are eligible to be paid or
reimbursed by Agriliance under this Article VIII, and neither party shall be entitled to
reimbursement of its own internal costs.

During the applicable Retained Responsibility Period, any party who has incurred costs to perform a
Retained Cleanup Responsibility shall be entitled to reimbursement from Agriliance in accordance
with Section 8.5 below. Prior to the expiration of the applicable Retained Responsibility Period,
CHS and LOL shall work together in good faith to determine amounts that are reasonably expected to
be required to pay future, ongoing costs associated with Retained Cleanup Responsibilities with
respect to the Properties for which payment was not made by Agriliance during the applicable
Retained Responsibility Period (“Anticipated Costs”), and Agriliance shall pay such Anticipated
Costs to CHS and WS as provided in this Section 8.3 and in Section 8.5. In determining Anticipated
Costs, the parties shall take into consideration the time periods during which the costs for
fulfilling such Retained Cleanup Responsibilities will likely be paid, the present value thereof,
and the effect of inflation on such costs.

The procedure for determining Anticipated Costs shall be as follows: Within thirty (30) days after
the expiration of the applicable Retained Responsibility Period, CHS and WS shall each deliver to
the other an itemized list of all outstanding Retained Cleanup Responsibilities pertaining to their
respective Properties, along with that party’s assessment of the Anticipated Costs for each, in
detail and with supporting documentation sufficient for the other party to evaluate the same. Each
party shall promptly furnish all additional information reasonably requested by the other party.
Within twenty (20) days following receipt of such information by both CHS and WS (the “Objection
Period”), CHS and WS shall notify the other party and Agriliance in writing of any objections they
may have to Agriliance paying the Anticipated Costs identified by the other party, and the basis
for such objections. Objections shall be made to specific itemized Anticipated Costs. All
Anticipated Costs for which no objection has been made within the Objection Period shall be paid by
Agriliance as provided in Section 8.5 below, and thereafter all Anticipated Costs for which
objections have been resolved shall be paid by Agriliance as provided in Section 8.5 below. The
parties shall work diligently and in good faith to resolve all objections within thirty (30) days
after the expiration of the Objection Period.

If the parties are unable to resolve all objections within the Objection Period, they shall engage
a neutral third party (“Neutral”) to assist in resolving the objections. The Neutral shall have
substantial experience in assessing costs associated with the Retained Cleanup Responsibilities to
which the objections pertain. CHS and WS shall work diligently and in good faith with the Neutral
to resolve all objections within sixty (60) days after the expiration of the Objection Period. If
the parties have not been able to resolve all objections within such 60-day period, the Neutral
shall resolve the objections in the Neutral’s sole and absolute discretion and the Neutral’s
determination shall be binding on the parties. In making a determination, the Neutral may engage
such additional, independent consultants as the Neutral deems necessary or desirable, in the
Neutral’s sole and absolute discretion. The Neutral shall be directed to use best efforts to make
its determination within ninety (90) days after the expiration of the Objection Period and the
parties shall provide such information and other cooperation as the Neutral may require. CHS and
WS shall share equally the cost of the Neutral and any consultants engaged by the Neutral;
provided, however, that if the Neutral determines that additional site assessment or other
investigation is required to reasonably determine any Anticipated Costs, such additional assessment
or investigation shall be performed by consultants engaged by the Neutral and the party who owns or
leases the Property in question shall be solely responsible for the costs of the same.

     8.4 Control of Process; Third Party Recoveries. The party owning or leasing the
Property in question (the “Controlling Party”) shall have the sole right to direct and control any
process, including any litigation or governmental investigation or enforcement action, concerning
any such property. During the applicable Retained Responsibility Period for the Properties,the
Controlling Party shall provide information and keep Agriliance and the other party informed as to
the particular matter to the extent practical. During and after the applicable Retained
Responsibility Period, the Controlling Party shall make reasonable efforts to pursue recovery from
third parties of

14

 

any costs paid to such party by Agriliance for a Retained Cleanup Responsibility, including from
any applicable insurance carriers and/or from programs administered by any Governmental Entity for
purposes of reimbursing investigation and cleanup costs associated with particular contaminants
(e.g., state petroleum tank release cost-recovery funds), to the extent that the Controlling Party,
in its sole discretion reasonably exercised, deems prudent and cost-effective. The Controlling
Party shall remit or credit fifty percent of any recoveries received (less the costs incurred by
the Controlling Party in obtaining such recoveries) promptly to the other party.

     8.5 Time for Payment. At any time during the applicable Retained Responsibility
Period , the party seeking reimbursement for costs incurred to perform a Retained Cleanup
Responsibility may submit any invoice to Agriliance and to the other party within a reasonable time
after a cost has been actually incurred, but no later than thirty (30) days after expiration of the
applicable Retained Responsibility Period. Such invoices shall describe the nature of the cost,
how it was incurred, and any other information reasonably required by the other party. Payment of
said invoices shall be made within thirty (30) days of receipt of such invoice by the other party
unless within such time period the other party objects by delivering written notice to both
Agriliance and the requesting party, which notice shall state the basis of the objection. In the
event of any objection, the parties shall work together in good faith and use best efforts to
promptly resolve such objection within thirty (30) days after notice of the objection has been
received by the requesting party. If the parties are unable to resolve any objection within such
period, the objection shall be resolved in accordance with the procedure set forth in Section 8.3
for resolving objections to Anticipated Costs and Agriliance shall make such payment as is
appropriate within fifteen (15) days after resolution of the objection. With respect to
Anticipated Costs, upon expiration of the Objection Period, Agriliance shall pay to CHS an amount
equal to the Anticipated Costs allocable to the CN Owned Real Property and CN Leased Real Property, and shall pay to WS an amount equal to the Anticipated Costs allocable to the CPP Owned Real
Property and CPP Leased Real Property; provided, however, that if either party has timely raised
objections to any Anticipated Costs, then Agriliance shall pay only such Anticipated Costs for
which no objections were timely made, and shall pay the remaining Anticipated Costs within fifteen
(15) days after resolution of the objections in accordance with Section 8.3.

     8.6 Known Matters. Set forth on Schedule 8.6 attached hereto is a list of ongoing CN
Site Contamination and CPP Site Contamination matters which the parties agree are among
Agriliance’s Retained Cleanup Responsibilities.

     8.7 Extended Period Sites. With respect to those sites listed on Schedule 8.1, the Retained
Responsibility Period for the Retained Cleanup Responsibilities shall be extended through the
calendar year 2020. Correspondingly, the notice period provided for in Section 8.2 shall be
extended through the calendar year 2020.

IX. SHARED EXPENSES; CONSENTS/TRANSFERS; AUDIT RIGHTS

     9.1 Transfer Expenses. The parties hereby agree that certain reasonable
expenses incurred to effectuate the distributions hereunder, including those reasonably incurred
after the Effective Time, shall be shared equally between them, and that such expenses shall be
borne by Agriliance. Therefore, the parties agree as follows:

     (a) Title Evidence, Closing Fees and Proration of Utilities.

     (i) Title Commitments. As evidence of title to the CN Owned Real Property and
the CPP Real Property, and if requested by a party and for informational purposes as
to the CN Leased Real Property or the CPP Leased Real Property, Agriliance shall
cause to be prepared and delivered to the either CHS or WS, as the case may be, at
Agriliance’s expense, a commitment or preliminary title report for the each property
(a “Title Commitment”) from First American Title Company (the “Title Company”)
together with copies of all exception documents, to issue to the respective receiving
party at the Distribution Date, an owner’s title insurance policy (for owned real
property only), subject to any easements and encroachments and other encumbrances
disclosed by the Title Commitments.

          (ii) Title Fees and Costs. Agriliance shall pay all fees charged by the Title Company
for the Title Commitments, as well as all costs to record the general warranty deeds,
including payment of any transfer tax, and the costs for the final title policy and
endorsements.

          (iii) Utility Charges. All utility charges, including gas, oil, electricity,
telephone, sewer

15

 

and water, pertaining to the CN Business Assets or the CPP Business Assets, shall be
prorated between Agriliance and the respective recipient as of the Effective Time.

          (iv) Surveys. Any surveys shall be done at the direction and expense of either CHS or
LOL, as applicable, and shall be completed within four months of the Distribution Date.

          (v) Title and /Survey Correction. Expenses reasonably incurred with third parties to
reasonably rectify any issues identified in the Title Commitments or surveys, other than
Permitted Encumbrances, shall be the responsibility of Agriliance.

     (b) Motor Vehicles. Agriliance shall take all actions and prepare all documents
necessary to effect the transfer to the appropriate recipient of all motor vehicle leases
and registrations pertaining to automobiles, trucks, and other motor vehicles of whatever
kind distributed hereunder in compliance with the motor vehicle registration and other
applicable Laws of any jurisdictions where such motor vehicles are registered. All transfer
taxes related to the distribution of motor vehicles shall be borne by Agriliance.

     (c) Property Taxes. As of the Effective Time, Agriliance shall ensure that all state
and local real and personal property Taxes, tonnage taxes, ad valorem and similar Taxes and
assessments (“Property Taxes”) which are past due or have become due and payable in the
normal course of business upon any of the distributed assets on or before the Effective Time
have been paid. All Property Taxes imposed by any Tax authority with respect to the
distributed assets that have been paid or are due and payable with respect to a Taxable
period beginning before the Effective Time and ending after the Effective Time (taking into
account whether the Property Taxes are payable in advance or in arrears) shall be
apportioned between: (1) the period beginning before and ending at the Effective Time (the
“Pre-Transfer Period”); and (2) the period beginning on the day immediately after the
Effective Time and ending on the last day of the relevant Taxable period (the “Post-Transfer
Period”). In performing the apportionment, all Property Taxes shall be prorated on the
assumption that an equal amount of Property Tax applies to each day of the relevant Taxable
period regardless of how installment payments are billed or made. Agriliance shall be
liable for all Property Taxes apportioned to the Pre-Transfer Period. The respective
recipient shall be liable for all the Property Taxes apportioned to the Post-Transfer
Period.

     (d) Governmental Authorizations; Product Registrations. Any transfer fees that
are required to transfer any Governmental Authorization, including CN Product Registration
Fees and CPP Product Registration Fees, shall be borne by each respective party, and not by
Agriliance.

     (e) Leasehold Rentals. All leasehold rentals shall be pro rated between
Agriliance and either CHS or WS as applicable as of the Effective Time.

     (f) Employees. Expenses incurred with respect to employees shall be shared as set forth
in Section 5.2(c).

     9.2 Consents/Transfers. The parties shall make good faith efforts
and cooperate with each other to obtain all consents and/or transfers necessary
to assign the Contracts, the Third Party Licenses, and the CN Equity Interests
and the CPP Equity Interests, or to otherwise effectuate the distributions
hereunder, as quickly as possible. All costs or fees incurred to obtain the
consents or transfers,with respect to Third Party Licenses shall be borne by the
party seeking the consent or transfer.

     9.3 Delayed Transfer. If any consent referenced in Section 9.2 above is not
obtained prior to the Effective Time, such Contract (other than Contracts pertaining to leased
properties, which are addressed below) Third Party License, or equity interest shall remain with
Agriliance until such time as consent is obtained. The party to which such Contract, Third Party
License, or equity interest is to be assigned shall bear all economic consequences of such
Contract, Third Party License, or equity interest after the Effective Time as if such had been
assigned as of the Effective Time. Similarly, if a Title Commitment is not obtained with respect
to any CPP Owned Real Property or CN Owned Real Property, or if consent to assign any of the CN
Leased Real Property or the CPP Leased Real Property is not obtained, prior to the Effective Time,
then such property shall remain with Agriliance until such Title Commitment or consent is
obtained, and, during such interim period, the party to whom the property is to be distributed
shall lease such property pursuant to the terms of that Master Lease Agreement attached hereto as

16

 

Exhibit D. Also, those vehicles for which transfer is delayed shall be subject to the
Vehicle Lease Agreements referenced in Article 10.1 as Ancillary Agreements.

     9.4 Audit and Access Rights. The parties recognize and agree that information
will need to be shared between them and verified for purposes of effectuating the terms of this
Agreement and, after the Effective Time, for the purposes of business operations and tax and other
regulatory purposes. Each party shall permit the other parties and their representatives
reasonable access to its books and records to verify any calculations made hereunder and for use
of such information for legitimate business, tax and regulatory purposes. At the expense of the
requesting party, each party shall have the right to conduct a reasonable audit of the other
parties’ books and records as reasonably necessary to verify any such calculation.

X. DELIVERIES ON THE DISTRIBUTION DATE

     The parties shall cause to be delivered to the appropriate party on the Distribution Date all
documents reasonably necessary to effectuate the intent hereunder, including the following:

     10.1 Ancillary Agreements.

     (a) Supply Agreement to CHS. That certain supply agreement by and between WS and LOL as
supplier and CHS as purchaser in the form of Exhibit E, attached hereto;

     (b) Transition Services Agreement. That certain transition services agreement by and
between LOL, Agriliance and CHS in the form of Exhibit F, attached hereto.

     (c) Amendment to Master Services Agreement. The Master Services Agreement between LOL
as service provider and Agriliance as modified, in the form of Exhibit G, attached hereto;
and,

     (d) Storage and Handling Agreements). Those certain storage and handling agreements by
and between CHS, WS and/or Agriliance, as applicable to the facilities located at Green Bay,
Wisconsin, and Winona, Minnesota, as referenced on Schedule 10.1(d) hereto.

     (f) Vehicle Leases that need to be assumed

     (g) Supply Agreements to Agriliance. Those certain supply agreements
by and between LOL and WS as supplier, and Agriliance as purchaser; and CHS as
supplier and Agriliance as purchaser, attached hereto as Exhibits H and I.

     (h) Vehicle Lease to CHS. With respect to those vehicles for which
transfer to CHS is delayed, that certain Vehicle Lease Agreement attached hereto
as Exhibit J.

     (i) Vehicle Lease to WS. With respect to those vehicles for which
transfer to WS is delayed, that certain form of Vehicle Lease Agreement attached
hereto as Exhibit K.

     10.2 Conveyance Documents to CHS and WS.

     (a) Warranty deeds in the form of Schedule 10.2(a), subject to Permitted Encumbrances,
for the CN Owned Real Property and the CPP Owned Real Property.

     (b) Assignment and Assumption Agreements for the CN Leased Real Properties and the CPP
Leased Real Properties in the form of Schedule 10.2(b).

     (c) Bills of Sale for the CN Tangible Personal Property and the CPP Tangible Personal
property in the form of Schedule 10.2(c).

     (d) Assignment and Assumption Agreements for the CN and CPP Contracts in the form of
Schedule 10.2(d).

     (e) Assignment and Assumption Agreements for the CN and CPP Equity
Interests in the form of Schedule 10.2(e).

17

 

     (f) Bills of Sale for the CN and CPP Inventories in the form of Schedule
10.2(f).

     (g) Affidavit of Owner in the form of Schedule 10.2(g), for the CN Owned Real Property
and the CPP Leased Real Property.

     (h) Such ancillary real property documents as may be necessary in the jurisdiction
where the CN Owned Real Property or CPP Owned Real Property is located.

     (i) Certificates of title for all vehicles duly endorsed for transfer.

     (k) Mutually acceptable documentation to transfer intellectual property.

     10.3 Assignment and Assumption Agreements. Those Assignment and Assumption
Agreements pertaining to the assumed obligations in the forms of Exhibits B and C.

18

 

XI. COVENANTS NOT TO COMPETE

     At the formation of Agriliance, CHS and LOL agreed not to directly or indirectly engage in
the wholesale marketing of fertilizer products and agricultural chemicals in North America so long
as they remained a member of Agriliance and for a period of time thereafter. Additionally, at the
formation of Agriliance, CHS agreed not to engage in the wholesale seed business. In
consideration of the distribution of assets and the other terms hereof, UCB and its parent entity,
CHS (for purposes of this Article XI, UCB and CHS shall be referred to collectively and
individually as “CHS”) and LOL and WS (for purposes of this Article XI, LOL and WS shall be
referred to collectively and individually as “LOL”), the parties hereby agree to modify their
non-compete covenants as follows.

     11.1 LOL Non-Compete. For a period of ten (10) years from the Distribution Date ,
LOL, individually and on behalf of its successors, assigns, subsidiaries, Agriliance and Affiliates
agrees not to directly or indirectly engage in the wholesale marketing and/or sale of crop
nutrient products in the territory of North America; except to the extent currently conducted by
any of the CPP Equity Interests or other equity interests held by Agriliance which may subsequently
be transferred to LOL or WS, by the Agronomy Company of Canada or by Agriliance through the
business retained by Agriliance after the Effective Time; and except with respect to the
distribution, marketing and sale of micro nutrient products or animal waste products; and except
with respect to the distribution, marketing and sale of organic lawn fertilizers through its
Bradfield Organics line of products and certain other home lawn care fertilizers, such as under its
Clear Lake lawn food line of products, provided that these endeavors shall not materially expand in
scope from their current state. Notwithstanding the foregoing, LOL shall not be deemed to be
indirectly competing in violation of this Section through ownership of a person or entity which
does not meet the definition of an Affiliate.

     11.2 CHS Non-Compete. For a period of ten (10) years from the Distribution Date,
CHS, individually and on behalf of its successors, assigns, subsidiaries, Agriliance and
Affiliates, agrees not to directly or indirectly engage in the wholesale marketing and/or sale of
micro nutrient products, agricultural chemicals and/or corn, soybeans, canola, alfalfa, cotton or
sorghum seed products, including seeds, seed coatings and seed treatments related to such
defined seed products, in the territory of North America, except to the extent currently conducted
by any of the CN Equity Interests or other equity interests held by Agriliance which may
subsequently be transferred to CHS, by the Agronomy Company of Canada or by Agriliance through the
business retained by Agriliance after the Effective Time. Notwithstanding the foregoing, CHS
shall not be deemed to be indirectly competing in violation of this Section through ownership of a
person or entity which does not meet the definition of an Affiliate.

     11.3 Definition. For the purposes of this Agreement, the term “wholesale
marketing and/or sale” shall be defined to include any activity to promote, market, sell or
otherwise transfer products to any entity or person (including local cooperatives, agronomy
centers, joint ventures, dealers, owned retail locations and the like) where such entity or person
will resell or otherwise transfer such products.

     11.4 Subsequent Acquisitions. Nothing in this Article XI shall be construed to
prevent CHS from making an acquisition that includes a wholesale micro nutrient, agricultural
chemical and/or seed marketing and/or sale business so long as LOL is given the option,
exercisable within six (6) months after the closing of such acquisition, for LOL to acquire from
CHS that portion of such acquisition relating to the wholesale agricultural chemical and/or seed
marketing and/or sale business for fair market value and otherwise on customary and commercially
reasonable terms. Similarly, nothing in this Section shall be construed to prevent LOL from making
an acquisition that includes a wholesale crop nutrient marketing and/or sale business so long as
CHS is given the option, exercisable within six (6) months after the closing of such acquisition,
for CHS to acquire from LOL that portion of such acquisition relating to the wholesale crop
nutrient marketing and/or sale business for fair market value and otherwise on customary and
commercially reasonable terms.

     11.5 Restrictions Reasonable. The parties believe that the restrictive covenants
contained in this Article XI are reasonable. However, if any court having jurisdiction shall at
any time hereafter hold any of these restrictions to be unenforceable or unreasonable, whether as
to scope, territory or period of time specified herein, and if such court shall declare or
determine the scope, territory or period of time which it deems to be reasonable, such scope,
territory or period of time shall be deemed to be reduced to that declared or determined by such
court to be reasonable.

     11.6 Equitable Remedies. Each party recognizes that in the event of violation
of any of the terms of this provision, the non-violating party will suffer irreparable damages and
that it will be difficult, if not impossible, to compute actual damages sustained by the
non-violating party as the result of such breach. Accordingly, in addition

19

 

to any relief at law
that may be available to the non-violating party for such violation or breach, the non-violating
party will be entitled to injunctive and other equitable relief restraining such violation,
breach or threatened breach (without any requirement that the non-violating provide any bond or
other security).

     11.7 Supercedes Existing Agreements. The covenants contained in this Article XI
supercede and replace in their entirety those provisions found in Section 8.3 of the original
Joint Venture Agreement dated January 1, 2000 by and between CHS and LOL, and those provisions
found in Section 8.2 of the original Seed Agreement dated February 18, 2000, by and between CHS
and LOL.

     XII. INDEMNIFICATION

     12.1. Indemnification by LOL and WS. LOL and WS, jointly and severally, will
indemnify Agriliance, CHS and/or UCB, and their respective officers, directors, and employees, and
hold them harmless against any Loss to the extent arising from the conduct of business by WS of
the CPP Business Assets after the Effective Time, or to the extent arising from the CPP
Obligations.

     12.2 Indemnification by CHS and UCB. CHS and UCB, jointly and severally, will
indemnify Agriliance, LOL and/or WS, and their respective officers, directors, and employees, and
hold them harmless against any Loss to the extent arising from the conduct of business by CHS of
the CN Business Assets after the Effective Time, or to the extent arising from the CN Obligations.

     12.3 Indemnification by Agriliance. Agriliance will indemnify CHS, UCB, LOL and
WS, and their respective officers, directors, and employees, and hold them harmless against any
Loss to the extent arising from any Retained Obligations.

     12.4 Indemnification Unavailable from Agriliance. In the event that indemnification
from Agriliance in accordance with Section 12.3 is unavailable for whatever reason, then CHS and
UCB shall share equally in any such Loss with LOL and WS, including, but not limited to, any Loss
resulting from any Liability or Litigation or Retained Cleanup Responsibilities, including
Anticipated Costs.

     12.5 Notice. Any claim for indemnification hereunder shall be made in a written
notice from the party seeking indemnification (the “Indemnified Party”) to the party from which
indemnification is sought (the “Indemnifying Party”) which will state in reasonable detail the
basis for such indemnification and the amount of the loss claimed. If the Indemnifying Party
notifies the Indemnified Party that it does not dispute the claim described in such notice or
fails to notify the Indemnified Party within forty-five (45) Business Days after delivery of such
notice whether it disputes the claim described in such notice, the loss amount specified in the
notice will be admitted by the Indemnifying Party, and the Indemnifying Party will pay the amount
of such loss to the Indemnified Party. If the Indemnifying Party has timely disputed its
liability with respect to such claim, the relevant parties will proceed in good faith to negotiate
a resolution of such dispute. If a resolution has not been resolved within sixty (60) days after
delivery of the original claim notice, either party may seek judicial recourse. In the event that
(i) an Indemnified Party does not deliver to the Indemnifying Party written notice of a claim
promptly after its discovery of a claim or (ii) such written notice inaccurately of incompletely
describes the basis or nature of the claim, each as required by this Section 12.5, then the
Indemnifying Party’s obligation to indemnify hereunder shall be reduced to the extent the
Indemnified Party’s failure to provide prompt, accurate and complete written notice has prejudiced
the Indemnifying Party.

     The Indemnifying Party will pay the amount of any claim within fifteen (15) days following
the final determination of the Indemnifying Party’s liability for and the amount of such loss.

     12.6 Third Party Actions. With respect to any Litigation instituted by any
Person against a party entitled to indemnification hereunder, (the “Indemnified Party”): The
Indemnified Party will give the party(ies) from which it seeks indemnity (the “Indemnifying
Party(ies) prompt written notice of the commencement of such third party action (“ Third Party
Action”). The complaint or other papers pursuant to which the third party commenced such Third
Party Action will be attached to such written notice. In the event that (i) the Indemnified Party
does not deliver to the Indemnifying Party prompt written notice of a Third Party Claim promptly
after commencement or (ii) fails to attach the entire complaint or all of the other papers
pursuant to which the third party commenced such Third Party Action, each as required by this
Section 12.6, then the Indemnifying Party’s obligation to indemnify shall be reduced to the extent
the Indemnified Party’s failure to provide prompt, accurate and complete written notice has

20

 

prejudiced the Indemnifying Party. The Indemnifying Party will contest and defend such Third
Party Action on
behalf of any Indemnified Party that requests that they do so. Notice of the intention to so
contest and defend will be given by Indemnifying Party to the requesting Indemnified Party within
twenty (20) Business Days after the Indemnified Party’s notice of such Third Party Action (but, in
all events, at least five (5) Business Days prior to the date that a response to such Third Party
Action is due to be filed). Such contest and defense will be conducted by reputable attorneys
retained by the Indemnifying Party. An Indemnified Party will be entitled at any time, at its own
cost and expense, to participate in such contest and defense and to be represented by attorneys of
its own choosing. If the Indemnified Party elects to participate in such defense, the Indemnified
Party will cooperate with the Indemnifying Party in the conduct of such defense. An Indemnified
Party will cooperate with the Indemnifying Party to the extent reasonably requested by the
Indemnifying Party in the contest and defense of such Third Party Action, including providing
reasonable access (upon reasonable notice) to the books, records and employees of the Indemnified
Party if relevant to the defense of such Third Party Action.

     Neither an Indemnified Party nor an Indemnifying Party may concede, settle or compromise any
Third Party Action without the consent of the other party, which consents will not be unreasonably
withheld.

     12.7 Losses Net of Insurance, Taxes. The amount of any loss for which
indemnification is provided under this Article XII shall be net of (i) any amounts recovered by
the Indemnified Party pursuant to any indemnification by or indemnification agreement with any
third party, (ii) any insurance proceeds or other cash receipts or sources of reimbursement
received as an offset against such loss (each source named in clauses (i) and (ii), a “Collateral
Source”), and (iii) an amount equal to the present value of the Tax benefit, if any, available to
or taken by the indemnified party attributable to such loss. The parties shall take all
reasonable steps to mitigate any loss upon becoming aware of any event that would reasonably be
expected to, or does, give rise thereto, including incurring costs only to the minimum extent
necessary to remedy a breach that gives rise to the loss. Indemnification under this Article XII
shall not be available to any party, unless the party seeking indemnification first uses
commercially reasonable efforts to seek recovery from all Collateral Sources. The parties
acknowledge and agree that no right of subrogation shall accrue or inure to the benefit of any
Collateral Source hereunder. The Indemnifying Party may require an Indemnified Party to assign
the rights to seek recovery pursuant to the preceding sentence; provided, however, that the
Indemnifying Party will then be responsible for pursuing such recovery at its own expense. If the
amount to be netted hereunder from any payment required under this Article XII is determined after
payment by the Indemnifying Party of any amount otherwise required to be paid to an Indemnified
Party, the Indemnified Party shall repay to the Indemnifying Party, promptly after such
determination, any amount that the Indemnifying Party would not have had to pay pursuant to this
Article XII had such determination been made at the time of such payment.

XIII. GENERAL

     13.1 Further Assurances Before and After the Effective Time. The parties will take
all appropriate action and execute any documents, instruments or conveyances of any kind that may
be reasonably requested by any of them, to carry out any of the provisions of this Agreement.

     13.2 Amendment and Waiver. This Agreement may not be amended, nor may any provision
of this Agreement be waived, except in a writing executed by the party against which such
amendment or waiver is sought to be enforced.

     13.3 Notices.  All notices, demands and other communications to be given or
delivered under or by reason of the provisions of this Agreement will be in writing and will be
deemed to have been given (i) when delivered if personally delivered by hand, (ii) when received
if sent by a nationally recognized overnight courier service (receipt requested), (iii) five
Business Days after being mailed, if sent by first class mail, return receipt requested, or (iv)
when receipt is acknowledged by an affirmative act of the party receiving notice, if sent by
facsimile, telecopy or other electronic transmission device (provided that such an acknowledgement
does not include an acknowledgment generated automatically by a facsimile or telecopy machine or
other electronic transmission device). Notices, demands and communications to the parties will,
unless another address is specified in writing, be sent to the address indicated below:

     If to LOL or Agriliance: Land O’Lakes, Inc. Attention: President

4001 Lexington Avenue North

21

 

Arden Hills, MN 551126

     With copies to:

Land O’Lakes, Inc.

Attention: General Counsel MS 2500

4001 Lexington Avenue North

Arden Hills, MN 551126

     If to CHS or UCB:

CHS Inc.

Attention: President and Chief Executive Officer

5500 Cenex Drive

Inver Grove Heights, MN 55077

With copies to:

CHS Inc.

Attention: General Counsel

5500 Cenex Drive

Inver Grove Heights, MN 55077

     13.4 Assignment. Neither this Agreement nor any of the rights, interests or
obligations under this Agreement may be assigned by any party to this Agreement without the prior
written consent of the other parties to this Agreement. Subject to the foregoing, this Agreement
and all of the provisions of this Agreement will be binding upon and inure to the benefit of the
parties to this Agreement and their respective successors and permitted assigns.

     13.5 No Third Party Beneficiaries. Nothing expressed or referred to in this
Agreement confers any rights or remedies upon any Person that is not a party or permitted assign
of a party to this Agreement.

     13.6 Severability. Whenever possible, each provision of this Agreement will be
interpreted in such manner as to be effective and valid under applicable Law, but if any provision
of this Agreement is held to be prohibited by or invalid under applicable Law, such provision will
be ineffective only to the extent of such prohibition or invalidity, without invalidating the
remainder of such provision or the remaining provisions of this Agreement.

     13.7 Complete Agreement. This Agreement, including the Exhibits and Schedules
hereto, contains the complete agreement between the parties and supersedes any prior
understandings, agreements or representations by or between the parties, written or oral with
respect to this reorganization of agronomy business.

     13.8 Signatures; Counterparts. This Agreement may be executed in one or more
counterparts, any one of which need not contain the signatures of more than one party, but all
such counterparts taken together will constitute one and the same instrument. A facsimile
signature will be considered an original signature.

     13.9 Governing Law. The domestic law, without regard to conflicts of laws
principles, of the State of Minnesota will govern all questions concerning the construction,
validity and interpretation of this Agreement and the performance of the obligations imposed by
this Agreement.

     13.10 Waiver of Jury Trial. Each party acknowledges and agrees that any
controversy that may arise under this Agreement is likely to involve complicated and difficult
issues, and therefore it irrevocably and unconditionally waives any right it may have to a trial
by jury in respect of any litigation directly or indirectly arising out of or relating to this
Agreement or the transactions contemplated by this Agreement. Each party certifies and
acknowledges that (i) No representative, agent or attorney of any other party has represented,
expressly or otherwise, that such other party would not, in the event of litigation, seek to
enforce the foregoing waiver, (ii) It understands and has considered the implications of such
waiver, (iii) It makes such waiver voluntarily and (iv) It has been induced to enter into this
Agreement by, among other things, the mutual waiver and certifications in this Section 13.

     13.11 Construction. The parties and their respective counsel have participated
jointly in the negotiation and

22

 

drafting of this Agreement. In addition, each of the parties
acknowledges that it is sophisticated and has been
advised by experienced counsel and, to the extent it deemed necessary, other advisors in
connection with the negotiation and drafting of this Agreement. In the event an ambiguity or
question of intent or interpretation arises, this Agreement will be construed as if drafted
jointly by the parties and no presumption or burden of proof will arise favoring or disfavoring
any party by virtue of the authorship of any of the provisions of this Agreement. Any reference
to any Law will be deemed to refer to all rules and regulations promulgated thereunder, unless the
context requires otherwise. References to sections, articles, schedules or exhibits are to the
sections, articles, schedules and exhibits contained in, referred to or attached to this
Agreement, unless otherwise specified. The word “including” means “including without limitation.”
The use of the masculine, feminine or neuter gender or the singular or plural form of words will
not limit any provisions of this Agreement.

23

 

     IN WITNESS WHEREOF, LOL, WS, UCB and CHS have executed this
Agreement as of the date first above written.

	 	 	 	 	 	 	 	 	 	 	 	 	 
	LAND O’LAKES, INC.	 	 	 	WINFIELD SOLUTIONS, LLC
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	BY: 

	 	 	 	 	 	 	 	BY: 	 	 	 	 
	 	 	 	 	 	 	 
	Print Name:	 	 	 	 	Print Name:	 
	 

	 	 	 
	 	 	 	 	 	 	 
	Title:

	 	 	 	 	 	 	Title:	 	 	 
	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	CHS, INC.	 	 	 	UNITED COUNTRY BRANDS, LLC
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	BY: 

	 	 	 	 	 	 	 	BY: 	 	 	 	 
	 	 	 	 	 	 	 
	Print Name:	 	 	 	 	Print Name:	 
	 

	 	 	 
	 	 	 	 	 	 	 
	Title:

	 	 	 	 	 	 	Title:	 	 	 
	 	 	 	 	 	 	 	 	 

24

 

EXHIBITS AND SCHEDULES

	 	 	 	 	 
	EXHIBITS	 	 	 
	 
	 	 	 	 
	 

	 	Exhibit A
	 	Agreement to Pay Debt
	 

	 	Exhibit B
	 	Assignment and Assumption of Certain CN Obligations
	 

	 	Exhibit C
	 	Assignment and Assumption of Certain CPP Obligations
	 

	 	Exhibit D
	 	Master Lease Agreement
	 

	 	Exhibit E
	 	Supply Agreement to CHS
	 

	 	Exhibit F
	 	Transition Services Agreement
	 

	 	Exhibit G
	 	Modified Master Services Agreement
	 

	 	Exhibit H
	 	Supply Agreement from CHS to Agriliance
	 

	 	Exhibit I
	 	Supply Agreement from LOL/WS to Agriliance
	 

	 	Exhibit J
	 	Vehicle Lease Agreement to CHS
	 

	 	Exhibit K
	 	Vehicle Lease Agreement to WS

	 	 	 	 	 
	SCHEDULES
	 	 	 	 	 

	3.1(a)	 	 	 	CN Owned Real Property

	3.1(b)	 	 	 	CN Leased Real Property

	3.1(c)	 	 	 	CN Tangible Personal Property

	3.1(d)	 	 	 	CN Contracts

	3.1(f)	 	 	 	CN Intellectual Property

	3.1(i)	 	 	 	CN Prepaid Accounts

	3.1(j)	 	 	 	CN Inventories

	3.1(k)	 	 	 	CN Product Registrations

	4.1(a)	 	 	 	CPP Owned Real Property

	4.1(b)	 	 	 	CPP Leased Real Property

	4.1(c)	 	 	 	CPP Tangible Personal Property

	4.1(e)	 	 	 	CPP Contracts

	4.1(h)	 	 	 	CPP Intellectual Property

	4.1(i)	 	 	 	CPP Inventories

	4.1(j)	 	 	 	CPP Prepaid Accounts

	4.1(k)	 	 	 	CPP Product Registrations

	6.2	 	 	 	Estimated Value Distributed

	7.1	 	 	 	CN Employees

	7.2
	 	 	 	CPP Employees

	7.4	 	 	 	Active Employees

	8.6	 	 	 	Known Retained Environmental Liabilities

	10.1(d)	 	 	 	Schedule of Leases of Shared Locations

	10.2(a)	 	 	 	Form of General Warranty Deed

	10.2(b)	 	 	 	Form of Assignment and Assumption Agreements for CN and CPP Leased Real
Property and CN Leased Real Property

	10.2(c)	 	 	 	Bills of Sale for CN and CPP Tangible Personal Property

	10.2(d)	 	 	 	Assignment and Assumption Agreements for the CN and CPP Contracts

	10.2(e)	 	 	 	Assignment and Assumption Agreements for the CN and CPP Equity Interests

	10.2(f)	 	 	 	Bills) Form of Sale for the CN and CPP Inventories

	10.2(g)	 	 	 	Owner’s Affidavits for the CN and CPP Real Property

25exv4w1

 

Exhibit 4.1

EXECUTION COPY

AVERY DENNISON CORPORATION

and

THE BANK OF NEW YORK TRUST COMPANY, N.A.

as Purchase Contract Agent

and

THE BANK OF NEW YORK TRUST COMPANY, N.A.

as Collateral Agent, Custodial Agent and Securities Intermediary

PURCHASE CONTRACT AND PLEDGE AGREEMENT

HiMEDSSM Units

Dated as of November 20, 2007

“HiMEDS” is a service mark of J.P. Morgan Securities Inc.

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION	 	 	1	 
	Section 1.01.
	 	Definitions	 	 	1	 
	Section 1.02.
	 	Compliance Certificates and Opinions	 	 	15	 
	Section 1.03.
	 	Form of Documents Delivered to Purchase Contract Agent	 	 	16	 
	Section 1.04.
	 	Acts of Holders; Record Dates	 	 	16	 
	Section 1.05.
	 	Notices	 	 	17	 
	Section 1.06.
	 	Notice to Holders; Waiver	 	 	18	 
	Section 1.07.
	 	Effect of Headings and Table of Contents	 	 	18	 
	Section 1.08.
	 	Successors and Assigns	 	 	18	 
	Section 1.09.
	 	Separability Clause	 	 	18	 
	Section 1.10.
	 	Benefits of Agreement	 	 	18	 
	Section 1.11.
	 	Governing Law; Submission to Jurisdiction; Waiver of Venue Objection	 	 	19	 
	Section 1.12.
	 	Legal Holidays	 	 	19	 
	Section 1.13.
	 	Counterparts	 	 	19	 
	Section 1.14.
	 	Inspection of Agreement	 	 	20	 
	Section 1.15.
	 	Appointment of Financial Institution as Agent for the Company	 	 	20	 
	Section 1.16.
	 	No Waiver	 	 	20	 
	Section 1.17.
	 	Tax Treatment	 	 	20	 
	 
	 	 	 	 	 	 
	ARTICLE 2 CERTIFICATE FORMS	 	 	20	 
	Section 2.01.
	 	Forms of Certificates Generally	 	 	20	 
	Section 2.02.
	 	Form of Purchase Contract Agent’s Certificate of Authentication	 	 	21	 
	Section 2.03.
	 	Global Certificates	 	 	21	 
	 
	 	 	 	 	 	 
	ARTICLE 3 THE HIMEDS UNITS	 	 	22	 
	Section 3.01.
	 	Amount; Form and Denominations	 	 	22	 
	Section 3.02.
	 	Rights and Obligations Evidenced by the Certificates	 	 	22	 
	Section 3.03.
	 	Execution, Authentication, Delivery and Dating	 	 	23	 
	Section 3.04.
	 	Temporary Certificates	 	 	23	 
	Section 3.05.
	 	Registration; Registration of Transfer and Exchange	 	 	24	 
	Section 3.06.
	 	Book-Entry Interests	 	 	25	 
	Section 3.07.
	 	Notices to Holders	 	 	26	 
	Section 3.08.
	 	Appointment of Successor Depositary	 	 	26	 
	Section 3.09.
	 	Definitive Certificates	 	 	26	 
	Section 3.10.
	 	Mutilated, Destroyed, Lost and Stolen Certificates	 	 	27	 
	Section 3.11.
	 	Persons Deemed Owners	 	 	28	 
	Section 3.12.
	 	Cancellation	 	 	29	 
	Section 3.13.
	 	Creation of Treasury HiMEDS Units by Substitution of Treasury Securities	 	 	29	 
	Section 3.14.
	 	Recreation of Corporate HiMEDS Units	 	 	31	 
	Section 3.15.
	 	Transfer of Collateral upon Occurrence of Termination Event	 	 	32	 
	Section 3.16.
	 	No Consent to Assumption	 	 	34	 
	Section 3.17.
	 	Substitutions	 	 	34	 
	 
	 	 	 	 	 	 
	ARTICLE 4 THE SENIOR NOTES	 	 	34	 

i

 

	 	 	 	 	 	 	 
	Section 4.01.
	 	Interest Payments; Rights to Interest Payments Preserved	 	 	34	 
	Section 4.02.
	 	Notice and Voting	 	 	35	 
	Section 4.03.
	 	Payments to Purchase Contract Agent	 	 	36	 
	Section 4.04.
	 	Payments Held in Trust	 	 	36	 
	 
	 	 	 	 	 	 
	ARTICLE 5 THE PURCHASE CONTRACTS	 	 	37	 
	Section 5.01.
	 	Purchase of Shares of Common Stock	 	 	37	 
	Section 5.02.
	 	Payment of Purchase Price; Remarketing	 	 	40	 
	Section 5.03.
	 	Issuance of Shares of Common Stock	 	 	45	 
	Section 5.04.
	 	Adjustment of Low Settlement Rate, Minimum Settlement Rate and Anti-Dilution Factor	 	 	46	 
	Section 5.05.
	 	Notice of Adjustments and Certain Other Events	 	 	58	 
	Section 5.06.
	 	Termination Event; Notice	 	 	58	 
	Section 5.07.
	 	Early Settlement	 	 	59	 
	Section 5.08.
	 	No Fractional Shares	 	 	61	 
	Section 5.09.
	 	Charges and Taxes	 	 	62	 
	Section 5.10.
	 	Contract Adjustment Payments	 	 	62	 
	Section 5.11.
	 	Deferral of Contract Adjustment Payments	 	 	67	 
	Section 5.12.
	 	No Net Cash Settlement	 	 	69	 
	 
	 	 	 	 	 	 
	ARTICLE 6 RIGHTS AND REMEDIES OF HOLDERS	 	 	69	 
	Section 6.01.
	 	Unconditional Right of Holders to Receive Contract Adjustment Payments and to Purchase Shares of Common Stock	 	 	69	 
	Section 6.02.
	 	Restoration of Rights and Remedies	 	 	70	 
	Section 6.03.
	 	Rights and Remedies Cumulative	 	 	70	 
	Section 6.04.
	 	Delay or Omission Not Waiver	 	 	70	 
	Section 6.05.
	 	Undertaking for Costs	 	 	70	 
	Section 6.06.
	 	Waiver of Stay or Extension Laws	 	 	70	 
	 
	 	 	 	 	 	 
	ARTICLE 7 THE PURCHASE CONTRACT AGENT	 	 	71	 
	Section 7.01.
	 	Certain Duties and Responsibilities	 	 	71	 
	Section 7.02.
	 	Notice of Default	 	 	72	 
	Section 7.03.
	 	Certain Rights of Purchase Contract Agent	 	 	72	 
	Section 7.04.
	 	Not Responsible for Recitals or Issuance of HiMEDS Units	 	 	73	 
	Section 7.05.
	 	May Hold HiMEDS Units	 	 	74	 
	Section 7.06.
	 	Money Held In Custody	 	 	74	 
	Section 7.07.
	 	Compensation and Reimbursement	 	 	74	 
	Section 7.08.
	 	Corporate Purchase Contract Agent Required; Eligibility	 	 	75	 
	Section 7.09.
	 	Resignation and Removal; Appointment of Successor	 	 	75	 
	Section 7.10.
	 	Acceptance of Appointment by Successor	 	 	76	 
	Section 7.11.
	 	Merger, Conversion, Consolidation or Succession to Business	 	 	77	 
	Section 7.12.
	 	Preservation of Information; Communications to Holders	 	 	77	 
	Section 7.13.
	 	No Obligations of Purchase Contract Agent	 	 	77	 
	Section 7.14.
	 	Tax Compliance	 	 	78	 
	 
	 	 	 	 	 	 
	ARTICLE 8 SUPPLEMENTAL AGREEMENTS	 	 	78	 
	Section 8.01.
	 	Supplemental Agreements without Consent of Holders	 	 	78	 

ii

 

	 	 	 	 	 	 	 
	Section 8.02.
	 	Supplemental Agreements with Consent of Holders	 	 	79	 
	Section 8.03.
	 	Execution of Supplemental Agreements	 	 	80	 
	Section 8.04.
	 	Effect of Supplemental Agreements	 	 	80	 
	Section 8.05.
	 	Reference to Supplemental Agreements	 	 	80	 
	 
	 	 	 	 	 	 
	ARTICLE 9 CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER OR LEASE	 	 	81	 
	Section 9.01.
	 	Covenant Not to Consolidate, Merge, Convey, Transfer or Lease Property Except under Certain Conditions	 	 	81	 
	Section 9.02.
	 	Rights and Duties of Successor Corporation	 	 	81	 
	Section 9.03.
	 	Officers’ Certificate and Opinion of Counsel Given to Purchase Contract Agent	 	 	82	 
	 
	 	 	 	 	 	 
	ARTICLE 10 COVENANTS	 	 	82	 
	Section 10.01.
	 	Performance under Purchase Contracts	 	 	82	 
	Section 10.02.
	 	Maintenance of Office or Agency	 	 	82	 
	Section 10.03.
	 	Company to Reserve Common Stock	 	 	83	 
	Section 10.04.
	 	Covenants as to Common Stock; Listing	 	 	83	 
	Section 10.05.
	 	Statements of Officers of the Company as to Default	 	 	83	 
	Section 10.06.
	 	ERISA	 	 	83	 
	 
	 	 	 	 	 	 
	ARTICLE 11 PLEDGE	 	 	84	 
	Section 11.01.
	 	Pledge	 	 	84	 
	Section 11.02.
	 	Termination	 	 	84	 
	 
	 	 	 	 	 	 
	ARTICLE 12 ADMINISTRATION OF COLLATERAL	 	 	84	 
	Section 12.01.
	 	Initial Deposit of Senior Notes	 	 	84	 
	Section 12.02.
	 	Establishment of Collateral Account	 	 	84	 
	Section 12.03.
	 	Treatment as Financial Assets	 	 	85	 
	Section 12.04.
	 	Sole Control by Collateral Agent	 	 	85	 
	Section 12.05.
	 	Jurisdiction	 	 	85	 
	Section 12.06.
	 	No Other Claims	 	 	85	 
	Section 12.07.
	 	Investment and Release	 	 	86	 
	Section 12.08.
	 	Statements and Confirmations	 	 	86	 
	Section 12.09.
	 	Tax Allocations	 	 	86	 
	Section 12.10.
	 	No Other Agreements	 	 	86	 
	Section 12.11.
	 	Powers Coupled with an Interest	 	 	86	 
	Section 12.12.
	 	Waiver of Lien; Waiver of Set-off	 	 	86	 
	 
	 	 	 	 	 	 
	ARTICLE 13 RIGHTS AND REMEDIES OF THE COLLATERAL AGENT	 	 	86	 
	Section 13.01.
	 	Rights and Remedies of the Collateral Agent	 	 	86	 
	 
	 	 	 	 	 	 
	ARTICLE 14 REPRESENTATIONS AND WARRANTIES TO COLLATERAL AGENT; HOLDER COVENANTS	 	 	87	 
	Section 14.01.
	 	Representations and Warranties	 	 	87	 
	Section 14.02.
	 	Covenants	 	 	88	 

iii

 

	 	 	 	 	 	 	 
	ARTICLE 15 THE COLLATERAL AGENT, THE CUSTODIAL AGENT AND THE SECURITIES INTERMEDIARY	 	 	88	 
	Section 15.01.
	 	Appointment, Powers and Immunities	 	 	88	 
	Section 15.02.
	 	Instructions of the Company	 	 	89	 
	Section 15.03.
	 	Reliance by Collateral Agent, Custodial Agent and Securities Intermediary	 	 	90	 
	Section 15.04.
	 	Certain Rights	 	 	90	 
	Section 15.05.
	 	Merger, Conversion, Consolidation or Succession to Business	 	 	90	 
	Section 15.06.
	 	Rights in Other Capacities	 	 	91	 
	Section 15.07.
	 	Non-reliance on Collateral Agent, the Custodial Agent and Securities Intermediary	 	 	91	 
	Section 15.08.
	 	Compensation and Indemnity	 	 	91	 
	Section 15.09.
	 	Failure to Act	 	 	92	 
	Section 15.10.
	 	Resignation and Removal of Collateral Agent, the Custodial Agent and the Securities Intermediary	 	 	93	 
	Section 15.11.
	 	Right to Appoint Agent or Advisor	 	 	94	 
	Section 15.12.
	 	Survival	 	 	94	 
	Section 15.13.
	 	Exculpation	 	 	94	 
	Section 15.14.
	 	Expenses, Etc.	 	 	94	 
	 
	 	 	 	 	 	 
	ARTICLE 16 MISCELLANEOUS	 	 	95	 
	Section 16.01.
	 	Security Interest Absolute	 	 	95	 
	Section 16.02.
	 	Notice of Termination Event	 	 	95	 

	 	 	 	 	 
	EXHIBIT A

	 	Form of Corporate HiMEDS Unit Certificate
	 	A-1
	EXHIBIT B

	 	Form of Treasury HiMEDS Unit Certificate
	 	B-1
	EXHIBIT C

	 	Instruction to Purchase Contract Agent From Holder To Create
Treasury HiMEDS Units of Corporate HiMEDS Units
	 	C-1
	EXHIBIT D

	 	Notice from Purchase Contract Agent to Holders Upon
Termination Event
	 	D-1
	EXHIBIT E 
	 	Notice to Settle by Separate Cash From Holder To Purchase
Contract Agent 	 	E-1
	EXHIBIT F

	 	Reserved	 	F-1
	EXHIBIT G

	 	Instructions from Purchase Contract Agent to Collateral Agent
Regarding Creation of Treasury HiMEDS Units
	 	G-1
	EXHIBIT H

	 	Instruction from Collateral Agent to Securities Intermediary
Regarding Creation of Treasury HiMEDS Units
	 	H-1
	EXHIBIT I

	 	Instruction from Purchase Contract Agent to Collateral Agent
Regarding Recreation of Corporate HiMEDS Units
	 	I-1
	EXHIBIT J

	 	Instruction from Collateral Agent to Securities Intermediary
Regarding Recreation of Corporate HiMEDS Units
	 	J-1
	EXHIBIT K

	 	Notice of Senior Notes to be Remarketed from [Collateral] [Custodial]
Agent to Purchase Contract Agent and Remarketing Agent
	 	K-1
	EXHIBIT L

	 	Instruction from Holder of Separate Senior Notes to Custodial
Agent Regarding Remarketing
	 	L-1

iv

 

	 	 	 	 	 
	EXHIBIT M

	 	Instruction from Holder of Separate Senior Notes to Custodial Agent
Regarding Withdrawal From Remarketing
	 	M-1

v

 

     PURCHASE CONTRACT AND PLEDGE AGREEMENT, dated as of November 20, 2007, among AVERY DENNISON
CORPORATION, a Delaware corporation (the “Company”), THE BANK OF NEW YORK TRUST COMPANY, N.A., a
New York banking corporation, acting as purchase contract agent for, and for purposes of the Pledge
created hereby as attorney-in-fact of, the Holders from time to time of the Units (in such
capacities, together with its successors and assigns in such capacities, the “Purchase Contract
Agent”), The Bank of New York Trust Company, N.A., as collateral agent hereunder for the benefit of
the Company (in such capacity, together with its successors in such capacity, the “Collateral
Agent”), as custodial agent (in such capacity, together with its successors in such capacity, the
“Custodial Agent”), and as securities intermediary (as defined in Section 8-102(a)(14) of the UCC)
with respect to the Collateral Account (in such capacity, together with its successors in such
capacity, the “Securities Intermediary”).

RECITALS

     WHEREAS, the Company has duly authorized the execution and delivery of this Agreement and the
Certificates evidencing the Units;

     WHEREAS, all things necessary to make the Purchase Contracts, when the Certificates are
executed by the Company and authenticated, executed on behalf of the Holders and delivered by the
Purchase Contract Agent, as provided in this Agreement, the valid obligations of the Company, and
to constitute these presents a valid agreement of the Company, in accordance with its terms, have
been done;

     WHEREAS, pursuant to the terms of this Agreement and the Purchase Contracts, the Holders of
the Units have irrevocably authorized the Purchase Contract Agent, as attorney-in-fact of such
Holders, among other things, to execute and deliver this Agreement on behalf of such Holders and to
grant the Pledge provided herein of the Collateral to secure the Obligations.

     NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE 1

DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

     Section 1.01. Definitions. For all purposes of this Agreement, except as otherwise expressly
provided or unless the context otherwise requires:

     (a) the terms defined in this Article have the meanings assigned to them in this Article and
include the plural as well as the singular, and nouns and pronouns of the masculine gender include
the feminine and neuter genders;

     (b) all accounting terms not otherwise defined herein have the meanings assigned to them in
accordance with generally accepted accounting principles in the United States;

     (c) the words “herein,” “hereof” and “hereunder” and other words of similar import refer to
this Agreement as a whole and not to any particular Article, Section, Exhibit or other subdivision;

 

 

     (d) the following terms which are defined in the UCC shall have the meanings set forth
therein: “certificated security,” “control,” “financial asset,” “entitlement order,” “securities
account” and “security entitlement”; and

     (e) the following terms have the meanings given to them in this Section 1.01(e):

     “Act” has the meaning, with respect to any Holder, set forth in Section 1.04(a).

     “Address for Notices” has the meaning set forth in Section 1.05.

     “Adjusted Applicable Market Value” has the meaning set forth in Section 5.01(a).

     “Affiliate” of any specified Person means any other Person directly or indirectly controlling
or controlled by or under direct or indirect common control with such specified Person. For the
purposes of this definition, “control” when used with respect to any specified Person means the
power to direct the management and policies of such Person, directly or indirectly, whether through
the ownership of voting securities, by contract or otherwise; and the terms “controlling” and
“controlled” have meanings correlative to the foregoing.

     “Agreement” means this instrument as originally executed or as it may from time to time be
supplemented or amended by one or more agreements supplemental hereto entered into pursuant to the
applicable provisions hereof.

     “Anti-Dilution Factor” has the meaning set forth in Section 5.01(a).

     “Applicable Market Value” has the meaning set forth in Section 5.01(a).

     “Applicants” has the meaning set forth in Section 7.12(b).

     “Bankruptcy Code” means Title 11 of the United States Code, or any other law of the United
States that from time to time provides a uniform system of bankruptcy laws.

     “Beneficial Owner” means, with respect to a Book-Entry Interest, a Person who is the
beneficial owner of such Book-Entry Interest as reflected on the books of the Depositary or on the
books of a Person maintaining an account with such Depositary (directly as a Depositary Participant
or as an indirect participant, in each case in accordance with the rules of such Depositary).

     “Board of Directors” means the board of directors of the Company or a duly authorized
committee of that board.

     “Board Resolution” means one or more resolutions of the Board of Directors, a copy of which
has been certified by the Secretary or an Assistant Secretary of the Company, to have been duly
adopted by the Board of Directors and to be in full force and effect on the date of such
certification and delivered to the Purchase Contract Agent.

2

 

     “Book-Entry Interest” means a beneficial interest in a Global Certificate, registered in the
name of a Depositary or a nominee thereof, ownership and transfers of which shall be maintained and
made through book entries by such Depositary as provided in Section 3.06.

     “Business Day” means any day other than a Saturday, Sunday or any other day on which banking
institutions and trust companies in New York City are permitted or required by any applicable law
to remain closed or a day on which the Indenture Trustee or the Collateral Agent is closed for
business; provided that for purposes of the second paragraph of Section 1.12 only, the term
“Business Day” shall also be deemed to exclude any day on which DTC is closed.

     “Cash” means any coin or currency of the United States as at the time shall be legal tender
for payment of public and private debts.

     “Cash Consideration” has the meaning set forth in Section 5.02(a)(ii).

     “Cash Merger” has the meaning set forth in Section 5.04(b)(ii).

     “Cash Settlement” has the meaning set forth in Section 5.02(a)(i).

     “Certificate” means a Corporate HiMEDS Units Certificate or a Treasury HiMEDS Units
Certificate.

     “Closing Price” has the meaning set forth in Section 5.01(a).

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Collateral” means the collective reference to:

     (i) the Collateral Account and all investment property and other financial assets from time to
time credited to the Collateral Account and all security entitlements with respect thereto,
including, without limitation, (A) the Senior Notes and security entitlements relating thereto that
are a component of the Corporate HiMEDS Units from time to time, (B) any Treasury Securities and
security entitlements relating thereto Transferred to the Securities Intermediary from time to time
in connection with the creation of Treasury HiMEDS Units in accordance with Section 3.13 and (C)
payments made by Holders pursuant to Section 5.02;

     (ii) all Proceeds of any of the foregoing (whether such Proceeds arise before or after the
commencement of any proceeding under any applicable bankruptcy, insolvency or other similar law, by
or against the pledgor or with respect to the pledgor); and

     (iii) all powers and rights now owned or hereafter acquired under or with respect to the
Collateral.

     “Collateral Account” means the securities account of The Bank of New York Trust Company, N.A.,
as Collateral Agent, maintained on the books of the Securities Intermediary and designated “The
Bank of New York Trust Company, N.A., as Collateral Agent of Avery Dennison Corporation, as pledgee
of The Bank of New York Trust Company, N.A., as the Purchase Contract Agent on behalf of and as
attorney-in-fact for the Holders.”

3

 

     “Collateral Agent” means the Person named as “Collateral Agent” in the first paragraph of this
Agreement until a successor Collateral Agent shall have become such pursuant to this Agreement, and
thereafter “Collateral Agent” shall mean the Person who is then the Collateral Agent hereunder.

     “Collateral Substitution” means:

     (i) with respect to a Corporate HiMEDS Unit, the substitution of the Pledged Senior Note
included in such Corporate HiMEDS Unit with Treasury Securities in an aggregate principal amount at
maturity equal to the aggregate principal amount of such Pledged Senior Note; or

     (ii) with respect to a Treasury HiMEDS Unit, the substitution of the Pledged Treasury
Securities included in such Treasury HiMEDS Unit with Senior Notes in an aggregate principal amount
equal to the aggregate principal amount at maturity of the Pledged Treasury Securities.

     “Common Stock” means the common stock, par value $1.00 per share, of the Company or, subject
to Section 5.04, shares of any class or classes resulting from any reclassification or
reclassifications thereof and which have no preference in respect of dividends or of amounts
payable in the event of any voluntary or involuntary liquidation, dissolution or winding up of the
Company and which are not subject to redemption by the Company; provided that if at any time there
shall be more than one such resulting class, the shares of each such class then so issuable on
exchange shall be substantially in the proportion which the total number of shares of such class
resulting from all such reclassifications bears to the total number of shares of all such classes
resulting from all such reclassifications.

     “Company” means the Person named as the “Company” in the first paragraph of this Agreement
until a successor shall have become such pursuant to the applicable provision of this Agreement,
and thereafter “Company” shall mean such successor.

     “Constituent Person” has the meaning set forth in Section 5.04(b)(i).

     “Contract Adjustment Payments” means the payments payable by the Company on the Payment Dates
in respect of each Purchase Contract, at a rate per year of 2.525% of the Stated Amount per
Purchase Contract.

     “Corporate HiMEDS Unit” means a HiMEDS Unit, initially issued in substantially the form set
forth as Exhibit A hereto in the Stated Amount of $50, which represents (i) beneficial ownership by
the Holder of a 1/20, or 5.00%, undivided beneficial ownership interest in a Senior Note with a
principal amount of $1,000 and (ii) the rights and obligations of the Company and the Holder under
one Purchase Contract.

     “Corporate HiMEDS Units Certificate” means a certificate evidencing the rights and obligations
of a Holder in respect of the number of Corporate HiMEDS Units specified on such certificate.

     “Corporate Trust Office” means the office of the Purchase Contract Agent at which, at any
particular time, its corporate trust business shall be principally administered, which office at
the date hereof is located at 601 Travis Street, 18th Floor, Houston, Texas 77002,
Attention: Corporate Trust Administration.

4

 

     “Current Market Price” per share of the Common Stock or any other security on any day means:

     (a) with respect to Section 5.04(a)(ii), Section 5.04(a)(iv) in the event of an adjustment not
relating to a Spin-Off and Section 5.04(a)(v), the average of the Closing Prices over the twenty
consecutive Trading Day period ending on the Trading Day before the Ex-Date with respect to the
issuance or distribution requiring such computation;

     (b) with respect to Section 5.04(a)(iv) in the event of an adjustment relating to a Spin-Off,
(i) if the Spin-Off is not effected simultaneously with an Initial Public Offering of the
securities being distributed in the Spin-Off, the average of the Closing Prices of the Common Stock
over the 10 consecutive Trading Day period commencing on and including the Trading Day following
the Effective Date of the Spin-Off and (ii) if an Initial Public Offering of the securities being
distributed in the Spin-Off is to be effected simultaneously with the Spin-Off, the Closing Price
of the Common Stock on the Trading Day on which the Initial Public Offering price of the securities
being distributed in the Spin-Off is determined; and

     (c) with respect to Section 5.04(a)(vi), the average of the Closing Prices over the twenty
consecutive Trading Day period commencing on the Trading Day immediately succeeding the Tender
Expiration Date.

     “Custodial Agent” means the Person named as Custodial Agent in the first paragraph of this
Agreement until a successor Custodial Agent shall have become such pursuant to the applicable
provisions of this Agreement, and thereafter “Custodial Agent” shall mean the Person who is then
the Custodial Agent hereunder.

     “Deferred Contract Adjustment Payments” has the meaning set forth in Section 5.11(a).

     “Depositary” means a clearing agency registered under Section 17A of the Exchange Act that is
designated to act as Depositary for the HiMEDS Units as contemplated by Sections 3.06 and 3.08.

     “Depositary Participant” means a broker, dealer, bank, other financial institution or other
Person for whom from time to time the Depositary effects book entry transfers and pledges of
securities deposited with the Depositary.

     “DTC” means The Depository Trust Company.

     “Early Settlement” has the meaning set forth in Section 5.07(a).

     “Early Settlement Amount” has the meaning set forth in Section 5.07(b).

     “Early Settlement Date” has the meaning set forth in Section 5.07(b).

5

 

     “Effective Date” has the meaning set forth in Section 5.04(b)(ii).

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

     “event of default” has the meaning set forth in Section 13.01(b).

     “Exchange Act” means the Securities Exchange Act of 1934 and any statute successor thereto, in
each case as amended from time to time, and the rules and regulations promulgated thereunder.

     “Exchange Property Unit” has the meaning set forth in Section 5.04(b)(i).

     “Ex-Date,” when used with respect to any issuance or distribution, shall mean the first date
on which the Common Stock or such other security, as applicable, trades in a regular way on the
principal U.S. securities exchange or quotation system on which the Common Stock or such other
security, as applicable, is listed or quoted at such time, without the right to receive such
issuance or distribution.

     “Expiration Date” has the meaning set forth in Section 1.04(e).

     “Extension Period” has the meaning set forth in Section 5.11(a).

     “Fair Market Value” means the fair market value as determined in good faith by the Board of
Directors, whose determination shall be conclusive and set forth in a resolution of the Board of
Directors; provided, however, that with respect to a Spin-Off, such term means (a) in the case of
any Spin-Off that is effected simultaneously with an Initial Public Offering of the securities
being distributed in the Spin-Off, the initial public offering price of those securities, and (b)
in the case of any other Spin-Off, the average of the Closing Prices of the securities being
distributed in the Spin-Off over the 10 consecutive Trading Day period commencing on and including
the Trading Day following the effective date of the Spin-Off.

     “Global Certificate” means a Certificate that evidences all or part of the HiMEDS Units and is
registered in the name of the Depositary or a nominee thereof.

     “High Settlement Rate” has the meaning set forth in Section 5.01(a)(i).

     “HiMEDS Unit” means a Corporate HiMEDS Unit or a Treasury HiMEDS Unit, as the case may be.

     “Holder” means, with respect to a HiMEDS Unit, the Person in whose name the HiMEDS Unit
evidenced by a Certificate is registered in the Security Register; provided, however, that solely
for the purpose of determining whether the Holders of the requisite number of HiMEDS Units have
voted on any matter (and not for any other purpose hereunder), if the HiMEDS Unit remains in the
form of one or more Global Certificates and if the Depositary that is the registered holder of such
Global Certificate has sent an omnibus proxy assigning voting rights to the Depositary Participants
to whose accounts the HiMEDS Units are credited on the record date, the term “Holder” shall mean
such Depositary Participant acting at the direction of the Beneficial Owners.

6

 

\

     “Indemnified Parties” has the meaning set forth in Section 15.08(b).

     “Indemnitees” has the meaning set forth in Section 7.07(c).

     “Indenture” means the Indenture, dated as of November 20, 2007, between the Company and the
Indenture Trustee (including any provisions of the TIA that are deemed incorporated therein), as
heretofore amended and supplemented and as amended and supplemented by the Supplemental Indenture
pursuant to which the Senior Notes will be issued.

     “Indenture Trustee” means The Bank of New York Trust Company, N.A., as trustee under the
Indenture, or any successor thereto.

     “Initial Public Offering” means the first time securities of the same class or type as the
securities being distributed in the Spin-Off are offered to the public for cash.

     “Issuer Order” means a written order signed in the name of the Company by (i) either its Chief
Executive Officer, its President or one of its Vice Presidents, and (ii) either its Corporate
Secretary or one of its Assistant Corporate Secretaries or its Treasurer or one of its Assistant
Treasurers, and delivered to the Purchase Contract Agent.

     “Last Failed Remarketing” has the meaning set forth in Section 5.02(c)(ii).

     “Loss” or ”Losses” has the meaning set forth in Section 15.08(b).

     “Low Settlement Rate” has the meaning set forth in Section 5.01(a)(iii).

     “Make-Whole Shares” has the meaning set forth in Section 5.04(b)(ii).

     “Merger Early Settlement” has the meaning set forth in Section 5.04(b)(ii).

     “Merger Early Settlement Date” has the meaning set forth in Section 5.04(b)(ii).

     “Minimum Settlement Rate” means 0.7682, subject to adjustment as contemplated by Section
5.04(a).

     “Minimum Stock Price” has the meaning set forth in Section 5.04(b)(iii)(3).

     “NASDAQ” means the NASDAQ Global Select Market.

     “NYSE” means the New York Stock Exchange.

     “Obligations” means, with respect to each Holder, all obligations and liabilities of such
Holder under such Holder’s Purchase Contract and this Agreement or any other document made,
delivered or given in connection herewith or therewith, in each case whether on account of
principal, interest (including, without limitation, interest accruing before and after the filing
of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like
proceeding, relating to such Holder, whether or not a claim for post-filing or post-petition
interest is allowed in such proceeding), fees, indemnities, costs, expenses or otherwise
(including, without limitation, all fees and disbursements of counsel to the Company or the
Collateral Agent or the Securities Intermediary that are required to be paid by the Holder
pursuant to the terms of any of the foregoing agreements).

7

 

     “Observation Period” means the 20 consecutive Trading Day period ending on the third scheduled
Trading Day immediately preceding the Purchase Contract Settlement Date.

     “Officers’ Certificate” means a certificate signed by (i) either the Company’s Chief Executive
Officer, its President or one of its Vice Presidents, and (ii) either the Company’s Corporate
Secretary or one of its Assistant Corporate Secretaries or its Treasurer or one of its Assistant
Treasurers, and delivered to the Purchase Contract Agent.

     Any Officers’ Certificate delivered with respect to compliance with a condition or covenant
provided for in this Agreement (other than the Officers’ Certificate provided for in Section 10.05)
shall include:

     (i) a statement that each officer signing the Officers’ Certificate has read the covenant or
condition and the definitions relating thereto;

     (ii) a brief statement of the nature and scope of the examination or investigation undertaken
by each officer in rendering the Officers’ Certificate;

     (iii) a statement that, in the opinion of each such officer, each such officer has made such
examination or investigation as is necessary to enable such officer to express an informed opinion
as to whether or not such covenant or condition has been complied with; and

     (iv) a statement as to whether, in the opinion of each such officer, such condition or
covenant has been complied with.

     “Opinion of Counsel” means a written opinion of counsel, who may be counsel to the Company
(and who may be an employee of the Company), and who shall be reasonably acceptable to the Purchase
Contract Agent. An opinion of counsel may rely on certificates as to matters of fact.

     “Outstanding HiMEDS Units” means, with respect to any HiMEDS Unit and as of the date of
determination, all HiMEDS Units evidenced by Certificates theretofore authenticated, executed and
delivered under this Agreement, except:

     (i) if a Termination Event has occurred, (x) Corporate HiMEDS Units for which the underlying
Senior Notes have been theretofore deposited with the Purchase Contract Agent in trust for the
Holders of such Corporate HiMEDS Units and (y) Treasury HiMEDS Units for which Treasury Securities
have been deposited with the Purchase Contract Agent in trust for the Holders of such Treasury
HiMEDS Units;

     (ii) HiMEDS Units evidenced by Certificates theretofore cancelled by the Purchase Contract
Agent or delivered to the Purchase Contract Agent for cancellation or deemed cancelled pursuant to
the provisions of this Agreement; and

8

 

     (iii) HiMEDS Units evidenced by Certificates in exchange for or in lieu of which other
Certificates have been authenticated, executed on behalf of the Holder and delivered pursuant to
this Agreement, other than any such Certificate in respect of which there shall have been presented
to the Purchase Contract Agent proof satisfactory to it that such Certificate is held by a
protected purchaser in whose hands the HiMEDS Units evidenced by such Certificate are valid
obligations of the Company;

provided, however, that in determining whether the Holders of the requisite number of the HiMEDS
Units have given any request, demand, authorization, direction, notice, consent or waiver
hereunder, HiMEDS Units owned by the Company or any Affiliate of the Company shall be disregarded
and deemed not to be Outstanding HiMEDS Units, except that, in determining whether the Purchase
Contract Agent shall be authorized and protected in relying upon any such request, demand,
authorization, direction, notice, consent or waiver, only HiMEDS Units that a Responsible Officer
of the Purchase Contract Agent actually knows to be so owned shall be so disregarded. HiMEDS Units
so owned that have been pledged in good faith may be regarded as Outstanding HiMEDS Units if the
pledgee establishes to the satisfaction of the Purchase Contract Agent the pledgee’s right so to
act with respect to such HiMEDS Units and that the pledgee is not the Company or any Affiliate of
the Company.

     “Payment Date” means each February 15, May 15, August 15 and November 15 of each year,
commencing February 15, 2008.

     “Person” means a legal person, including any individual, corporation, estate, partnership,
joint venture, association, joint-stock company, limited liability company, trust, unincorporated
organization or government or any agency or political subdivision thereof or any other entity of
whatever nature.

     “Plan” means an “employee benefit plan” within the meaning of Section 3(3) of ERISA that is
subject to Title I of ERISA, a plan, individual retirement account or other arrangement that is
subject to Section 4975 of the Code or provisions under any Similar Laws, and entities whose
underlying assets are considered to include “plan assets” of any such plan, account or arrangement.

     “Pledge” means the lien and security interest in the Collateral created by this Agreement.

     “Pledged Senior Notes” means Senior Notes and security entitlements with respect thereto from
time to time credited to the Collateral Account and not then released from the Pledge.

     “Pledged Treasury Securities” means Treasury Securities and security entitlements with respect
thereto from time to time credited to the Collateral Account and not then released from the Pledge.

     “Predecessor Certificate” means a Predecessor Corporate HiMEDS Units Certificate or a
Predecessor Treasury HiMEDS Units Certificate.

     “Predecessor Corporate HiMEDS Units Certificate” of any particular Corporate HiMEDS Units
Certificate means every previous Corporate HiMEDS Units Certificate
evidencing all or a portion of the rights and obligations of the Company and the Holder under
the Corporate HiMEDS Units evidenced thereby; and, for the purposes of this definition, any

9

 

Corporate HiMEDS Units Certificate authenticated and delivered under Section 3.10 in exchange for
or in lieu of a mutilated, destroyed, lost or stolen Corporate HiMEDS Units Certificate shall be
deemed to evidence the same rights and obligations of the Company and the Holder as the mutilated,
destroyed, lost or stolen Corporate HiMEDS Units Certificate.

     “Predecessor Treasury HiMEDS Units Certificate” of any particular Treasury HiMEDS Units
Certificate means every previous Treasury HiMEDS Units Certificate evidencing all or a portion of
the rights and obligations of the Company and the Holder under the Treasury HiMEDS Units evidenced
thereby; and, for the purposes of this definition, any Treasury HiMEDS Units Certificate
authenticated and delivered under Section 3.10 in exchange for or in lieu of a mutilated,
destroyed, lost or stolen Treasury HiMEDS Units Certificate shall be deemed to evidence the same
rights and obligations of the Company and the Holder as the mutilated, destroyed, lost or stolen
Treasury HiMEDS Units Certificate.

     “Proceeds” has the meaning ascribed thereto in the UCC and includes, without limitation, all
interest, dividends, cash, instruments, securities, financial assets and other property received,
receivable or otherwise distributed upon the sale (including, without limitation, the remarketing),
exchange, collection or disposition of any financial assets from time to time credited to the
Collateral Account.

     “Pro Rata” shall mean pro rata to each Holder according to the aggregate Stated Amount of the
HiMEDS Units held by such Holder in relation to the aggregate Stated Amount of all HiMEDS Units
outstanding.

     “Prospectus” means the prospectus relating to the delivery of shares or any securities in
connection with an Early Settlement pursuant to Section 5.07 or a Merger Early Settlement of
Purchase Contracts pursuant to Section 5.04(b)(ii), in the form in which first filed, or
transmitted for filing, with the Securities and Exchange Commission after the effective date of the
Registration Statement pursuant to Rule 424(b) under the Securities Act, including the documents
incorporated by reference therein as of the date of such Prospectus.

     “Purchase Contract” means, with respect to any HiMEDS Unit, the contract forming a part of
such HiMEDS Unit and obligating the Company to (i) sell, and the Holder of such HiMEDS Unit to
purchase, not later than the Purchase Contract Settlement Date, for $50 in cash, a number of shares
of Common Stock equal to the applicable Settlement Rate, and (ii) pay the Holder thereof Contract
Adjustment Payments, in each case on the terms and subject to the conditions set forth in Article
5.

     “Purchase Contract Agent” means the Person named as the “Purchase Contract Agent” in the first
paragraph of this Agreement until a successor Purchase Contract Agent shall have become such
pursuant to the applicable provisions of this Agreement, and thereafter “Purchase Contract Agent”
shall mean such Person or any subsequent successor who is appointed pursuant to this Agreement.

10

 

     “Purchase Contract Settlement Date” means November 15, 2010; provided, however, that in the
event one or more of the three scheduled Trading Days immediately following the last Trading Day of
the Observation Period shall not be a Trading Day, the Purchase Contract Settlement Date shall be
postponed until such Trading Day that is the third Trading Day immediately following the last
Trading Day of the Observation Period.

     “Purchase Contract Settlement Fund” has the meaning set forth in Section 5.03(a).

     “Purchase Price” has the meaning set forth in Section 5.01(a).

     “Purchased Shares” has the meaning set forth in Section 5.04(a)(vi).

     “Put Right” has the meaning set forth in Section 5.03(a) of the Supplemental Indenture.

     “Record Date” for any distribution and any Contract Adjustment Payment and any Deferred
Contract Adjustment Payment payable on any Payment Date means, as to any Global Certificate or any
other Certificate, the first day of the calendar month in which the relevant Payment Date falls
(whether or not a Business Day).

     “Reference Dividend” has the meaning set forth in Section 5.04(a)(v).

     “Reference Price” has the meaning set forth in Section 5.01(a)(ii).

     “Registration Statement” means a registration statement under the Securities Act prepared by
the Company covering, inter alia, the delivery by the Company of any securities in connection with
an Early Settlement on the Early Settlement Date or a Merger Early Settlement of Purchase Contracts
on the Merger Early Settlement Date under Section 5.04(b)(ii), including all exhibits thereto and
the documents incorporated by reference in the prospectus contained in such registration statement,
and any post-effective amendments thereto.

     “Remarketing Agent” has the meaning set forth in Section 5.02(c)(i).

     “Remarketing Agreement” means the Remarketing Agreement to be entered into by and among the
Company, the Remarketing Agent and the Purchase Contract Agent.

     “Remarketing Date” means the ninth scheduled Business Day immediately preceding the Purchase
Contract Settlement Date, which Business Day is expected to be November 1, 2010.

     “Remarketing Fee” has the meaning set forth in Section 5.02(c)(i).

     “Remarketing Notice” has the meaning set forth in Section 5.02(c)(i).

     “Remarketing Period” means the seven scheduled Business Day period beginning on the
Remarketing Date; provided, however, that in no event shall the Remarketing Period extend beyond
the third scheduled Trading Day immediately preceding the Purchase Contract Settlement Date.

11

 

     “Remarketing Value” means, with respect to any Senior Note, the $1,000 principal amount of
such Senior Note.

     “Reorganization Event” means:

     (i) any consolidation or merger of the Company with or into another Person or of another
Person with or into the Company;

     (ii) any sale, transfer, lease or conveyance to another Person of the assets and property of
the Company as an entirety or substantially as an entirety;

     (iii) any statutory share exchange of the Company with another Person (other than in
connection with a merger or acquisition); or

     (iv) any liquidation, dissolution or termination of the Company (other than as a result of or
after the occurrence of a Termination Event).

     “Reset Rate” has the meaning set forth in Section 5.01(f)(i) of the Supplemental Indenture.

     “Responsible Officer” means, when used with respect to the Purchase Contract Agent, any
officer of the Purchase Contract Agent within the Corporate Trust Administration (or any successor
unit, department or division of the Purchase Contract Agent) located at the Corporate Trust Office
of the Purchase Contract Agent who has direct responsibility for the administration of the
Agreement and, for the purposes of Section 7.01(b)(ii), also means, with respect to a particular
corporate trust matter, any other officer, trust officer or person performing similar functions to
whom such matter is referred because of his or her knowledge of and familiarity of the particular
subject.

     “Rights” has the meaning set forth in Section 5.04(a)(x).

     “Securities Act” means the Securities Act of 1933 and any statute successor thereto, in each
case as amended from time to time, and the rules and regulations promulgated thereunder.

     “Securities Intermediary” means the Person named as Securities Intermediary in the first
paragraph of this Agreement until a successor Securities Intermediary shall have become such
pursuant to the applicable provisions of this Agreement, and thereafter “Securities Intermediary”
shall mean such successor or any subsequent successor.

     “Security Register” and “Security Registrar” have the respective meanings set forth in Section
3.05.

     “Senior Indebtedness” means indebtedness of any kind of the Company unless the instrument
under which such indebtedness is incurred expressly provides that it is on a parity in right of
payment with or subordinate in right of payment to the Contract Adjustment Payments.

     “Senior Notes” means the series of notes designated the Senior Notes due 2020 to be issued by
the Company under the Indenture, which Senior Notes will mature on November 15,
2020, or on such earlier date not earlier than November 15, 2012 as the Company may elect in
accordance with the Indenture in connection with a successful remarketing.

12

 

     “Separate Senior Notes” means Senior Notes that are not components of Corporate HiMEDS Units.

     “Settlement Date” means, as applicable, the Purchase Contract Settlement Date, the Early
Settlement Date or the Merger Early Settlement Date.

     “Settlement Rate” has the meaning set forth in Section 5.01(a).

     “Similar Law” means provisions under any federal, state, local, non-U.S. or other laws or
regulations that are similar to the fiduciary responsibility provisions of Title I of ERISA or the
prohibited transaction provisions of Title I of ERISA or Section 4975 of the Code.

     “Spin-Off” means a distribution to all or substantially all holders of the Common Stock
consisting of shares of capital stock of any class or series of, or similar equity interests in, or
relating to a subsidiary or other business unit of the Company.

     “Stated Amount” means $50.

     “Stock Price” has the meaning set forth in Section 5.04(b)(iii).

     “Subsequent Remarketing Date” has the meaning set forth in Section 5.02(c)(i).

     “Supplemental Indenture” means the First Supplemental Indenture, dated as of the date hereof,
between the Company and the Indenture Trustee, pursuant to which the Senior Notes are issued.

     “Tender Expiration Date” has the meaning set forth in Section 5.04(a)(vi).

     “Tender Expiration Time” has the meaning set forth in Section 5.04(a)(vi).

     “Termination Date” means the date, if any, on which a Termination Event occurs.

     “Termination Event” means the occurrence of any of the following events:

     (i) at any time on or prior to the Purchase Contract Settlement Date, a judgment, decree or
court order shall have been entered granting relief under the Bankruptcy Code, adjudicating the
Company to be insolvent, or approving as properly filed a petition seeking reorganization or
liquidation of the Company or any other similar applicable Federal or state law and if such
judgment, decree or order shall have been entered more than 60 days prior to the Purchase Contract
Settlement Date, such decree or order shall have continued undischarged and unstayed for a period
of 60 days;

     (ii) at any time on or prior to the Purchase Contract Settlement Date, a judgment, decree or
court order for the appointment of a receiver or liquidator or trustee or assignee in bankruptcy or
insolvency of the Company or of its property, or for the termination or liquidation

13

 

of its affairs, shall have been entered and if such judgment, decree or order shall have been
entered more than 60 days prior to the Purchase Contract Settlement Date, such judgment, decree or
order shall have continued undischarged and unstayed for a period of 60 days; or

     (iii) at any time on or prior to the Purchase Contract Settlement Date, the Company shall file
a petition for relief under the Bankruptcy Code, or shall consent to the filing of a bankruptcy
proceeding against it, or shall file a petition or answer or consent seeking reorganization or
liquidation under the Bankruptcy Code or any other similar applicable Federal or State law, or
shall consent to the filing of any such petition, or shall consent to the appointment of a receiver
or liquidator or trustee or assignee in bankruptcy or insolvency of it or of its property, or shall
make an assignment for the benefit of creditors, or shall admit in writing its inability to pay its
debts generally as they become due.

     “Threshold Appreciation Price” has the meaning set forth in Section 5.01(a)(i).

     “TIA” means the Trust Indenture Act of 1939, as amended from time to time, or any successor
legislation.

     “TRADES” means the Treasury/Reserve Automated Debt Entry System maintained by the Federal
Reserve Bank of New York pursuant to the TRADES Regulations.

     “TRADES Regulations” means the regulations of the United States Department of the Treasury,
published at 31 C.F.R. Part 357, as amended from time to time. Unless otherwise defined herein,
all terms defined in the TRADES Regulations are used herein as therein defined.

     “Trading Day” has the meaning set forth in Section 5.01(a).

     “Transfer” means:

     (i) in the case of certificated securities in registered form, delivery as provided in Section
8-301(a) of the UCC, indorsed to the transferee or in blank by an effective endorsement;

     (ii) in the case of Treasury Securities, registration of the transferee as the owner of such
Treasury Securities on TRADES; and

     (iii) in the case of security entitlements, including, without limitation, security
entitlements with respect to Treasury Securities, a securities intermediary indicating by book
entry that such security entitlement has been credited to the transferee’s securities account.

     “Treasury HiMEDS Unit” means a HiMEDS Unit, initially issued in substantially the form set
forth as Exhibit B hereto in a Stated Amount of $50, which represents (i) a 1/20, or 5.00%,
undivided beneficial ownership interest in a Treasury Security having a principal amount at
maturity equal to $1,000 and (ii) the rights and obligations of the Company and the Holder under
one Purchase Contract.

     “Treasury HiMEDS Units Certificate” means a certificate evidencing the rights and obligations
of a Holder in respect of the number of Treasury HiMEDS Units specified on such certificate.

14

 

     “Treasury Securities” means zero-coupon U.S. treasury securities that mature on November 15,
2010 (CUSIP No. 912820MJ3).

     “UCC” means the Uniform Commercial Code as in effect in the State of New York from time to
time.

     “Underwriters” means the underwriters identified in Schedule 1 to the Underwriting Agreement.

     “Underwriting Agreement” means the Underwriting Agreement, dated as of November 14, 2007,
among the Company and the Underwriters, relating to the offer and sale by the Company of Corporate
HiMEDS Units.

     “Value” means, with respect to any item of Collateral on any date, as to:

     (i) Cash, the amount thereof;

     (ii) Senior Notes, the aggregate principal amount thereof; and

     (ii) Treasury Securities, the aggregate principal amount at maturity thereof.

     “Vice President” means any vice president, whether or not designated by a number or a word or
words added before or after the title “vice president.”

     Section 1.02. Compliance Certificates and Opinions. Except as otherwise expressly provided by
this Agreement, upon any application or request by the Company to the Purchase Contract Agent to
take any action in accordance with any provision of this Agreement, the Company shall furnish to
the Purchase Contract Agent an Officers’ Certificate stating that all conditions precedent, if any,
provided for in this Agreement relating to the proposed action have been complied with and, if
requested by the Purchase Contract Agent, an Opinion of Counsel stating that, in the opinion of
such counsel, all such conditions precedent, if any, have been complied with, except that in the
case of any such application or request as to which the furnishing of such documents is
specifically required by any provision of this Agreement relating to such particular application or
request, no additional certificate or opinion need be furnished.

     Every certificate or opinion with respect to compliance with a condition or covenant provided
for in this Agreement (other than the Officers’ Certificate provided for in Section 10.05) shall
include:

     (i) a statement that each individual signing such certificate or opinion has read such
covenant or condition and the definitions herein relating thereto;

     (ii) a brief statement as to the nature and scope of the examination or investigation upon
which the statements or opinions contained in such certificate or opinion are based;

     (iii) a statement that, in the opinion of each such individual, he or she has made such
examination or investigation as is necessary to enable such individual to express an informed
opinion as to whether or not such covenant or condition has been complied with; and

15

 

     (iv) a statement as to whether, in the opinion of each such individual, such condition or
covenant has been complied with.

     Section 1.03. Form of Documents Delivered to Purchase Contract Agent. In any case where
several matters are required to be certified by, or covered by an opinion of, any specified Person,
it is not necessary that all such matters be certified by, or covered by the opinion of, only one
such Person, or that they be so certified or covered by only one document, but one such Person may
certify or give an opinion with respect to some matters and one or more other such Persons as to
other matters, and any such Person may certify or give an opinion as to such matters in one or
several documents. Any certificate or opinion of an officer of the Company may be based, insofar as
it relates to legal matters, upon a certificate or opinion of, or representations by, counsel,
unless such officer knows, or in the exercise of reasonable care should know, that the certificate
or opinion or representations with respect to the matters upon which its certificate or opinion is
based are erroneous. Any such certificate or Opinion of Counsel may be based, insofar as it
relates to factual matters, upon a certificate or opinion of, or representations by, an officer or
officers of the Company unless such counsel knows, or in the exercise of reasonable care should
know, that the certificate or opinion or representations with respect to such matters are
erroneous.

     Where any Person is required to make, give or execute two or more applications, requests,
consents, certificates, statements, opinions or other instruments under this Agreement, they may,
but need not, be consolidated and form one instrument.

     Section 1.04. Acts of Holders; Record Dates. (a) Any request, demand, authorization,
direction, notice, consent, waiver or other action provided by this Agreement to be given or taken
by Holders may be embodied in and evidenced by one or more instruments of substantially similar
tenor signed by such Holders in person or by an agent duly appointed in writing; and, except as
herein otherwise expressly provided, such action shall become effective when such instrument or
instruments are delivered to the Purchase Contract Agent and, where it is hereby expressly
required, to the Company. Such instrument or instruments (and the action embodied therein and
evidenced thereby) are herein sometimes referred to as the “Act” of the Holders signing such
instrument or instruments. Reasonable proof of execution of any such instrument or of a writing
appointing any such agent shall be sufficient for any purpose of this Agreement and (subject to
Section 7.01) conclusive in favor of the Purchase Contract Agent and the Company, if made in the
manner provided in this Section.

     (b) The fact and date of the execution by any Person of any such instrument or writing may be
proved in any manner which the Purchase Contract Agent deems sufficient.

     (c) The ownership of HiMEDS Units shall be proved by the Security Register.

     (d) Any request, demand, authorization, direction, notice, consent, waiver or other Act of the
Holder of any HiMEDS Unit shall bind every future Holder of the same HiMEDS Unit and the Holder of
every Certificate evidencing such HiMEDS Unit issued upon the registration of transfer thereof or
in exchange therefor or in lieu thereof in respect of anything done, omitted or suffered to be done
by the Purchase Contract Agent or the Company in reliance thereon, whether or not notation of such
action is made upon such Certificate.

16

 

     (e) The Company may set any date as a record date for the purpose of determining the Holders
of Outstanding HiMEDS Units entitled to give, make or take any request, demand, authorization,
direction, notice, consent, waiver or other action provided or permitted by this Agreement to be
given, made or taken by Holders of HiMEDS Units. If any record date is set pursuant to this
Section 1.04(e), the Holders of the Outstanding Corporate HiMEDS Units and the Outstanding Treasury
HiMEDS Units, as the case may be, on such record date, and no other Holders, shall be entitled to
take the relevant action with respect to the Corporate HiMEDS Units or the Treasury HiMEDS Units,
as the case may be, whether or not such Holders remain Holders after such record date; provided
that no such action shall be effective hereunder unless taken prior to or on the applicable
Expiration Date by Holders of the requisite number of Outstanding HiMEDS Units on such record date.
Nothing contained in this Section 1.04(e), shall be construed to prevent the Company from setting
a new record date for any action for which a record date has previously been set pursuant to this
Section 1.04(e) (whereupon the record date previously set shall automatically and with no action by
any Person be cancelled and be of no effect), and nothing contained in this Section 1.04(e) shall
be construed to render ineffective any action taken by Holders of the requisite number of
Outstanding HiMEDS Units on the date such action is taken. Promptly after any record date is set
pursuant to this Section 1.04(e), the Company, at its own expense, shall cause notice of such
record date, the proposed action by Holders and the applicable Expiration Date to be given to the
Purchase Contract Agent in writing and to each Holder of HiMEDS Units in the manner set forth in
Section 1.06.

     With respect to any record date set pursuant to this Section 1.04(e), the Company may
designate any date as the “Expiration Date” and from time to time may change the Expiration Date to
any earlier or later day; provided that no such change shall be effective unless notice of the
proposed new Expiration Date is given to the Purchase Contract Agent in writing, and to each Holder
of HiMEDS Units in the manner set forth in Section 1.06, prior to or on the existing Expiration
Date. If an Expiration Date is not designated with respect to any record date set pursuant to this
Section, the Company shall be deemed to have initially designated the 180th day after such record
date as the Expiration Date with respect thereto, subject to its right to change the Expiration
Date as provided in this Section 1.04(e). Notwithstanding the foregoing, no Expiration Date shall
be later than the 180th day after the applicable record date.

     Section 1.05. Notices. All notices, requests, consents and other communications provided for
herein (including, without limitation, any modifications of, or waivers or consents under, this
Agreement) shall be given or made in writing (including, without limitation, by telecopy) delivered
to the intended recipient at the “Address for Notices” specified below its name on the signature
pages hereof or, as to any party, at such other address as shall be designated by such party in a
notice to the other parties. Except as otherwise provided in this Agreement, all such
communications shall be deemed to have been duly given when transmitted by telecopier or personally
delivered or, in the case of a mailed notice, upon receipt, in each case given or addressed as
aforesaid.

     The Purchase Contract Agent shall send to the Indenture Trustee at the following address a
copy of any notices in the form of Exhibits C, D, E or F hereto it sends or receives:

17

 

The Bank of New York Trust Company, N.A.

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

     Section 1.06. Notice to Holders; Waiver.

     Where this Agreement provides for notice to Holders of any event, such notice shall be
sufficiently given (unless otherwise herein expressly provided) if in writing and mailed,
first-class postage prepaid, to each Holder affected by such event, at its address as it appears in
the Security Register, not later than the latest date, and not earlier than the earliest date,
prescribed for the giving of such notice. In any case where notice to Holders is given by mail,
neither the failure to mail such notice, nor any defect in any notice so mailed to any particular
Holder shall affect the sufficiency of such notice with respect to other Holders. Where this
Agreement provides for notice in any manner, such notice may be waived in writing by the Person
entitled to receive such notice, either before or after the event, and such waiver shall be the
equivalent of such notice. Waivers of notice by Holders shall be filed with the Purchase Contract
Agent, but such filing shall not be a condition precedent to the validity of any action taken in
reliance upon such waiver.

     In case by reason of the suspension of regular mail service or by reason of any other cause it
shall be impracticable to give such notice by mail, then such notification as shall be made with
the approval of the Purchase Contract Agent shall constitute a sufficient notification for every
purpose hereunder.

     Section 1.07. Effect of Headings and Table of Contents. The Article and Section headings
herein and the Table of Contents are for convenience only and shall not affect the construction
hereof.

     Section 1.08. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the respective successors and assigns of the Company, the Purchase Contract Agent, the
Collateral Agent, the Custodial Agent, the Securities Intermediary and the Purchase Contract Agent,
and the Holders from time to time of the HiMEDS Units, by their acceptance of the same, shall be
deemed to have agreed to be bound by the provisions hereof and to have ratified the agreements of,
and the grant of the Pledge hereunder by, the Purchase Contract Agent.

     Section 1.09. Separability Clause. In case any provision in this Agreement or in the HiMEDS
Units shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions hereof and thereof shall not in any way be affected or impaired thereby.

     Section 1.10. Benefits of Agreement. Nothing contained in this Agreement or in the HiMEDS
Units, express or implied, shall give to any Person, other than the parties hereto and their
successors hereunder and, to the extent provided hereby, the Holders, any benefits or any

18

 

legal or equitable right, remedy or claim under this Agreement. The Holders from time to time
shall be beneficiaries of this Agreement and shall be bound by all of the terms and conditions
hereof and of the HiMEDS Units evidenced by their Certificates by their acceptance of delivery of
such Certificates.

     Section 1.11.
Governing Law; Submission to Jurisdiction; Waiver of Venue Objection

. THIS AGREEMENT AND THE HiMEDS UNITS SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE LAWS OF THE STATE OF NEW YORK. The Company, the Collateral Agent, the Custodial Agent, the
Securities Intermediary and the Holders from time to time of the HiMEDS Units, acting through the
Purchase Contract Agent as their attorney-in-fact, hereby submit to the nonexclusive jurisdiction
of the United States District Court for the Southern District of New York and of any New York state
court sitting in New York City for the purposes of all legal proceedings arising out of or relating
to this Agreement or the transactions contemplated hereby. The Company, the Collateral Agent, the
Custodial Agent, the Securities Intermediary and the Holders from time to time of the HiMEDS Units,
acting through the Purchase Contract Agent as their attorney-in-fact, irrevocably waive, to the
fullest extent permitted by applicable law, any objection which they may now or hereafter have to
the laying of the venue of any such proceeding brought in such a court and any claim that any such
proceeding brought in such a court has been brought in an inconvenient forum.

     Section 1.12. Legal Holidays. In any case where any Payment Date shall not be a Business Day
(notwithstanding any other provision of this Agreement or the HiMEDS Units), Contract Adjustment
Payments or other distributions shall not be paid on such date, but Contract Adjustment Payments
and Deferred Contract Adjustment Payments or such other distributions shall be paid on the next
succeeding Business Day, unless such Business Day is in the next succeeding calendar year, in which
case such Contract Adjustment Payments or other distributions shall be paid on the immediately
preceding Business Day, in each case with the same force and effect as if made on such scheduled
Payment Date; provided that no interest or other payment shall accrue or be payable by the Company
or to any Holder in respect of such payment or distribution for the period from and after any such
scheduled Payment Date.

     In any case where the Purchase Contract Settlement Date or any Early Settlement Date or Merger
Early Settlement Date shall not be a Business Day (notwithstanding any other provision of this
Agreement or the HiMEDS Units), Purchase Contracts shall not be performed and Early Settlement and
Merger Early Settlement shall not be effected on such date, but Purchase Contracts shall be
performed or Early Settlement or Merger Early Settlement shall be effected, as applicable, on the
next succeeding Business Day with the same force and effect as if made on such Purchase Contract
Settlement Date, Early Settlement Date or Merger Early Settlement Date, as applicable.

     Section 1.13. Counterparts. This Agreement may be executed in any number of counterparts by
the parties hereto on separate counterparts, each of which, when so executed and delivered, shall
be deemed an original, but all such counterparts shall together constitute one and the same
instrument.

19

 

     Section 1.14. Inspection of Agreement. A copy of this Agreement shall be available at all
reasonable times during normal business hours at the Corporate Trust Office for inspection by any
Holder or Beneficial Owner.

     Section 1.15. Appointment of Financial Institution as Agent for the Company. The Company may appoint a financial institution (which may be the Collateral Agent) to act
as its agent in performing its obligations and in accepting and enforcing performance of the
obligations of the Purchase Contract Agent and the Holders, under this Agreement and the Purchase
Contracts, by giving notice of such appointment in the manner provided in Section 1.05. Any such
appointment shall not relieve the Company in any way from its obligations hereunder.

     Section 1.16. No Waiver. No failure on the part of the Company, the Purchase Contract Agent,
the Collateral Agent, the Securities Intermediary or any of their respective agents to exercise,
and no course of dealing with respect to, and no delay in exercising, any right, power or remedy
hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by the
Company, the Collateral Agent, the Securities Intermediary or any of their respective agents of any
right, power or remedy hereunder preclude any other or further exercise thereof or the exercise of
any other right, power or remedy. The remedies herein are cumulative and are not exclusive of any
remedies provided by law.

     Section 1.17. Tax Treatment. The Company intends to treat and each beneficial owner of a
Corporate HiMEDS Unit or Treasury HiMEDS Unit, by acceptance of a beneficial interest in a
Corporate HiMEDS Unit or Treasury HiMEDS Unit, as applicable, agrees to treat:

          (i) each Corporate HiMEDS Unit as an investment unit consisting of an interest in a Senior
Note and a Purchase Contract;

          (ii) the initial fair market value of each Senior Note as $50 and the initial fair market
value of each Purchase Contract as $0 and to allocate the purchase price for each Corporate HiMEDS
Unit accordingly;

          (iii) each Treasury HiMEDS Unit as an investment unit consisting of Treasury securities and a
Purchase Contract;

          (iv) such Holder, for all purposes, as the owner of the applicable interests in the Collateral
Account, including the Senior Notes or the Treasury Securities; and

          (v) the Senior Notes as indebtedness for tax purposes.

ARTICLE 2

CERTIFICATE FORMS

     Section 2.01. Forms of Certificates Generally. The Certificates (including the form of
Purchase Contract forming part of each Unit evidenced thereby) shall be in substantially the form
set forth in Exhibit A hereto (in the case of Corporate HiMEDS Units Certificates) or Exhibit B
hereto (in the case of Treasury HiMEDS Units Certificates), with such letters, numbers or
other marks of identification or designation and such legends or endorsements printed, lithographed
or

20

 

engraved thereon as may be required by the rules of any securities exchange on which the HiMEDS
Units are listed or any depositary therefor, or as may, consistently herewith, be determined by the
officers of the Company executing such Certificates, as evidenced by their execution of the
Certificates.

     The definitive Certificates shall be produced in any manner as determined by the officers of
the Company executing the HiMEDS Units evidenced by such Certificates, consistent with the
provisions of this Agreement, as evidenced by their execution thereof.

     Every Global Certificate authenticated, executed on behalf of the Holders and delivered
hereunder shall bear a legend in substantially the following form:

“THIS CERTIFICATE IS A GLOBAL CERTIFICATE WITHIN THE MEANING OF THE PURCHASE CONTRACT
AGREEMENT HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF CEDE & CO., AS NOMINEE OF
THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (THE “DEPOSITARY”), THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY. THIS CERTIFICATE IS EXCHANGEABLE FOR CERTIFICATES
REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE
LIMITED CIRCUMSTANCES DESCRIBED IN THE PURCHASE CONTRACT AGREEMENT AND NO TRANSFER OF THIS
CERTIFICATE (OTHER THAN A TRANSFER OF THIS CERTIFICATE AS A WHOLE BY THE DEPOSITARY TO A
NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER
NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES.

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REQUESTED IN
THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
THE DEPOSITARY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER
USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER
HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.”

     Section 2.02. Form of Purchase Contract Agent’s Certificate of Authentication. The form of the Purchase Contract Agent’s certificate of authentication of the HiMEDS Units
shall be in substantially the form set forth on the form of the applicable Certificates.

     Section 2.03. Global Certificates. So long as the HiMEDS Units are evidenced by one or more Global Certificates deposited with
the Depositary, procedures for transfer, exchange, Cash Settlement, Early Settlement or Merger
Early Settlement will be governed by standing arrangements between the Depositary and the Purchase
Contract Agent.

21

 

ARTICLE 3

THE HIMEDS UNITS

     Section 3.01. Amount; Form and Denominations. The aggregate number of HiMEDS Units evidenced by Certificates authenticated, executed on
behalf of the Holders and delivered hereunder is limited to 8,000,000 (up to 8,800,000 if the
Underwriters exercise their over-allotment option in accordance with the terms of the Underwriting
Agreement), except for Certificates authenticated, executed and delivered upon registration of
transfer of, in exchange for, or in lieu of, other Certificates pursuant to Section 3.04, Section
3.05, Section 3.10, Section 3.13, Section 3.14 or Section 8.05.

     The Certificates shall be issuable only in registered form and only in denominations of a
single Corporate HiMEDS Unit or Treasury HiMEDS Unit and any integral multiple thereof.

     Section 3.02. Rights and Obligations Evidenced by the Certificates. Each Corporate HiMEDS Units Certificate shall evidence the number of Corporate HiMEDS Units
specified therein, with each such Corporate HiMEDS Unit representing (i) the ownership by the
Holder thereof of a 1/20, or 5.00%, undivided beneficial interest in $1,000 principal amount of a
Senior Note, subject to the Pledge of such interest by such Holder pursuant to this Agreement and
(ii) the rights and obligations of the Holder thereof and the Company under one Purchase Contract.
The Purchase Contract Agent is hereby authorized, as attorney-in-fact for, and on behalf of, the
Holder of each Corporate HiMEDS Unit, to pledge, pursuant to Article 11 hereof, the Senior Note,
forming a part of such Corporate HiMEDS Unit, to the Collateral Agent for the benefit of the
Company, and to grant to the Collateral Agent, for the benefit of the Company, a security interest
in the right, title and interest of such Holder in such Senior Note to secure the obligation of the
Holder under each Purchase Contract to purchase shares of Common Stock.

     Upon the formation of a Treasury HiMEDS Unit pursuant to Section 3.13, each Treasury HiMEDS
Unit Certificate shall evidence the number of Treasury HiMEDS Units specified therein, with each
such Treasury HiMEDS Unit representing (i) the ownership by the Holder thereof of a 1/20, or 5.00%,
undivided beneficial interest in a Treasury Security with a principal amount at maturity equal to
$1,000, subject to the Pledge of such interest by such Holder pursuant to this Agreement, and (ii)
the rights and obligations of the Holder thereof and the Company under one Purchase Contract. The
Purchase Contract Agent is hereby authorized, as attorney-in-fact for, and on behalf of, the Holder
of each Treasury HiMEDS Unit, to pledge, pursuant to Article 11, such Holder’s interest in the
Treasury Security forming a part of such Treasury HiMEDS Unit, to the Collateral Agent for the
benefit of the Company, and to grant to the Collateral Agent for the benefit of the Company, a
security interest in the right, title and interest of such Holder in such Treasury Security to secure the obligation of the Holder under
each Purchase Contract to purchase shares of Common Stock.

     Prior to the purchase of shares of Common Stock under each Purchase Contract, such Purchase
Contracts shall not entitle the Holder of a HiMEDS Unit to any of the rights of a holder of shares
of Common Stock, including, without limitation, the right to vote or receive any dividends or other
payments or to consent or to receive notice as a stockholder in respect of the meetings of
stockholders or for the election of directors of the Company or for any other matter, or any other
rights whatsoever as a stockholder of the Company.

22

 

     Section 3.03. Execution, Authentication, Delivery and Dating. Subject to the provisions of Section 3.13 and Section 3.14, upon the execution and delivery
of this Agreement, and at any time and from time to time thereafter, the Company may deliver
Certificates executed by the Company to the Purchase Contract Agent for authentication, execution
on behalf of the Holders and delivery, together with its Issuer Order for authentication of such
Certificates, and the Purchase Contract Agent in accordance with such Issuer Order shall
authenticate, execute on behalf of the Holders and deliver such Certificates.

     The Certificates shall be executed on behalf of the Company by any one of its Chairman of the
Board of Directors, its Chief Executive Officer, its President, its Treasurer or one of its Vice
Presidents. The signature of any of these officers on the Certificates may be manual or facsimile.

     Certificates bearing the manual or facsimile signatures of individuals who were at any time
the proper officers of the Company shall bind the Company, notwithstanding that such individuals or
any of them have ceased to hold such offices prior to the authentication and delivery of such
Certificates or did not hold such offices at the date of such Certificates.

     No Purchase Contract evidenced by a Certificate shall be valid until such Certificate has been
executed on behalf of the Holder by the manual signature of an authorized officer of the Purchase
Contract Agent, as such Holder’s attorney-in-fact. Such signature by an authorized officer of the
Purchase Contract Agent shall be conclusive evidence that the Holder of such Certificate has
entered into the Purchase Contract or Purchase Contracts evidenced by such Certificate.

     Each Certificate shall be dated the date of its authentication.

     No Certificate shall be entitled to any benefit under this Agreement or be valid or obligatory
for any purpose unless there appears on such Certificate a certificate of authentication
substantially in the form provided for herein executed by an authorized officer of the Purchase
Contract Agent by manual signature, and such certificate upon any Certificate shall be conclusive
evidence, and the only evidence, that such Certificate has been duly authenticated and delivered
hereunder.

     Section 3.04. Temporary Certificates. Pending the preparation of definitive Certificates, the Company shall execute and deliver
to the Purchase Contract Agent, and the Purchase Contract Agent shall authenticate, execute on
behalf of the Holders, and deliver, in lieu of such definitive Certificates, temporary Certificates
which are in substantially the form set forth in Exhibit A or Exhibit B hereto, as the case may be,
with such letters, numbers or other marks of identification or designation and such legends or
endorsements printed, lithographed or engraved thereon as may be required by the rules of any
securities exchange on which the Corporate HiMEDS Units or Treasury HiMEDS Units, as the case may
be, are listed, or as may, consistently herewith, be determined by the officers of the Company
executing such Certificates, as evidenced by their execution of the Certificates.

23

 

     If temporary Certificates are issued, the Company will cause definitive Certificates to be
prepared without unreasonable delay. After the preparation of definitive Certificates, the
temporary Certificates shall be exchangeable for definitive Certificates upon surrender of the
temporary Certificates at the Corporate Trust Office, at the expense of the Company and without
charge to the Holder. Upon surrender for cancellation of any one or more temporary Certificates,
the Company shall execute and deliver to the Purchase Contract Agent, and the Purchase Contract
Agent shall authenticate, execute on behalf of the Holder, and deliver in exchange therefor, one or
more definitive Certificates of like tenor and denominations and evidencing a like number of HiMEDS
Units as the temporary Certificate or Certificates so surrendered. Until so exchanged, the
temporary Certificates shall in all respects evidence the same benefits and the same obligations
with respect to the HiMEDS Units evidenced thereby as definitive Certificates.

     Section 3.05. Registration; Registration of Transfer and Exchange. The Purchase Contract Agent shall keep at the Corporate Trust Office a register (the
“Security Register”) in which, subject to such reasonable regulations as it may prescribe, the
Purchase Contract Agent shall provide for the registration of Certificates and of transfers of
Certificates (the Purchase Contract Agent, in such capacity, the “Security Registrar”). The
Security Registrar shall record separately the registration and transfer of the Certificates
evidencing Corporate HiMEDS Units and Treasury HiMEDS Units.

     Upon surrender for registration of transfer of any Certificate at the Corporate Trust Office,
the Company shall execute and deliver to the Purchase Contract Agent, and the Purchase Contract
Agent shall authenticate, execute on behalf of the designated transferee or transferees, and
deliver, in the name of the designated transferee or transferees, one or more new Certificates of
any authorized denominations, like tenor, and evidencing a like number of Corporate HiMEDS Units or
Treasury HiMEDS Units, as the case may be.

     At the option of the Holder, Certificates may be exchanged for other Certificates, of any
authorized denominations and evidencing a like number of Corporate HiMEDS Units or Treasury HiMEDS
Units, as the case may be, upon surrender of the Certificates to be exchanged at the Corporate
Trust Office. Whenever any Certificates are so surrendered for exchange, the Company shall execute
and deliver to the Purchase Contract Agent, and the Purchase Contract Agent shall authenticate,
execute on behalf of the Holder, and deliver the Certificates which the Holder making the exchange
is entitled to receive.

     All Certificates issued upon any registration of transfer or exchange of a Certificate shall
evidence the ownership of the same number of Corporate HiMEDS Units or Treasury HiMEDS Units, as
the case may be, and be entitled to the same benefits and subject to the same obligations under
this Agreement as the Corporate HiMEDS Units or Treasury HiMEDS Units, as the case may be,
evidenced by the Certificate surrendered upon such registration of transfer or exchange.

     Every Certificate presented or surrendered for registration of transfer or exchange shall (if
so required by the Purchase Contract Agent) be duly endorsed, or be accompanied by a written
instrument of transfer in form satisfactory to the Company and the Purchase Contract Agent duly
executed, by the Holder thereof or its attorney duly authorized in writing.

24

 

     No service charge shall be made for any registration of transfer or exchange of a Certificate,
but the Company and the Purchase Contract Agent may require payment from the Holder of a sum
sufficient to cover any tax or other governmental charge that may be imposed in connection with any
registration of transfer or exchange of Certificates, other than any exchanges pursuant to Section
3.04, Section 3.06 and Section 8.05 not involving any transfer.

     Notwithstanding the foregoing, the Company shall not be obligated to execute and deliver to
the Purchase Contract Agent, and the Purchase Contract Agent shall not be obligated to
authenticate, execute on behalf of the Holder and deliver any Certificate in exchange for any other
Certificate presented or surrendered for registration of transfer or for exchange on or after the
Business Day immediately preceding the earliest to occur of any Early Settlement Date with respect
to such Certificate, any Merger Early Settlement Date with respect to such Certificate, the
Purchase Contract Settlement Date or the Termination Date. In lieu of delivery of a new
Certificate, upon satisfaction of the applicable conditions specified above in this Section and
receipt of appropriate registration or transfer instructions from such Holder, the Purchase
Contract Agent shall:

     (i) if the Purchase Contract Settlement Date or an Early Settlement Date or a Merger
Early Settlement Date with respect to such other Certificate has occurred, deliver the
 shares of Common Stock issuable in respect of the Purchase Contracts forming a part of the
HiMEDS Units evidenced by such other Certificate; or

     (ii) if a Termination Event, Early Settlement, or Merger Early Settlement shall have
occurred prior to the Purchase Contract Settlement Date, or a Cash Settlement shall have
occurred, transfer the Senior Notes, or the Treasury Securities, as the case may be,
evidenced thereby, in each case subject to the applicable conditions and in accordance with
the applicable provisions of Section 3.15 and Article 5.

     Section 3.06. Book-Entry Interests. The Certificates, on original issuance, will be issued in the form of one or more fully
registered Global Certificates, to be delivered to the Depositary or its custodian by, or on behalf
of, the Company. The Company hereby designates DTC as the initial Depositary. Such Global
Certificates shall initially be registered on the Security Register in the name of Cede & Co., the
nominee of the Depositary, and no Beneficial Owner will receive a definitive Certificate
representing such Beneficial Owner’s interest in such Global Certificate, except as provided in Section 3.09. The Purchase Contract Agent shall enter into an agreement with the Depositary
if so requested by the Company. Unless and until definitive, fully registered Certificates have
been issued to Beneficial Owners pursuant to Section 3.09:

     (i) the provisions of this Section 3.06 shall be in full force and effect;

     (ii) the Company shall be entitled to deal with the Depositary for all purposes of this
Agreement (including, without limitation, making Contract Adjustment Payments and receiving
approvals, votes or consents hereunder) as the Holder of the HiMEDS Units and the sole
holder of the Global Certificates and shall have no obligation to the Beneficial Owners;
provided that a Beneficial Owner may directly enforce against the Company, without any
consent, proxy, waiver or involvement of the Depositary of any kind, such Beneficial Owner’s
right to receive a definitive Certificate representing the HiMEDS Units beneficially owned
by such Beneficial Owner, as set forth in Section 3.09;

25

 

     (iii) to the extent that the provisions of this Section 3.06 conflict with any other
provisions of this Agreement, the provisions of this Section 3.06 shall control; and

     (iv) except as set forth in the proviso of clause (ii) of this Section 3.06, the rights
of the Beneficial Owners shall be exercised only through the Depositary and shall be limited
to those established by law and agreements between such Beneficial Owners and the Depositary
or the Depositary Participants. The Depositary will make book entry transfers among
Depositary Participants and receive and transmit payments of Contract Adjustment Payments to
such Depositary Participants.

Transfers of securities evidenced by Global Certificates shall be made through the facilities of
the Depositary, and any cancellation of, or increase or decrease in the number of, such securities
(including the creation of Treasury HiMEDS Units and the recreation of Corporate HiMEDS Units
pursuant to Section 3.13 and Section 3.14 respectively) shall be accomplished by making appropriate
annotations on the Schedule of Increases and Decreases for such Global Certificate.

     Section 3.07. Notices to Holders. Whenever a notice or other communication to the Holders is required to be given under this
Agreement, the Company or the Company’s agent shall give such notices and communications to the
Holders and, with respect to any HiMEDS Units registered in the name of the Depositary or the
nominee of the Depositary, the Company or the Company’s agent shall, except as set forth herein,
have no obligations to the Beneficial Owners.

     Section 3.08. Appointment of Successor Depositary. If the Depositary elects to discontinue its services as securities depositary with respect
to the HiMEDS Units, the Company may, in its sole discretion, appoint a successor Depositary with
respect to the HiMEDS Units.

     Section 3.09. Definitive Certificates.

     If:

     (i) the Depositary notifies the Company that it is unwilling or unable to continue its
services as securities depositary with respect to the HiMEDS Units and no successor
Depositary has been appointed pursuant to Section 3.08 within 90 days after such notice; or

     (ii) the Depositary ceases to be a “clearing agency” registered under Section 17A of
the Exchange Act when the Depositary is required to be so registered to act as the
Depositary and so notifies the Company, and no successor Depositary has been appointed
pursuant to Section 3.08 within 90 days after such notice;

     (iii) to the extent permitted by the Depositary, the Company determines at any time
that the HiMEDS Units shall no longer be represented by Global Certificates and shall inform
such Depositary of such determination and participants in such Depositary elect to withdraw
their beneficial interests in the HiMEDS Units from such Depositary, following notification
by the Depositary of their right to do so; or

26

 

     (iv) a Beneficial Owner requests to exchange such Beneficial Owner’s interest in the
Global Certificates for definitive Certificates in order to exercise or enforce such
Beneficial Owner’s rights under the HiMEDS Units represented by such Global Certificates,

then (x) definitive Certificates shall be prepared by the Company with respect to such HiMEDS Units
and delivered to the Purchase Contract Agent and (y) upon surrender of the Global Certificates
representing the HiMEDS Units by the Depositary, accompanied by registration instructions (other
than in the case of clause (iv) above), the Company shall cause definitive Certificates to be
delivered to Beneficial Owners in accordance with instructions provided by the Depositary. The
Company and the Purchase Contract Agent shall not be liable for any delay in delivery of such
instructions and may conclusively rely on and shall be authorized and protected in relying on, such
instructions. Each definitive Certificate so delivered shall evidence HiMEDS Units of the same
kind and tenor as the Global Certificate so surrendered in respect thereof.

     Section 3.10. Mutilated, Destroyed, Lost and Stolen Certificates. If any mutilated Certificate is surrendered to the Purchase Contract Agent, the Company
shall execute and deliver to the Purchase Contract Agent, and the Purchase Contract Agent shall
authenticate, execute on behalf of the Holder, and deliver in exchange therefor, a new Certificate,
evidencing the same number of Corporate HiMEDS Units or Treasury HiMEDS Units, as the case may be,
and bearing a Certificate number not contemporaneously outstanding.

     If there shall be delivered to the Company and the Purchase Contract Agent (i) evidence to
their satisfaction of the destruction, loss or theft of any Certificate, and (ii) such security or
indemnity as may be required by them to hold each of them and any agent of any of them harmless,
then, in the absence of notice to the Company or the Purchase Contract Agent that such Certificate
has been acquired by a protected purchaser, the Company shall execute and deliver to the Purchase
Contract Agent, and the Purchase Contract Agent shall authenticate, execute on behalf of the
Holder, and deliver to the Holder, in lieu of any such destroyed, lost or stolen
Certificate, a new Certificate, evidencing the same number of Corporate HiMEDS Units or
Treasury HiMEDS Units, as the case may be, and bearing a Certificate number not contemporaneously
outstanding.

     Notwithstanding the foregoing, the Company shall not be obligated to execute and deliver to
the Purchase Contract Agent, and the Purchase Contract Agent shall not be obligated to
authenticate, execute on behalf of the Holder, and deliver to the Holder, a Certificate on or after
the Business Day immediately preceding the earliest of any Early Settlement Date with respect to
such lost or mutilated Certificate, any Merger Early Settlement Date with respect to such lost or
mutilated Certificate, the Purchase Contract Settlement Date or the Termination Date. In lieu of
delivery of a new Certificate, upon satisfaction of the applicable conditions specified above in
this Section and receipt of appropriate registration or transfer instructions from such Holder, the
Purchase Contract Agent shall:

     (i) if the Purchase Contract Settlement Date (including upon any Cash Settlement) or an
Early Settlement Date or a Merger Early Settlement Date with respect to such lost, stolen,
destroyed or mutilated Certificate has occurred, deliver the shares of Common Stock issuable
in respect of the Purchase Contracts forming a part of the HiMEDS Units evidenced by such
Certificate; or

27

 

     (ii) if a Merger Early Settlement or an Early Settlement with respect to such lost or
mutilated Certificate or if a Termination Event shall have occurred prior to the Purchase
Contract Settlement Date or a Cash Settlement shall have occurred, transfer the Senior Notes
or the Treasury Securities, evidenced thereby, in each case subject to the applicable
conditions and in accordance with the applicable provisions of Section 3.15 and Article 5.

     Upon the issuance of any new Certificate under this Section, the Company and the Purchase
Contract Agent may require the payment by the Holder of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation thereto and any other fees and expenses
(including, without limitation, the fees and expenses of the Purchase Contract Agent) connected
therewith.

     Every new Certificate issued pursuant to this Section in lieu of any destroyed, lost or stolen
Certificate shall constitute an original additional contractual obligation of the Company and of
the Holder in respect of the HiMEDS Units evidenced thereby, whether or not the destroyed, lost or
stolen Certificate (and the HiMEDS Units evidenced thereby) shall be at any time enforceable by
anyone, and shall be entitled to all the benefits and be subject to all the obligations of this
Agreement equally and proportionately with any and all other Certificates delivered hereunder.

     The provisions of this Section are exclusive and shall preclude, to the extent lawful, all
other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost
or stolen Certificates.

     Section 3.11. Persons Deemed Owners. Prior to due presentment of a Certificate for registration of transfer, the Company and the
Purchase Contract Agent, and any agent of the Company or the Purchase Contract Agent, may treat the
Person in whose name such Certificate is registered as the owner of the HiMEDS Units evidenced
thereby for purposes of (subject to any applicable record date) any payment or distribution with
respect to the Senior Notes, payment of Contract Adjustment Payments and performance of the
Purchase Contracts and for all other purposes whatsoever in connection with such HiMEDS Units,
whether or not such payment, distribution, or performance shall be overdue and notwithstanding any
notice to the contrary, and neither the Company nor the Purchase Contract Agent, nor any agent of
the Company or the Purchase Contract Agent, shall be affected by notice to the contrary.

     Notwithstanding the foregoing, with respect to any Global Certificate, nothing contained
herein shall prevent the Company, the Purchase Contract Agent or any agent of the Company or the
Purchase Contract Agent, from giving effect to any written certification, proxy or other
authorization furnished by the Depositary (or its nominee), as a Holder, with respect to such
Global Certificate, or impair, as between such Depositary and the related Beneficial Owner, the
operation of customary practices governing the exercise of rights of the Depositary (or its
nominee) as Holder of such Global Certificate. None of the Company, the Purchase Contract Agent or
any agent of the Company or the Purchase Contract Agent will have any responsibility

28

 

or liability for any aspect of the records relating to or payments made on account of beneficial ownership
interests of a Global Certificate or maintaining, supervising or reviewing any records relating to
such beneficial ownership interests.

     Section 3.12. Cancellation. All Certificates surrendered for delivery of shares of Common Stock on or after the
Purchase Contract Settlement Date or in connection with an Early Settlement or a Merger Early
Settlement or for delivery of the Senior Notes underlying the appropriate ownership interests in
the Senior Notes or Treasury Securities, as the case may be, after the occurrence of a Termination
Event or pursuant to a Cash Settlement, an Early Settlement or a Merger Early Settlement, or upon
the registration of transfer or exchange of a HiMEDS Unit, or a Collateral Substitution or the
recreation of Corporate HiMEDS Units shall, if surrendered to any Person other than the Purchase
Contract Agent, be delivered to the Purchase Contract Agent along with appropriate written
instructions regarding the cancellation thereof and, if not already cancelled, shall be promptly
cancelled by it. The Company may at any time deliver to the Purchase Contract Agent for
cancellation any Certificates previously authenticated, executed and delivered hereunder which the
Company may have acquired in any manner whatsoever, and all Certificates so delivered shall, upon
an Issuer Order, be promptly cancelled by the Purchase Contract Agent. No Certificates shall be
authenticated, executed on behalf of the Holder and delivered in lieu of or in exchange for any
Certificates cancelled as provided in this Section, except as expressly permitted by this
Agreement. All cancelled Certificates held by the Purchase Contract Agent shall be disposed of in
accordance with its customary practices.

     If the Company or any Affiliate of the Company shall acquire any Certificate, such acquisition
shall not operate as a cancellation of such Certificate unless and until such Certificate is
delivered to the Purchase Contract Agent cancelled or for cancellation.

     Section 3.13. Creation of Treasury HiMEDS Units by Substitution of Treasury Securities. (a) Subject to the conditions set forth in this Agreement, a Holder of Corporate HiMEDS
Units may, at any time from and after the date of this Agreement and on or prior to 4:00 p.m., New
York City time, on the second Business Day immediately preceding the Remarketing Date, effect a
Collateral Substitution and separate the Senior Notes from the related Purchase Contracts in
respect of such Holder’s Corporate HiMEDS Units by substituting for such Senior Notes, Treasury
Securities in an aggregate principal amount at maturity equal to the aggregate principal amount of
such Senior Notes; provided that Holders may make Collateral Substitutions only in integral
multiples of 20 Corporate HiMEDS Units. To effect such substitution, the Holder must:

	 	(1)	 	Transfer to the Securities Intermediary, for credit to the Collateral Account,
Treasury Securities or security entitlements with respect thereto having a Value equal
to the aggregate principal amount of the Pledged Senior Notes to be released; and
	 
	 	(2)	 	Transfer the related Corporate HiMEDS Units to the Purchase Contract Agent
accompanied by a notice to the Purchase Contract Agent, substantially in the form of
Exhibit C hereto, (i) stating that the Holder has Transferred the relevant amount of
Treasury Securities to the Securities Intermediary for credit to the Collateral Account
and (ii) requesting that the Purchase Contract Agent instruct the

29

 

	 	 	 	Collateral Agent to release the Pledged Senior Notes underlying such Corporate HiMEDS Units, whereupon the
Purchase Contract Agent shall promptly provide an instruction to such effect to the
Collateral Agent, substantially in the form of Exhibit G hereto (A) stating that such
Holder has notified the Purchase Contract Agent that such Holder has Transferred
Treasury Securities or security entitlements with respect thereto to the Securities
Intermediary for credit to the Collateral Account, (B) stating the Value of the
Treasury Securities or security entitlements with respect thereto Transferred by such
Holder and (C) requesting that the Collateral Agent release from the Pledge the Pledged
Senior Notes that are a component of such Corporate HiMEDS Units.

     Upon confirmation that the Treasury Securities described in clause (1) above or security
entitlements with respect thereto have been credited to the Collateral Account and receipt of the
instruction to the Collateral Agent described in clause (2) above, the Collateral Agent shall
release such Pledged Senior Notes from the Pledge and shall instruct the Securities Intermediary by
a notice, substantially in the form of Exhibit H hereto, to Transfer such Pledged Senior Notes to
the Purchase Contract Agent for distribution to such Holder, free and clear of the Pledge created
hereby.

     Upon credit to the Collateral Account of Treasury Securities or security entitlements with
respect thereto delivered by a Holder of Corporate HiMEDS Units and receipt of the related
instruction from the Collateral Agent, the Securities Intermediary shall promptly Transfer the
appropriate Pledged Senior Notes to the Purchase Contract Agent for distribution to such Holder,
free and clear of the Pledge created hereby.

     Upon receipt of such Senior Notes, the Purchase Contract Agent shall promptly:

     (i) cancel the related Corporate HiMEDS Units;

     (ii) Transfer the Pledged Senior Notes to the Holder (such Senior Notes shall be
tradable as a separate security, independent of the resulting Treasury HiMEDS Units); and

     (iii) authenticate, execute on behalf of such Holder and deliver Treasury HiMEDS Units
in book-entry form, or if applicable, in the form of a Treasury HiMEDS Units Certificate
executed by the Company in accordance with Section 3.03 evidencing the same number of
Purchase Contracts as were evidenced by the cancelled Corporate HiMEDS Units.

     Holders who elect to separate the Senior Notes from the related Purchase Contracts and to
substitute Treasury Securities for such Senior Notes shall be responsible for any fees or expenses
(including, without limitation, fees and expenses payable to the Collateral Agent) in respect of
the substitution, and neither the Company nor the Purchase Contract Agent shall be responsible for
any such fees or expenses.

     (b) In the event a Holder making a Collateral Substitution pursuant to this Section 3.13 fails
to effect a book-entry transfer of the Corporate HiMEDS Units or fails to deliver Corporate HiMEDS
Units Certificates to the Purchase Contract Agent after depositing Treasury

30

 

Securities with the Securities Intermediary, as the case may be, any distributions on the Senior Notes constituting a
part of such Corporate HiMEDS Units shall be held in the name of the Purchase Contract Agent or its
nominee in trust for the benefit of such Holder, until such Corporate HiMEDS Units are so
transferred or the Corporate HiMEDS Units Certificate is so delivered, as the case may be, or such
Holder provides evidence satisfactory to the Company and the Purchase Contract Agent that such
Corporate HiMEDS Units Certificate has been destroyed, lost or stolen, together with any indemnity
that may be required by the Purchase Contract Agent and the Company.

     (c) Except as described in Section 5.02 or in this Section 3.13 or in connection with a Cash
Settlement, an Early Settlement, a Merger Early Settlement or a Termination Event, for so long as
the Purchase Contract underlying a Corporate HiMEDS Unit remains in effect, such Corporate HiMEDS
Units shall not be separable into its constituent parts, and the rights and obligations of the
Holder in respect of the 1/20, or 5.00% of a Senior Note and the Purchase Contract comprising such
Corporate HiMEDS Units may be acquired, and may be transferred and exchanged, only as single
Corporate HiMEDS Unit or integral multiples thereof.

     Section 3.14. Recreation of Corporate HiMEDS Units. (a) Subject to the conditions set forth in this Agreement, a Holder of Treasury HiMEDS
Units may recreate Corporate HiMEDS Units at any time on or prior to 4:00 p.m., New York City time,
on the second Business Day immediately preceding the Remarketing Date; provided that Holders of
Treasury HiMEDS Units may only recreate Corporate HiMEDS Units in integral multiples of 20 Treasury
HiMEDS Units. To recreate Corporate HiMEDS Units, the Holder must:

	 	(1)	 	Transfer to the Securities Intermediary for credit to the Collateral Account,
Senior Notes or security entitlements with respect thereto having a Value equal to the
aggregate principal amount at maturity of the Pledged Treasury Securities to be
released; and
	 
	 	(2)	 	Transfer the related Treasury HiMEDS Units to the Purchase Contract Agent
accompanied by a notice to the Purchase Contract Agent, substantially in the form of
Exhibit C hereto, (i) stating that the Holder has Transferred the relevant amount of
Senior Notes to the Securities Intermediary for the credit to the Collateral Account
and (ii) requesting that the Purchase Contract Agent instruct the Collateral Agent to
release the Pledged Treasury Securities underlying such Treasury HiMEDS Units,
whereupon the Purchase Contract Agent shall promptly provide an instruction to such
effect to the Collateral Agent, substantially in the form of Exhibit I hereto (A)
stating that such Holder has notified the Purchase Contract Agent that such Holder has
Transferred Senior Notes or security entitlements with respect thereto to the
Securities Intermediary for credit to the Collateral Account, (B) stating the Value of
the Senior Notes or security entitlements with respect thereto Transferred by such
Holder and (C) requesting that the Collateral Agent release from the Pledge the Pledged
Treasury Securities that are a component of such Treasury HiMEDS Units.

31

 

     Upon confirmation that the Senior Notes described in clause (1) above or security entitlements
with respect thereto has been credited to the Collateral Account and receipt of the instruction to
the Collateral Agent to the Collateral Agent described in clause (2) above, the Collateral Agent
shall release such Pledged Treasury Securities from the Pledge and shall instruct the Securities
Intermediary by a notice, substantially in the form of Exhibit J hereto, to Transfer such Pledged
Treasury Securities to the Purchase Contract Agent for distribution to such Holder, free and clear
of the Pledge created hereby.

     Upon credit to the Collateral Account of Senior Notes or security entitlements with respect
thereto delivered by a Holder of Treasury HiMEDS Units and receipt of the related instruction from
the Collateral Agent, the Securities Intermediary shall promptly Transfer the appropriate Pledged
Treasury Securities to the Purchase Contract Agent for distribution to such Holder, free and clear
of the Pledge created hereby.

     Upon receipt of such Treasury Securities, the Purchase Contract Agent shall promptly:

     (i) cancel the related Treasury HiMEDS Units;

     (ii) Transfer the Pledged Treasury Securities to the Holder; and

     (iii) authenticate, execute on behalf of such Holder and deliver Corporate HiMEDS Units
in book-entry form or, if applicable, in the form of a Corporate HiMEDS Units Certificate
executed by the Company in accordance with Section 3.03 evidencing the same number of
Purchase Contracts as were evidenced by the cancelled Treasury HiMEDS Units.

     Holders who elect to recreate Corporate HiMEDS Units shall be responsible for any fees or
expenses (including, without limitation, fees and expenses payable to the Collateral Agent) in
respect of the recreation, and neither the Company nor the Purchase Contract Agent shall be
responsible for any such fees or expenses.

     (b) Except as provided in Section 5.02 or in this Section 3.14 or in connection with a Cash
Settlement, an Early Settlement, a Merger Early Settlement or a Termination Event, for so long as
the Purchase Contract underlying a Treasury HiMEDS Unit remains in effect, such Treasury HiMEDS
Unit shall not be separable into its constituent parts and the rights and obligations of the Holder
of such Treasury HiMEDS Unit in respect of the 1/20, or 5.00%, of a Treasury Security and the
Purchase Contract comprising such Treasury HiMEDS Unit may be acquired, and may be transferred and
exchanged, only as a single Treasury HiMEDS Unit or integral multiples thereof.

     Section 3.15. Transfer of Collateral upon Occurrence of Termination Event. (a) Upon receipt by the Collateral Agent of written notice pursuant to Section 5.06 from
the Company that a Termination Event has occurred, the Collateral Agent shall release all
Collateral from the Pledge and shall promptly instruct the Securities Intermediary to Transfer:

     (i) any Pledged Senior Notes or security entitlements with respect thereto;

     (ii) any Pledged Treasury Securities,

     (iii) any payments by Holders pursuant to Section 5.02; and

32

 

     (iv) any Proceeds and all principal payments the Collateral Agent receives in respect
of the foregoing,

to the Purchase Contract Agent for the benefit of the Holders for distribution to such Holders, in
accordance with their respective interests, free and clear of the Pledge created hereby.

     (b) If such Termination Event shall result from the Company’s becoming a debtor under the
Bankruptcy Code, and if the Collateral Agent shall for any reason fail or be unable promptly to
effectuate the release and Transfer of all Pledged Senior Notes, Pledged Treasury Securities and
payments by Holders pursuant to Section 5.02 and Proceeds of any of the foregoing, as the case may
be, as provided by this Section 3.15, the Purchase Contract Agent shall use its commercially
reasonable efforts to obtain an opinion of a nationally recognized law firm to the effect that,
notwithstanding the Company’s being the debtor in such a bankruptcy case, the Collateral Agent will
not be prohibited from releasing or Transferring the Collateral as provided in this Section 3.15,
and shall deliver or cause to be delivered such opinion to the Collateral Agent within ten days
after the occurrence of such Termination Event, and if (A) the Purchase Contract Agent shall be
unable to obtain such opinion within ten days after the occurrence of such Termination Event or (B)
the Collateral Agent shall continue, after delivery of such opinion, to refuse to effectuate the
release and Transfer of all Pledged Senior Notes, Pledged Treasury Securities and the payments by
Holders pursuant to Section 5.02 and Proceeds of any of the foregoing, as the case may be, as
provided in this Section 3.15, then the Purchase Contract Agent shall within fifteen days after the
occurrence of such Termination Event commence an action or proceeding in the court having jurisdiction of the Company’s case under
the Bankruptcy Code seeking an order requiring the Collateral Agent to effectuate the release and
transfer of all Pledged Senior Notes, Pledged Treasury Securities and the payments by Holders
pursuant to Section 5.02 and Proceeds of any of the foregoing, or as the case may be, as provided
by this Section 3.15.

     (c) Upon the occurrence of a Termination Event and the Transfer to the Purchase Contract Agent
of the Pledged Senior Notes or the Pledged Treasury Securities, as the case may be, pursuant to
Section 3.15(a), the Purchase Contract Agent shall request transfer instructions with respect to
such Pledged Senior Notes or Pledged Treasury Securities, as the case may be, from each Holder by
written request, substantially in the form of Exhibit D hereto, mailed to such Holder at its
address as it appears in the Security Register.

     (d) Upon book-entry transfer of the Corporate HiMEDS Units or the Treasury HiMEDS Units or
delivery of a Corporate HiMEDS Units Certificate or Treasury HiMEDS Units Certificate to the
Purchase Contract Agent with such transfer instructions, the Purchase Contract Agent shall transfer
the Pledged Senior Notes or Pledged Treasury Securities, as the case may be, and Proceeds of any of
the foregoing, underlying such Corporate HiMEDS Units or Treasury HiMEDS Units, as the case may be,
to such Holder by book-entry transfer, or other appropriate procedures, in accordance with such
instructions and, in the case of the Pledged Senior Notes, in accordance with the terms of the
Supplemental Indenture. In the event a Holder of Corporate HiMEDS Units or Treasury HiMEDS Units
fails to effect such transfer or delivery, the Pledged Senior Notes or Pledged Treasury Securities,
as the case may be, and Proceeds of any of the foregoing and any distributions thereon, shall be
held in the name of the Purchase Contract Agent or its nominee in trust for the benefit of such
Holder, until the earlier to occur of:

33

 

     (i) the transfer of such Corporate HiMEDS Units or Treasury HiMEDS Units or surrender
of the Corporate HiMEDS Units Certificate or Treasury HiMEDS Units Certificate or the
receipt by the Company and the Purchase Contract Agent from such Holder of satisfactory
evidence that such Corporate HiMEDS Units Certificate or Treasury HiMEDS Units Certificate
has been destroyed, lost or stolen, together with any indemnity that may be required by the
Purchase Contract Agent and the Company; and

     (ii) the expiration of the time period specified in the abandoned property laws of the
state in which the Purchase Contract Agent holds such property.

     Section 3.16. No Consent to Assumption. Each Holder of a Unit, by acceptance thereof, shall be deemed expressly to have withheld
any consent to the assumption under Section 365 of the Bankruptcy Code or otherwise, of the
Purchase Contract by the Company or its trustee, receiver, liquidator or a person or entity
performing similar functions in the event that the Company becomes the debtor under the Bankruptcy
Code or subject to other similar state or Federal law providing for reorganization or liquidation.

     Section 3.17. Substitutions. Whenever a Holder has the right to substitute Treasury Securities, Senior Notes or security
entitlements for any of them, as the case may be, for financial assets held in the Collateral
Account, such substitution shall not constitute a novation of the security interest created hereby.

ARTICLE 4

THE SENIOR NOTES

     Section 4.01. Interest Payments; Rights to Interest Payments Preserved. (a) The Collateral Agent shall transfer all income and distributions received by it on
account of the Pledged Senior Notes from time to time held in the Collateral Account (The Bank of
New York Trust Company, N.A. ABA# 021000018, for credit to GLA# 211065, for final credit to:
TAS#765910, Ref.: Avery Dennison HiMEDS Units Collateral Account, Attn: Brian R. Echausse) to the
Purchase Contract Agent for distribution to the applicable Holders as provided in this Agreement
and the Purchase Contracts.

     (b) Any payment on any Pledged Senior Note which is paid on any Payment Date shall, subject to
receipt thereof by the Purchase Contract Agent from the Company or from the Collateral Agent as
provided in Section 4.01(a), be paid by the Purchase Contract Agent to the Person in whose name the
Corporate HiMEDS Units Certificate (or one or more Predecessor Corporate HiMEDS Units Certificates)
of which such Pledged Senior Note forms a part is registered at 5:00 p.m., New York City time, on
the Record Date for such Payment Date or to the Holder of Corporate HiMEDS Units transforming
Corporate HiMEDS Units into Treasury HiMEDS Units or exercising an Early Settlement in accordance
with Section 5.07.

     (c) Each Corporate HiMEDS Units Certificate evidencing Senior Notes delivered under this
Agreement upon registration of transfer of or in exchange for or in lieu of any other Corporate
HiMEDS Units Certificate shall carry the right to accrued and unpaid interest, and to accrue
interest, which were carried by the Senior Notes underlying such other Corporate HiMEDS Units
Certificate.

34

 

     (d) In the case of any Corporate HiMEDS Unit with respect to which:

     (i) Cash Settlement of the underlying Purchase Contract is properly effected pursuant
to Section 5.02(a);

     (ii) Early Settlement of the underlying Purchase Contract is properly effected pursuant
to Section 5.07;

     (iii) Merger Early Settlement of the underlying Purchase Contract is properly effected
pursuant to Section 5.04(b)(ii); or

     (iv) a Collateral Substitution is properly effected pursuant to Section 3.13,

in each case on a date that is after any Record Date and prior to or on the next succeeding Payment
Date, interest on the Senior Notes underlying such Corporate HiMEDS Unit otherwise payable on such
Payment Date shall be payable on such Payment Date notwithstanding such Cash Settlement, Early Settlement, Merger Early Settlement or Collateral Substitution, and such
payment or distributions shall, subject to receipt thereof by the Purchase Contract Agent, be
payable to the Person in whose name the Corporate HiMEDS Units Certificate (or one or more
Predecessor Corporate HiMEDS Units Certificates) was registered at 5:00 p.m., New York City time,
on the Record Date.

     (e) Except as otherwise expressly provided in Section 4.01(d), in the case of any Corporate
HiMEDS Units with respect to which Cash Settlement, Early Settlement or Merger Early Settlement of
the underlying Purchase Contract is properly effected, or with respect to which a Collateral
Substitution has been effected, payments on the related Senior Notes that would otherwise be
payable or made after the Purchase Contract Settlement Date, Early Settlement Date, Merger Early
Settlement Date or the date of the Collateral Substitution, as the case may be, shall not be
payable hereunder to the Holder of such Corporate HiMEDS Units; provided, however, that to the
extent that such Holder continues to hold Separate Senior Notes that formerly comprised a part of
such Holder’s Corporate HiMEDS Units, such Holder shall be entitled to receive payments on such
Separate Senior Notes.

     Section 4.02. Notice and Voting. (a) Upon receipt of any notices and other communications in respect of any Pledged Senior
Notes, including notice of any meeting at which holders of the Senior Notes are entitled to vote or
solicitation of consents, waivers or proxies of holders of the Senior Notes, the Collateral Agent
shall use reasonable efforts to send promptly to the Purchase Contract Agent such notice or
communication, and as soon as reasonably practicable after receipt of a written request therefor
from the Purchase Contract Agent, execute and deliver to the Purchase Contract Agent such proxies
and other instruments in respect of such Pledged Senior Notes (in form and substance satisfactory
to the Collateral Agent) as are prepared by the Company and delivered to the Purchase Contract
Agent with respect to the Pledged Senior Notes.

     (b) Upon receipt of notice of any meeting at which holders of Senior Notes are entitled to
vote or upon any solicitation of consents, waivers or proxies of holders of Senior Notes, the
Purchase Contract Agent shall, as soon as practicable thereafter, mail, first class, postage
pre-paid, to the Holders of Corporate HiMEDS Units a notice:

35

 

     (i) containing such information as is contained in the notice or solicitation;

     (ii) stating that each Holder on the record date set by the Purchase Contract Agent
therefor (which, to the extent possible, shall be the same date as the record date for
determining the holders of Senior Notes, as the case may be, entitled to vote) shall be
entitled to instruct the Purchase Contract Agent as to the exercise of the voting rights
pertaining to such Senior Notes underlying their Corporate HiMEDS Units; and

     (iii) stating the manner in which such instructions may be given.

Upon the written request of the Holders of Corporate HiMEDS Units on such record date received by
the Purchase Contract Agent at least six days prior to such meeting, the Purchase Contract Agent
shall endeavor insofar as practicable to vote or cause to be voted, in accordance with the
instructions set forth in such requests, the maximum number of Senior Notes, as the case
may be, as to which any particular voting instructions are received. In the absence of specific
instructions from the Holder of a Corporate HiMEDS Unit, the Purchase Contract Agent shall abstain
from voting the Senior Notes underlying such Corporate HiMEDS Unit. The Company hereby agrees, if
applicable, to solicit Holders of Corporate HiMEDS Units to timely instruct the Purchase Contract
Agent in order to enable the Purchase Contract Agent to vote such Senior Notes.

     (c) The Holders of Corporate HiMEDS Units and Treasury HiMEDS Units shall have no voting or
other rights in respect of Common Stock.

     Section 4.03. Payments to Purchase Contract Agent. The Securities Intermediary shall use commercially reasonable efforts to deliver any
payments required to be made by it to the Purchase Contract Agent hereunder to the account
designated by the Purchase Contract Agent for such purpose not later than 12:00 p.m., New York City
time, on the Business Day such payment is received by the Securities Intermediary; provided,
however, that if such payment is received on a day that is not a Business Day or after 11:00 a.m.,
New York City time, on a Business Day, then the Securities Intermediary shall use commercially
reasonable efforts to deliver such payment to the Purchase Contract Agent no later than 10:30 a.m.,
New York City time, on the next succeeding Business Day.

     Section 4.04. Payments Held in Trust. If the Purchase Contract Agent or any Holder shall receive any principal payments on
account of financial assets credited to the Collateral Account and not released therefrom in
accordance with this Agreement, the Purchase Contract Agent or such Holder shall hold the same as
trustee of an express trust for the benefit of the Company and, upon receipt of an Officers’
Certificate of the Company so directing, promptly deliver the same to the Securities Intermediary
for credit to the Collateral Account or to the Company for application to the Obligations of the
Holders, and the Purchase Contract Agent and Holders shall acquire no right, title or interest in
any such payments of principal amounts so received. The Purchase Contract Agent shall have no
liability under this Section 4.04 unless and until it has been notified in writing that such
payment was delivered to it erroneously and shall have no liability for any action taken, suffered
or omitted to be taken prior to its receipt of such notice.

36

 

ARTICLE 5

THE PURCHASE CONTRACTS

     Section 5.01. Purchase of Shares of Common Stock. (a) Each Purchase Contract shall obligate the Holder of
the related HiMEDS Units to purchase, and the Company to sell, on the Purchase Contract Settlement
Date at a price equal to the Stated Amount (the “Purchase Price”), a number of newly issued shares
of Common Stock (subject to Section 5.08) equal to the Settlement Rate unless an Early Settlement,
a Merger Early Settlement or a Termination Event with respect to the HiMEDS Units of which such
Purchase Contract is a part shall have occurred. The “Settlement Rate” is equal to:

     (i) if the Adjusted Applicable Market Value is equal to or greater than $65.09 (the
“Threshold Appreciation Price”), the Settlement Rate will equal a number of shares of Common
Stock determined by the following formula (such Settlement Rate being referred to as the
“High Settlement Rate”):

     where:

     “SA” refers to the Stated Amount ($50.00);

     “RP” refers to the Reference Price ($51.25);

     “AAMV” refers to the Adjusted Applicable Market Value;

     “TAP” refers to the Threshold Appreciation Price ($65.09); and

     “AF” refers to the Anti-Dilution Factor.

     (ii) if the Adjusted Applicable Market Value is less than the Threshold Appreciation
Price of $65.09 but greater than $51.25 (the “Reference Price”), the Settlement Rate will be
the number of shares of Common Stock per Purchase Contact having a value equal to the Stated
Amount divided by the Applicable Market Value;

     (iii) if the Adjusted Applicable Market Value is less than or equal to the Reference
Price, the Settlement Rate will be 0.9756 shares of Common Stock per Purchase Contract (such
Settlement Rate being referred to as the “Low Settlement Rate”);

and in each case rounded upward or downward to the nearest 1/10,000th of a share.

“Adjusted Applicable Market Value” means the product of:

     (x) the Applicable Market Value; and

37

 

     (y) the Anti-Dilution Factor in effect on the relevant Settlement Date;

provided, however, that if an adjustment to the Anti-Dilution Factor is required to be made
pursuant to Section 5.04 during the period taken into consideration for determining the
Applicable Market Value, appropriate and customary adjustments shall be made to the Anti-Dilution
Factor.

     “Applicable Market Value” means the average of the Closing Prices per share of Common Stock
(or any securities distributed in a Spin-Off or any common stock constituting part of an Exchange
Property Unit) over the Trading Days in the Observation Period; provided, however, that if the
Company enters into a Reorganization Event, Applicable Market Value shall mean the Exchange
Property Unit value. Following the occurrence of any such event, references herein to the purchase
or issuance of shares of our Common Stock should be construed to be references to settlement into
Exchange Property Units. For purposes of calculating the Exchange Property Unit value, if
applicable:

     (i) the value of any common stock shall be determined using the average of the Closing Prices
per unit of such common stock during the Observation Period; and

     (ii) the value of any other property, including securities other than common stock, shall be
the value of such property determined at the effective time of the applicable Reorganization Event.

     The “Closing Price” per share of Common Stock, or any securities distributed in a Spin-Off or
any common stock constituting part of an Exchange Property Unit, as the case may be, on any date of
determination means:

     (i) the closing sale price (or, if no closing sale price is reported, the last reported sale
price) per share on the principal U.S. national or regional securities exchange on which such
security is so listed or quoted;

     (ii) if such security is not so listed or quoted on a U.S. national or regional securities
exchange, the last quoted bid price for the such security in the over-the-counter market as
reported by the Pink Sheets LLC or similar organization; or

     (iii) if such quoted bid price is not available, the market value of such security on such
date as determined by a nationally recognized independent investment banking firm retained for this
purpose by the Company.

     A “Trading Day” means a day during which trading in securities generally occurs on:

     (i) the principal U.S. national or regional securities exchange on which the Common Stock, any
security distributed in a Spin-Off or any common stock constituting part of an Exchange Property
Unit, as the case may be, is then listed; or

     (ii) if the Common Stock, any security distributed in a Spin-Off or any common stock
constituting part of an Exchange Property Unit, as the case may be, is not listed on a U.S.
national or regional securities exchange, on the principal over-the-counter market on which the
Common Stock, any security distributed in a Spin-Off or any common stock constituting part of an
Exchange Property Unit, as the case may be, is then traded;

38

 

provided, however, that no day on which the Common Stock, any security distributed in a Spin-Off or
any common stock constituting part of an Exchange Property Unit, as the case may be, experiences
any of the following, however, will count as a Trading Day:

	 	(1)	 	any suspension of or limitation imposed on trading of the Common Stock, any
security distributed in a Spin-Off or any common stock constituting part of an Exchange
Property Unit, as the case may be, on the principal U.S. national or regional
securities exchange or automated inter-dealer quotation system or over-the-counter
market on which it is listed or traded;
	 
	 	(2)	 	any event (other than an event listed clause (3) below) that disrupts or
impairs the ability of market participants in general to effect transactions in or
obtain market values for the Common Stock, any security distributed in a Spin-Off or
any common stock constituting part of an Exchange Property Unit, as the case may be, on
the principal U.S. national or regional securities exchange or automated inter-dealer
quotation system or over-the-counter market on which it is listed or traded; or
	 
	 	(3)	 	the principal U.S. national or regional securities exchange or automated
inter-dealer quotation system or over-the-counter market on which the Common Stock, any
security distributed in a Spin-Off or any common stock constituting part of an Exchange
Property Unit, as the case may be, is listed or traded closes on any exchange business
day prior to its scheduled closing time unless, in the case of an exchange or automated
inter-dealer quotation system, such earlier closing time is announced by the exchange
or system at least one hour prior to the earlier of (i) the actual closing time for the
regular trading session on that exchange and (ii) the submission deadline for orders to
be entered into the exchange for execution on that exchange business day.

     The “Anti-Dilution Factor” shall initially be equal to one and shall be subject to adjustment
as set forth in Section 5.04.

     (b) Each Holder of a Corporate HiMEDS Unit or a Treasury HiMEDS Unit, by its acceptance of
such HiMEDS Unit:

     (i) irrevocably authorizes the Purchase Contract Agent to enter into and perform the
related Purchase Contract on its behalf as its attorney-in-fact (including, without
limitation, the execution of Certificates on behalf of such Holder);

     (ii) agrees to be bound by the terms and provisions thereof;

     (iii) covenants and agrees to perform its obligations under such Purchase Contract for
so long as such Holder remains a Holder of a Corporate HiMEDS Unit or a Treasury HiMEDS
Unit;

39

 

     (iv) consents to the provisions hereof;

     (v) irrevocably authorizes the Purchase Contract Agent to enter into and perform this
Agreement on its behalf and in its name as its attorney-in-fact; and

     (vi) consents to, and agrees to be bound by, the Pledge of such Holder’s right, title
and interest in and to the Collateral Account, including the Senior Notes or the Treasury
Securities pursuant to this Agreement,

provided that upon a Termination Event, the rights of the Holder of such HiMEDS Units under the
Purchase Contract may be enforced without regard to any other rights or obligations.

     (c) Each Holder of a Corporate HiMEDS Unit or a Treasury HiMEDS Unit, by its acceptance
thereof, further covenants and agrees that to the extent and in the manner provided in Section
5.02, but subject to the terms thereof, Proceeds of the Pledged Senior Notes or the Pledged
Treasury Securities on the Purchase Contract Settlement Date, shall be paid by the Collateral Agent
to the Company in satisfaction of such Holder’s obligations under such Purchase Contract and such
Holder shall acquire no right, title or interest in such Proceeds.

     (d) Upon registration of transfer of a Certificate, the transferee shall be bound (without the
necessity of any other action on the part of such transferee) by the terms of this Agreement and
the Purchase Contracts underlying such Certificate and the transferor shall be released from the
obligations under this Agreement and the Purchase Contracts underlying the Certificate so
transferred. The Company covenants and agrees, and each Holder of a Certificate, by its acceptance
thereof, likewise covenants and agrees, to be bound by the provisions of this Section 5.01(d).

     Section 5.02. Payment of Purchase Price; Remarketing. (a) (i) Unless a Termination Event has occurred,
or a Holder of a Corporate HiMEDS Unit has settled the underlying Purchase Contract through an
Early Settlement pursuant to Section 5.07 or a Merger Early Settlement pursuant to Section
5.04(b)(ii), each Holder of a Corporate HiMEDS Unit may pay in cash (“Cash Settlement”) the
Purchase Price for the Common Stock to be purchased pursuant to a Purchase Contract if such Holder
notifies the Purchase Contract Agent by surrender of the Corporate HiMEDS Unit Certificate, if in
certificated form, and delivery of a notice in substantially the form of Exhibit E hereto of its
intention to make a Cash Settlement. Such notice shall be made at any time following the Company’s
issuance of the Remarketing Notice on or prior to 4:00 p.m., New York City time, on the second
Business Day immediately preceding the Remarketing Date. The Purchase Contract Agent shall promptly
notify the Collateral Agent of the receipt of such a notice from a Holder intending to make a Cash
Settlement.

          A Holder of Corporate HiMEDS Units may cash settle the related Purchase Contracts pursuant to
this Section 5.02(a) only in integral multiples of 20 Corporate HiMEDS Units.

          (ii) After the Company or the Purchase Contract Agent has issued the Remarketing Notice, a
Holder of a Corporate HiMEDS Unit who has so notified the Purchase Contract Agent of its intention
to make a Cash Settlement is required to pay the requisite amount of cash in lawful money of the
United States by certified or cashier’s check or wire transfer, in

40

 

each case, in immediately available funds, equal to the Purchase Price per Purchase Contract (the
“Cash Consideration”) to the Securities Intermediary for deposit in the Collateral Account on
or prior to 4:00 p.m. New York City time on the second Business Day immediately preceding the
Remarketing Date as set forth in the Remarketing Notice and following the procedures to exchange
its Corporate HiMEDS Units for Treasury HiMEDS Units (substituting references to Treasury
Securities with references to Cash Consideration) as described in Section 3.13. In such event, all
references to the Treasury Securities or Pledged Treasury Securities herein, including for purposes
of Sections 3.15 and 5.06, shall be deemed to include such Cash Consideration in addition to the
Treasury Securities. The Collateral Agent will hold the Cash Consideration for the benefit of the
Company and apply such Cash Consideration to secure such Holder’s obligations under the Purchase
Contracts. On the Business Day immediately preceding the first day of the Remarketing Period, the
Collateral Agent will deliver the Pledged Senior Notes of such Holder to the Purchase Contract
Agent and within three Business Days thereof, the Purchase Contract Agent shall distribute such
Senior Notes to the Holders entitled thereto. Any Cash Consideration received by the Collateral
Agent will be paid to the Company on the Purchase Contract Settlement Date in settlement of the
Purchase Contract in accordance with the terms of this Agreement, and any funds received by the
Collateral Agent in excess of the Purchase Price for the Common Stock to be purchased by such
Holder shall be distributed to the Purchase Contract Agent when received for payment to the Holder.

          (iii) If a Holder of a Corporate HiMEDS Unit fails to notify the Purchase Contract Agent of
its intention to make a Cash Settlement in accordance with Section 5.02(a)(i), the Holder shall be
deemed to have consented to the disposition of the Pledged Senior Notes pursuant to the remarketing
as described in Section 5.02(c). If a Holder of a Corporate HiMEDS Unit does notify the Purchase
Contract Agent as provided in Section 5.02(a)(i) of its intention to pay the Purchase Price in
cash, but fails to make such payment as required by Section 5.02(a)(ii), the Holder shall be deemed
to have consented to the disposition of the Pledged Senior Notes pursuant to the remarketing as
described in Section 5.02(c). By 6:00 p.m., New York City time, on the second Business Day
immediately preceding the Remarketing Date, the Collateral Agent shall notify the Purchase Contract
Agent and the Remarketing Agent of the aggregate principal amount of the Pledged Senior Notes to be
remarketed by delivering a notice in the form of Exhibit K hereto and by noon, New York City time,
on the Business Day immediately preceding the Remarketing Date, shall deliver to the Remarketing
Agent for remarketing all Pledged Senior Notes.

     (b) On or prior to 4:00 p.m., New York City time, on the second Business Day immediately
preceding the Remarketing Date but no earlier than 35 Business Days prior to the Remarketing Date,
holders of Separate Senior Notes may elect to have their Separate Senior Notes remarketed under the
Remarketing Agreement by delivering their Separate Senior Notes, along with a notice of such
election, substantially in the form of Exhibit L hereto, to the Custodial Agent. The Custodial
Agent shall hold the Separate Senior Notes in an account separate from the Collateral Account in
which the Pledged Senior Notes shall be held. Holders of Separate Senior Notes electing to have
their Separate Senior Notes remarketed will also have the right to withdraw that election by
written notice to the Custodial Agent, substantially in the form of Exhibit M hereto, on or prior
to 4:00 p.m., New York City time, on the second Business Day immediately preceding the Remarketing
Date, upon which notice the Custodial Agent shall return such Separate Senior Notes to such holder.
After such time, such election to remarket shall

41

 

become an irrevocable election to have such Separate Senior Notes remarketed in such
remarketing. By 6:00 p.m., New York City time, on the second Business Day immediately
preceding the Remarketing Date, the Custodial Agent shall notify the Purchase Contract Agent and
the Remarketing Agent of the aggregate principal amount of the Separate Senior Notes to be
remarketed by delivering a notice in the form of Exhibit K hereto and by noon, New York City time,
on the Business Day immediately preceding the Remarketing Date, shall deliver to the Remarketing
Agent for remarketing all Separate Senior Notes delivered to the Custodial Agent pursuant to this
Section 5.02(b) and not withdrawn pursuant to the terms hereof prior to such date.

     (c) (i) The Company shall engage, no later than 35 days prior to the Remarketing Date, a
nationally recognized investment banking firm (the “Remarketing Agent”) pursuant to a Remarketing
Agreement to be entered into among the Company, the Remarketing Agent and the Purchase Contract
Agent, providing for remarketing procedures substantially as set forth below to sell the Senior
Notes of Holders of Corporate HiMEDS Units, other than Holders that have elected not to participate
in the remarketing pursuant to the procedures set forth in Section 5.02(a), and to sell the Senior
Notes of holders of Separate Senior Notes that have elected to participate in the remarketing
pursuant to the procedures set forth herein and Section 5.02 of the Supplemental Indenture.

          The Company or the Purchase Contract Agent, at the Company’s request, shall notify (the
“Remarketing Notice”), not later than 12:00 noon, New York City time, on the twenty-third Business
Day immediately preceding the Purchase Contract Settlement Date, Holders of Corporate HiMEDS Units,
and holders of Separate Senior Notes, of the remarketing to take place on the Remarketing Date, and
if necessary, on the eighth Business Day immediately preceding the Purchase Contract Settlement
Date, and if necessary, on the seventh Business Day immediately preceding the Purchase Contract
Settlement Date, and if necessary, on the sixth Business Day immediately preceding the Purchase
Contract Settlement Date, and if necessary, on the fifth Business Day immediately preceding the
Purchase Contract Settlement Date, and if necessary, on the fourth Business Day immediately
preceding the Purchase Contract Settlement Date, and if necessary, on the third Business Day
immediately preceding the Purchase Contract Settlement Date (each such date other than the
Remarketing Date, a “Subsequent Remarketing Date”); provided, however, that, in the event any such
date falls on a date following the third scheduled Trading Day immediately preceding the Purchase
Contract Settlement Date, such date shall not be a Subsequent Remarketing Date (and if such
Corporate HiMEDS Units or Separate Senior Notes are held in global form, the Company, or the
Purchase Contract Agent, at the Company’s request, will cause the Depositary to notify the
Depositary Participants of such remarketing by no later than the twenty-third Business Day
immediately preceding the Purchase Contract Settlement Date). The Remarketing Notice will include
the amount of cash that must be delivered by the Holders of Corporate HiMEDS Units that elect not
to participate in the remarketing and the deadline for such delivery, as well as information with
respect to the exercise of the Put Right.

          The Purchase Contract Agent shall notify, by 6:00 p.m., New York City time, on the second
Business Day immediately preceding the Remarketing Date, the Remarketing Agent and the Collateral
Agent of the aggregate principal amount of Senior Notes of Corporate HiMEDS Unit Holders to be
remarketed. On the second Business Day immediately preceding

42

 

the Remarketing Date, no later than by 6:00 p.m., New York City time, pursuant to the terms of
this Agreement, the Custodial Agent will notify the Remarketing Agent of the aggregate
principal amount of Separate Senior Notes to be remarketed. No later than noon, New York City
time, on the Business Day immediately preceding the Remarketing Date, the Collateral Agent and the
Custodial Agent, pursuant to the terms of this Agreement, will deliver for remarketing to the
Remarketing Agent all Senior Notes to be remarketed. Upon receipt of such notice from the Purchase
Contract Agent, the Collateral Agent and the Custodial Agent and such Senior Notes from the
Collateral Agent and the Custodial Agent, the Remarketing Agent will, on the Remarketing Date, and
if necessary, on each Subsequent Remarketing Date, use its reasonable best efforts to sell such
Senior Notes on such date(s) at a price per Senior Note equal to 100.25% of the Remarketing Value.

          In the event of a successful remarketing pursuant to this Section 5.02, the Remarketing Agent
will deduct and will retain for itself as a remarketing fee from the proceeds of the remarketing an
amount not exceeding 25 basis points (0.25%) of the Remarketing Value of such Notes (the
“Remarketing Fee”).

          The Remarketing Agent will then remit:

          (1) to the Custodial Agent, for the benefit of the holders of Separate Senior Notes that were
remarketed, proceeds from the remarketing equal to the principal amount of the Separate Senior
Notes included in the remarketing;

          (2) to the Collateral Agent, for the benefit of the Company, proceeds from the remarketing
equal to the principal amount of the Senior Notes included in the remarketing that were not
Separate Senior Notes, such proceeds to be used to pay the Company in direct settlement of the
Holders’ obligations under the Purchase Contracts; and

          (3) any excess amount to the Custodial Agent and the Purchase Contract Agent for distribution
to holders of the Separate Senior Notes and Holders of Corporate HiMEDS Units, in each case, on or
prior to the Purchase Contract Settlement Date.

          Holders whose Senior Notes are so remarketed will not otherwise be responsible for the payment
of any Remarketing Fee in connection therewith.

          On the Purchase Contract Settlement Date, the Collateral Agent will release the proceeds from
the remarketing of the Senior Notes that were not Separate Senior Notes to the Purchase Contract
Agent which shall pay the Company in full satisfaction of the obligations of the Holders of
Corporate HiMEDS Units under their related Purchase Contracts.

          (ii) If, in spite of using its reasonable best efforts, the Remarketing Agent cannot remarket
the Senior Notes included in the remarketing at a price per Senior Note equal to 100.25% of the
Remarketing Value of the Senior Notes included in the remarketing on the Remarketing Date, the
Remarketing Agent will attempt to establish a Reset Rate meeting these requirements on each of the
Subsequent Remarketing Dates. If, in spite of using its reasonable best efforts, the Remarketing
Agent fails to remarket the Senior Notes included in the remarketing at a price per Senior Note
equal to 100.25% of the Remarketing Value of the Senior Notes included in the remarketing on or
prior to 4:00 p.m., New York City time, on the third

43

 

scheduled Business Day immediately preceding the Purchase Contract Settlement Date, the
remarketing will be deemed to have failed (the “Last Failed Remarketing”), and in this case, the
Remarketing Agent will agree to advise the Collateral Agent in writing that it cannot remarket the
Senior Notes.

          Within three Business Days following the date of the Last Failed Remarketing, the Remarketing
Agent shall return any Senior Notes delivered to it to the Collateral Agent and the Custodial
Agent, as applicable. The Collateral Agent, for the benefit of the Company will exercise its rights
as a secured party with respect to such Senior Notes, including those actions specified in Section
5.02(c)(iii); provided that, if upon the Last Failed Remarketing, the Collateral Agent exercises
such rights for the benefit of the Company with respect to such Pledged Senior Notes, any accrued
and unpaid interest on such Pledged Senior Notes will become payable by the Company to the Purchase
Contract Agent for payment to the Holders of the Corporate HiMEDS Units to which such Pledged
Senior Notes relate. Such payment will be made by the Company on or prior to 2:00 p.m., New York
City time, on the Purchase Contract Settlement Date in lawful money of the United States by
certified or cashier’s check or wire transfer in immediately available funds payable to or upon the
order of the Purchase Contract Agent.

          In the event of any failed remarketing and/or of the Last Failed Remarketing, the Company
shall issue a press release announcing such failed remarketing or the Last Failed Remarketing by
9:00 a.m., New York City time, on the Business Day following such failed remarketing or the Last
Failed Remarketing, as the case may be. The Company shall also release this information available
on the Company’s website or through another published medium as may be used at that time and will
also release this information by means of Bloomberg and Reuters (or successor or equivalent)
newswire.

          (iii) With respect to any Senior Notes which constitute part of Corporate HiMEDS Units which
are subject to the Last Failed Remarketing, the Collateral Agent for the benefit of the Company
reserves all of its rights as a secured party with respect thereto and, subject to applicable law
and Section 5.04(f), upon instructions from the Company, shall (A) retain and cancel such Senior
Notes or (B) cause the Senior Notes to be sold, in either case, in full satisfaction of the
Holders’ obligations under the Purchase Contracts.

     (d) Following the maturity of the Pledged Treasury Securities underlying the Treasury HiMEDS
Units, on the Purchase Contract Settlement Date the Collateral Agent shall remit to the Company an
amount equal to the aggregate Purchase Price applicable to such Treasury HiMEDS Units, as payment
for the Common Stock issuable upon settlement thereof without needing to receive any instructions
from the Holders of such Treasury HiMEDS Units. In the event the payments in respect of the Pledged
Treasury Securities underlying a Treasury HiMEDS Unit are in excess of the Purchase Price of the
Purchase Contract being settled thereby, the Collateral Agent will distribute such excess to the
Purchase Contract Agent for the benefit of the Holder of such Treasury HiMEDS Unit when received.

     (e) Any distribution to Holders of excess funds and interest described in Section 5.02(c) and
Section 5.02(d) shall be payable at the office of the Purchase Contract Agent, or, if the HiMEDS
Units do not remain in book-entry only form, at the option of the Company, by

44

 

check mailed to the address of the Person entitled thereto at such Person’s address as it appears
on the Register or by wire transfer to the account maintained in the United States designated by
written notice given ten Business Days prior to the applicable payment date by such Person.

     (f) Notwithstanding anything to the contrary herein, the obligations of each Holder to pay the
Purchase Price are non-recourse obligations and are payable solely out of the proceeds of any
Collateral pledged to secure the obligations of the Holders (except to the extent paid by Cash
Settlement, Early Settlement or Merger Early Settlement), and in no event will Holders be liable
for any deficiency between such payments and the Purchase Price.

     (g) Notwithstanding anything to the contrary herein, the Company shall not be obligated to
issue any Common Stock in respect of a Purchase Contract or deliver any certificates therefor to
the Holder of the related HiMEDS Unit unless the Company shall have:

          (i) received payment in full of the aggregate Purchase Price for the Common Stock to be
purchased thereunder by such Holder in the manner herein set forth; or

          (ii) become entitled to exercise its rights as a secured party under Section 5.02(c)(iii).

     (h) The Company agrees to use its commercially reasonable efforts to ensure that, if required
by applicable law, a registration statement with regard to the full amount of the Senior Notes to
be remarketed shall be effective with the Securities and Exchange Commission in a form that will
enable the Remarketing Agent to rely on it in connection with such remarketing.

     Section 5.03. Issuance of Shares of Common Stock. (a) Unless a Termination Event, an Early Settlement or a
Merger Early Settlement shall have occurred, subject to Section 5.04(b), on the Purchase Contract
Settlement Date upon receipt of the aggregate Purchase Price payable on all Outstanding HiMEDS
Units or, following the Last Failed Remarketing, upon the Collateral Agent retaining and cancelling
the Pledged Senior Notes or selling them as directed by the Company, the Company shall issue and
deposit with the Purchase Contract Agent, for the benefit of the Holders of the Outstanding HiMEDS
Units, one or more certificates representing newly issued shares of Common Stock registered in the
name of the Purchase Contract Agent (or its nominee) as custodian for the Holders (such
certificates for shares of Common Stock, together with any dividends or distributions for which a
record date and payment date for such dividend or distribution has occurred after the Purchase
Contract Settlement Date, being hereinafter referred to as the “Purchase Contract Settlement Fund”)
to which the Holders are entitled hereunder.

     (b) Subject to the foregoing, upon surrender of a Certificate to the Purchase Contract Agent
on or after the Purchase Contract Settlement Date, together with settlement instructions thereon
duly completed and executed, the Holder of such Certificate shall be entitled to receive forthwith
in exchange therefor a certificate representing that number of newly issued whole shares of Common
Stock which such Holder is entitled to receive pursuant to the provisions of this Article 5 (after
taking into account all HiMEDS Units then held by such Holder), together with cash in lieu of
fractional shares as provided in Section 5.08 and any dividends or distributions with respect to
such shares constituting part of the Purchase Contract Settlement

45

 

Fund, but without any interest thereon, and the Certificate so surrendered shall forthwith be
cancelled. Such shares shall be registered in the name of the Holder or the Holder’s designee
as specified in the settlement instructions provided by the Holder to the Purchase Contract Agent.
If any shares of Common Stock issued in respect of a Purchase Contract are to be registered to a
Person other than the Person in whose name the Certificate evidencing such Purchase Contract is
registered (but excluding any Depositary or nominee thereof), no such registration shall be made
unless the Person requesting such registration has paid any transfer and other taxes required by
reason of such registration in a name other than that of the registered Holder of the Certificate
evidencing such Purchase Contract or has established to the satisfaction of the Company that such
tax either has been paid or is not payable.

     Section 5.04. Adjustment of Low Settlement Rate, Minimum Settlement Rate and Anti-Dilution Factor. (a) The Low
Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor shall be subject to the
following adjustments:

     (i) Stock Dividends. In case the Company shall issue to all or substantially all
holders of its Common Stock, as a dividend or other distribution, each of the Low Settlement
Rate, the Minimum Settlement Rate and the Anti-Dilution Factor, as in effect at 5:00 p.m.,
New York City time, on the day following the record date fixed for the determination of
stockholders of the Company entitled to receive such dividend or other distribution shall be
increased by dividing each of the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor by a fraction of which (a) the numerator shall be the number of shares
of Common Stock outstanding at 5:00 p.m., New York City time, on the record date for such
dividend or other distribution, and (b) the denominator shall be the sum of such number of
outstanding shares and the total number of shares constituting such dividend or other
distribution.

     Any adjustment made pursuant to this Section 5.04(a)(i) shall become effective
immediately after 5:00 p.m., New York City time, on the record date for such dividend or
other distribution. If any dividend or distribution described in this Section 5.04(a)(i) is
declared but not so paid or made, each of the Low Settlement Rate, the Minimum Settlement
Rate and the Anti-Dilution Factor shall be readjusted, effective as of the date the Board of
Directors publicly announces its decision not to make such dividend or distribution, to the
Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor that would
then be in effect if such dividend or distribution had not been declared.

     (ii) Stock Purchase Rights. In case the Company shall issue to all or substantially
all holders of its Common Stock rights, options, warrants or other securities, entitling
them to subscribe for or purchase shares of Common Stock for a period expiring within 45
days from the date of issuance of such rights, options, warrants or other securities at a
price per share of Common Stock less than the Current Market Price of the Common Stock
(other than pursuant to a dividend reinvestment, share purchase or similar plan), each of
the Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor in effect
at 5:00 p.m., New York City time, on the record date fixed for the determination of
stockholders of the Company entitled to receive such distribution shall be increased by
dividing each of the Low Settlement Rate, the Minimum Settlement

46

 

Rate and the Anti-Dilution Factor by a fraction of which (a) the numerator shall be the
sum of the number of shares of Common Stock outstanding at 5:00 p.m., New York City
time, on the record date for such distribution and the number of shares of Common Stock
which the aggregate consideration expected to be received by the Company upon the exercise,
conversion or exchange of such rights, options, warrants or securities would purchase at the
Current Market Price of the Common Stock, and (b) the denominator shall be the sum of the
number of shares of Common Stock outstanding at the 5:00 p.m., New York City time, on the
record date for such distribution and the number of shares of Common Stock so offered for
subscription or purchase, either directly or indirectly.

     Any adjustment made pursuant to this Section 5.04(a)(ii) shall become effective
immediately after 5:00 p.m., New York City time, on the record date for such distribution.
In the event that such rights, options, warrants or other securities described in this
Section 5.04(a)(ii) are not so distributed, the Low Settlement Rate, the Minimum Settlement
Rate and the Anti-Dilution Factor shall be readjusted, effective as of the date the Board of
Directors publicly announces its decision not to issue such rights, options, warrants or
other securities, to the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor that would then be in effect if the record date for such distribution
had not occurred. To the extent that such rights, options, warrants or other securities are
not exercised prior to their expiration or shares of Common Stock are otherwise not
delivered pursuant to such rights, options, warrants or other securities upon the exercise
of such rights, options, warrants or other securities, the Low Settlement Rate, the Minimum
Settlement Rate and the Anti-Dilution Factor shall be readjusted to the Low Settlement Rate,
the Minimum Settlement Rate and the Anti-Dilution Factor that would then be in effect had
the adjustments made upon the issuance of such rights, options, warrants or other securities
been made on the basis of delivery of only the numbers of shares of Common Stock actually
delivered. In determining the aggregate consideration expected to be received by the
Company for such shares of Common Stock, there shall be taken into account any consideration
received for such rights, options, warrants or other securities and the value of such
consideration if other than cash to be determined, in good faith, by the Board of Directors,
whose determination shall be conclusive and described in a Board Resolution.

     (iii) Stock Splits; Reverse Splits; and Reclassifications. In case outstanding shares
of Common Stock shall be split or reclassified into a greater number of shares of Common
Stock, each of the Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution
Factor in effect at 5:00 p.m., New York City time, on the day upon which such split or
reclassification becomes effective shall be proportionately increased. Conversely, in case
outstanding shares of Common Stock shall each be split or reclassified into a smaller number
of shares of Common Stock, each of the Low Settlement Rate, the Minimum Settlement Rate and
the Anti-Dilution Factor in effect at 5:00 p.m., New York City time, on the day upon which
such combination or reclassification becomes effective shall be proportionately reduced.

     Any adjustment made pursuant to this Section 5.04(a)(iii) shall become effective
immediately after 5:00 p.m., New York City time, on the effective date of such stock split,
reverse split or reclassification.

47

 

     (iv) Debt, Asset or Security Distributions. (1) In case the Company shall distribute
to all or substantially all holders of its Common Stock, by dividend or otherwise, evidences
of its indebtedness, assets (including cash) or securities, but excluding any dividend or
distribution referred to in Section 5.04(a)(i), any rights, options, warrants or other
securities referred to in Section 5.04(a)(ii), any dividend or distribution paid exclusively
in cash referred to in Section 5.04(a)(v), or any Spin-Off to which the provisions in this
Section 5.04(a)(iv) shall apply, each of the Low Settlement Rate, the Minimum Settlement
Rate and the Anti-Dilution Factor in effect at 5:00 p.m., New York City time, on the record
date fixed for the determination of stockholders of the Company entitled to receive such
distribution shall be increased by dividing each of the Low Settlement Rate, the Minimum
Settlement Rate and the Anti-Dilution Factor by a fraction of which (a) the numerator shall
be the Current Market Price of the Common Stock minus the Fair Market Value, on the record
date for such distribution, of the portion of the evidences of its indebtedness, assets
(including cash) or securities so distributed applicable to one share of Common Stock, and
(b) the denominator shall be such Current Market Price of the Common Stock.

          (2) In the case of a Spin-Off, that is, or, when issued, will be, traded or quoted on
the New York Stock Exchange or any other U.S. national or regional securities exchange or
market, each of the Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution
Factor in effect at 5:00 p.m., New York City time, on the record date fixed for the
determination of stockholders of the Company entitled to receive such distribution will be
increased by dividing each of the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor by a fraction of which (a) the numerator is the Current Market Price of
Common Stock, and (b) the denominator is the sum of the Current Market Price of Common Stock
and the Fair Market Value, as determined by the Board of Directors, of the portion of those
shares of capital stock or similar equity interests so distributed applicable to one share
of Common Stock.

     Any adjustment made pursuant to this Section 5.04(a)(iv) shall become effective
immediately after 5:00 p.m., New York City time, on the record date for such dividend or
distribution. In the event that such dividend or distribution described in this
Section(a)(iv) is not so made, the Low Settlement Rate, the Minimum Rate and the
Anti-Dilution Factor shall be readjusted, effective as of the date the Board of Directors
publicly announces its decision not to pay such distribution, to the Low Settlement Rate,
the Minimum Settlement Rate and the Anti-Dilution Factor that would then be in effect if
such distribution had not been declared. If an adjustment to the Low Settlement rate, the
Minimum Settlement Rate and the Anti-Dilution Factor is required under this Section
5.04(a)(iv) during any settlement period in respect of the Purchase Contracts that have been
tendered for settlement, delivery of the related settlement consideration will be delayed to
the extent necessary in order to complete the calculations provided for in this Section
5.04(a)(iv).

     (v) Cash Distributions. In case the Company shall make any distribution to all or
substantially all holders of Common Stock, by dividend or otherwise, exclusively in cash
during any quarterly period in an amount that exceeds $0.41 per share of Common Stock (such
per share amount being referred to as the “Reference Dividend”) (but

48

 

excluding any cash that is distributed in a Reorganization Event to which Section
5.04(b) applies), each of the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor in effect at 5:00 p.m., New York City time, on the record date fixed
for the determination of stockholders entitled to receive such distribution shall be
increased by dividing each of the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor by a fraction of which (a) the numerator shall be equal to the Current
Market Price of the Common Stock minus the per share amount of the cash distribution, and
(b) the denominator shall be equal to the Current Market Price of Common Stock minus the
Reference Dividend.

     Any adjustment made pursuant to this Section 5.04(a)(v) shall become effective
immediately after 5:00 p.m., New York City time, on the record date for such dividend or
distribution. In the event that any dividend or distribution described in this Section
5.04(a)(v) is not so made, the Low Settlement Rate, the Minimum Settlement Rate and the
Anti-Dilution Factor shall be readjusted, effective as of the date the Board of Directors
publicly announces its decision not to pay such dividend or distribution, to the Low
Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor which would then
be in effect if such dividend or distribution had not been declared.

     (vi) Tender Offers and Exchange Offers. In the case that a tender or exchange offer
made by the Company or any subsidiary of the Company for all or any portion of the Common
Stock shall expire and such tender or exchange offer (as amended through the expiration
thereof) shall require the payment to stockholders of the Company (based on the acceptance
(up to any maximum specified in the terms of the tender or exchange offer) of Purchased
Shares) of an aggregate consideration having a Fair Market Value per share of the Common
Stock that exceeds the Closing Price of the Common Stock on the Trading Day next succeeding
the last date (the “Tender Expiration Date”) on which tenders or exchanges may be made
pursuant to such tender or exchange offer, then each of the Low Settlement Rate, the Minimum
Settlement Rate and the Anti-Dilution Factor in effect at 5:00 p.m., New York City time, on
the Tender Expiration Date shall be increased by dividing each of the Low Settlement Rate,
the Minimum Settlement Rate and the Anti-Dilution Factor by a fraction of which (a) the
numerator shall be equal to the product of the Current Market Price of the Common Stock and
the number of shares of Common Stock outstanding immediately prior to the last time tenders
or exchanges may be made pursuant to such tender or exchange offer (the “Tender Expiration
Time”) on the Tender Expiration Date, and (b) the denominator shall be equal to the sum of
(x) the aggregate amount of cash and the Fair Market Value on the Tender Expiration Date of
the other consideration payable for shares validly tendered or exchanged and not withdrawn
as of the Tender Expiration Date (such validly tendered shares being referred to as the
“Purchased Shares”) and (y) the product of (i) the Current Market Price of the Common Stock
and (ii) the number of shares of Common Stock outstanding immediately after the Tender
Expiration Time on the Tender Expiration Date.

     Any adjustment made pursuant to this Section 5.04(a)(vi) shall become effective
immediately after 5:00 p.m., New York City time, on the Tender Expiration Date. In the
event that the Company, or one its subsidiaries, is obligated to purchase shares of Common
Stock pursuant to any such tender offer or exchange offer, but the Company, or

49

 

such subsidiary, is permanently prevented by applicable law from effecting any such
purchases, or all such purchases are rescinded, then each of the Low Settlement Rate, the
Minimum Settlement Rate and the Anti-Dilution factor shall be readjusted to be the Low
Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor that would then be
in effect if such tender offer or exchange offer had not been made. Except as set forth in
the preceding sentence, if the application of this Section 5.04(a)(vi) to any tender offer
or exchange offer would result in a decrease in each of the Low Settlement Rate, the Minimum
Settlement Rate and the Anti-Dilution Factor, no adjustment shall be made for such tender
offer or exchange offer under this Section 5.04(a)(vi). If an adjustment to each of the Low
Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor is required
pursuant to this Section 5.04(a)(vi) during any settlement period in respect of Purchase
Contracts that have been tendered for settlement, delivery of the related settlement
consideration will be delayed to the extent necessary in order to complete the calculations
provided for in this Section 5.04(a)(vi).

     (vii) Except with respect to a Spin-Off, in cases where the Fair Market Value (or the
amount of cash) of assets (including cash), debt securities or certain rights, warrants or
options to purchase the securities as to which Section 5.04(a)(iv) and Section 5.04(a)(v)
apply, applicable to one share of Common Stock, distributed to stockholders of the Company
equals or exceeds the average of the Closing Prices of the Common Stock over the 20
consecutive Trading Day period ending on the Trading Day before the Ex-Date for such
distribution, rather than being entitled to an adjustment in each of the Low Settlement
Rate, the Minimum Settlement Rate and the Anti-Dilution Factor, Holders will be entitled to
receive upon settlement, in addition to a number of shares of Common Stock equal to the
applicable Settlement Rate in effect on the applicable Settlement Date, the kind and amount
of assets (including cash), debt securities or rights, warrants or options comprising the
distribution that such holder would have received if such holder had settled its Purchase
Contracts immediately prior to the record date for determining the holders of Common Stock
entitled to receive the distribution calculated by multiplying the kind and amount of assets
(including cash), debt securities or rights, warrants or options comprising the distribution
by the number of shares of the Common Stock equal to the Settlement Rate in effect on the
applicable Settlement Date. For this purpose only, the Settlement Rate will be calculated
based on an Adjusted Applicable Market Value equal to the average of the Closing Prices of
the Common Stock over the 20 consecutive Trading Day period ending on the third Trading Day
immediately preceding the record date fixed for the determination of stockholders pf the
Company entitled to receive such distribution. For the avoidance of doubt, such calculated
Settlement Rate shall be applied for this purpose only and shall not be applicable in
connection with the calculation of the Settlement Rate for purposes of determining the
number of shares of Common Stock issuable in connection with the settlement of the Purchase
Contracts.

     (viii) Calculation of Adjustments. All adjustments to the Low Settlement Rate, the
Minimum Settlement rate and the Anti-Dilution Factor shall be calculated to the nearest
1/10,000th of a share of Common Stock. No adjustment in the Low Settlement Rate, the
Minimum Settlement Rate or the Anti-Dilution Factor shall be required unless such adjustment
would require an increase or decrease of at least one percent therein;

50

 

provided, that any adjustments which by reason of this Section 5.04(a)(viii) are not
required to be made shall be carried forward and taken into account in any subsequent
adjustment; and provided, further, that effect shall be given to anti-dilution adjustments
not later than (i) the first Trading Day of the 20 consecutive Trading Day period used to
calculate the Adjusted Applicable Market Value for purposes of calculating the Settlement
Rate in connection with the earlier of a Merger Early Settlement Date or the Purchase
Contract Settlement Date, or (ii) upon Early Settlement.

     (ix) Increase of Settlement Rate. The Company may make such increases in the Settlement
Rate, in addition to those required by this Section 5.04(a), as the Board of Directors
considers advisable in order to avoid or diminish any income tax to any holders of shares of
Common Stock resulting from any dividend or distribution of shares of Common Stock or
issuance of rights or warrants to purchase or subscribe for shares of Common Stock or from
any event treated as a dividend or distribution for income tax purposes or for any other
reasons.

     (x) Rights. If the Company hereafter adopts any stockholder rights plan involving the
issuance of preference share purchase rights or other similar rights (the “Rights”) to all
holders of the Common Stock, a Holder shall be entitled to receive upon settlement of any
Purchase Contract, in addition to the shares of Common Stock issuable upon settlement of
such Purchase Contract, the related Rights for the Common Stock, unless, prior to such
Settlement Date, such Rights under the future stockholder rights plan have separated from
the Common Stock at the time of conversion, in which case the Low Settlement Rate, the
Minimum Settlement Rate and the Anti-Dilution Factor shall be adjusted as provided in
Section 5.04(a)(iv) on the date such Rights separate from the Common Stock, subject to
readjustment in the event of the expiration, termination or redemption of such Rights.

     (b) Adjustment for Consolidation, Merger or Other Reorganization Event. (i) Upon a
Reorganization Event, each HiMEDS Unit shall thereafter, in lieu of a variable number of shares of
Common Stock, be settled by delivery of Exchange Property Units. An “Exchange Property Unit”
represents the right to receive the kind and amount of securities, cash and other property
receivable in such Reorganization Event (without any interest thereon, and without any right to
dividends or distributions thereon which have a record date that is prior to the applicable
Settlement Date) per share of Common Stock by a holder of Common Stock that is not a Person with
which the Company consolidated or into which the Company merged or which merged into the Company or
to which such sale or transfer was made, as the case may be (any such Person, a “Constituent
Person”), or an Affiliate of a Constituent Person to the extent such Reorganization Event provides
for different treatment of Common Stock held by Affiliates of the Company and non-Affiliates. In
the event holders of Common Stock have the opportunity to elect the form of consideration to be
received in such transaction, the Exchange Property Unit that Holders of the Corporate HiMEDS Units
or Treasury HiMEDS Units would have been entitled to receive will be deemed to be the weighted
average of the types and amounts of consideration received by the holders of Common Stock that
affirmatively make an election. If an Exchange Property Unit includes property other than common
stock, upon settlement, the Company may elect to deliver additional shares of common stock in lieu
of such other property; the number of such additional shares of common stock will be equal to the
Applicable Market Value of such other property

51

 

divided by the Applicable Market Value per share of such common stock. The Company may only
deliver additional shares of common stock in lieu of such other property if the Company provides
notice to the Holders of the Company’s election to do so at least three Business Days prior to the
first Trading Day that will be included in the calculation of Applicable Market Value used for
purposes of determining the Settlement Rate applicable to such settlement. The Company hereby
covenants and agrees to use its reasonable best efforts to cause any such shares of common stock
delivered in lieu of such other property on the applicable Settlement Date to be freely
transferable under the U.S. Federal securities laws by the recipients thereof upon delivery
thereto, including, if necessary, causing one or more registration statements in respect of such
shares of common stock to be filed with and declared effective by the Securities and Exchange
Commission.

          In the event of such a Reorganization Event, the Person formed by such consolidation or merger
or the Person which acquires the assets and property of the Company shall execute and deliver to
the Purchase Contract Agent an agreement supplemental hereto providing that the Holder of each
HiMEDS Unit that remains outstanding after the Reorganization Event (if any) shall have the rights
provided by this Section 5.04(b)(i). Such supplemental agreement shall provide for adjustments to
the amount of any securities constituting all or a portion of an Exchange Property Unit which, for
events subsequent to the effective date of such Reorganization Event, shall be as nearly equivalent
as may be practicable to the adjustments provided for in this Section 5.04. The above provisions
of this Section 5.04(b)(i) shall similarly apply to successive Reorganization Events.

          (ii) Prior to the Purchase Contract Settlement Date, if the Company enters into a
consolidation, acquisition or merger in which 10% or more of the total consideration paid for the
Common Stock consists of cash or cash equivalents (a “Cash Merger”), then following such Cash
Merger a Holder will have the right to accelerate and settle (“Merger Early Settlement”) its
Purchase Contract, upon the conditions set forth below, at the Settlement Rate in effect
immediately prior to the closing of the Cash Merger, provided, however, for purposes of calculating
this Settlement Rate, the Applicable Market Value shall mean the average of the Closing Prices of
the Common Stock over the 20 consecutive Trading Day period ending on the Trading Day immediately
preceding the date on which the Cash Merger becomes effective (the “Effective Date”), and the
Company will increase the applicable Settlement Rate by a number of an additional shares (such
additional number of shares being referred to as the “Make-Whole Shares”); provided that no Merger
Early Settlement will be permitted pursuant to this Section 5.04(b)(ii) unless, at the time such
Merger Early Settlement is effected, there is an effective Registration Statement with respect to
any securities to be issued and delivered in connection with such Merger Early Settlement, if such
a Registration Statement is required (in the view of counsel, which need not be in the form of a
written opinion, for the Company) under the Securities Act. If such a Registration Statement is so
required, the Company covenants and agrees to use its commercially reasonable efforts to (x) have
in effect a Registration Statement covering any securities to be delivered in respect of the
Purchase Contracts being settled and (y) provide a Prospectus in connection therewith, in each case
in a form that may be used in connection with such Merger Early Settlement. In the event that a
Holder seeks to exercise its Merger Early Settlement right and a Registration Statement is required
to be effective in connection with the exercise of such right but no such Registration Statement is
then effective, the Holder’s exercise of such right shall be void unless and until such a
Registration Statement

52

 

shall be effective and the Company shall have no further obligation with respect to any such
Registration Statement if, notwithstanding using its commercially reasonable efforts, no
Registration Statement is then effective.

          If a Holder elects a Merger Early Settlement of some or all of its Purchase Contracts, such
Holder shall be entitled to receive, on the Merger Early Settlement Date, the aggregate amount of
any accrued and unpaid Contract Adjustment Payments including and any Deferred Contract Adjustment
Payments, in each case, to but not including the Merger Early Settlement Date (unless the Merger
Early Settlement occurs after the Record Date for such Contract Adjustment Payments or Deferred
Contract Adjustment Payments), with respect to such Purchase Contracts. The Company shall pay such
amount as a credit against the amount otherwise payable by such Holder to effect such Merger Early
Settlement.

          Within five Business Days of the Effective Date, the Company shall provide written notice to
Holders of HiMEDS Units of such completion of a Cash Merger, which shall specify:

          (1) the deadline for submitting the notice to settle early in cash pursuant to this Section
5.04(b)(ii) and how and where such notice to settle early should be delivered;

          (2) the date on which such Merger Early Settlement shall occur (which date shall be no later
than the earlier of 21 Business Days after the date of such notice or two Business Days prior to
the Remarketing Date) (the “Merger Early Settlement Date”);

          (3) the amount of cash payable in respect of the exercise of such Merger Early Settlement
(giving effect to the credit for any accrued and unpaid Contract Adjustment Payments including and
any Deferred Contract Adjustment Payments as provided in the preceding paragraph);

          (4) the applicable Settlement Rate;

          (5) the number of Make-Whole Shares by which the applicable settlement rate will be increased;
and

          (6) the amount (per share of Common Stock) of cash, securities and other consideration
receivable by the Holder upon settlement, including any amount of Contract Adjustment Payments and
Deferred Contract Adjustment Payments, in each case, to but not including the Merger Early
Settlement Date (to the extent that such Contract Adjustment Payments and Deferred Contract
Adjustment Payments are not credited as provided in the preceding paragraph).

          Corporate HiMEDS Units Holders and Treasury HiMEDS Units Holders may only effect Merger Early
Settlement pursuant to this Section 5.04(b)(ii) in integral multiples of 20 Corporate HiMEDS Units
or Treasury HiMEDS Units, as the case may be. Other than the provisions relating to timing of
notice and settlement, which shall be as set forth above, the provisions of Section 5.01 shall
apply with respect to a Merger Early Settlement pursuant to this Section 5.04(b)(ii).

53

 

          In order to exercise the right to effect Merger Early Settlement with respect to any Purchase
Contracts, the Holder of the Certificate evidencing HiMEDS Units shall deliver, no later than 4:00
p.m., New York City time, on the Business Day immediately preceding the Merger Early Settlement
Date, such Certificate, if in certificated form, to the Purchase Contract Agent at the Corporate
Trust Office duly endorsed for transfer to the Company or in blank with the form of Election to
Settle Early/Merger Early Settlement on the reverse thereof duly completed and accompanied by
payment (payable to the Company in immediately available funds) in an amount equal to the sum of:

          (i) product of (A) the Stated Amount and (B) the number of Purchase Contracts with
respect to which the Holder has elected to effect Merger Early Settlement, less

          (ii) the amount of any accrued and unpaid Contract Adjustment Payments and any Deferred
Contract Adjustment Payments, in each case, to but not including the Merger Early Settlement
Date (excluding, if the Merger Early Settlement occurs after the Record Date for such
Contract Adjustment Payments or Deferred Contract Adjustment Payments, the amount of such
payments to be made on the Payment Date immediately succeeding such Record Date).

          In the event that HiMEDS Units are held by or through DTC or another Depositary, the exercise
of the right to effect Merger Early Settlement shall occur in conformity with the procedures
established by DTC or such Depositary.

          Upon receipt of any such Certificate and payment of such funds, the Purchase Contract Agent
shall pay the Company from such funds the related Purchase Price pursuant to the terms of the
related Purchase Contracts, and notify the Collateral Agent that all the conditions necessary for a
Merger Early Settlement by a Holder of HiMEDS Units have been satisfied pursuant to which the
Purchase Contract Agent has received from such Holder, and paid to the Company as confirmed in
writing by the Company, the related Purchase Price.

          Upon receipt by the Collateral Agent of the notice from the Purchase Contract Agent set forth
in the preceding paragraph, the Collateral Agent shall release from the Pledge, (1) the Pledged
Senior Notes, in the case of a Holder of Corporate HiMEDS Units, or (2) Pledged Treasury
Securities, in the case of a Holder of Treasury HiMEDS Units, in each case with a Value equal to
the product of (x) the Stated Amount and (y) the number of Purchase Contracts as to which such
Holder has elected to effect Merger Early Settlement, and shall instruct the Securities
Intermediary to Transfer all such Pledged Senior Notes or Pledged Treasury Securities, as the case
may be, to the Purchase Contract Agent for distribution to such Holder, in each case free and clear
of the Pledge created hereby.

     If a Holder properly effects an effective Merger Early Settlement in accordance with the
provisions of this Section 5.04(b)(ii), the Company will deliver (or will cause the Collateral
Agent to deliver) to the Holder on the Merger Early Settlement Date:

54

 

     (A) the kind and amount of securities, cash and other property receivable upon
such Cash Merger by a Holder of the number of shares of
Common Stock issuable on account of each Purchase Contract if the Purchase
Contract Settlement Date had occurred immediately prior to such Cash Merger (based
on the Settlement Rate in effect at such time plus the Make-Whole Shares), assuming
such Holder of Common Stock is not a Constituent Person or an Affiliate of a
Constituent Person to the extent such Cash Merger provides for different treatment
of Common Stock held by Affiliates of the Company and non-Affiliates. In the event
holders of Common Stock have the opportunity to elect the form of consideration to
be received in the Cash Merger, the kind and amount of securities, cash and other
property receivable by Holders of the Corporate HiMEDS Units or Treasury HiMEDS
Units exercising their Merger Early Settlement right will be deemed to be the
weighted average of the types and amounts of consideration received by the holders
of Common Stock that affirmatively make an election. For the avoidance of doubt,
for the purposes of determining the Applicable Market Value (in connection with
determining the appropriate Settlement Rate to be applied in the foregoing
sentence), the Effective Date of the Cash Merger shall be deemed to be the Purchase
Contract Settlement Date;

     (B) the Senior Notes or Treasury Securities, as the case may be, related to the
Purchase Contracts with respect to which the Holder is effecting a Merger Early
Settlement;

     (C) any accrued and unpaid Contract Adjustment Payments and any deferred
Contract Adjustment Payments, in each case, to but not including the cash merger
settlement date (to the extent such payments are not offset to settle the Purchase
Contracts); and

     (D) if so required under the Securities Act, a Prospectus as contemplated by
this Section 5.04(b)(ii).

          The Corporate HiMEDS Units or the Treasury HiMEDS Units of the Holders who do not elect Merger
Early Settlement in accordance Section 5.04(b)(ii) will continue to remain outstanding and be
subject to settlement on the Purchase Contract Settlement Date in accordance with the terms hereof.

          (iii) The number of Make-Whole Shares by which the applicable Settlement Rate will be
increased with respect to a Merger Early Settlement will be determined by reference to the table
below, based on the Effective Date and the price (the “Stock Price”) paid per share for Common
Stock in such Cash Merger. If holders of Common Stock receive only cash in such transaction, the
Stock Price paid per share will be the cash amount paid per share. Otherwise, the Stock Price paid
per share will be the average of the Closing Prices of the Common Stock over the 20 consecutive
Trading Day period ending on the Trading Day immediately preceding the Effective Date of such Cash
Merger.

55

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Stock Price on Effective Date
	 	 	$ 10.25	 	$ 20.50	 	$30.75	 	$ 41.00	 	$ 51.25	 	$ 61.50	 	$ 65.09	 	$ 76.88	 	$102.50	 	$153.75	 	$205.00	 	$256.25
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Effective Date
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	November 20, 2007
	 	 	0.6074	 	 	 	0.2994	 	 	 	0.1725	 	 	 	0.0783	 	 	 	0.0000	 	 	 	0.1321	 	 	 	0.1682	 	 	 	0.1216	 	 	 	0.0785	 	 	 	0.0509	 	 	 	0.0383	 	 	 	0.0306	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	November 15, 2008
	 	 	0.4159	 	 	 	0.2070	 	 	 	0.1236	 	 	 	0.0481	 	 	 	0.0000	 	 	 	0.0970	 	 	 	0.1326	 	 	 	0.0877	 	 	 	0.0536	 	 	 	0.0349	 	 	 	0.0262	 	 	 	0.0209	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	November 15, 2009
	 	 	0.2139	 	 	 	0.1069	 	 	 	0.0687	 	 	 	0.0255	 	 	 	0.0000	 	 	 	0.0589	 	 	 	0.0916	 	 	 	0.0477	 	 	 	0.0271	 	 	 	0.0179	 	 	 	0.0134	 	 	 	0.0108	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	November 15, 2010
	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 

          In the event that the Stock Price and/or Effective Date applicable to a Cash Merger is not
expressly set forth on the table, then the Make-Whole Shares will be determined as follows:

     (1) if the Stock Price is between two Stock Prices on the table or the Effective Date
is between two Effective Dates on the table, the Make-Whole Shares will be determined by
straight-line interpolation between the Make-Whole Shares set forth for the higher and lower
Stock Prices and the two Effective Dates, as applicable, based on a 365-day year;

     (2) if the Stock Price is in excess of $256.25 per share (subject to adjustment as
described above), then the Make-Whole Shares will be zero; and

     (3) if the Stock Price is less than $10.25 per share (subject to adjustment) (the
“Minimum Stock Price”), then the Make-Whole Shares will be determined as if the Stock Price
equaled the Minimum Stock Price, using straight-line interpolation, as described herein, if
the Effective Date is between two Effective Dates on the above table.

          The Stock Prices set forth in the first row of the table (i.e., the column headers) will be
adjusted upon the occurrence of certain events requiring anti-dilution adjustments to the Low
Settlement Rate, Minimum Settlement Rate and Anti-Dilution Factor pursuant to Section 5.04(a). The
adjusted Stock Prices will equal the Stock Prices divided by the Anti-Dilution Factor. The
Make-Whole Shares set forth in the table will also be subject to adjustment upon the occurrence of
the anti-dilution adjustment events and in the same manner as the Minimum Settlement Rate as set
forth in Section 5.04(a).

          Notwithstanding the foregoing, in no circumstances will the total shares deliverable (i.e.,
the sum of the applicable Settlement Rate in effect immediately prior to the Effective Date plus
the Make-Whole Shares) exceed 1.5830 (subject to adjustment).

     (c) No adjustment to the Low Settlement Rate, the Minimum Settlement Rate or the Anti-Dilution
Factor need be made if Holders may participate in the transaction that would otherwise give rise to
an adjustment. For the avoidance of doubt, in order for Holders to have been deemed to have
participated in such transaction, Holders must receive the same kind and

56

 

amount of property as holders of Common Stock on the same date as holders of Common Stock. For
purposes of determining the amount of such property Holders are entitled to receive as a result of
such transaction only, a Settlement Rate will be calculated based on an Adjusted Applicable Market
Value equal to the average of the Closing Prices per share of Common Stock over the 20 consecutive
Trading Day period ending on the third Trading Day immediately preceding the record date fixed for
the determination of stockholders of the Company entitled to receive such distribution. For the
avoidance of doubt, such calculated Settlement Rate shall be applied for this purpose only and
shall not be applicable in connection with the calculation of the Settlement Rate for purposes of
determining the number of shares of Common Stock issuable in connection with the settlement of the
Purchase Contracts.

     (d) If:

          (i) the record date for a dividend or distribution on Common Stock occurs after the end of the
20 consecutive Trading Day period used for calculating the Adjusted Applicable Market Value and
before the Purchase Contract Settlement Date; and

          (ii) such dividend or distribution would have resulted in an adjustment of the number of
shares of Common Stock issuable to the Holders had such record date occurred on or before the last
Trading Day of such 20-Trading Day period,

then the Company shall deem the Holders to be holders of record of Common Stock for purposes of
that dividend or distribution. In this case, the Holders would receive the dividend or distribution
on Common Stock together with the number of shares of Common Stock issuable upon the Purchase
Contract Settlement Date.

     (e) The Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor shall
not be adjusted:

	 	(1)	 	upon the issuance of any shares of Common Stock pursuant to any
present or future plan providing for the reinvestment of dividends or interest
payable on the Company’s securities and the investment of additional optional
amounts in shares of Common Stock under any plan;
	 
	 	(2)	 	upon the issuance of any shares of Common Stock or options or
rights to purchase those shares pursuant to any present or future employee,
director or consultant benefit plan or program of or assumed by the Company or
any of its subsidiaries;
	 
	 	(3)	 	upon the issuance of any shares of Common Stock pursuant to any
option, warrant, right or exercisable, exchangeable or convertible security
outstanding as of the date the HiMEDS Units were first issued; or
	 
	 	(4)	 	for a change in the par value or no par value of the Common
Stock.

     (f) Promptly after the calculation of the Low Settlement Rate, the Minimum Settlement Rate and
the Anti-Dilution Factor the Company shall give the Purchase Contract Agent notice thereof
accompanied by an Officers’ Certificate setting forth the bases for the

57

 

calculation in reasonable detail. All calculations and determinations of the Low Settlement
Rate, the Minimum Settlement Rate and the Anti-Dilution Factor shall be made by the Company or its
agent based on their good faith calculations and the Purchase Contract Agent shall bear no
responsibility with respect thereto.

     Section 5.05. Notice of Adjustments and Certain Other Events. (a) Whenever the Low
Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor are adjusted as herein
provided, the Company shall within 10 Business Days following the occurrence of an event that
requires such adjustment pursuant to Section 5.04 (or if the Company is not aware of such
occurrence, as soon as practicable after becoming so aware):

     (i) compute each adjusted Low Settlement Rate, Minimum Settlement Rate and
Anti-Dilution Factor in accordance with Section 5.04 and prepare and transmit to the
Purchase Contract Agent an Officers’ Certificate setting forth such adjusted Low Settlement
Rate, Minimum Settlement Rate and Anti-Dilution Factor, the method of calculation thereof in
reasonable detail, and the facts requiring such adjustment and upon which such adjustment is
based; and

     (ii) provide a written notice to the Holders of the HiMEDS Units of the occurrence of
such event and a statement in reasonable detail setting forth the method by which the
adjustment to the Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution
Factor was determined and setting forth each adjusted Low Settlement Rate, Minimum
Settlement Rate and Anti-Dilution Factor.

     (b) The Purchase Contract Agent shall not at any time be under any duty or responsibility to
any Holder of HiMEDS Units to determine whether any facts exist which may require any adjustment of
the Low Settlement Rate, the Minimum Settlement Rate and the Anti-Dilution Factor, or with respect
to the nature or extent or calculation of any such adjustment when made, or with respect to the
method employed in making the same. The Purchase Contract Agent shall be fully authorized and
protected in relying on any Officers’ Certificate delivered pursuant to Section 5.05(a)(i) and any
adjustment contained therein and the Purchase Contract Agent shall not be deemed to have knowledge
of any adjustment unless and until it has received such certificate. The Purchase Contract Agent
shall not be accountable with respect to the validity or value (or the kind or amount) of any
shares of Common Stock, or of any securities or property, which may at the time be issued or
delivered with respect to any Purchase Contract; and the Purchase Contract Agent makes no
representation with respect thereto. The Purchase Contract Agent shall not be responsible for any
failure of the Company to issue, transfer or deliver any shares of Common Stock pursuant to a
Purchase Contract or to comply with any of the duties, responsibilities or covenants of the Company
contained in this Article.

     Section 5.06. Termination Event; Notice. The Purchase Contracts and all obligations and
rights of the Company and the Holders thereunder, including, without limitation, the rights of the
Holders to receive and the obligation of the Company to pay any Contract Adjustment Payments
(including any accrued and unpaid Contract Adjustment Payments and any Deferred Contract Adjustment
Payments), and the rights and obligations of Holders to purchase Common Stock, shall immediately
and automatically terminate, without the necessity of any notice or
action by any Holder, the Purchase Contract Agent or the Company, if, prior to or on the
Purchase Contract Settlement Date, a Termination Event shall have occurred.

58

 

     Upon and after the occurrence of a Termination Event, the HiMEDS Units shall thereafter
represent the right to receive the Senior Notes or the Treasury Securities, as the case may be,
forming part of such Units, in accordance with the provisions of Section 3.15. Upon the occurrence
of a Termination Event, the Company shall promptly but in no event later than two Business Days
thereafter give written notice to the Purchase Contract Agent, the Collateral Agent and the
Holders, at their addresses as they appear in the Security Register.

     Section 5.07. Early Settlement. (a) Subject to and upon compliance with the provisions of
this Section 5.07 and the last sentence of this Section 5.07(a), at the option of the Holder
thereof, Purchase Contracts underlying HiMEDS Units may be settled early (“Early Settlement”) at
any time on or prior to 4:00 p.m., New York City time, on the Business Day immediately preceding
the first scheduled Trading Day of the Observation Period; provided that no Early Settlement will
be permitted pursuant to this Section 5.07 unless, at the time such Early Settlement is effected,
there is an effective Registration Statement with respect to any securities to be issued and
delivered in connection with such Early Settlement, if such a Registration Statement is required
(in the view of counsel, which need not be in the form of a written opinion, for the Company) under
the Securities Act. In the event that a Holder seeks to exercise its right to early settle Purchase
Contracts and a Registration Statement is required to be effective in connection with the exercise
of such right but no such Registration Statement is then effective, the Holder’s exercise of such
right shall be void unless and until such a Registration Statement shall be effective. If such a
Registration Statement is so required, the Company covenants and agrees to use commercially
reasonable efforts to (i) have in effect a Registration Statement covering any securities to be
delivered in respect of the Purchase Contracts being settled and (ii) provide a Prospectus in
connection therewith, in each case in a form that may be used in connection with such Early
Settlement. The Company shall have no further obligation with respect to any such Registration
Statement if, notwithstanding using its commercially reasonable efforts, no Registration Statement
is then effective.

     (b) In order to exercise the right to effect Early Settlement with respect to any Purchase
Contracts, the Holder of the Certificate evidencing HiMEDS Units shall deliver, at any time on or
prior to 4:00 p.m., New York City time, on the Business Day immediately preceding the first
scheduled Trading Day of the Observation Period, such Certificate, if in certificated form, to the
Purchase Contract Agent at the Corporate Trust Office duly endorsed for transfer to the Company or
in blank with the form of Election to Settle Early/Merger Early Settlement on the reverse thereof
duly completed and accompanied by payment (payable to the Company in immediately available funds)
in an amount (the “Early Settlement Amount”) equal to:

     (i) the product of (A) the Stated Amount and (B) the number of Purchase Contracts with
respect to which the Holder has elected to effect Early Settlement, plus

     (ii) if such delivery is made with respect to any Purchase Contracts during the period
from 5:00 p.m., New York City time, on any Record Date next preceding any Payment Date to
9:00 a.m., New York City time, on such Payment Date, an amount equal
to the Contract Adjustment Payments payable on such Payment Date with respect to such
Purchase Contracts, minus

59

 

     (iii) the amount of any Deferred Contract Adjustment Payments accrued and unpaid to but
not including the Payment Date immediately preceding the Early Settlement Date.

     Except as provided in the immediately preceding sentence, no payment shall be made upon Early
Settlement of any Purchase Contract on account of any Contract Adjustment Payments accrued on such
Purchase Contract or on account of any dividends on the Common Stock issued upon such Early
Settlement. If the foregoing requirements are first satisfied with respect to Purchase Contracts
underlying any HiMEDS Units on or prior to 4:00 p.m., New York City time, on a Business Day, such
day shall be the “Early Settlement Date” with respect to such HiMEDS Units and if such requirements
are first satisfied after 4:00 p.m., New York City time, on a Business Day or on a day that is not
a Business Day, the “Early Settlement Date” with respect to such HiMEDS Units shall be the next
succeeding Business Day.

     Upon the receipt of such Certificate and Early Settlement Amount from the Holder, the Purchase
Contract Agent shall pay to the Company such Early Settlement Amount, the receipt of which payment
the Company shall confirm in writing. The Purchase Contract Agent shall then notify the Collateral
Agent that:

     (A) such Holder has elected to effect an Early Settlement, which notice shall set forth the
number of such Purchase Contracts as to which such Holder has elected to effect Early Settlement;

     (B) the Purchase Contract Agent has received from such Holder, and paid to the Company as
confirmed in writing by the Company, the related Early Settlement Amount; and

     (C) all conditions to such Early Settlement have been satisfied.

     Upon receipt by the Collateral Agent of the notice from the Purchase Contract Agent set forth
in the preceding paragraph, the Collateral Agent shall release from the Pledge, (1) the Pledged
Senior Notes, in the case of a Holder of Corporate HiMEDS Units or (2) Pledged Treasury Securities,
in the case of a Holder of Treasury HiMEDS Units, in each case with a Value equal to the product of
(x) the Stated Amount and (y) the number of Purchase Contracts as to which such Holder has elected
to effect Early Settlement, and shall instruct the Securities Intermediary to Transfer all such
Pledged Senior Notes or Pledged Treasury Securities, as the case may be, to the Purchase Contract
Agent for distribution to such Holder, in each case free and clear of the Pledge created hereby.

     Holders of HiMEDS Units may only effect Early Settlement pursuant to this Section 5.07 in
integral multiples of 20 HiMEDS Units.

     Upon Early Settlement of the Purchase Contracts, the rights of the Holders to receive and the
obligation of the Company to pay any Contract Adjustment Payments (including any accrued and unpaid
Contract Adjustment Payments) with respect to such Purchase Contracts shall immediately and
automatically terminate.

60

 

     (c) Upon Early Settlement of Purchase Contracts by a Holder of the related HiMEDS Units, the
Company shall issue, and the Holder shall be entitled to receive, a number of shares of Common
Stock (or in the case of an Early Settlement following a Reorganization Event, a number of units of
Exchange Property) equal to the Minimum Settlement Rate for each Purchase Contract as to which
Early Settlement is effected.

     (d) No later than the third Business Day after the applicable Early Settlement Date, the
Company shall cause the shares of Common Stock issuable upon Early Settlement of Purchase Contracts
to be issued and delivered, together with payment in lieu of any fraction of a share, as provided
in Section 5.08.

     (e) Upon Early Settlement of any Purchase Contracts, and subject to receipt of shares of
Common Stock from the Company and the Senior Notes or Treasury Securities, as the case may be, from
the Securities Intermediary, as applicable, the Purchase Contract Agent shall, in accordance with
the instructions provided by the Holder thereof on the applicable form of Election to Settle
Early/Merger Early Settlement on the reverse of the Certificate evidencing the related HiMEDS
Units:

     (i) transfer to the Holder the Senior Notes or Treasury Securities, as the case may be,
forming a part of such HiMEDS Units free and clear of the security interest, and

     (ii) deliver to the Holder a certificate or certificates for the full number of shares
of Common Stock issuable upon such Early Settlement, together with payment in lieu of any
fraction of a share, as provided in Section 5.08.

     (f) The Company shall, if so required under the Securities Act, deliver a Prospectus for the
shares of Common Stock issuable upon such Early Settlement as contemplated by Section 5.07(a).

     (g) In the event that Early Settlement is effected with respect to Purchase Contracts
underlying less than all the HiMEDS Units evidenced by a Certificate, upon such Early Settlement
the Company shall execute and the Purchase Contract Agent shall execute on behalf of the Holder,
authenticate and deliver to the Holder thereof, at the expense of the Company, a Certificate
evidencing the HiMEDS Units as to which Early Settlement was not effected.

     (h) A Holder of a HiMEDS Unit who effects Early Settlement may elect to have the Senior Notes
no longer a part of a Corporate HiMEDS Unit remarketed in accordance with the provisions of Section
5.02.

     Section 5.08. No Fractional Shares. No fractional shares or scrip representing fractional
shares of Common Stock shall be issued or delivered upon settlement on the Purchase Contract
Settlement Date, or upon Early Settlement or Merger Early Settlement of any Purchase Contracts. If
Certificates evidencing more than one Purchase Contract shall be surrendered for settlement at one
time by the same Holder, the number of full shares of Common Stock which shall be delivered upon
settlement shall be computed on the basis of the aggregate number of Purchase Contracts evidenced
by the Certificates so surrendered. Instead of any fractional share of Common Stock which would
otherwise be deliverable upon settlement of any Purchase Contracts on the Purchase Contract
Settlement Date, or upon Early Settlement or Merger Early

61

 

Settlement, the Company, through the Purchase Contract Agent, shall make a cash payment in
respect of such fractional interest in an amount equal to the percentage of such fractional share
times the Applicable Market Value (calculated in accordance with Section 5.01(a) in connection with
a settlement on the Purchase Contract Settlement Date, as the average of the Closing Prices of the
Common Stock over the 20 consecutive Trading Day period ending on the third Trading Day immediately
preceding the Early Settlement Date, and in accordance with Section 5.04(b)(ii) in connection with
an Merger Early Settlement, respectively). The Company shall provide the Purchase Contract Agent
from time to time with sufficient funds to permit the Purchase Contract Agent to make all cash
payments required by this Section 5.08 in a timely manner.

     Section 5.09. Charges and Taxes. The Company will pay all stock transfer and similar taxes
attributable to the initial issuance and delivery of the shares of Common Stock pursuant to the
Purchase Contracts; provided, however, that the Company shall not be required to pay any such tax
or taxes which may be payable in respect of any exchange of or substitution for a Certificate
evidencing a HiMEDS Unit or any issuance of a share of Common Stock in a name other than that of
the registered Holder of a Certificate surrendered in respect of the HiMEDS Units evidenced
thereby, other than in the name of the Purchase Contract Agent, as custodian for such Holder, and
the Company shall not be required to issue or deliver such share certificates or Certificates
unless or until the Person or Persons requesting the transfer or issuance thereof shall have paid
to the Company the amount of such tax or shall have established to the satisfaction of the Company
that such tax has been paid.

     Section 5.10. Contract Adjustment Payments. (a) Subject to Section 5.10(d) and 5.11, the
Company shall pay, on each Payment Date, the Contract Adjustment Payments payable in respect of
each Purchase Contract to the Person in whose name a Certificate is registered at 5:00 p.m., New
York City time, on the Record Date relating to such Payment Date. The Contract Adjustment Payments
will be payable at the office of the Purchase Contract Agent maintained for that purpose. If the
book-entry system for the HiMEDS Units has been terminated, the Contract Adjustment Payments will
be payable, at the option of the Company, by check mailed to the address of the Person entitled
thereto at such Person’s address as it appears on the Security Register, or by wire transfer to the
account designated by such Person by a prior written notice to the Purchase Contract Agent.
Contract Adjustment Payments payable for any period will be computed (1) for any full quarterly
period on the basis of a 360-day year of twelve 30-day months and (2) for any period other than a
full quarterly period on the basis of the actual number of days elapsed and a 360-day year.
Contract Adjustment Payments will accrue from November 20, 2007.

     (b) Upon the occurrence of a Termination Event, the Company’s obligation to pay future
Contract Adjustment Payments (including any accrued Contract Adjustment Payments) and any Deferred
Contract Adjustment Payments shall cease.

     (c) Each Certificate delivered under this Agreement upon registration of transfer of or in
exchange for or in lieu of (including as a result of a Collateral Substitution or the recreation of
Corporate HiMEDS Units) any other Certificate shall carry the right to accrued and unpaid Contract
Adjustment Payments and Deferred Contract Adjustment Payments, which right was carried by the
Purchase Contracts underlying such other Certificates.

62

 

     (d) In the case of any HiMEDS Unit with respect to which Early Settlement or Merger Early
Settlement of the underlying Purchase Contract is effected on a date that is after any Record Date
and prior to or on the next succeeding Payment Date, Contract Adjustment Payments and Deferred
Contract Adjustment Payments otherwise payable on such Payment Date shall be payable on such
Payment Date notwithstanding such Early Settlement or Merger Early Settlement, and such Contract
Adjustment Payments and Deferred Contract Adjustment Payments shall be paid to the Person in whose
name the Certificate evidencing such HiMEDS Unit is registered at 5:00 p.m., New York City time, on
such Record Date. Except as otherwise expressly provided in the immediately preceding sentence,
and the right to receive accrued and unpaid Contract Adjustment Payments as set forth in Section
5.04(b)(ii), in the case of any HiMEDS Unit with respect to which Early Settlement or Merger Early
Settlement of the underlying Purchase Contract is effected, Contract Adjustment Payments (but not,
for the avoidance of doubt, Deferred Contract Adjustment Payments) that would otherwise be payable
after the Early Settlement or Merger Early Settlement Date with respect to such Purchase Contract
shall not be payable.

     (e) The Company’s obligations with respect to Contract Adjustment Payments and Deferred
Contract Adjustment Payments, if any, will be subordinated and junior in right of payment to the
Company’s obligations under any Senior Indebtedness.

     (f) In the event:

          (x) of any payment by, or distribution of assets of, the Company of any kind or character,
whether in cash, property or securities, to creditors upon any dissolution, winding-up, liquidation
or reorganization of the Company, whether voluntary or involuntary or in bankruptcy, insolvency,
receivership or other proceedings; or

          (y) subject to the provisions of Section 5.10(h), that (i) a default shall have occurred and
be continuing with respect to the payment of principal, interest or any other monetary amounts due
and payable on any Senior Indebtedness and such default shall have continued beyond the period of
grace, if any, specified in the instrument evidencing such Senior Indebtedness (and the Purchase
Contract Agent shall have received written notice thereof from the Company or one or more holders
of Senior Indebtedness or their representative or representatives or the trustee or trustees under
any indenture pursuant to which any such Senior Indebtedness may have been issued) or (ii) the
maturity of any Senior Indebtedness shall have been accelerated because of a default in respect of
such Senior Indebtedness (and the Purchase Contract Agent shall have received written notice
thereof from the Company or one or more holders of Senior Indebtedness or their representative or
representatives or the trustee or trustees under any indenture pursuant to which any such Senior
Indebtedness may have been issued),

then:

     (i) the holders of all Senior Indebtedness shall first be entitled to receive, in the
case of clause (x) above, payment of all amounts due or to become due upon all Senior
Indebtedness and, in the case of subclauses (i) and (ii) of clause (y) above, payment of all
amounts due thereon, or provision shall be made for such payment in money or money’s worth,
before the Holders of any of the HiMEDS Units are entitled to
receive any Contract Adjustment Payments or Deferred Contract Adjustment Payments on
the Purchase Contracts underlying the HiMEDS Units;

63

 

     (ii) any payment by, or distribution of assets of, the Company of any kind or
character, whether in cash, property or securities, to which the Holders of any of the
HiMEDS Units would be entitled except for the provisions of Section 5.10(e) through (q),
including any such payment or distribution which may be payable or deliverable by reason of
the payment of any other indebtedness of the Company being subordinated to the payment of
such Contract Adjustment Payments or Deferred Contract Adjustment Payments on the Purchase
Contracts underlying the HiMEDS Units, shall be paid or delivered by the Person making such
payment or distribution, whether a trustee in bankruptcy, a receiver or liquidating trustee
or otherwise, directly to the representative or representatives of the holders of Senior
Indebtedness or to the trustee or trustees under any indenture under which any instruments
evidencing any of such Senior Indebtedness may have been issued, ratably according to the
aggregate amounts remaining unpaid on account of such Senior Indebtedness held or
represented by each, to the extent necessary to make payment in full of all Senior
Indebtedness remaining unpaid after giving effect to any concurrent payment or distribution
(or provision therefor) to the holders of such Senior Indebtedness, before any payment or
distribution is made of such Contract Adjustment Payments or Deferred Contract Adjustment
Payments to the Holders of such HiMEDS Units; and

     (iii) in the event that, notwithstanding the foregoing, any payment by, or distribution
of assets of, the Company of any kind or character, whether in cash, property or securities,
including any such payment or distribution which may be payable or deliverable by reason of
the payment of any other indebtedness of the Company being subordinated to the payment of
Contract Adjustment Payments or Deferred Contract Adjustment Payments on the Purchase
Contracts underlying the HiMEDS Units, shall be received by the Purchase Contract Agent or
the Holders of any of the HiMEDS Units when such payment or distribution is prohibited
pursuant to Section 5.10(e) through (q), such payment or distribution shall be paid over to
the representative or representatives of the holders of Senior Indebtedness or to the
trustee or trustees under any indenture pursuant to which any instruments evidencing any
such Senior Indebtedness may have been issued, ratably as aforesaid, for application to the
payment of all Senior Indebtedness remaining unpaid until all such Senior Indebtedness shall
have been paid in full, after giving effect to any concurrent payment or distribution (or
provision therefor) to the holders of such Senior Indebtedness.

     (g) For purposes of Section 5.10(e) through (q), the words “cash, property or securities”
shall not be deemed to include shares of stock of the Company as reorganized or readjusted, or
securities of the Company or any other Person provided for by a plan of reorganization or
readjustment, the payment of which is subordinated at least to the extent provided in Section
5.10(e) through (q) with respect to such Contract Adjustment Payments or Deferred Contract
Adjustment Payments on the HiMEDS Units to the payment of all Senior Indebtedness which may at the
time be outstanding; provided that (i) the indebtedness or guarantee of indebtedness, as the case
may be, that constitutes Senior Indebtedness is assumed by the Person, if any, resulting from any
such reorganization or readjustment, and (ii) the rights
of the holders of the Senior Indebtedness are not, without the consent of each such holder
adversely affected thereby, altered by such reorganization or readjustment;

64

 

     (h) Any failure by the Company to make any payment on or perform any other obligation under
Senior Indebtedness, other than any indebtedness incurred by the Company or assumed or guaranteed,
directly or indirectly, by the Company for money borrowed (or any deferral, renewal, extension or
refunding thereof) or any indebtedness or obligation as to which the provisions of Section 5.10(e)
through (q) shall have been waived by the Company in the instrument or instruments by which the
Company incurred, assumed, guaranteed or otherwise created such indebtedness or obligation, shall
not be deemed a default or event of default if (i) the Company shall be disputing its obligation to
make such payment or perform such obligation and (ii) either (A) no final judgment relating to such
dispute shall have been issued against the Company which is in full force and effect and is not
subject to further review, including a judgment that has become final by reason of the expiration
of the time within which a party may seek further appeal or review, and (B) in the event a judgment
that is subject to further review or appeal has been issued, the Company shall in good faith be
prosecuting an appeal or other proceeding for review and a stay of execution shall have been
obtained pending such appeal or review.

     (i) Subject to the irrevocable payment in full of all Senior Indebtedness, the Holders of the
HiMEDS Units shall be subrogated (equally and ratably with the holders of all obligations of the
Company which by their express terms are subordinated to Senior Indebtedness of the Company to the
same extent as payment of the Contract Adjustment Payments and Deferred Contract Adjustment
Payments in respect of the Purchase Contracts underlying the HiMEDS Units is subordinated and which
are entitled to like rights of subrogation) to the rights of the holders of Senior Indebtedness to
receive payments or distributions of cash, property or securities of the Company applicable to the
Senior Indebtedness until all such Contract Adjustment Payments and Deferred Contract Adjustment
Payments owing on the HiMEDS Units shall be paid in full, and as between the Company, its creditors
other than holders of such Senior Indebtedness and the Holders, no such payment or distribution
made to the holders of Senior Indebtedness by virtue of Section 5.10(e) through (q) that otherwise
would have been made to the Holders shall be deemed to be a payment by the Company on account of
such Senior Indebtedness, it being understood that the provisions of Section 5.10(e) through (q)
are and are intended solely for the purpose of defining the relative rights of the Holders, on the
one hand, and the holders of Senior Indebtedness, on the other hand.

     (j) Nothing contained in Section 5.10(e) through (q) or elsewhere in this Agreement or in the
HiMEDS Units is intended to or shall impair, as among the Company, its creditors other than the
holders of Senior Indebtedness and the Holders, the obligation of the Company, which is absolute
and unconditional, to pay to the Holders such Contract Adjustment Payments and Deferred Contract
Adjustment Payments on the HiMEDS Units as and when the same shall become due and payable in
accordance with their terms, or is intended to or shall affect the relative rights of the Holders
and creditors of the Company other than the holders of Senior Indebtedness, nor shall anything
herein or therein prevent the Purchase Contract Agent or any Holder from exercising all remedies
otherwise permitted by applicable law upon default under this Agreement, subject to the rights, if
any, under Section 5.10(e) through (q), of the holders of
Senior Indebtedness in respect of cash, property or securities of the Company received upon
the exercise of any such remedy.

65

 

     (k) Upon payment or distribution of assets of the Company referred to in Section 5.10(e)
through (q), the Purchase Contract Agent and the Holders shall be entitled to rely upon any order
or decree made by any court of competent jurisdiction in which any such dissolution, winding up,
liquidation or reorganization proceeding affecting the affairs of the Company is pending or upon a
certificate of the trustee in bankruptcy, receiver, assignee for the benefit of creditors,
liquidating trustee or Purchase Contract Agent or other person making any payment or distribution,
delivered to the Purchase Contract Agent or to the Holders, for the purpose of ascertaining the
Persons entitled to participate in such payment or distribution, the holders of the Senior
Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the
amount or amounts paid or distributed thereon and all other facts pertinent thereto or to these
Section 5.10(e) through (q).

     (l) The Purchase Contract Agent shall be entitled to rely on the delivery to it of a written
notice by a Person representing himself to be a holder of Senior Indebtedness (or a trustee or
representative on behalf of such holder) to establish that such notice has been given by a holder
of Senior Indebtedness or a trustee or representative on behalf of any such holder or holders. In
the event that the Purchase Contract Agent determines in good faith that further evidence is
required with respect to the right of any Person as a holder of Senior Indebtedness to participate
in any payment or distribution pursuant to Section 5.10(e) through (q), the Purchase Contract Agent
may request such Person to furnish evidence to the reasonable satisfaction of the Purchase Contract
Agent as to the amount of Senior Indebtedness held by such Person, the extent to which such Person
is entitled to participate in such payment or distribution and any other facts pertinent to the
rights of such Person under Section 5.10(e) through (q), and, if such evidence is not furnished,
the Purchase Contract Agent may defer payment to such Person pending judicial determination as to
the right of such Person to receive such payment.

     (m) Nothing contained in Section 5.10(e) through (q) shall affect the obligations of the
Company to make, or prevent the Company from making, payment of the Contract Adjustment Payments
and Deferred Contract Adjustment Payments, except as otherwise provided in these Section 5.10(e)
through (q).

     (n) Each Holder of HiMEDS Units, by its acceptance thereof, authorizes and directs the
Purchase Contract Agent on its behalf to take such action as may be necessary or appropriate to
effectuate the subordination provided in Section 5.10(e) through (q) and appoints the Purchase
Contract Agent its attorney-in-fact, as the case may be, for any and all such purposes.

     (o) The Company shall give prompt written notice to the Purchase Contract Agent of any fact
known to the Company that would prohibit the making of any payment of moneys to or by the Purchase
Contract Agent in respect of the HiMEDS Units pursuant to the provisions of this Section.
Notwithstanding the provisions of Section 5.10(e) through (q) or any other provisions of this
Agreement, the Purchase Contract Agent shall not be charged with knowledge of the existence of any
facts that would prohibit the making of any payment of moneys to or by the Purchase Contract Agent,
or the taking of any other action by the Purchase Contract Agent, unless and until the Purchase
Contract Agent shall have received written notice thereof mailed or

66

 

delivered to the Purchase Contract Agent at its Institutional Trust Services department from
the Company, any Holder, or the holder or representative of any Senior Indebtedness; provided that
if at least two Business Days prior to the date upon which by the terms hereof any such moneys may
become payable for any purpose, the Purchase Contract Agent shall not have received with respect to
such moneys the notice provided for in this Section, then, anything herein contained to the
contrary notwithstanding, the Purchase Contract Agent shall have full power and authority to
receive such moneys and to apply the same to the purpose for which they were received and shall not
be affected by any notice to the contrary that may be received by it within two Business Days prior
to or on or after such date.

     (p) The Purchase Contract Agent in its individual capacity shall be entitled to all the rights
set forth in this Section with respect to any Senior Indebtedness at the time held by it, to the
same extent as any other holder of Senior Indebtedness and nothing in this Agreement shall deprive
the Purchase Contract Agent of any of its rights as such holder.

     (q) No right of any present or future holder of any Senior Indebtedness to enforce the
subordination herein shall at any time or in any way be prejudiced or impaired by any act or
failure to act on the part of the Company or by any noncompliance by the Company with the terms,
provisions and covenants of this Agreement, regardless of any knowledge thereof which any such
holder may have or be otherwise charged with.

     (r) Nothing in this Section 5.10 shall apply to claims of, or payments to, the Purchase
Contract Agent under or pursuant to Section 7.07.

     (s) With respect to the holders of Senior Indebtedness:

     (i) the duties and obligations of the Purchase Contract Agent shall be determined
solely by the express provisions of this Agreement;

     (ii) the Purchase Contract Agent shall not be liable to any such holders if it shall,
acting in good faith, mistakenly pay over or distribute to the Holders or to the Company or
any other Person cash, property or securities to which any holders of Senior Indebtedness
shall be entitled by virtue of this Section 5.10 or otherwise;

     (iii) no implied covenants or obligations shall be read into this Agreement against the
Purchase Contract Agent; and

     (iv) the Purchase Contract Agent shall not be deemed to be a fiduciary as to such
holders.

     Section 5.11. Deferral of Contract Adjustment Payments. (a) The Company has the right at any
time, and from time to time, to defer payment of all or part of the Contract Adjustment Payments in
respect of each Purchase Contract by extending the period for payment of Contract Adjustment
Payments to any subsequent Payment Date (an “Extension Period”), but not beyond the Purchase
Contract Settlement Date (or, with respect to Purchase Contracts for which an Early Settlement or
Merger Early Settlement is effected, the Early Settlement Date or Merger Early Settlement Date, as
the case may be). Prior to the expiration of any Extension Period, the Company may further extend
such Extension Period to any subsequent Payment
Date, but not beyond the Purchase Contract Settlement Date (or any applicable Early Settlement
Date or Merger Early Settlement Date).

67

 

     If the Company so elects to defer Contract Adjustment Payments, the Company shall pay
additional Contract Adjustment Payments on such deferred installments of Contract Adjustment
Payments at a rate equal to 6.00% per annum, compounding on each succeeding Payment Date, until
such deferred installments are paid in full (such deferred installments of Contract Adjustment
Payments together with the accrued additional Contract Adjustment Payments thereon, being referred
to herein as the “Deferred Contract Adjustment Payments”).

     At the end of each Extension Period, including as the same may be extended as provided above,
or, in the event of an Early Settlement or Merger Early Settlement is effected, on the Early
Settlement Date or Merger Early Settlement Date, as the case may be, the Company shall pay all
Deferred Contract Adjustment Payments then due in the manner set forth in Section 5.10(a) (in the
case of the end of an Extension Period), in the manner set forth in Section 5.07(b) (in the case of
an Early Settlement) or in the manner set forth in Section 5.04(b)(ii) (in the case of a Merger
Early Settlement) to the extent such amounts are not deducted from the amount otherwise payable by
the Holder in the case of an Early Settlement or a Merger Early Settlement. In the event of an
Early Settlement, the Company shall pay all Deferred Contract Adjustment Payments due on the
Purchase Contracts being settled early to but not including the Payment Date immediately preceding
the applicable Early Settlement Date. In the event of a Merger Early Settlement, the Company shall
pay all Deferred Contract Adjustment Payments due on the Purchase Contracts being settled on the
Merger Early Settlement Date to but including such Merger Early Settlement Date.

     Upon termination of any Extension Period and the payment of all Deferred Contract Adjustment
Payments and all accrued and unpaid Contract Adjustment Payments then due, the Company may commence
a new Extension Period, provided that such Extension Period, together with all extensions thereof,
may not extend beyond the Purchase Contract Settlement Date (or any applicable Early Settlement
Date or Merger Early Settlement Date). Except in the case of an Early Settlement or Merger Early
Settlement, no Contract Adjustment Payments shall be due and payable during an Extension Period
except at the end thereof, except that prior to the end of such Extension Period, the Company, at
its option, may prepay on any Payment Date all or any portion of the Deferred Contract Adjustment
Payments accrued during the then elapsed portion of such Extension Period.

     (b) The Company shall give written notice to the Purchase Contract Agent (and the Purchase
Contract Agent shall give notice thereof to Holders of Purchase Contracts) of its election to
extend any period for the payment of Contract Adjustment Payments, the expected length of any such
Extension Period and any extension of any Extension Period, at least five Business Days before the
earlier of:

     (i) the Record Date for the Payment Date on which Contract Adjustment Payments would
have been payable except for the election to begin or extend the Extension Period; or

68

 

     (ii) the date the Purchase Contract Agent is required to give notice to any securities
exchange or to Holders of Purchase Contracts of such Record Date or such Payment Date.

     (c) The Company shall give written notice to the Purchase Contract Agent (and the Purchase
Contract Agent shall give notice thereof to Holders of Purchase Contracts) of the end of an
Extension Period or its election to pay any portion of the Deferred Contract Adjustment Payments on
a payment date prior to the end of an Extension Period, at least five Business Days before the
earlier of:

     (i) the Record Date for the Payment Date on which such Extension Period shall end or
such payment of Deferred Contract Adjustment Payments shall be made; or

     (ii) the date the Purchase Contract Agent is required to give notice to any securities
exchange or to Holders of Purchase Contracts of such Record Date or such Payment Date.

     In the event the Company exercises its option to defer the payment of Contract Adjustment
Payments, then, until the Deferred Contract Adjustment Payments have been paid in full, the Company
shall not, and shall not permit any of its subsidiaries to, declare or pay dividends on, make
distributions with respect to, or redeem, purchase or acquire, or make a liquidation payment with
respect to, any of its capital stock or their capital stock or make guarantee payments with respect
to the foregoing; provided that the foregoing will not restrict:

     (i) the Company from declaring or paying dividends on the outstanding shares of its
capital stock in shares of its capital stock; or

     (ii) the Company’s subsidiaries from declaring or paying any dividends, or making any
distributions, to the Company or any of the Company’s other subsidiaries.

     Section 5.12. No Net Cash Settlement . In the event the Company does not have an effective
Registration Statement, there is no circumstance that would require the Company to “net cash”
settle the HiMEDS units.

ARTICLE 6

RIGHTS AND REMEDIES OF HOLDERS

     Section 6.01. Unconditional Right of Holders to Receive Contract Adjustment Payments and to
Purchase Shares of Common Stock. Each Holder of a HiMEDS Unit shall have the right, which is
absolute and unconditional:

     (i) subject to Article 5, to receive each Contract Adjustment Payment and Deferred Contract
Adjustment Payment with respect to the Purchase Contract comprising part of such HiMEDS Unit on the
respective Payment Date for such HiMEDS Unit; and

     (ii) except upon and following a Termination Event, to purchase shares of Common Stock
pursuant to such Purchase Contract; and,

69

 

in each such case, to institute suit for the enforcement of any such right to receive Contract
Adjustment Payments and the right to purchase shares of Common Stock, and such rights shall not be
impaired without the consent of such Holder.

     Section 6.02. Restoration of Rights and Remedies. If any Holder has instituted any proceeding
to enforce any right or remedy under this Agreement and such proceeding has been discontinued or
abandoned for any reason, or has been determined adversely to such Holder, then and in every such
case, subject to any determination in such proceeding, the Company and such Holder shall be
restored severally and respectively to their former positions hereunder, and thereafter all rights
and remedies of such Holder shall continue as though no such proceeding had been instituted.

     Section 6.03. Rights and Remedies Cumulative. Except as otherwise provided with respect to
the replacement or payment of mutilated, destroyed, lost or stolen Certificates in the last
paragraph of Section 3.10, no right or remedy herein conferred upon or reserved to the Holders is
intended to be exclusive of any other right or remedy, and every right and remedy shall, to the
extent permitted by law, be cumulative and in addition to every other right and remedy given
hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or
employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent
assertion or employment of any other appropriate right or remedy.

     Section 6.04. Delay or Omission Not Waiver. No delay or omission of any Holder to exercise
any right upon a default or remedy upon a default shall impair any such right or remedy or
constitute a waiver of any such right. Every right and remedy given by this Article or by law to
the Holders may be exercised from time to time, and as often as may be deemed expedient, by such
Holders.

     Section 6.05. Undertaking for Costs. All parties to this Agreement agree, and each Holder of
a HiMEDS Unit, by its acceptance of such HiMEDS Unit shall be deemed to have agreed, that any court
may in its discretion require, in any suit for the enforcement of any right or remedy under this
Agreement, or in any suit against the Purchase Contract Agent for any action taken, suffered or
omitted by it as Purchase Contract Agent, the filing by any party litigant in such suit of an
undertaking to pay the costs of such suit, and that such court may in its discretion assess
reasonable costs, including reasonable attorneys’ fees and costs against any party litigant in such
suit, having due regard to the merits and good faith of the claims or defenses made by such party
litigant; provided that the provisions of this Section shall not apply to any suit instituted by
the Purchase Contract Agent, to any suit instituted by any Holder, or group of Holders, holding in
the aggregate more than 10% of the Outstanding HiMEDS Units, or to any suit instituted by any
Holder for the enforcement of interest on any Senior Notes or Contract Adjustment Payments on or
after the respective Payment Date therefor in respect of any HiMEDS Unit held by such Holder
(subject to Section 5.11), or for enforcement of the right to purchase shares of Common Stock under
the Purchase Contracts constituting part of any HiMEDS Unit held by such Holder.

     Section 6.06. Waiver of Stay or Extension Laws. The Company covenants (to the extent that it
may lawfully do so) that it will not at any time insist upon, or plead, or in any manner whatsoever
claim or take the benefit or advantage of, any stay or extension law wherever

70

 

enacted, now or at
any time hereafter in force, which may affect the covenants or the performance of this Agreement;
and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or
advantage of any such law and covenants that it will not hinder, delay or impede the execution of
any power herein granted to the Purchase Contract Agent or the Holders, but will suffer and permit
the execution of every such power as though no such law had been enacted.

ARTICLE 7

THE PURCHASE CONTRACT AGENT

     Section 7.01. Certain Duties and Responsibilities. (a) The Purchase Contract Agent:

     (i) undertakes to perform, with respect to the HiMEDS Units, such duties and only such
duties as are specifically set forth in this Agreement and the Remarketing Agreement and no
implied covenants or obligations shall be read into this Agreement or the Remarketing
Agreement against the Purchase Contract Agent; and

     (ii) in the absence of bad faith or gross negligence on its part, may, with respect to
the HiMEDS Units, conclusively rely, as to the truth of the statements and the correctness
of the opinions expressed therein, upon certificates or opinions furnished to the Purchase
Contract Agent and conforming on their face to the requirements of this Agreement or the
Remarketing Agreement, as applicable, but in the case of any certificates or opinions which
by any provision hereof are specifically required to be furnished to the Purchase Contract
Agent, the Purchase Contract Agent shall be under a duty to examine the same to determine
whether or not they conform on their face to the requirements of this Agreement or the
Remarketing Agreement, as applicable (but need not confirm or investigate the accuracy of
the mathematical calculations, facts stated therein or the substance or sufficiency
thereof).

     (b) No provision of this Agreement or the Remarketing Agreement shall be construed to relieve
the Purchase Contract Agent from liability for its own grossly negligent action, its own grossly
negligent failure to act, or its own willful misconduct, except that:

     (i) this paragraph shall not be construed to limit the effect of Section 7.01(a);

     (ii) the Purchase Contract Agent shall not be liable for any error of judgment made in
good faith by a Responsible Officer, unless it shall be conclusively determined by a court
of competent jurisdiction that the Purchase Contract Agent was grossly negligent in
ascertaining the pertinent facts; and

     (iii) no provision of this Agreement or the Remarketing Agreement shall require the
Purchase Contract Agent to expend or risk its own funds or otherwise incur any financial
liability in the performance of any of its duties hereunder, or in the exercise of any of
its rights or powers.

     (c) Whether or not therein expressly so provided, every provision of this Agreement and the
Remarketing Agreement relating to the conduct or affecting the liability of or affording protection
to the Purchase Contract Agent shall be subject to the provisions of this Section.

71

 

     (d) The Purchase Contract Agent is authorized to execute and deliver the Remarketing Agreement
in its capacity as Purchase Contract Agent.

     Section 7.02. Notice of Default. Within 30 days after the occurrence of any default by the
Company hereunder of which a Responsible Officer of the Purchase Contract Agent has actual
knowledge, the Purchase Contract Agent shall transmit by mail to the Company and the Holders of
HiMEDS Units, as their names and addresses appear in the Security Register, notice of such default
hereunder, unless such default shall have been cured or waived.

     Section 7.03. Certain Rights of Purchase Contract Agent. Subject to the provisions of Section
7.01:

     (a) the Purchase Contract Agent may, in the absence of bad faith, conclusively rely and shall
be fully protected in acting or refraining from acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note,
other evidence of indebtedness or other paper or document believed by it to be genuine and to have
been signed or presented by the party or parties specified therein;

     (b) any request or direction of the Company mentioned herein shall be sufficiently evidenced
by an Officers’ Certificate or Issuer Order, and any resolution of the Board of Directors of the
Company may be sufficiently evidenced by a Board Resolution;

     (c) whenever in the administration of this Agreement or the Remarketing Agreement the Purchase
Contract Agent shall deem it desirable that a matter be proved or established prior to taking,
suffering or omitting to take any action hereunder, the Purchase Contract Agent (unless other
evidence be herein specifically prescribed in this Agreement) may, in the absence of bad faith on
its part, conclusively rely upon an Officers’ Certificate of the Company and any Opinion of Counsel
delivered therewith;

     (d) the Purchase Contract Agent may consult with counsel of its selection and the advice of
such counsel or any Opinion of Counsel shall be full and complete authorization and protection in
respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance
thereon;

     (e) the Purchase Contract Agent shall not be bound to make any investigation into the facts or
matters stated in any resolution, certificate, statement, instrument, opinion, report, notice,
request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other
paper or document, but the Purchase Contract Agent, in its discretion, may make reasonable further
inquiry or investigation into such facts or matters related to the execution, delivery and
performance of the Purchase Contracts as it may see fit, and, if the Purchase Contract Agent shall
determine to make such further inquiry or investigation, it shall be entitled to examine the
relevant books, records and premises of the Company, personally or by agent or attorney;

     (f) the Purchase Contract Agent may execute any of the powers hereunder or perform any duties
hereunder either directly or by or through agents, attorneys, custodians or nominees or an
Affiliate and the Purchase Contract Agent shall not be responsible for any misconduct or negligence
on the part of any agent, attorney, custodian or nominee or an Affiliate appointed with due care by
it hereunder;

72

 

     (g) the Purchase Contract Agent shall be under no obligation to exercise any of the rights or
powers vested in it by this Agreement at the request or direction of any of the Holders pursuant to
this Agreement, unless such Holders shall have offered to the Purchase Contract Agent security or
indemnity satisfactory to the Purchase Contract Agent against the costs, expenses and liabilities
which might be incurred by it in compliance with such request or direction;

     (h) the Purchase Contract Agent shall not be liable for any action taken, suffered, or omitted
to be taken by it in the absence of bad faith or gross negligence by it;

     (i) the Purchase Contract Agent shall not be deemed to have notice of adjustment to the
Settlement Rate, the occurrence of a Termination Event or any default hereunder unless a
Responsible Officer of the Purchase Contract Agent has actual knowledge thereof or unless written
notice of any such adjustment, occurrence or event which is in fact such a default is received by a
Responsible Offer at the Corporate Trust Office of the Purchase Contract Agent, and such notice
references the HiMEDS Units and this Agreement;

     (j) the Purchase Contract Agent may request that the Company deliver an Officers’ Certificate
setting forth the names of individuals and/or titles of officers authorized at such time to take
specified actions pursuant to this Agreement, which Officers’ Certificate may be signed by any
person authorized to sign an Officers’ Certificate, including any person specified as so authorized
in any such certificate previously delivered and not superseded;

     (k) the rights, privileges, protections, immunities and benefits given to the Purchase
Contract Agent, including, without limitation, its right to be indemnified, are extended to, and
shall be enforceable by, the Purchase Contract Agent in each of its capacities hereunder, and to
each agent, custodian and other Person employed to act hereunder;

     (l) the Purchase Contract Agent shall not be required to initiate or conduct any litigation or
collection proceedings hereunder and shall have no responsibilities with respect to any default
hereunder except as expressly set forth herein; and

     (m) the Purchase Contract Agent shall not be responsible or liable for any failure or delay in
the performance of its obligations under this Agreement arising out of or caused directly or
indirectly, by acts of God; earthquake; fires; floods; wars; civil or military disturbances;
terrorist acts; sabotage; epidemics; riots; interruptions, loss or malfunctions of utilities;
accidents; labor disputes; and acts of civil or military authority or governmental actions; it
being understood that the Purchase Contract Agent shall use reasonable efforts which are consistent
with accepted practices in the banking industry to resume performance as soon as practicable under
the circumstances.

     Section 7.04. Not Responsible for Recitals or Issuance of HiMEDS Units. The recitals
contained herein, in the Remarketing Agreement and in the Certificates shall be taken as the
statements of the Company, and the Purchase Contract Agent assumes no responsibility for their
accuracy or validity. The Purchase Contract Agent makes no representations as to the validity or
sufficiency of either this Agreement, the Remarketing Agreement or of the HiMEDS Units or the
Pledge or the Collateral and shall have no responsibility for perfecting or maintaining the

73

 

perfection of any security interest in the Collateral. The Purchase Contract Agent shall not be
accountable for the use or application by the Company of the proceeds in respect of the HiMEDS
Units or the Purchase Contracts.

     Section 7.05. May Hold HiMEDS Units. Any Security Registrar or any other agent of the
Company, or the Purchase Contract Agent and its Affiliates, in their individual or any other
capacity, may become the owner or pledgee of HiMEDS Units and may otherwise deal with the Company,
the Collateral Agent or any other Person with the same rights it would have if it were not Security
Registrar or such other agent, or the Purchase Contract Agent. The Company may become the owner or
pledgee of HiMEDS Units.

     Section 7.06. Money Held In Custody. Money held by the Purchase Contract Agent in custody
hereunder need not be segregated from the Purchase Contract Agent’s other funds except to the
extent required by law or provided herein. The Purchase Contract Agent shall be under no
obligation to invest or pay interest on any money received by it hereunder except as otherwise
provided hereunder or agreed in writing with the Company.

     Section 7.07. Compensation and Reimbursement. The Company agrees: (a) to pay to the
Purchase Contract Agent compensation for all services rendered by it hereunder and under the
Remarketing Agreement as the Company and the Purchase Contract Agent shall from time to time agree
in writing;

     (b) except as otherwise expressly provided for herein, to reimburse the Purchase Contract
Agent upon its request for all expenses, disbursements and advances incurred or made by the
Purchase Contract Agent in accordance with any provision of this Agreement and the Remarketing
Agreement (including the compensation and the expenses and disbursements of its agents and counsel)
in connection with the negotiation, preparation, execution and delivery and performance of this
Agreement and the Remarketing Agreement and any modification, supplement or waiver of any of the
terms thereof, except any such expense, disbursement or advance as may be attributable to its gross
negligence, willful misconduct or bad faith; and

     (c) to indemnify the Purchase Contract Agent and any predecessor Purchase Contract Agent (and
each of its directors, officers, agents and employees (collectively, the “Indemnitees”) for, and to
hold each Indemnitee harmless against, any loss, claim, damage, fine, penalty, liability or expense
(including fees and expenses of counsel) incurred without gross negligence, willful misconduct or
bad faith on its part, arising out of or in connection with the acceptance or administration of its
duties hereunder and the Remarketing Agreement, including the Indemnitees’ reasonable costs and
expenses of defending themselves against any claim (whether asserted by the Company, a Holder or
any other person) or liability in connection with the exercise or performance of any of the
Purchase Contract Agent’s powers or duties hereunder or thereunder.

     In addition, and without prejudice to the rights provided to the Purchase Contract Agent
hereunder, when the Purchase Contract Agent incurs expenses or renders services after a Termination
Event occurs, the expenses and the compensation for the services (including the fees and expenses
of its counsel) are intended to constitute expenses of administration under any applicable federal
or state bankruptcy law.

74

 

     The provisions of this Section shall survive the resignation and removal of the Purchase
Contract Agent, the satisfaction and discharge of the HiMEDS Units and the termination of this
Agreement.

     Section 7.08. Corporate Purchase Contract Agent Required; Eligibility. There shall at all
times be a Purchase Contract Agent hereunder which shall be a Person organized and doing business
under the laws of the United States of America, any State thereof or the District of Columbia,
authorized under such laws to exercise corporate trust powers, having (or being a member of a bank
holding company having) a combined capital and surplus of at least $50,000,000, subject to
supervision or examination by Federal or State authority. If such Person publishes or files
reports of condition at least annually, pursuant to law or to the requirements of said supervising
or examining authority, then for the purposes of this Section, the combined capital and surplus of
such Person shall be deemed to be its combined capital and surplus as set forth in its most recent
report of condition so published or filed. If at any time the Purchase Contract Agent shall cease
to be eligible in accordance with the provisions of this Section, it shall resign immediately in
the manner and with the effect hereinafter specified in this Article.

     Section 7.09. Resignation and Removal; Appointment of Successor. (a) No resignation or
removal of the Purchase Contract Agent and no appointment of a successor Purchase Contract Agent
pursuant to this Article shall become effective until the acceptance of appointment by the
successor Purchase Contract Agent in accordance with the applicable requirements of Section 7.10.

     (b) The Purchase Contract Agent may resign at any time by giving written notice thereof to the
Company 60 days prior to the effective date of such resignation. If the instrument of acceptance
by a successor Purchase Contract Agent required by Section 7.10 shall not have been delivered to
the Purchase Contract Agent within 30 days after the giving of such notice of resignation, the
resigning Purchase Contract Agent may petition, at the expense of the Company, any court of
competent jurisdiction for the appointment of a successor Purchase Contract Agent.

     (c) The Purchase Contract Agent may be removed at any time by Act of the Holders of a majority
in number of the Outstanding HiMEDS Units delivered to the Purchase Contract Agent and the Company.
If the instrument of acceptance by a successor Purchase Contract Agent required by Section 7.10
shall not have been delivered to the Purchase Contract Agent within 30 days after such Act, the
Purchase Contract Agent being removed may petition any court of competent jurisdiction for the
appointment of a successor Purchase Contract Agent.

     (d) If at any time:

     (i) the Purchase Contract Agent fails to comply with Section 310(b) of the TIA, as if
the Purchase Contract Agent were an indenture trustee under an indenture
qualified under the TIA, and shall fail to resign after written request therefor by the
Company or by any Holder who has been a bona fide Holder of a HiMEDS Unit for at least six
months;

75

 

     (ii) the Purchase Contract Agent shall cease to be eligible under Section 7.08 and
shall fail to resign after written request therefor by the Company or by any such Holder; or

     (iii) the Purchase Contract Agent shall become incapable of acting or shall be adjudged
a bankrupt or insolvent or a receiver of the Purchase Contract Agent or of its property
shall be appointed or any public officer shall take charge or control of the Purchase
Contract Agent or of its property or affairs for the purpose of rehabilitation, conservation
or liquidation,

then, in any such case, (i) the Company by a Board Resolution may remove the Purchase
Contract Agent, or (ii) any Holder who has been a bona fide Holder of a HiMEDS Unit for at
least six months may, on behalf of himself and all others similarly situated, petition any
court of competent jurisdiction for the removal of the Purchase Contract Agent and the
appointment of a successor Purchase Contract Agent.

     (e) If the Purchase Contract Agent shall resign, be removed or become incapable of acting, or
if a vacancy shall occur in the office of Purchase Contract Agent for any cause, the Company, by a
Board Resolution, shall promptly appoint a successor Purchase Contract Agent and shall comply with
the applicable requirements of Section 7.10. If no successor Purchase Contract Agent shall have
been so appointed by the Company and accepted appointment in the manner required by Section 7.10,
any Holder who has been a bona fide Holder of a HiMEDS Unit for at least six months, on behalf of
itself and all others similarly situated, or the Purchase Contract Agent may petition at the
expense of the Company, any court of competent jurisdiction for the appointment of a successor
Purchase Contract Agent.

     (f) The Company shall give, or shall cause such successor Purchase Contract Agent to give,
notice of each resignation and each removal of the Purchase Contract Agent and each appointment of
a successor Purchase Contract Agent by mailing written notice of such event by first-class mail,
postage prepaid, to all Holders as their names and addresses appear in the Security Register. Each
notice shall include the name of the successor Purchase Contract Agent and the address of its
Corporate Trust Office.

     Section 7.10. Acceptance of Appointment by Successor. (a) In case of the appointment
hereunder of a successor Purchase Contract Agent, every such successor Purchase Contract Agent so
appointed shall execute, acknowledge and deliver to the Company and to the retiring Purchase
Contract Agent an instrument accepting such appointment, and thereupon the resignation or removal
of the retiring Purchase Contract Agent shall become effective and such successor Purchase Contract
Agent, without any further act, deed or conveyance, shall become vested with all the rights,
powers, agencies and duties of the retiring Purchase Contract Agent; but, on the request of the
Company or the successor Purchase Contract Agent, such retiring Purchase Contract Agent shall, upon
payment of amounts owed to it pursuant to Section 7.07, execute and deliver an instrument
transferring to such successor Purchase Contract Agent all the
rights, powers and trusts of the retiring Purchase Contract Agent and duly assign, transfer
and deliver to such successor Purchase Contract Agent all property and money held by such retiring
Purchase Contract Agent hereunder.

76

 

     (b) Upon request of any such successor Purchase Contract Agent, the Company shall execute any
and all instruments for more fully and certainly vesting in and confirming to such successor
Purchase Contract Agent all such rights, powers and agencies referred to in Section 7.10(a).

     (c) No successor Purchase Contract Agent shall accept its appointment unless at the time of
such acceptance such successor Purchase Contract Agent shall be qualified and eligible under this
Article.

     Section 7.11. Merger, Conversion, Consolidation or Succession to Business. Any Person into
which the Purchase Contract Agent may be merged or converted or with which it may be consolidated,
or any Person resulting from any merger, conversion or consolidation to which the Purchase Contract
Agent shall be a party, or any Person succeeding to all or substantially all the corporate trust
business of the Purchase Contract Agent, shall be the successor of the Purchase Contract Agent
hereunder, provided that such Person shall be otherwise qualified and eligible under this Article,
without the execution or filing of any paper or any further act on the part of any of the parties
hereto. In case any Certificates shall have been authenticated and executed on behalf of the
Holders, but not delivered, by the Purchase Contract Agent then in office, any successor by merger,
conversion or consolidation to such Purchase Contract Agent may adopt such authentication and
execution and deliver the Certificates so authenticated and executed with the same effect as if
such successor Purchase Contract Agent had itself authenticated and executed such HiMEDS Units.

     Section 7.12. Preservation of Information; Communications to Holders. (a) The Purchase
Contract Agent shall preserve, in as current a form as is reasonably practicable, the names and
addresses of Holders received by the Purchase Contract Agent in its capacity as Security Registrar.

     (b) If three or more Holders (herein referred to as “Applicants”) apply in writing to the
Purchase Contract Agent, and furnish to the Purchase Contract Agent reasonable proof that each such
Applicant has owned a HiMEDS Unit for a period of at least six months preceding the date of such
application, and such application states that the Applicants desire to communicate with other
Holders with respect to their rights under this Agreement or under the HiMEDS Units and is
accompanied by a copy of the form of proxy or other communication which such Applicants propose to
transmit, then the Purchase Contract Agent shall mail to all the Holders copies of the form of
proxy or other communication which is specified in such request, with reasonable promptness after a
tender to the Purchase Contract Agent of the materials to be mailed and of payment, or provision
for the payment, of the reasonable expenses of such mailing.

     Section 7.13. No Obligations of Purchase Contract Agent. Except to the extent otherwise
expressly provided in this Agreement, the Purchase Contract Agent assumes no obligations and shall
not be subject to any liability under this Agreement, the Remarketing
Agreement or any Purchase Contract in respect of the obligations of the Holder of any HiMEDS
Unit thereunder. The Company agrees, and each Holder of a Certificate, by its acceptance thereof,
shall be deemed to have agreed, that the Purchase Contract Agent’s execution of the Certificates on
behalf of the Holders shall be solely as agent and attorney-in-fact of the Holders,

77

 

and that the
Purchase Contract Agent shall have no obligation to perform such Purchase Contracts on behalf of
the Holders, except to the extent expressly provided in Article Five. Anything contained in this
Agreement to the contrary notwithstanding, in no event shall the Purchase Contract Agent or its
officers, directors, employees or agents be liable under this Agreement or the Remarketing
Agreement for indirect, incidental, special, punitive, or consequential loss or damage of any kind
whatsoever, including lost profits, whether or not the likelihood of such loss or damage was known
to the Purchase Contract Agent and regardless of the form of action.

     Section 7.14. Tax Compliance. (a) The Purchase Contract Agent, on its own behalf and on
behalf of the Company, will comply with all applicable certification, information reporting and
withholding (including “backup” withholding) requirements imposed by applicable tax laws,
regulations or administrative practice with respect to (i) any payments made with respect to the
HiMEDS Units or (ii) the issuance, delivery, holding, transfer, redemption or exercise of rights
under the HiMEDS Units. Such compliance shall include, without limitation, the preparation and
timely filing of required returns and the timely payment of all amounts required to be withheld to
the appropriate taxing authority or its designated agent.

     (b) The Purchase Contract Agent shall comply in accordance with the terms hereof with any
written direction received from the Company with respect to the execution or certification of any
required documentation and the application of such requirements to particular payments or Holders
or in other particular circumstances, and may for purposes of this Agreement conclusively rely on
any such direction in accordance with the provisions of Section 7.01.

     (c) The Purchase Contract Agent shall maintain all appropriate records documenting compliance
with such requirements, and shall make such records available, on written request, to the Company
or its authorized representative within a reasonable period of time after receipt of such request.

ARTICLE 8

SUPPLEMENTAL AGREEMENTS

     Section 8.01. Supplemental Agreements without Consent of Holders. Without the consent of any
Holders, the Company, when authorized by a Board Resolution, the Purchase Contract Agent, the
Collateral Agent, the Custodial Agent and the Securities Intermediary at any time and from time to
time, may enter into one or more agreements supplemental hereto, in form satisfactory to the
Company and the Purchase Contract Agent, to:

     (a) evidence the succession of another Person to the Company, and the assumption by any such
successor of the covenants of the Company herein and in the Certificates;

     (b) evidence and provide for the acceptance of appointment hereunder by a successor Purchase
Contract Agent, Collateral Agent, Securities Intermediary or Custodial Agent;

     (c) add to the covenants of the Company for the benefit of the Holders, or surrender any right
or power herein conferred upon the Company, provided that such covenants or such
surrender do not adversely affect the validity, perfection or priority of the Pledge created hereunder;

78

 

     (d) make provision with respect to the rights of Holders pursuant to and consistent with the
requirements of Section 5.04(b)(i);

     (e) cure any ambiguity (or formal defect), or correct or supplement any provisions herein that
may be inconsistent with any other provisions herein; or

     (f) make any other provisions with respect to such matters or questions arising under this
Agreement; provided that such action shall not adversely affect the interests of the Holders in any
material respect; provided, further, that any amendment made solely to conform the provisions of
this Agreement to the description of the HiMEDS Units and the Purchase Contracts contained in the
Prospectus will not be deemed to adversely affect the interests of the Holders.

     Section 8.02. Supplemental Agreements with Consent of Holders. With the consent of the
Holders of not less than a majority of the Outstanding HiMEDS Units voting together as one class,
including without limitation the consent of the Holders obtained in connection with a tender or an
exchange offer, by Act of said Holders delivered to the Company, the Purchase Contract Agent, the
Collateral Agent, the Securities Intermediary, the Custodial Agent and the Company, when authorized
by a Board Resolution, may enter into an agreement or agreements supplemental hereto for the
purpose of modifying in any manner the terms of the Purchase Contracts, or the provisions of this
Agreement or the rights of the Holders in respect of the HiMEDS Units; provided, however, that,
except as contemplated herein, no such supplemental agreement shall, without the unanimous consent
of the Holders of each outstanding Purchase Contract affected thereby,

     (a) change any Payment Date;

     (b) change the amount of Collateral required to be Pledged to secure a Holder’s obligations
under the Purchase Contract (except for the rights of holders of Corporate HiMEDS Units to
substitute Treasury Securities for the Pledged Senior Notes or the rights of Holders of Treasury
HiMEDS Units to substitute Senior Notes for the Pledged Treasury Securities), impair the right of
the Holder of any HiMEDS Units to receive distributions on the related Collateral or otherwise
adversely affect the Holder’s rights in or to such Collateral;

     (c) impair the Holders’ right to institute suit for the enforcement of any Purchase Contract
or any payment of any Contract Adjustment Payments or any Deferred Contract Adjustment Payments;

     (d) reduce the number of shares of Common Stock or the amount of any other property to be
purchased pursuant to any Purchase Contract, increase the price to purchase shares of Common Stock
or any other property upon settlement of any Purchase Contract except, in
each case, to the extent expressly provided in Section 5.04 or change the Purchase Contract
Settlement Date or the right to Early Settlement or Merger Early Settlement or otherwise adversely
affect the Holder’s rights under the Purchase Contract;

79

 

     (e) reduce any Contract Adjustment Payments or any Deferred Contract Adjustment Payments or
change any place where, or the coin or currency in which, any Contract Adjustment Payment is
payable;

     (f) reduce the percentage of the outstanding Purchase Contracts the consent of whose Holders
is required for any modification or amendment to the provisions of this Agreement or the Purchase
Contracts; or

     (g) otherwise effect any action that would require the consent of the Holder of each
Outstanding HiMEDS Unit affected thereby if such action were effected by a modification or
amendment of the provisions of this Agreement;

     provided that if any amendment or proposal referred to above would adversely affect only the
Corporate HiMEDS Units or the Treasury HiMEDS Units, then only the affected class of Holders as of
the record date for the Holders entitled to vote thereon will be entitled to vote on such amendment
or proposal, and such amendment or proposal shall not be effective except with the consent of
Holders of not less than a majority of such class; and provided, further, that the unanimous
consent of the Holders of each outstanding Purchase Contract of such class affected thereby shall
be required to approve any amendment or proposal specified in clauses (a) through (g) above.

     It shall not be necessary for any Act of Holders under this Section to approve the particular
form of any proposed supplemental agreement, but it shall be sufficient if such Act shall approve
the substance thereof.

     Section 8.03. Execution of Supplemental Agreements. In executing, or accepting the additional
agencies created by, any supplemental agreement permitted by this Article or the modifications
thereby of the agencies created by this Agreement, the Purchase Contract Agent, the Collateral
Agent, the Securities Intermediary and the Custodial Agent shall be provided, and (subject to
Section 7.01 with respect to the Purchase Contract Agent) shall be fully authorized and protected
in relying upon, an Officers’ Certificate and an Opinion of Counsel stating that the execution of
such supplemental agreement is authorized or permitted by this Agreement and that any and all
conditions precedent to the execution and delivery of such supplemental agreement have been
satisfied. The Purchase Contract Agent, the Collateral Agent, the Securities Intermediary and the
Custodial Agent may, but shall not be obligated to, enter into any such supplemental agreement
which affects their own rights, duties or immunities under this Agreement or otherwise.

     Section 8.04. Effect of Supplemental Agreements. Upon the execution of any supplemental
agreement under this Article, this Agreement shall be modified in accordance therewith, and such
supplemental agreement shall form a part of this Agreement for all purposes; and every Holder of
Certificates theretofore or thereafter authenticated, executed on behalf of the Holders and
delivered hereunder, shall be bound thereby.

     Section 8.05. Reference to Supplemental Agreements. Certificates authenticated, executed on
behalf of the Holders and delivered after the execution of any supplemental agreement pursuant to
this Article may, and shall if required by the Purchase Contract Agent,

80

 

bear a notation in form approved by the Purchase Contract Agent as to any
matter provided for in such supplemental agreement. If the Company shall so determine, new
Certificates so modified as to conform, in the opinion of the Purchase Contract Agent and the
Company, to any such supplemental agreement may be prepared and executed by the Company and
authenticated, executed on behalf of the Holders and delivered by the Purchase Contract Agent in
exchange for outstanding Certificates.

ARTICLE 9

CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER OR LEASE

     Section 9.01. Covenant Not to Consolidate, Merge, Convey, Transfer or Lease Property Except
under Certain Conditions. The Company covenants that it will not consolidate with, convert into, or merge with and
into, any other Person or sell, assign, transfer, lease or convey all or substantially all of its
properties and assets to any Person, unless:

     (a) either the Company shall be the surviving Person, or the successor (if other than the
Company) shall be a corporation or limited liability company organized and existing under the laws
of the United States of America or a State thereof or the District of Columbia and such corporation
or limited liability company shall expressly assume all the obligations of the Company under the
Purchase Contracts, this Agreement (including the Pledge provided for herein), the Indenture
(including any supplement thereto) and the Remarketing Agreement by one or more supplemental
agreements in form reasonably satisfactory to the Purchase Contract Agent and the Collateral Agent,
executed and delivered to the Purchase Contract Agent and the Collateral Agent by such corporation
or limited liability company; and

     (b) the Company or such successor corporation or limited liability company, as the case may
be, shall not, immediately after such consolidation, conversion, merger, sale, assignment,
transfer, lease or conveyance, be in default of payment obligations under the Purchase Contracts,
this Agreement, the Indenture (including any supplement thereto) or the Remarketing Agreement or in
material default in the performance of any other covenants under any of the foregoing agreements.

     Section 9.02. Rights and Duties of Successor Corporation. In case of any such merger, consolidation, share exchange, sale, assignment, transfer,
lease or conveyance and upon any such assumption by a successor corporation in accordance with
Section 9.01, such surviving Person shall succeed to and be substituted for the Company with the
same effect as if it had been named herein as the Company. Such surviving Person thereupon may
cause to be signed, and may issue either in its own name or in the name of Avery Dennison
Corporation any or all of the Certificates evidencing HiMEDS Units issuable hereunder which
theretofore shall not have been signed by the Company and delivered to the Purchase Contract Agent;
and, upon the order of such surviving Person, instead of the Company, and subject to all the terms,
conditions and limitations in this Agreement prescribed, the Purchase Contract Agent shall
authenticate and execute on behalf of the Holders and deliver any Certificates which previously
shall have been signed and delivered by the officers of the Company to the Purchase Contract Agent
for authentication and execution, and any Certificate evidencing HiMEDS Units which such surviving
Person thereafter shall cause to be signed and delivered to the Purchase Contract Agent for that
purpose. All the Certificates issued shall in all respects have the same legal rank and

81

 

benefit under this Agreement as the Certificates theretofore or thereafter issued in accordance with the
terms of this Agreement as though all of such Certificates had been issued at the date of the
execution hereof.

     In case of any such merger, consolidation, share exchange, sale, assignment, transfer, lease
or conveyance such change in phraseology and form (but not in substance) may be made in the
Certificates evidencing HiMEDS Units thereafter to be issued as may be appropriate.

     Section 9.03. Officers’ Certificate and Opinion of Counsel Given to Purchase Contract Agent. The Purchase Contract Agent, subject to Section 7.01 and Section 7.03, shall receive an
Officers’ Certificate and an Opinion of Counsel as conclusive evidence that any such merger,
consolidation, share exchange, sale, assignment, transfer, lease or conveyance, and any such
assumption, complies with the provisions of this Article and that all conditions precedent to the
consummation of any such merger, consolidation, share exchange, sale, assignment, transfer, lease
or conveyance have been met.

ARTICLE 10

COVENANTS

     Section 10.01. Performance under Purchase Contracts. The Company covenants and agrees for the benefit of the Holders from time to time of the
HiMEDS Units that it will duly and punctually perform its obligations under the Purchase Contracts
in accordance with the terms of the Purchase Contracts and this Agreement.

     Section 10.02. Maintenance of Office or Agency. The Company will maintain an office or agency where Certificates may be presented or
surrendered for acquisition of shares of Common Stock upon settlement of the Purchase Contracts on
the Purchase Contract Settlement Date or upon Early Settlement or Merger Early Settlement and for
transfer of Collateral upon occurrence of a Termination Event, where Certificates may be
surrendered for registration of transfer or exchange, for a Collateral Substitution or recreation
of Corporate HiMEDS Units and where notices and demands to or upon the Company in respect of the
HiMEDS Units and this Agreement may be served. The Company will give prompt written notice to the
Purchase Contract Agent of the location, and any change in the location, of such office or agency.
The Company initially designates the Corporate Trust Office of the Purchase Contract Agent as such
office of the Company, and the Company hereby appoints the Purchase Contract Agent as its agent to
receive all such presentations, surrenders, notices and demands. If at any time the Company shall
fail to maintain any such required office or agency or shall fail to furnish the Purchase Contract
Agent with the address thereof, such presentations, surrenders, notices and demands may be made or
served at the Corporate Trust Office, and the Company hereby appoints the Purchase Contract Agent
as its agent to receive all such presentations, surrenders, notices and demands.

     The Company may also from time to time designate one or more other offices or agencies where
Certificates may be presented or surrendered for any or all such purposes and may from time to time rescind such designations. The Company will give prompt written notice to the
Purchase Contract Agent of any such designation or rescission and of any change in the location of
any such other office or agency. The Company hereby designates as the place of payment for

82

 

the
HiMEDS Units the Corporate Trust Office and appoints the Purchase Contract Agent at its Corporate
Trust Office as paying agent in the city in which such Corporate Trust Office is located.

     Section 10.03. Company to Reserve Common Stock. The Company shall at all times prior to the Purchase Contract Settlement Date reserve and
keep available, free from preemptive rights, out of its authorized but unissued Common Stock the
full number of shares of Common Stock issuable against tender of payment in respect of all Purchase
Contracts constituting a part of Outstanding HiMEDS Units.

     Section 10.04. Covenants as to Common Stock; Listing. (a) The Company covenants that all shares of Common Stock which may be issued against
tender of payment in respect of any Purchase Contract constituting a part of the Outstanding HiMEDS
Units will, upon issuance, be duly authorized, validly issued, fully paid and nonassessable.

     The Company further covenants that, if at any time the Common Stock shall be listed on the
NYSE, the NASDAQ or any other national securities exchange or automated quotation system, the
Company will, if permitted by the rules of such exchange or automated quotation system, list and
keep listed, or obtain and maintain approval for listing subject to notice of issuance (which
notice the Company covenants to give concurrently with the issuance of Common Stock pursuant
hereto), so long as the Common Stock shall be so listed on such exchange or automated quotation
system, all Common Stock issuable upon Settlement of Purchase Contracts; provided, however, that,
if the rules of such exchange or automated quotation system permit the Company to defer the listing
of such Common Stock until the date on which any Purchase Contract first settles in accordance with
the provisions of this Agreement, the Company covenants to list such Common stock issuable upon
Settlement of the Purchase Contracts in accordance with the requirements of such exchange or
automated quotation system at such time.

     Section 10.05. Statements of Officers of the Company as to Default. The Company will deliver to the Purchase Contract Agent, within 120 days after the end of
each fiscal year of the Company, commencing with the fiscal year ending December 30, 2007, an
Officers’ Certificate, stating whether or not to the knowledge of the signers thereof) the Company
is in default in the performance and observance of any of the terms, provisions and conditions
hereof, and if the Company shall be in default, specifying all such defaults and the nature and
status thereof of which they may have knowledge.

     Section 10.06. ERISA. Each Holder from time to time of the HiMEDS Units that is a Plan or who used assets of a
Plan to purchase or hold HiMEDS Units (or any securities comprising or underlying such securities)
hereby represents that from and including the date if its acquisition of the HiMEDS Units (or any
security comprising or underlying such securities) through and including the date of the
satisfaction of the obligation under the purchase contract and/or the disposition of any such
HiMEDS Units (the components comprising or underlying such securities) either (i) no portion of the
assets used by such Holder to acquire or hold the HiMEDS Units (or any securities comprising or underlying such securities) constitutes the
assets of any Plan or (ii) the purchase or holding of the Corporate HiMEDS Units (or any securities
comprising or underlying such securities) by such Holder will not constitute or result in a
non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or similar
violation under any applicable Similar Laws.

83

 

ARTICLE 11

PLEDGE

     Section 11.01. Pledge. Each Holder, acting through the Purchase Contract Agent as such Holder’s attorney-in-fact,
and the Purchase Contract Agent, acting solely as such attorney-in-fact, hereby pledges and grants
to the Collateral Agent, as agent of and for the benefit of the Company, a continuing first
priority security interest in and to, and a lien upon and right of set-off against, all of such
Person’s right, title and interest in and to the Collateral to secure the prompt and complete
payment and performance when due (whether at stated maturity, by acceleration or otherwise) of the
Obligations. The Collateral Agent shall have all of the rights, remedies and recourses with respect
to the Collateral afforded a secured party by the UCC, in addition to, and not in limitation of,
the other rights, remedies and recourses afforded to the Collateral Agent by this Agreement.

     Section 11.02. Termination. As to each Holder, the Pledge created hereby shall terminate upon the satisfaction of such
Holder’s Obligations. Upon such termination, the Collateral Agent shall instruct the Securities
Intermediary to Transfer such portion of the Collateral attributable to such Holder to the Purchase
Contract Agent for distribution to such Holder, free and clear of the Pledge created hereby.

ARTICLE 12

ADMINISTRATION OF COLLATERAL

     Section 12.01. Initial Deposit of Senior Notes. (a) Prior to or concurrently with the execution and delivery of this Agreement, the
Purchase Contract Agent, on behalf of the initial Holders of the Corporate HiMEDS Units, shall
Transfer to the Securities Intermediary, for credit to the Collateral Account, the Senior Notes or
security entitlements relating thereto and, with respect to any such security entitlements, the
Securities Intermediary shall indicate by book-entry that a securities entitlement with respect to
such Senior Notes has been credited to the Collateral Account.

     (a) The Collateral Agent may, at any time or from time to time, in its sole discretion, cause
any or all securities or other property underlying any financial assets credited to the Collateral
Account to be registered in the name of the Securities Intermediary, the Collateral Agent or their
respective nominees; provided, however, that unless any Event of Default (as defined in the
Indenture) shall have occurred and be continuing, the Collateral Agent agrees not to cause any
Senior Notes to be so re-registered.

     Section 12.02. Establishment of Collateral Account. The Securities Intermediary hereby confirms that:

     (a) the Securities Intermediary has established the Collateral Account;

     (b) the Collateral Account is a securities account;

84

 

     (c) subject to the terms of this Agreement, the Securities Intermediary shall identify in its
records the Collateral Agent as the entitlement holder entitled to exercise the rights that
comprise any financial asset credited to the Collateral Account;

     (d) all property delivered to the Securities Intermediary pursuant to this Agreement will be
credited promptly to the Collateral Account; and

     (e) all securities or other property underlying any financial assets credited to the
Collateral Account shall be (i) registered in the name of the Purchase Contract Agent and indorsed
to the Securities Intermediary or in blank, (ii) registered in the name of the Securities
Intermediary or (iii) credited to another securities account maintained in the name of the
Securities Intermediary. In no case will any financial asset credited to the Collateral Account be
registered in the name of the Purchase Contract Agent (in its capacity as such) or any Holder or
specially indorsed to the Purchase Contract Agent (in its capacity as such) or any Holder, unless
such financial asset has been further indorsed to the Securities Intermediary or in blank.

     Section 12.03. Treatment as Financial Assets. Each item of property (whether investment property, financial asset, security, instrument
or cash) credited to the Collateral Account shall be treated as a financial asset.

     Section 12.04. Sole Control by Collateral Agent. Except as provided in Section 15.01, at all times prior to the termination of the Pledge,
the Collateral Agent shall have sole control of the Collateral Account, and the Securities
Intermediary shall take instructions and directions, and comply with entitlement orders, with
respect to the Collateral Account or any financial asset credited thereto solely from the
Collateral Agent. If at any time the Securities Intermediary shall receive an entitlement order
issued by the Collateral Agent and relating to the Collateral Account, the Securities Intermediary
shall comply with such entitlement order without further consent by the Purchase Contract Agent or
any Holder or any other Person. Except as otherwise permitted under this Agreement, until
termination of the Pledge, the Securities Intermediary will not comply with any entitlement orders
issued by the Purchase Contract Agent or any Holder.

     Section 12.05. Jurisdiction. The Collateral Account, and the rights and obligations of the Securities Intermediary, the
Collateral Agent, the Purchase Contract Agent and the Holders with respect thereto, shall be
governed by the laws of the State of New York. Regardless of any provision in any other agreement,
the Securities Intermediary’s jurisdiction is the State of New York.

     Section 12.06. No Other Claims. Except for the claims and interest of the Collateral Agent and of the Purchase Contract
Agent and the Holders in the Collateral Account, the Securities Intermediary (without having
conducted any investigation) does not know of any claim to, or interest in, the Collateral Account
or in any financial asset credited thereto. If any Person asserts any lien, encumbrance or adverse
claim (including any writ, garnishment, judgment, warrant of attachment, execution or similar
process) against the Collateral Account or in any financial asset carried therein, the Securities
Intermediary will promptly notify the Collateral Agent and the Purchase Contract Agent.

85

 

     Section 12.07. Investment and Release. All proceeds of financial assets from time to time credited to the Collateral Account shall
be invested and reinvested as provided in this Agreement. At all times prior to termination of the
Pledge, no property shall be released from the Collateral Account except in accordance with this
Agreement or upon written instructions of the Collateral Agent.

     Section 12.08. Statements and Confirmations. The Securities Intermediary will promptly send copies of all statements, confirmations and
other correspondence concerning the Collateral Account and any financial assets credited thereto
simultaneously to each of the Purchase Contract Agent and the Collateral Agent at their addresses
for notices under this Agreement.

     Section 12.09. Tax Allocations. The Purchase Contract Agent shall report all items of income, gain, expense and loss
recognized in the Collateral Account, to the extent such reporting is required by law, to the
Internal Revenue Service authorities in the manner required by law. Neither the Securities
Intermediary nor the Collateral Agent shall have any tax reporting duties hereunder.

     Section 12.10. No Other Agreements. The Securities Intermediary has not entered into, and prior to the termination of the
Pledge will not enter into, any agreement with any other Person relating to the Collateral Account
or any financial assets credited thereto, including, without limitation, any agreement to comply
with entitlement orders of any Person other than the Collateral Agent.

     Section 12.11. Powers Coupled with an Interest. The rights and powers granted in this Agreement to the Collateral Agent have been granted
in order to perfect its security interests in the Collateral Account, are powers coupled with an
interest and will be affected neither by the bankruptcy of the Purchase Contract Agent or any
Holder nor by the lapse of time. The obligations of the Securities Intermediary under this Purchase
Contract and Pledge Agreement shall continue in effect until the termination of the Pledge.

     Section 12.12. Waiver of Lien; Waiver of Set-off. The Securities Intermediary waives any security interest, lien or right to make deductions
or set-offs that it may now have or hereafter acquire in or with respect to the Collateral Account,
any financial asset credited thereto or any security entitlement in respect thereof. Neither the
financial assets credited to the Collateral Account nor the security entitlements in respect
thereof will be subject to deduction, set-off, banker’s lien, or any other right in favor of any
person other than the Company.

ARTICLE 13

RIGHTS AND REMEDIES OF THE COLLATERAL AGENT

     Section 13.01. Rights and Remedies of the Collateral Agent. (a) In addition to the rights and remedies set forth herein or otherwise available at law
or in equity, after an event of default (as specified in Section 13.01(b)) hereunder, the
Collateral Agent shall have all of the rights and remedies with respect to the Collateral of a
secured party under the UCC (whether or not the UCC is in effect in the jurisdiction where the
rights and remedies are asserted) and the TRADES Regulations and such additional rights and
remedies to which a secured party is entitled under

86

 

the laws in effect in any jurisdiction where any rights and remedies hereunder may be
asserted. Without limiting the generality of the foregoing, such remedies may include, to the
extent permitted by applicable law, (1) retention of the Pledged Senior Notes or Pledged Treasury
Securities in full satisfaction of the Holders’ obligations under the Purchase Contracts and the
Purchase Contract Agreement or (2) sale of the Pledged Senior Notes or Pledged Treasury Securities
in one or more public or private sales.

     (b) Without limiting any rights or powers otherwise granted by this Agreement to the
Collateral Agent, in the event the Collateral Agent is unable to make payments to the Company, or
on account of principal payments of any Pledged Treasury Securities as provided in this Agreement
in satisfaction of the Obligations of the Holder of the HiMEDS Units of which such Pledged Treasury
Securities are a part under the related Purchase Contracts, the inability to make such payments
shall constitute an “event of default” hereunder and the Collateral Agent shall have and may
exercise, with reference to such Pledged Treasury Securities any and all of the rights and remedies
available to a secured party under the UCC and the TRADES Regulations after default by a debtor,
and as otherwise granted herein or under any other law.

     (c) Without limiting any rights or powers otherwise granted by this Agreement to the
Collateral Agent, the Collateral Agent is hereby irrevocably authorized to receive, collect and
apply to the satisfaction of the Obligations all payments of (i) the principal amount of the
Pledged Senior Notes and (ii) the principal amount of the Pledged Treasury Securities, subject, in
each case, to the provisions of this Agreement, and as otherwise provided herein.

     (d) The Purchase Contract Agent and each Holder of HiMEDS Units agrees that, from time to
time, upon the written request of the Collateral Agent or the Purchase Contract Agent, such Holder
shall execute and deliver such further documents and do such other acts and things as the
Collateral Agent may reasonably request in order to maintain the Pledge, and the perfection and
priority thereof, and to confirm the rights of the Collateral Agent hereunder. The Purchase
Contract Agent shall have no liability to any Holder for executing any documents or taking any such
acts requested by the Collateral Agent hereunder, except for liability for its own grossly
negligent acts, its own grossly negligent failure to act or its own willful misconduct.

ARTICLE 14

REPRESENTATIONS AND WARRANTIES TO

COLLATERAL AGENT; HOLDER COVENANTS

     Section 14.01. Representations and Warranties. Each Holder from time to time, acting through the Purchase Contract Agent as
attorney-in-fact (it being understood that the Purchase Contract Agent shall not be liable for any
representation or warranty made by or on behalf of a Holder), hereby represents and warrants to the
Collateral Agent (with respect to such Holder’s interest in the Collateral), which representations
and warranties shall be deemed repeated on each day a Holder Transfers Collateral, that:

     (a) such Holder has the power to grant a security interest in and lien on the Collateral;

87

 

     (b) such Holder is the sole beneficial owner of the Collateral and, in the case of Collateral
delivered in physical form, is the sole holder of such Collateral and is the sole beneficial owner
of, or has the right to Transfer, the Collateral it Transfers to the Collateral Agent for credit to
the Collateral Account, free and clear of any security interest, lien, encumbrance, call, liability
to pay money or other restriction other than the security interest and lien granted under Article
11;

     (c) upon the Transfer of the Collateral to the Securities Intermediary for credit to the
Collateral Account, the Collateral Agent, for the benefit of the Company, will have a valid and
perfected first priority security interest therein (assuming that any central clearing operation or
any securities intermediary or other entity not within the control of the Holder involved in the
Transfer of the Collateral, including the Collateral Agent and the Securities Intermediary, gives
the notices and takes the action required of it hereunder and under applicable law for perfection
of that interest and assuming the establishment and exercise of control pursuant to Article 12);
and

     (d) the execution and performance by the Holder of its obligations under this Agreement will
not result in the creation of any security interest, lien or other encumbrance on the Collateral
other than the security interest and lien granted under Article 11 or violate any provision of any
existing law or regulation applicable to it or of any mortgage, charge, pledge, indenture, contract
or undertaking to which it is a party or which is binding on it or any of its assets.

     Section 14.02. Covenants. The Purchase Contract Agent and the Holders from time to time, acting through the Purchase
Contract Agent as their attorney-in-fact (it being understood that the Purchase Contract Agent
shall not be liable for any covenant made by or on behalf of a Holder), hereby covenant to the
Collateral Agent that for so long as the Collateral remains subject to the Pledge:

     (a) neither the Purchase Contract Agent nor such Holders will create or purport to create or
allow to subsist any mortgage, charge, lien, pledge or any other security interest whatsoever over
the Collateral or any part of it other than pursuant to this Agreement; and

     (b) neither the Purchase Contract Agent nor such Holders will sell or otherwise dispose (or
attempt to dispose) of the Collateral or any part of it except for the beneficial interest therein,
subject to the Pledge hereunder, transferred in connection with a Transfer of the HiMEDS Units.

ARTICLE 15

THE COLLATERAL AGENT, THE CUSTODIAL AGENT AND THE SECURITIES INTERMEDIARY

     It is hereby agreed as follows:

     Section 15.01. Appointment, Powers and Immunities. The Collateral Agent, the Custodial Agent and the Securities Intermediary shall act as
agent for the Company hereunder with such powers as are specifically vested in the Collateral
Agent, the Custodial Agent and the Securities Intermediary, as the case may be, by the terms of this Agreement. The Collateral
Agent, the Custodial Agent and Securities Intermediary shall:

88

 

     (a) have no duties or responsibilities except those expressly set forth in this Agreement and
no implied covenants or obligations shall be inferred from this Agreement against the Collateral
Agent, the Custodial Agent or the Securities Intermediary, nor shall the Collateral Agent, the
Custodial Agent or the Securities Intermediary be bound by the provisions of any agreement by any
party hereto beyond the specific terms hereof;

     (b) not be responsible for any recitals contained in this Agreement, or in any certificate or
other document referred to or provided for in, or received by it under, this Agreement, the HiMEDS
Units or the Purchase Contract Agreement, or for the value, validity, effectiveness, genuineness,
enforceability or sufficiency of this Agreement (other than as against the Collateral Agent, the
Custodial Agent or the Securities Intermediary, as the case may be), the HiMEDS Units, any
Collateral or the Purchase Contract Agreement or any other document referred to or provided for
herein or therein or for any failure by the Company or any other Person (except the Collateral
Agent, the Custodial Agent or Securities Intermediary, as the case may be) to perform any of its
obligations hereunder or thereunder or for the perfection, priority or, except as expressly
required hereby, maintenance of any security interest created hereunder;

     (c) not be required to initiate or conduct any litigation or collection proceedings hereunder
(except pursuant to directions furnished under Section 15.02, subject to Section 15.08);

     (d) not be responsible for any action taken or omitted to be taken by it hereunder or under
any other document or instrument referred to or provided for herein or in connection herewith or
therewith, except for its own gross negligence or willful misconduct; and

     (e) not be required to advise any party as to selling or retaining, or taking or refraining
from taking any action with respect to, any securities or other property deposited hereunder.

     Subject to the foregoing, during the term of this Agreement, the Collateral Agent, the
Custodial Agent and the Securities Intermediary shall take all reasonable action in connection with
the safekeeping and preservation of the Collateral hereunder as determined by industry standards.

     No provision of this Agreement shall require the Collateral Agent, the Custodial Agent or the
Securities Intermediary to expend or risk its own funds or otherwise incur any financial liability
in the performance of any of its duties hereunder. In no event shall the Collateral Agent, the
Custodial Agent or the Securities Intermediary be liable for any amount in excess of the Value of
the Collateral.

     Section 15.02. Instructions of the Company. The Company shall have the right, by one or more written instruments executed and delivered
to the Collateral Agent, to direct the time, method and place of conducting any proceeding for the
realization of any right or remedy available to the Collateral Agent, or of exercising any power
conferred on the Collateral Agent, or to direct the taking or refraining from taking of any action
authorized by this Agreement;

89

 

provided, however, that (i) such direction shall not conflict with the provisions of any law
or of this Agreement or involve the Collateral Agent in personal liability and (ii) the Collateral
Agent shall be indemnified to its satisfaction as provided herein. Nothing contained in this
Section 15.02 shall impair the right of the Collateral Agent in its discretion to take any action
or omit to take any action which it deems proper and which is not inconsistent with such direction.
None of the Collateral Agent, the Custodial Agent or the Securities Intermediary has any
obligation or responsibility to file UCC financing statements.

     Section 15.03. Reliance by Collateral Agent, Custodial Agent and Securities Intermediary. Each of the Securities Intermediary, the Custodial Agent and the Collateral Agent shall be
entitled to rely conclusively upon any certification, order, judgment, opinion, notice or other
written communication (including, without limitation, any thereof by telecopy) believed by it to be
genuine and correct and to have been signed or sent by or on behalf of the Person or Persons
specified therein (without being required to determine the correctness of any fact stated therein,
or the substance or sufficiency thereof) and consult with and conclusively rely upon advice,
opinions and statements of legal counsel and other experts selected by the Collateral Agent, the
Custodial Agent or the Securities Intermediary, as the case may be, as well as on any Officers’
Certificates and any Opinions of Counsel delivered therewith. As to any matters not expressly
provided for by this Agreement, the Collateral Agent, the Custodial Agent and the Securities
Intermediary shall in all cases be fully protected in acting, or in refraining from acting,
hereunder in accordance with instructions given by the Company in accordance with this Agreement.

     Section 15.04. Certain Rights. (a) Whenever in the administration of the provisions of this Agreement the Collateral
Agent, the Custodial Agent or the Securities Intermediary shall deem it necessary or desirable that
a matter be proved or established prior to taking or suffering any action to be taken hereunder,
such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in
the absence of gross negligence or bad faith on the part of the Collateral Agent, the Custodial
Agent or the Securities Intermediary, be deemed to be conclusively proved and established by a
certificate signed by one of the Company’s officers, and delivered to the Collateral Agent, the
Custodial Agent or the Securities Intermediary and such certificate, in the absence of gross
negligence or bad faith on the part of the Collateral Agent, the Custodial Agent or the Securities
Intermediary, shall be full warrant to the Collateral Agent, the Custodial Agent or the Securities
Intermediary for any action taken, suffered or omitted by it under the provisions of this Agreement
upon the faith thereof.

     (a) The Collateral Agent, the Custodial Agent or the Securities Intermediary shall not be
bound to make any investigation into the facts or matters stated in any resolution, certificate,
statement, instrument, opinion, report, notice, request, consent, entitlement order, approval or
other paper or document.

     Section 15.05. Merger, Conversion, Consolidation or Succession to Business. Any corporation into which the Collateral Agent, the Custodial Agent or the Securities
Intermediary may be merged or converted or with which it may be consolidated, or any corporation
resulting from any merger, conversion or consolidation to which the Collateral Agent, the Custodial
Agent or the Securities Intermediary shall be a party, or any corporation succeeding to all or
substantially all of the corporate trust business of the Collateral Agent, the Custodial Agent or

90

 

the Securities Intermediary shall be the successor of the Collateral Agent, the Custodial
Agent or the Securities Intermediary hereunder without the execution or filing of any paper with
any party hereto or any further act on the part of any of the parties hereto except where an
instrument of transfer or assignment is required by law to effect such succession, anything herein
to the contrary notwithstanding.

     Section 15.06. Rights in Other Capacities. The Collateral Agent, the Custodial Agent and the Securities Intermediary and their
affiliates may (without having to account therefor to the Company) accept deposits from, lend money
to, make their investments in and generally engage in any kind of banking, trust or other business
with the Purchase Contract Agent, any other Person interested herein and any Holder of HiMEDS Units
(and any of their respective subsidiaries or affiliates) as if it were not acting as the Collateral
Agent, the Custodial Agent or the Securities Intermediary, as the case may be, and the Collateral
Agent, the Custodial Agent, the Securities Intermediary and their affiliates may accept fees and
other consideration from the Purchase Contract Agent and any Holder of HiMEDS Units without having
to account for the same to the Company; provided that each of the Securities Intermediary, the
Custodial Agent and the Collateral Agent covenants and agrees with the Company that it shall not
accept, receive or permit there to be created in favor of itself and shall take no affirmative
action to permit there to be created in favor of any other Person, any security interest, lien or
other encumbrance of any kind in or upon the Collateral other than the lien created by the Pledge.

     Section 15.07. Non-reliance on Collateral Agent, the Custodial Agent and Securities
Intermediary. None of the Securities Intermediary, the Custodial Agent or the Collateral Agent shall be
required to keep itself informed as to the performance or observance by the Purchase Contract Agent
or any Holder of HiMEDS Units of this Agreement, the HiMEDS Units or any other document referred to
or provided for herein or therein or to inspect the properties or books of the Purchase Contract
Agent or any Holder of HiMEDS Units. None of the Collateral Agent, the Custodial Agent or the
Securities Intermediary shall have any duty or responsibility to provide the Company with any
credit or other information concerning the affairs, financial condition or business of the Purchase
Contract Agent or any Holder of HiMEDS Units (or any of their respective affiliates) that may come
into the possession of the Collateral Agent, the Custodial Agent or the Securities Intermediary or
any of their respective affiliates.

     Section 15.08. Compensation and Indemnity. The Company agrees to:

     (a) pay the Collateral Agent, the Custodial Agent and the Securities Intermediary from time to
time such compensation as shall be agreed in writing between the Company and the Collateral Agent,
the Custodial Agent or the Securities Intermediary, as the case may be, for all services rendered
by them hereunder;

     (b) indemnify and hold harmless the Collateral Agent, the Custodial Agent, the Securities
Intermediary and each of their respective directors, officers, agents and employees (collectively,
the “Indemnified Parties”), from and against any and all claims, liabilities, losses, damages,
fines, penalties and expenses (including reasonable fees and expenses of counsel) (collectively,
“Losses” and individually, a “Loss”) that may be imposed on, incurred by, or asserted against, the
Indemnified Parties or any of them for following any instructions or other directions upon which
any of the Collateral Agent, the Custodial Agent or the Securities

91

 

Intermediary is entitled to rely pursuant to the terms of this Agreement, provided that the
Collateral Agent, the Custodial Agent or the Securities Intermediary has not acted with gross
negligence or engaged in willful misconduct or bad faith with respect to the specific Loss against
which indemnification is sought; and

     (c) in addition to and not in limitation of Section 15.08(b), indemnify and hold the
Indemnified Parties and each of them harmless from and against any and all Losses that may be
imposed on, incurred by or asserted against, the Indemnified Parties or any of them in connection
with or arising out of the Collateral Agent’s, the Custodial Agent’s or the Securities
Intermediary’s acceptance or performance of its powers and duties under this Agreement, provided
the Collateral Agent, the Custodial Agent or the Securities Intermediary has not acted with gross
negligence or engaged in willful misconduct or bad faith with respect to the specific Loss against
which indemnification is sought.

     The provisions of this Section and Section 15.14 shall survive the resignation or removal of
the Collateral Agent, the Custodial Agent or the Securities Intermediary and the termination of
this Agreement.

     Section 15.09. Failure to Act. In the event of any ambiguity in the provisions of this Agreement or any dispute between or
conflicting claims by or among the parties hereto or any other Person with respect to any funds or
property deposited hereunder, then at its sole option, each of the Collateral Agent, the Custodial
Agent and the Securities Intermediary shall be entitled, after prompt notice to the Company and the
Purchase Contract Agent, to refuse to comply with any and all claims, demands or instructions with
respect to such property or funds so long as such dispute or conflict shall continue, and the
Collateral Agent, the Custodial Agent and the Securities Intermediary shall not be or become liable
in any way to any of the parties hereto for its failure or refusal to comply with such conflicting
claims, demands or instructions. The Collateral Agent, the Custodial Agent and the Securities
Intermediary shall be entitled to refuse to act until either:

     (a) such conflicting or adverse claims or demands shall have been finally determined by a
court of competent jurisdiction or settled by agreement between the conflicting parties as
evidenced in a writing satisfactory to the Collateral Agent, the Custodial Agent or the Securities
Intermediary; or

     (b) the Collateral Agent, the Custodial Agent or the Securities Intermediary shall have
received security or an indemnity satisfactory to it sufficient to save it harmless from and
against any and all loss, liability or reasonable out-of-pocket expense which it may incur by
reason of its acting.

     The Collateral Agent, the Custodial Agent and the Securities Intermediary may in addition
elect to commence an interpleader action or seek other judicial relief or orders as the Collateral
Agent, the Custodial Agent or the Securities Intermediary may deem necessary. Notwithstanding
anything contained herein to the contrary, none of the Collateral Agent, the Custodial Agent or the
Securities Intermediary shall be required to take any action that is in its opinion contrary to law
or to the terms of this Agreement, or which would in its opinion subject it or any of its officers,
employees or directors to liability.

92

 

     Section 15.10. Resignation and Removal of Collateral Agent, the Custodial Agent and the
Securities Intermediary. (a) Subject to the appointment and acceptance of a successor Collateral Agent, Custodial
Agent or Securities Intermediary as provided below:

     (i) the Collateral Agent, the Custodial Agent or the Securities Intermediary may resign
at any time by giving notice thereof to the Company and the Purchase Contract Agent as
attorney-in-fact for the Holders of HiMEDS Units;

     (ii) the Collateral Agent, the Custodial Agent or the Securities Intermediary may be
removed at any time by the Company; and

     (iii) if the Collateral Agent, the Custodial Agent or the Securities Intermediary fails
to perform any of its material obligations hereunder in any material respect for a period of
not less than 20 days after receiving written notice of such failure by the Purchase
Contract Agent and such failure shall be continuing, the Collateral Agent, the Custodial
Agent and the Securities Intermediary may be removed by the Purchase Contract Agent, acting
at the direction of the Holders of HiMEDS Units.

     The Purchase Contract Agent shall promptly notify the Company of any removal of the Collateral
Agent, the Custodial Agent or the Securities Intermediary pursuant to clause (iii) of this Section
15.10. Upon any such resignation or removal, the Company shall have the right to appoint a
successor Collateral Agent, Custodial Agent or Securities Intermediary, as the case may be, which
shall not be an Affiliate of the Purchase Contract Agent. If no successor Collateral Agent,
Custodial Agent or Securities Intermediary shall have been so appointed and shall have accepted
such appointment within 30 days after the retiring Collateral Agent’s, Custodial Agent’s or
Securities Intermediary’s giving of notice of resignation or the Company’s or the Purchase Contract
Agent’s giving notice of such removal, then the retiring or removed Collateral Agent, Custodial
Agent or Securities Intermediary may petition any court of competent jurisdiction, at the expense
of the Company, for the appointment of a successor Collateral Agent, Custodial Agent or Securities
Intermediary. The Collateral Agent, the Custodial Agent and the Securities Intermediary shall each
be a bank or a national banking association with a combined capital and surplus of at least
$50,000,000. Upon the acceptance of any appointment as Collateral Agent, Custodial Agent or
Securities Intermediary hereunder by a successor Collateral Agent, Custodial Agent or Securities
Intermediary, as the case may be, such successor Collateral Agent, Custodial Agent or Securities
Intermediary, as the case may be, shall thereupon succeed to and become vested with all the rights,
powers, privileges and duties of the retiring Collateral Agent, Custodial Agent or Securities
Intermediary, as the case may be, and the retiring Collateral Agent, Custodial Agent or Securities
Intermediary, as the case may be, shall take all appropriate action, subject to payment of any
amounts then due and payable to it hereunder, to transfer any money and property held by it
hereunder (including the Collateral) to such successor. The retiring Collateral Agent, Custodial
Agent or Securities Intermediary shall, upon such succession, be discharged from its duties and
obligations as Collateral Agent, Custodial Agent or Securities Intermediary hereunder. After any
retiring Collateral Agent’s, Custodial Agent’s or Securities Intermediary’s resignation hereunder
as Collateral Agent, Custodial Agent or Securities Intermediary, the provisions of this Article 15
shall continue in effect for its benefit in respect of any actions taken or omitted to be taken by
it while it was acting as the Collateral Agent, the Custodial Agent or the Securities Intermediary.
Any

93

 

resignation or removal of the Collateral Agent, the Custodial Agent or the Securities
Intermediary hereunder, at a time when such Person is acting as the Collateral Agent, the Custodial
Agent or the Securities Intermediary, shall be deemed for all purposes of this Agreement as the
simultaneous resignation or removal of the Collateral Agent, the Securities Intermediary or the
Custodial Agent, as the case may be.

     (b) Because The Bank of New York Trust Company, N.A. is serving as the Collateral Agent
hereunder and as the Purchase Contract Agent hereunder, if an event of default occurs hereunder The
Bank of New York Trust Company, N.A. will resign as the Collateral Agent, Custodial Agent and the
Securities Intermediary, but continue to act as the Purchase Contract Agent. A successor
Collateral Agent, Custodial Agent and Securities Intermediary will be appointed in accordance with
the terms hereof.

     Section 15.11. Right to Appoint Agent or Advisor. The Collateral Agent shall have the right to appoint agents or advisors in connection with
any of its duties hereunder, and the Collateral Agent shall not be liable for any action taken or
omitted by, or in reliance upon the advice of, such agents or advisors selected in good faith. The
appointment of agents pursuant to this Section 15.11 shall be subject to prior written consent of
the Company, which consent shall not be unreasonably withheld.

     Section 15.12. Survival. The provisions of this Article 15 shall survive termination of this Agreement and the
resignation or removal of the Collateral Agent, the Custodial Agent or the Securities Intermediary.

     Section 15.13. Exculpation. Anything contained in this Agreement to the contrary notwithstanding, in no event shall the
Collateral Agent, the Custodial Agent or the Securities Intermediary or their officers, directors,
employees or agents be liable under this Agreement for indirect, special, punitive, or
consequential loss or damage of any kind whatsoever, including, but not limited to, lost profits,
whether or not the likelihood of such loss or damage was known to the Collateral Agent, the
Custodial Agent or the Securities Intermediary, or any of them and regardless of the form of
action. Section 7.03(m) is hereby made applicable to the Collateral Agent, the Custodial Agent and
the Securities Intermediary as if they and each of them were named therein in place of the Purchase
Contract Agent.

     Section 15.14. Expenses, Etc. The Company agrees to reimburse the Collateral Agent, the Custodial Agent and the Securities
Intermediary for:

     (a) all reasonable costs and expenses of the Collateral Agent, the Custodial Agent and the
Securities Intermediary (including, without limitation, the reasonable fees and expenses of counsel
to the Collateral Agent, the Custodial Agent and the Securities Intermediary), in connection with
(i) the negotiation, preparation, execution and delivery or performance of this Agreement and (ii)
any modification, supplement or waiver of any of the terms of this Agreement;

     (b) all reasonable costs and expenses of the Collateral Agent, the Custodial Agent and the
Securities Intermediary (including, without limitation, reasonable fees and expenses of counsel) in
connection with (i) any enforcement or proceedings resulting or incurred in

94

 

connection with causing any Holder of HiMEDS Units to satisfy its obligations under the
Purchase Contracts forming a part of the HiMEDS Units and (ii) the enforcement of this Section
15.14;

     (c) all transfer, stamp, documentary or other similar taxes, assessments or charges levied by
any governmental or revenue authority in respect of this Agreement or any other document referred
to herein and all costs, expenses, taxes, assessments and other charges incurred in connection with
any filing, registration, recording or perfection of any security interest contemplated hereby;

     (d) all reasonable fees and expenses of any agent or advisor appointed by the Collateral Agent
and consented to by the Company under Section 15.11; and

     (e) any other out-of-pocket costs and expenses reasonably incurred by the Collateral Agent,
the Custodial Agent and the Securities Intermediary in connection with the performance of their
duties hereunder.

ARTICLE 16

MISCELLANEOUS

     Section 16.01. Security Interest Absolute. All rights of the Collateral Agent and security interests hereunder, and all obligations of
the Holders from time to time hereunder, shall be absolute and unconditional irrespective of:

     (a) any lack of validity or enforceability of any provision of the Purchase Contracts or the
HiMEDS Units or any other agreement or instrument relating thereto;

     (b) any change in the time, manner or place of payment of, or any other term of, or any
increase in the amount of, all or any of the obligations of Holders of the HiMEDS Units under the
related Purchase Contracts, or any other amendment or waiver of any term of, or any consent to any
departure from any requirement of, the Purchase Contract Agreement or any Purchase Contract or any
other agreement or instrument relating thereto; or

     (c) any other circumstance which might otherwise constitute a defense available to, or
discharge of, a borrower, a guarantor or a pledgor.

     Section 16.02. Notice of Termination Event. Upon the occurrence of a Termination Event, the Company shall deliver written notice to the
Purchase Contract Agent, the Collateral Agent and the Securities Intermediary. Upon the written
request of the Collateral Agent or the Securities Intermediary, the Company shall inform such party
whether or not a Termination Event has occurred.

[SIGNATURES ON THE FOLLOWING PAGE]

95

 

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the day and year first above written.

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	AVERY DENNISON CORPORATION	 	 	 	THE BANK OF NEW YORK TRUST COMPANY,
N.A., as Purchase Contract Agent and as
attorney-in-fact of the Holders from
time to time of the HiMEDS Units	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Karyn E. Rodriguez	 	 	 	By:	 	/s/ Brian R. Echausse	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 

	 	Name:
	 	Karyn E. Rodriguez
	 	 	 	 	 	Name:
	 	Brian R. Echausse	 	 
	 

	 	Title:
	 	Vice President and Treasurer
	 	 	 	 	 	Title:
	 	Trust Officer	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Address for Notices:	 	Address for Notices:
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Avery Dennison Corporation

150 North Orange Grove Boulevard

Pasadena, California 91103

Telecopier No.: (626) 304-2251

Attention: Richard P. Randall	 	 	 	The Bank of New York Trust Company, 
N.A.

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	THE BANK OF NEW YORK TRUST COMPANY, N.A.

as Collateral Agent, Custodial Agent and
Securities Intermediary	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	By:
	 	/s/ Brian R. Echausse	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	Name:
	 	Brian R. Echausse	 	 	 	 	 	 	 	 	 	 
	 

	 	Title:
	 	Trust Officer	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Address for Notices:	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	The Bank of New York Trust Company, N.A.

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration	 	 	 	 	 	 	 	 	 	 

 

 

EXHIBIT A

(FORM OF FACE OF CORPORATE HiMEDS UNIT CERTIFICATE)

     [For inclusion in Global Certificates only — THIS CERTIFICATE IS A GLOBAL CERTIFICATE WITHIN
THE MEANING OF THE PURCHASE CONTRACT AND PLEDGE AGREEMENT HEREINAFTER REFERRED TO AND IS REGISTERED
IN THE NAME OF CEDE & CO., AS THE NOMINEE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(THE “DEPOSITARY”), THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY. THIS CERTIFICATE IS
EXCHANGEABLE FOR CERTIFICATES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS
NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE PURCHASE CONTRACT AND PLEDGE AGREEMENT
AND NO TRANSFER OF THIS CERTIFICATE (OTHER THAN A TRANSFER OF THIS CERTIFICATE AS A WHOLE BY THE
DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES.

     UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME
OF CEDE & CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY
(AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN
INTEREST HEREIN.]

			
	 	 	 
	No.
	 	CUSIP No. 053611307
	Number of Corporate HiMEDS Units:
	 	ISIN: US0536113071

AVERY DENNISON CORPORATION

Corporate HiMEDS Units

     This Corporate HiMEDS Units Certificate certifies that                      is the registered Holder
of the number of Corporate HiMEDS Units set forth above [For inclusion in Global Certificates only
— or such other number of Corporate HiMEDS Units reflected in the Schedule of Increases or
Decreases in Global Certificate attached hereto]. Each Corporate HiMEDS Unit consists of:

     (i) beneficial ownership by the Holder of a 1/20, or 5.00%, undivided beneficial ownership
interest in $1,000 principal amount of Senior Note, subject to the Pledge of such Senior Note by
the Holder pursuant to the Purchase Contract and Pledge Agreement; and

A-1

 

     (ii) the rights and obligations of the Company and the Holder under one Purchase Contract.

All capitalized terms used herein which are defined in the Purchase Contract and Pledge Agreement
(as defined on the reverse hereof) have the meaning set forth therein.

     Pursuant to the Purchase Contract and Pledge Agreement, the Senior Note constituting part of
each Corporate HiMEDS Unit evidenced hereby have been pledged to the Collateral Agent, for the
benefit of the Company, to secure the obligations of the Holder under the Purchase Contract
comprising part of such Corporate HiMEDS Unit.

     The Purchase Contract and Pledge Agreement provides that all payments of the principal amount
with respect to any of the Pledged Senior Notes (as defined in the Purchase Contract and Pledge
Agreement) or interest or distributions on any Pledged Senior Notes constituting part of the
Corporate HiMEDS Units received by the Securities Intermediary shall be paid by wire transfer in
same day funds:

     (i) in the case of (A) interest on Pledged Senior Notes and (B) any payments of the principal
amount of any Senior Notes that have been released from the Pledge pursuant to the Purchase
Contract and Pledge Agreement, to the Purchase Contract Agent to the account designated by the
Purchase Contract Agent, on the Business Day such payment is received by the Securities
Intermediary (provided that in the event such payment is received by the Securities Intermediary on
a day that is not a Business Day or after 11:00 a.m., New York City time, on a Business Day, then
such payment shall be made no later than 10:30 a.m., New York City time, on the next succeeding
Business Day); and

     (ii) in the case of payments received in connection with a remarketing, the principal amount
of the Pledged Senior Notes following a successful remarketing to the Company on the Purchase
Contract Settlement Date (as described herein) in accordance with the terms of the Purchase
Contract and Pledge Agreement, in full satisfaction of the respective obligations of the Holders of
the Corporate HiMEDS Units of which such Pledged Senior Notes are a part under the Purchase
Contracts forming a part of such Corporate HiMEDS Units.

     Interest on the Senior Notes forming part of a Corporate HiMEDS Units evidenced hereby, which
are payable quarterly in arrears on February 15, May 15, August 15, and November 15 of each year,
commencing February 15, 2008 (each, a “Payment Date”), shall, subject to receipt thereof by the
Purchase Contract Agent from the Securities Intermediary, be paid to the Person in whose name this
Corporate HiMEDS Units Certificate (or a Predecessor Corporate HiMEDS Units Certificate) is
registered at 5:00 p.m., New York City time, on the Record Date for such Payment Date.

     Each Purchase Contract evidenced hereby obligates the Holder of this Corporate HiMEDS Units
Certificate to purchase, and the Company to sell, on the Purchase Contract Settlement Date, at a
price equal to $50.00 (the “Stated Amount”), a number of newly issued shares of common stock, par value $1.00 per share (“Common Stock”), of the Company, equal to
the Settlement Rate, unless on or prior to the Purchase Contract Settlement Date there shall have
occurred a Termination Event, an Early Settlement or a Merger Early Settlement with

A-2

 

respect to such Purchase Contract, all as provided in the Purchase Contract and Pledge Agreement and more fully
described on the reverse hereof. The Purchase Price for the shares of Common Stock purchased
pursuant to each Purchase Contract evidenced hereby, if not paid earlier, shall be paid on the
Purchase Contract Settlement Date by application of payment received in respect of the principal
amount with respect to any Pledged Senior Notes pursuant to the remarketing pledged to secure the
obligations under such Purchase Contract of the Holder of the Corporate HiMEDS Units of which such
Purchase Contract is a part or by the Company exercising its rights as a secured party with respect
to such Pledged Senior Notes.

     The Company shall pay, on each Payment Date, in respect of each Purchase Contract forming part
of a Corporate HiMEDS Unit evidenced hereby, an amount (the “Contract Adjustment Payments”) equal
to 2.525% per year of the Stated Amount, computed (i) for any full quarterly period on the basis of
a 360-day year consisting of twelve 30-day months and (ii) for any period other than a full
quarterly period on the basis of the actual number of days elapsed and a 360-day year. The Company
may, at its option, defer such Contract Adjustment Payments as described in the Purchase Contract
and Pledge Agreement.

     Contract Adjustment Payments shall be payable to the Person in whose name this Corporate
HiMEDS Units Certificate evidencing such Purchase Contract is registered at 5:00 p.m., New York
City time, on the Record Date for such Payment Date. If the book-entry system for the Corporate
HiMEDS Units has been terminated, the Contract Adjustment Payments will be payable, at the option
of the Company, by check mailed to the address of the Person entitled thereto at such Person’s
address as it appears on the Security Register, or by wire transfer to the account designated by
such Person by a prior written notice to the Purchase Contract Agent.

     Each Corporate HiMEDS Unit evidenced hereby obligates the beneficial owner thereof to agree,
for tax purposes, to treat:

     (i) each Corporate HiMEDS Unit as an investment unit consisting of an interest in a Senior
Note and a Purchase Contract;

     (ii) the initial fair market value of each Senior Note as $50 and the initial fair market
value of each Purchase Contract as $0 and to allocate the purchase price for each Corporate HiMEDS
Unit accordingly;

     (iii) itself as the owner of the applicable interests in the Collateral Account, including the
Senior Notes; and

     (iv) the Senior Notes as indebtedness for tax purposes.

     Reference is hereby made to the further provisions set forth on the reverse hereof, which
further provisions shall for all purposes have the same effect as if set forth at this place.

     Unless the certificate of authentication hereon has been executed by the Purchase Contract
Agent by manual signature, this Corporate HiMEDS Units Certificate shall not be entitled to any benefit under the Purchase Contract and Pledge Agreement or be valid or
obligatory for any purpose.

A-3

 

     IN WITNESS WHEREOF, the Company and the Holder specified above have caused this instrument to
be duly executed.

	 	 	 	 	 
	 	AVERY DENNISON CORPORATION

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	ATTEST:

 	 	 
	By:  	
 	 	 
	 	Name:  	 	 	 
	 	Title:  	 
of Avery Dennison Corporation 	 	 
	 

	 	 	 	 	 
	 	HOLDER SPECIFIED ABOVE (as to
obligations of such Holder under the Purchase
Contracts)
 	 
	 
	 	By:  	THE BANK OF NEW YORK TRUST COMPANY, N.A.,

not individually but solely as attorney
in-fact of such Holder
 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

A-4

 

CERTIFICATE OF AUTHENTICATION

OF PURCHASE CONTRACT AGENT

     This is one of the Corporate HiMEDS Units Certificates referred to in the within mentioned
Purchase Contract and Pledge Agreement.

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST COMPANY, N.A.,
as Purchase Contract Agent
 	 
	 	By:  	 	 
	 	 	Authorized Officer 	 
	 

Dated:

A-5

 

(FORM OF REVERSE OF CORPORATE HiMEDS UNIT CERTIFICATE)

     Each Purchase Contract evidenced hereby is governed by a Purchase Contract and Pledge
Agreement, dated as of November 20, 2007 (as may be supplemented from time to time, the “Purchase
Contract and Pledge Agreement”), among the Company, The Bank of New York Trust Company, N.A., as
Purchase Contract Agent (including its successors hereunder, the “Purchase Contract Agent”) and
attorney-in-fact of the Holders from time to time, and The Bank of New York Trust Company, N.A., as
Collateral Agent, Custodial Agent and Securities Intermediary, to which Purchase Contract and
Pledge Agreement and supplemental agreements thereto reference is hereby made for a description of
the respective rights, limitations of rights, obligations, duties and immunities thereunder of the
Purchase Contract Agent, the Company, and the Holders and of the terms upon which the Corporate
HiMEDS Units Certificates are, and are to be, executed and delivered.

     Each Purchase Contract evidenced hereby obligates the Holder of this Corporate HiMEDS Units
Certificate to purchase, and the Company to sell, on the Purchase Contract Settlement Date at a
price equal to the Stated Amount (the “Purchase Price”), a number of shares of Common Stock equal
to the Settlement Rate (as defined in the Purchase Contract and Pledge Agreement), unless a
Termination Event or an Early Settlement or a Merger Early Settlement with respect to the Corporate
HiMEDS Unit of which such Purchase Contract is a part shall have occurred.

     In accordance with the terms of the Purchase Contract and Pledge Agreement, the Holder of this
Corporate HiMEDS Units Certificate may pay the Purchase Price for the shares of Common Stock
purchased pursuant to each Purchase Contract evidenced hereby by effecting a Cash Settlement, an
Early Settlement or, if applicable, a Merger Early Settlement or from the proceeds of a remarketing
of the related Pledged Senior Notes. A Holder of Corporate HiMEDS Units who has not effected an
Early Settlement or, if applicable, a Merger Early Settlement and who does not, on or prior to 4:00
p.m., New York City time, on the second Business Day immediately preceding the Remarketing Date,
notify the Purchase Contract Agent of its intention to effect a Cash Settlement, or who does so
notify the Purchase Contract Agent but fails to make an effective Cash Settlement on or prior to
4:00 p.m., New York City time, on the second Business Day immediately preceding the Remarketing
Date, shall pay the Purchase Price, less the amount of any Deferred Contract Adjustment Payments
payable to such Holder, for the shares of Common Stock to be delivered under the related Purchase
Contract from the proceeds of the sale of the related Pledged Senior Notes held by the Collateral
Agent in the remarketing. In the event of a Last Failed Remarketing, the Purchase Price shall be
satisfied by (A) the Pledged Senior Notes being retained and cancelled or (B) the Pledged Senior
Notes being sold, in either case, in full satisfaction of the Holders’ obligations under the
Purchase Contracts. As provided in the Purchase Contract and Pledge Agreement, upon the occurrence
of a Last Failed Remarketing, the Collateral Agent, for the benefit of the Company, shall exercise
its rights as secured creditor in full satisfaction of a Holder’s Obligation under the Purchase
Agreement to pay the Purchase Price.

     The Company shall not be obligated to issue any shares of Common Stock in respect of a
Purchase Contract or deliver any certificates therefor to the Holder unless it shall have received
payment of the aggregate Purchase Price, less any Deferred Contract Adjustment Payments, for

A-6

 

the shares of Common Stock to be purchased thereunder in the manner set forth in the Purchase
Contract and Pledge Agreement or become entitled to exercise its rights as a secured party in the
manner set forth in the Purchase Contract Agreement. If, as provided in the Purchase Contract
Agreement, upon the occurrence of a Last Failed Remarketing the Collateral Agent, for the benefit
of the Company, exercises its rights as a secured creditor with respect to the Pledged Senior Notes
related to this Corporate HiMEDS Units Certificate, any accrued and unpaid interest on such Pledged
Senior Notes will become payable by the Company to the Holder of this Corporate HiMEDS Units
Certificate in the manner provided for in the Purchase Contract Agreement.

     The Corporate HiMEDS Units Certificates are issuable only in registered form and only in
denominations of a single Corporate HiMEDS Units and any integral multiple thereof. The transfer
of any Corporate HiMEDS Units Certificate will be registered, and Corporate HiMEDS Units
Certificates may be exchanged, as provided in the Purchase Contract and Pledge Agreement.

     Subject to the conditions set forth in the Purchase Contract and Pledge Agreement, the Holder
of Corporate HiMEDS Units may substitute, at any time on or prior to 4:00 p.m., New York City time,
on the second Business Day immediately preceding the Remarketing Date, for the Pledged Senior Notes
securing such Holder’s obligations under the related Purchase Contracts, Treasury Securities in an
aggregate principal amount at maturity equal to the aggregate principal amount of the Pledged
Senior Notes in accordance with the terms of the Purchase Contract and Pledge Agreement. From and
after such Collateral Substitution, each HiMEDS Unit for which such Pledged Treasury Securities
secures the Holder’s obligation under the Purchase Contract shall be referred to as a “Treasury
HiMEDS Unit”. A Holder may make such Collateral Substitution only in integral multiples of 20
Corporate HiMEDS Units. A Holder who elects to substitute a Treasury Security for a Senior Note,
thereby creating Treasury HiMEDS Units, shall be responsible for any fees or expenses payable in
connection therewith.

     Each Purchase Contract evidenced hereby and all obligations and rights of the Company and the
Holder thereunder, including, without limitation, the rights of the Holder to receive and the
obligation of the Company to pay any Contract Adjustment Payments, shall immediately and
automatically terminate, without the necessity of any notice or action by any Holder, the Purchase
Contract Agent or the Company, if, on or prior to the Purchase Contract Settlement Date, a
Termination Event shall occur. Upon the occurrence of a Termination Event, the Company shall, no
later than two Business Days thereafter, give written notice to the Purchase Contract Agent, the
Collateral Agent and the Holders, at their addresses as they appear in the Security Register. Upon
and after the occurrence of a Termination Event, the Collateral Agent shall release the Pledged
Senior Notes forming a part of each Corporate HiMEDS Unit from the Pledge in accordance with the
provisions of the Purchase Contract and Pledge Agreement. A Corporate HiMEDS Unit shall thereafter
represent the right to receive the Senior Note forming a part of such Corporate HiMEDS Units, in
accordance with the terms of the Purchase Contract and Pledge Agreement.

     Subject to and upon compliance with the provisions of the Purchase Contract and Pledge
Agreement, at the option of the Holder thereof, Purchase Contracts underlying HiMEDS Units may be
settled early at any time on or prior to 4:00 p.m., New York City time, on the Business

A-7

 

Day immediately preceding the first scheduled Trading Day of the Observation Period (“Early
Settlement”) as provided in the Purchase Contract and Pledge Agreement. Upon Early Settlement of
Purchase Contracts by a Holder of the related Corporate HiMEDS Units, the Pledged Senior Notes
underlying such Corporate HiMEDS Units shall be released from the Pledge as provided in the
Purchase Contract and Pledge Agreement and the Holder shall be entitled to receive a number of
shares of Common Stock on account of each Purchase Contract forming part of a Corporate HiMEDS Unit
as to which Early Settlement is effected equal to the Minimum Settlement Rate.

     Upon the occurrence of a Cash Merger, a Holder of Corporate HiMEDS Units may effect Merger
Early Settlement of the Purchase Contract underlying such Corporate HiMEDS Units pursuant to the
terms of Section 5.04(b)(ii) of the Purchase Contract and Pledge Agreement. Upon Merger Early
Settlement of Purchase Contracts by a Holder of the related Corporate HiMEDS Units, the Pledged
Senior Notes underlying such Corporate HiMEDS Units shall be released from the Pledge as provided
in the Purchase Contract and Pledge Agreement.

     Under the terms of the Purchase Contract and Pledge Agreement, the Purchase Contract Agent
will be entitled to exercise the voting and any other consensual rights pertaining to the Pledged
Senior Notes, but only to the extent instructed in writing by the Holders. Upon receipt of notice
of any meeting at which holders of Senior Notes are entitled to vote or upon any solicitation of
consents, waivers or proxies of holders of Senior Notes, the Purchase Contract Agent shall, as soon
as practicable thereafter, mail, first class, postage pre-paid, to the Corporate HiMEDS Units
Holders the notice required by the Purchase Contract and Pledge Agreement:

     (i) containing such information as is contained in the notice or solicitation;

     (ii) stating that each Holder on the record date set by the Purchase Contract Agent therefor
(which, to the extent possible, shall be the same date as the record date for determining the
holders of Senior Notes, as the case may be, entitled to vote) shall be entitled to instruct the
Purchase Contract Agent as to the exercise of the voting rights pertaining to the Senior Notes
underlying such Holder’s Corporate HiMEDS Units; and

     (iii) stating the manner in which such instructions may be given.

     The Holder of this Corporate HiMEDS Units Certificate, by its acceptance hereof, irrevocably
authorizes the Purchase Contract Agent to enter into and perform the related Purchase Contracts
forming part of the Corporate HiMEDS Units evidenced hereby on its behalf as its attorney-in-fact,
agrees to be bound by the terms and provisions thereof, covenants and agrees to perform its
obligations under such Purchase Contracts, consents to the provisions of the Purchase Contract and
Pledge Agreement, irrevocably authorizes the Purchase Contract Agent to enter into and perform the
Purchase Contract and Pledge Agreement on its behalf as its attorney-in-fact, consents to the
Pledge of the Senior Notes underlying this Corporate HiMEDS Units Certificate pursuant to the
Purchase Contract and Pledge Agreement and expressly withholds any consent to the assumption (i.e.,
affirmance) of the Purchase Contracts by the Company or its trustee in the event that the Company
becomes the subject of a case under the Bankruptcy Code. The Holder further covenants and agrees
that, to the extent and in the manner provided in the Purchase Contract and Pledge Agreement, but
subject to the terms thereof, payments with

A-8

 

respect to the aggregate principal amount of the Pledged Senior Notes on the Purchase Contract
Settlement Date less any Deferred Contract Adjustment Payments shall be paid by the Collateral
Agent to the Company in satisfaction of such Holder’s obligations under such Purchase Contract and
such Holder shall acquire no right, title or interest in such payments.

     Upon registration of transfer of this Corporate HiMEDS Units Certificate, the transferee shall
be bound (without the necessity of any other action on the part of such transferee, except as may
be required by the Purchase Contract Agent pursuant to the Purchase Contract and Pledge Agreement),
under the terms of the Purchase Contract and Pledge Agreement and the Purchase Contracts evidenced
hereby and the transferor shall be released from the obligations under the Purchase Contracts
evidenced by this Corporate HiMEDS Units Certificate. The Company covenants and agrees, and the
Holder, by its acceptance hereof, likewise covenants and agrees, to be bound by the provisions of
this paragraph.

     Prior to due presentment of this Certificate for registration of transfer, the Company, the
Purchase Contract Agent and its Affiliates and any agent of the Company or the Purchase Contract
Agent may treat the Person in whose name this Corporate HiMEDS Units Certificate is registered as
the owner of the Corporate HiMEDS Units evidenced hereby for the purpose of receiving payments of
interest payable on the Senior Notes, receiving payments of Contract Adjustment Payments (subject
to any applicable record date), performance of the Purchase Contracts and for all other purposes
whatsoever, whether or not any payments in respect thereof be overdue and notwithstanding any
notice to the contrary, and neither the Company, the Purchase Contract Agent nor any such agent
shall be affected by notice to the contrary.

     The Purchase Contracts shall not, prior to the settlement thereof, entitle the Holder to any
of the rights of a holder of shares of Common Stock.

     Subject to certain exceptions, the provisions of the Purchase Contract and Pledge Agreement
may be amended with the consent of the Holders of a majority of the Outstanding HiMEDS Units.

     The Purchase Contracts shall be governed by, and construed in accordance with, the laws of the
State of New York.

     A copy of the Purchase Contract and Pledge Agreement is available for inspection at the
offices of the Purchase Contract Agent.

A-9

 

ABBREVIATIONS

     The following abbreviations, when used in the inscription on the face of this instrument,
shall be construed as though they were written out in full according to applicable laws or
regulations:

	 	 	 	 	 	 	 	 	 	 	 
	TEN COM	 	as tenants in common	 	 	 	 
	UNIF GIFT MIN ACT:

	 	 	 	Custodian	 	 	 	 	 	 
	 

	 	 

(cust)
	 	 	 	 

(minor)	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Under Uniform Gifts to Minors Act of	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	TENANT:	 	as tenants by the entireties	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	JT TEN:	 	as joint tenants with right of survivorship and not as tenants 
in common	 	 

	 	 	 	 	 	 	 	 	 
	Additional abbreviations may also be used though not in the above list.
	 
	 

	 	FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto
	 	 	 	 	 	 
	 

	 	 	 	 
	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	(Please insert Social Security or Taxpayer I.D. or other Identifying Number of Assignee)
	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	(Please Print or Type Name and Address Including Postal Zip Code of Assignee)
	 	 

the within Corporate HiMEDS Units Certificates and all rights thereunder, hereby irrevocably
constituting and appointing attorney                     , to transfer said Corporate HiMEDS Units
Certificates on the books of Avery Dennison Corporation, with full power of substitution in the
premises.

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	Signature:	 	 	 	 	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	NOTICE: The signature to this assignment must
correspond with the name as it appears upon the
face of the 
within Corporate HiMEDS
Units Certificates in every particular,

without alteration or enlargement or any change
whatsoever.	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	Signature

Guarantee:	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

A-10

 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

A-11

 

SETTLEMENT INSTRUCTIONS

     The undersigned Holder directs that a certificate for shares of Common Stock deliverable upon
settlement of the Purchase Contracts underlying the number of Corporate HiMEDS Units evidenced by
this Corporate HiMEDS Units Certificate be registered in the name of, and delivered, together with
a check in payment for any fractional share, to the undersigned at the address indicated below
unless a different name and address have been indicated below. If shares are to be registered in
the name of a Person other than the undersigned, the undersigned will pay any transfer tax payable
incident thereto.

	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	Signature	 	 
	 

	 	 

	 	 	 	Signature Guarantee:	 	 
	 	 	 	 	 	 	(if assigned to another person)

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

	 	 	 	 	 
	If shares are to be registered in the name of and delivered
to a Person other than the Holder, please (i) print such Person’s name and
address and (ii) provide a guarantee of your signature:

	 	 	 	 

	 
	 	 	 	 
	 
	 	 	 	 
	 

Name
	 	 	 	 
	 
	 	 	 	 
	 

Address
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Social Security or other Taxpayer Identification Number, if any
	 	 	 	 

A-12

 

	 	 	 	 	 
	REGISTERED HOLDER
	 	 	 	 
	 
	 	 	 	 
	Please print name and address of Registered Holder:
	 	 	 	 
	 
	 	 	 	 
	 

Name
	 	 	 	 
	 
	 	 	 	 
	 

Address
	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	DTC Participant #:                                                                 
	 	 	 	 

A-13

 

ELECTION TO SETTLE EARLY/ MERGER EARLY SETTLEMENT

     The undersigned Holder of this Corporate HiMEDS Units Certificate hereby irrevocably exercises
the option to effect [Early Settlement] [Merger Early Settlement] in accordance with the terms of
the Purchase Contract and Pledge Agreement with respect to the Purchase Contracts underlying the
number of Corporate HiMEDS Units evidenced by this Corporate HiMEDS Units Certificate specified
below. The option to effect [Early Settlement] [Merger Early Settlement] may be exercised only
with respect to Purchase Contracts underlying Corporate HiMEDS Units in integral multiples of 20
Corporate HiMEDS Units. The undersigned Holder directs that a certificate for shares of Common
Stock or other securities deliverable upon such [Early Settlement] [Merger Early Settlement] be
registered in the name of, and delivered, together with a check in payment for any fractional share
and any Corporate HiMEDS Units Certificate representing any Corporate HiMEDS Units evidenced hereby
as to which [Early Settlement] [Merger Early Settlement] of the related Purchase Contracts is not
effected, to the undersigned at the address indicated below unless a different name and address
have been indicated below. Pledged Senior Notes deliverable upon such [Early Settlement] [Merger
Early Settlement] will be transferred in accordance with the transfer instructions set forth below.
If shares are to be registered in the name of a Person other than the undersigned, the undersigned
will pay any transfer tax payable incident thereto.

	 	 	 	 	 	 	 	 	 	 	 
	Dated:
	 	 	 	 	 	 	 	 	 	 
	 	 	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature:	 	 	 	 
	 

	 	 	 	 	 	Signature

Guarantee:	 	 	 	 
	 

	 	 	 	 	 	 	 	 

	 	 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

	 	 	 	 	 
	DTC 
Participant No.:
	 	 	 	 
	 

	 	 

	 	 

A-14

 

     Number of HiMEDS Units evidenced hereby as to which [Early Settlement] [Merger Early
Settlement] of the related Purchase Contracts is being elected:

	 	 	 	 	 	 	 	 	 
	If shares of Common Stock or
Corporate HiMEDS Units Certificates
are to be registered in the name of
and delivered to and Pledged Senior
Notes are to be transferred to a
Person other than the Holder, please
print such Person’s name and
address:	 	 	 	REGISTERED HOLDER

Please print name and address of
Registered Holder:	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Name

	 	 	 	Name	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Address

	 	 	 	Address	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Social Security or other 

Taxpayer Identification 

Number, if any

	 	 	 	DTC Participant #:
	 	 
	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 

Transfer Instructions for Pledged Senior Notes transferable upon [Early Settlement] [Merger Early
Settlement]:

A-15

 

[TO BE ATTACHED TO GLOBAL CERTIFICATES]

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL CERTIFICATE

The initial number of Corporate HiMEDS Units evidenced by this Global Certificate is 8,000,000.
The following increases or decreases in this Global Certificate have been made:

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Number of Corporate	 	 
	 	 	Amount of increase	 	Amount of	 	HiMEDS Units	 	 
	 	 	in	 	decrease in	 	evidenced by this	 	Signature of
	 	 	Number of Corporate	 	Number of Corporate	 	Global	 	authorized
	 	 	HiMEDS Units	 	HiMEDS Units	 	Certificate	 	signatory of
	 	 	evidenced by the	 	evidenced by the	 	following such	 	Purchase
	Date	 	Global Certificate	 	Global Certificate	 	decrease or increase	 	Contract Agent
	 

A-16

 

EXHIBIT B

(FORM OF FACE OF TREASURY HiMEDS UNIT CERTIFICATE)

     [For inclusion in Global Certificate only — THIS CERTIFICATE IS A GLOBAL CERTIFICATE WITHIN
THE MEANING OF THE PURCHASE CONTRACT AND PLEDGE AGREEMENT HEREINAFTER REFERRED TO AND IS REGISTERED
IN THE NAME OF CEDE & CO., AS NOMINEE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (THE
“DEPOSITARY”), THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY. THIS CERTIFICATE IS
EXCHANGEABLE FOR CERTIFICATES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS
NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE PURCHASE CONTRACT AND PLEDGE AGREEMENT
AND NO TRANSFER OF THIS CERTIFICATE (OTHER THAN A TRANSFER OF THIS CERTIFICATE AS A WHOLE BY THE
DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES.

     UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME
OF CEDE & CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY
(AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN
INTEREST HEREIN.]

	 	 	 
	No.

	 	CUSIP No. 053611406
	Number of Treasury HiMEDS Units:

	 	ISIN: US0536114061

AVERY DENNISON CORPORATION

Treasury HiMEDS Units

     This Treasury HiMEDS Units Certificate certifies that                      is the registered Holder of
the number of Treasury HiMEDS Units set forth above [For inclusion in Global Certificates only — or
such other number of Treasury HiMEDS Units reflected in the Schedule of Increases or Decreases in
Global Certificate attached hereto]. Each Treasury HiMEDS Unit consists of:

     (i) a 1/20, or 5.00%, undivided beneficial ownership interest of a Treasury Security having a
principal amount at maturity equal to $1,000, subject to the Pledge of such Treasury Security by
such Holder pursuant to the Purchase Contract and Pledge Agreement; and

B-1

 

     (ii) the rights and obligations of the Holder under one Purchase Contract with Avery Dennison
Corporation, a Delaware corporation (the “Company”).

All capitalized terms used herein which are defined in the Purchase Contract and Pledge Agreement
(as defined on the reverse hereof) have the meaning set forth therein.

     Pursuant to the Purchase Contract and Pledge Agreement, the Treasury Securities constituting
part of each Treasury HiMEDS Unit evidenced hereby have been pledged to the Collateral Agent, for
the benefit of the Company, to secure the obligations of the Holder under the Purchase Contract
comprising part of such Treasury HiMEDS Unit.

     Each Purchase Contract evidenced hereby obligates the Holder of this Treasury HiMEDS Units
Certificate to purchase, and the Company to sell, on the Purchase Contract Settlement Date, at a
price equal to $50 (the “Stated Amount”), a number of newly issued shares of common stock, par
value $1.00 per share (“Common Stock”), of the Company, equal to the Settlement Rate, unless on or
prior to the Purchase Contract Settlement Date there shall have occurred a Termination Event, an
Early Settlement or a Merger Early Settlement with respect to such Purchase Contract, all as
provided in the Purchase Contract and Pledge Agreement and more fully described on the reverse
hereof. The Purchase Price for the shares of Common Stock purchased pursuant to each Purchase
Contract evidenced hereby, if not paid earlier, shall be paid on the Purchase Contract Settlement
Date by application of the proceeds from the Treasury Securities at maturity pledged to secure the
obligations under such Purchase Contract of the Holder of the Treasury HiMEDS Units of which such
Purchase Contract is a part.

     The Company shall pay, on each Payment Date, in respect of each Purchase Contract forming part
of a Treasury HiMEDS Unit evidenced hereby, an amount (the “Contract Adjustment Payments”) equal to
2.525% per year of the Stated Amount, computed (i) for any full quarterly period on the basis of a
360-day year of twelve 30-day months and (ii) for any period other than a full quarterly period on
the basis of the actual number of days elapsed and a 360-day year. The Company may, at its option,
defer such Contract Adjustment Payments, as described in the Purchase Contract and Pledge
Agreement.

     Contract Adjustment Payments shall be payable to the Person in whose name this Treasury HiMEDS
Units Certificate evidencing such Purchase Contracts is registered at 5:00 p.m., New York City
time, on the Record Date for such Payment Date. If the book-entry system for the Treasury HiMEDS
Units has been terminated, the Contract Adjustment Payments will be payable, at the option of the
Company, by check mailed to the address of the Person entitled thereto at such Person’s address as
it appears on the Security Register, or by wire transfer to the account designated by such Person
by a prior written notice to the Purchase Contract Agent.

     Each Treasury HiMEDS Unit evidenced hereby obligates the beneficial owner thereof to agree,
for tax purposes, to treat:

     (i) each Treasury HiMEDS Unit as an investment unit consisting of Treasury Securities and a
Purchase Contract; and

     (ii) itself as the owner of the applicable interests in the Collateral Account, including the
Treasury Securities.

B-2

 

     Reference is hereby made to the further provisions set forth on the reverse hereof, which
further provisions shall for all purposes have the same effect as if set forth at this place.

     Unless the certificate of authentication hereon has been executed by the Purchase Contract
Agent by manual signature, this Treasury HiMEDS Units Certificate shall not be entitled to any
benefit under the Purchase Contract and Pledge Agreement or be valid or obligatory for any purpose.

B-3

 

     IN WITNESS WHEREOF, the Company and the Holder specified above have caused this instrument to
be duly executed.

	 	 	 	 	 
	 	AVERY DENNISON CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	ATTEST:

 	 	 
	By:  	 	 	 
	 	Name:  	 	 	 
	 	Title:  	 	 	 
	 	  	of Avery Dennison Corporation 	 	 
	 

	 	 	 	 	 
	 	HOLDER SPECIFIED ABOVE (as to
obligations of such Holder under the Purchase Contracts)

 	 
	 	By:  THE BANK OF NEW YORK TRUST COMPANY, N.A.,
 	 
	 	 	not individually but solely as attorney 	 
	 	 	in-fact of such Holder 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

B-4

 

	 	 	 	 	 

CERTIFICATE OF AUTHENTICATION OF

PURCHASE CONTRACT AGENT

     This is one of the Treasury HiMEDS Units referred to in the within-mentioned Purchase Contract
and Pledge Agreement.

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST COMPANY, N.A.,

as Purchase Contract Agent

 	 
	 	By:  	 	 
	 	 	Authorized Officer 	 
	 	 	 	 
	 

     Dated:    
                          

B-5

 

(REVERSE OF TREASURY HiMEDS UNIT CERTIFICATE)

     Each Purchase Contract evidenced hereby is governed by a Purchase Contract and Pledge
Agreement, dated as of November 20, 2007 (as may be supplemented from time to time, the “Purchase
Contract and Pledge Agreement”), among the Company, The Bank of New York Trust Company, N.A., as
Purchase Contract Agent (including its successors hereunder, the “Purchase Contract Agent”) and
attorney-in-fact of the Holders from time to time, and The Bank of New York Trust Company, N.A., as
Collateral Agent, Custodial Agent and Securities Intermediary, to which Purchase Contract and
Pledge Agreement and supplemental agreements thereto reference is hereby made for a description of
the respective rights, limitations of rights, obligations, duties and immunities thereunder of the
Purchase Contract Agent, the Company, and the Holders and of the terms upon which the Treasury
HiMEDS Units Certificates are, and are to be, executed and delivered.

     Each Purchase Contract evidenced hereby obligates the Holder of this Treasury HiMEDS Units
Certificate to purchase, and the Company to sell, on the Purchase Contract Settlement Date at a
price equal to the Stated Amount (the “Purchase Price”) a number of newly issued shares of Common
Stock equal to the Settlement Rate, unless a Termination Event or an Early Settlement or a Merger
Early Settlement with respect to the Treasury HiMEDS Unit of which such Purchase Contract is a part
shall have occurred.

     In accordance with the terms of the Purchase Contract and Pledge Agreement, the Holder of this
Treasury HiMEDS Unit Certificate shall pay the Purchase Price for the shares of the Common Stock
purchased pursuant to each Purchase Contract evidenced hereby either by effecting an Early
Settlement or, if applicable, a Merger Early Settlement of each such Purchase Contract or by
applying the principal amount of the Pledged Treasury Securities underlying such Holder’s Treasury
HiMEDS Unit equal to the Stated Amount of such Purchase Contract to the purchase of the Common
Stock. A Holder of Treasury HiMEDS Units who has not effected an Early Settlement or, if
applicable, a Merger Early Settlement shall pay the Purchase Price, less the amount of any Deferred
Contract Adjustment Payments payable to such Holder, for the shares of Common Stock to be issued
under the related Purchase Contract from the proceeds of the Pledged Treasury Securities.

     The Company shall not be obligated to issue any shares of Common Stock in respect of a
Purchase Contract or deliver any certificates therefor to the Holder unless it shall have received
payment of the aggregate Purchase Price, less any Deferred Contract Payments for the shares of
Common Stock to be purchased thereunder in the manner set forth in the Purchase Contract and Pledge
Agreement.

     The Treasury HiMEDS Units Certificates are issuable only in registered form and only in
denominations of single Treasury HiMEDS Unit and any integral multiple thereof. The transfer of
any Treasury HiMEDS Units Certificate will be registered and Treasury HiMEDS Units Certificates may
be exchanged as provided in the Purchase Contract and Pledge Agreement.

     Subject to the conditions set forth in the Purchase Contract and Pledge Agreement, a Holder of
Treasury HiMEDS Units may recreate, at any time on or prior to 4:00 p.m., New York City time, on
the second Business Day immediately preceding the Remarketing Date, Corporate

B-6

 

HiMEDS Units by delivering to the Securities Intermediary Senior Notes with an aggregate
principal amount, equal to the aggregate principal amount at maturity of the Pledged Treasury
Securities in exchange for the release of such Pledged Treasury Securities in accordance with the
terms of the Purchase Contract and Pledge Agreement. From and after such substitution, the
Holder’s HiMEDS Units shall be referred to as a “Corporate HiMEDS Unit.” Any such recreation of
Corporate HiMEDS Units may be effected only in multiples of 20 Treasury HiMEDS Units. A Holder who
elects to substitute a Senior Note, for Treasury Securities, thereby recreating Corporate HiMEDS
Units, shall be responsible for any fees or expenses associated therewith.

     Each Purchase Contract evidenced hereby and all obligations and rights of the Company and the
Holder thereunder, including, without limitation, the rights of the Holder to receive and the
obligation of the Company to pay any Contract Adjustment Payments, shall immediately and
automatically terminate, without the necessity of any notice or action by any Holder, the Purchase
Contract Agent or the Company, if, on or prior to the Purchase Contract Settlement Date, a
Termination Event shall occur. Upon the occurrence of a Termination Event, the Company shall, no
later than two Business Days thereafter, give written notice to the Purchase Contract Agent, the
Collateral Agent and the Holders, at their addresses as they appear in the Security Register. Upon
and after the occurrence of a Termination Event, the Collateral Agent shall release the Pledged
Treasury Securities forming a part of each Treasury HiMEDS Unit from the Pledge in accordance with
the provisions of the Purchase Contract and Pledge Agreement. A Treasury HiMEDS Unit shall
thereafter represent the right to receive the Proceeds of the Treasury Security forming a part of
such Treasury HiMEDS Unit, in accordance with the terms of the Purchase Contract and Pledge
Agreement.

     Subject to and upon compliance with the provisions of the Purchase Contract and Pledge
Agreement, at the option of the Holder thereof, Purchase Contracts underlying HiMEDS Units may be
settled early at any time on or prior to 4:00 p.m., New York City time, on the Business Day
immediately preceding the first scheduled Trading Day of the Observation Period (“Early
Settlement”) as provided in the Purchase Contract and Pledge Agreement. Upon Early Settlement of
Purchase Contracts by a Holder of the related Treasury HiMEDS Units, the Pledged Treasury
Securities underlying such Treasury HiMEDS Units shall be released from the Pledge as provided in
the Purchase Contract and Pledge Agreement and the Holder shall be entitled to receive a number of
shares of Common Stock on account of each Purchase Contract forming part of a Treasury HiMEDS Unit
as to which Early Settlement is effected equal to the Minimum Settlement Rate.

     Upon the occurrence of a Cash Merger, a Holder of Treasury HiMEDS Units may effect Merger
Early Settlement of the Purchase Contract underlying such Treasury HiMEDS Units pursuant to the
terms of Section 5.04(b)(ii) of the Purchase Contract and Pledge Agreement. Upon Merger Early
Settlement of Purchase Contracts by a Holder of the related Treasury HiMEDS Units, the Pledged
Treasury Securities underlying such Treasury HiMEDS Units shall be released from the Pledge as
provided in the Purchase Contract and Pledge Agreement.

     The Holder of this Treasury HiMEDS Units Certificate, by its acceptance hereof, irrevocably
authorizes the Purchase Contract Agent to enter into and perform the related Purchase Contracts
forming part of the Treasury HiMEDS Units evidenced hereby on its behalf

B-7

 

as its attorney-in-fact, agrees to be bound by the terms and provisions thereof, covenants and
agrees to perform its obligations under such Purchase Contracts, consents to the provisions of the
Purchase Contract and Pledge Agreement, authorizes the Purchase Contract Agent to enter into and
perform the Purchase Contract and Pledge Agreement on its behalf as its attorney-in-fact, consents
to the Pledge of the Treasury Securities underlying this Treasury HiMEDS Units Certificate pursuant
to the Purchase Contract and Pledge Agreement and expressly withholds any consent to the assumption
(i.e., affirmance) of the Purchase Contracts by the Company or its trustee in the event that the
Company becomes the subject of a case under the Bankruptcy Code. The Holder further covenants and
agrees, that, to the extent and in the manner provided in the Purchase Contract and Pledge
Agreement, but subject to the terms thereof, payments in respect to the aggregate principal amount
of the Pledged Treasury Securities on the Purchase Contract Settlement Date less any Deferred
Contract Adjustment Payments shall be paid by the Collateral Agent to the Company in satisfaction
of such Holder’s obligations under such Purchase Contract and such Holder shall acquire no right,
title or interest in such payments.

     Upon registration of transfer of this Treasury HiMEDS Units Certificate, the transferee shall
be bound (without the necessity of any other action on the part of such transferee, except as may
be required by the Purchase Contract Agent pursuant to the Purchase Contract and Pledge Agreement),
under the terms of the Purchase Contract and Pledge Agreement and the Purchase Contracts evidenced
hereby and the transferor shall be released from the obligations under the Purchase Contracts
evidenced by this Treasury HiMEDS Units Certificate. The Company covenants and agrees, and the
Holder, by its acceptance hereof, likewise covenants and agrees, to be bound by the provisions of
this paragraph.

     Prior to due presentment of this Certificate for registration or transfer, the Company, the
Purchase Contract Agent and its Affiliates and any agent of the Company or the Purchase Contract
Agent may treat the Person in whose name this Treasury HiMEDS Units Certificate is registered as
the owner of the Treasury HiMEDS Units evidenced hereby for the purpose of receiving payments of
Contract Adjustment Payments (subject to any applicable record date), performance of the Purchase
Contracts and for all other purposes whatsoever, whether or not any payments in respect thereof be
overdue and notwithstanding any notice to the contrary, and neither the Company, the Purchase
Contract Agent nor any such agent shall be affected by notice to the contrary.

     The Purchase Contracts shall not, prior to the settlement thereof, entitle the Holder to any
of the rights of a holder of shares of Common Stock.

     Subject to certain exceptions, the provisions of the Purchase Contract and Pledge Agreement
may be amended with the consent of the Holders of a majority of the Outstanding HiMEDS Units.

     The Purchase Contracts shall be governed by, and construed in accordance with, the laws of the
State of New York.

     A copy of the Purchase Contract and Pledge Agreement is available for inspection at the
offices of the Purchase Contract Agent.

B-8

 

ABBREVIATIONS

     The following abbreviations, when used in the inscription on the face of this instrument,
shall be construed as though they were written out in full according to applicable laws or
regulations:

	 	 	 	 	 	 	 	 	 	 	 
	TEN COM:	 	as tenants in common	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	UNIF GIFT MIN ACT:

	 	 	 	Custodian	 	 	 	 	 	 
	 

	 	 

(cust)
	 	 	 	 

(minor)	 	 	 	 
	 	 	Under Uniform Gifts to Minors Act of	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	TENANT:	 	as tenants by the entireties	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	JT TEN:	 	as joint tenants with right of survivorship and not as tenants in common	 	 

     Additional abbreviations may also be used though not in the above list.

	 	 	 	 	 	 	 
	 

	 	FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and
transfer(s) unto	 	 	 	 
	 

	 	 	 	 
	 	 
	 
	 	 	 	 	 	 
	 	 	 
(Please insert Social Security or Taxpayer I.D. or other Identifying Number of Assignee)

	 
	 	 	 	 	 	 
	 	 	 
(Please Print or Type Name and Address Including Postal Zip Code of Assignee)

the within Treasury HiMEDS Units Certificates and all rights thereunder, hereby irrevocably
constituting and appointing attorney                     , to transfer said Treasury HiMEDS Units
Certificates on the books of Avery Dennison Corporation, with full power of substitution in the
premises.

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	Signature	 	 	 	 	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	NOTICE: The signature to this
assignment must correspond with the
name as it appears upon the face of
the within Treasury HiMEDS Units
Certificates in every particular,
without alteration or enlargement or
any change whatsoever.	 	 
	 

	 	Signature

Guarantee:	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

B-9

 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

B-10

 

SETTLEMENT INSTRUCTIONS

The undersigned Holder directs that a certificate for shares of Common Stock deliverable upon
settlement of the Purchase Contracts underlying the number of Treasury HiMEDS Units evidenced by
this Treasury HiMEDS Units Certificate be registered in the name of, and delivered, together with a
check in payment for any fractional share, to the undersigned at the address indicated below unless
a different name and address have been indicated below. If shares are to be registered in the name
of a Person other than the undersigned, the undersigned will pay any transfer tax payable incident
thereto.

	 	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	Signature	 	 
	 

	 	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature Guarantee:	 	 
	 

	 	 	 	 	 	 	 	 

	 	 	 	 	(if assigned to another person)

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

	 	 	 	 	 	 	 
	If shares are to be registered in the name of and delivered to a Person other
than the Holder, please (i) print such Person’s name and address and (ii)
provide a guarantee of your signature

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 

Name
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

Address
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Social Security or other Taxpayer Identification Number, if any
	 	 	 	 	 	 

B-11

 

	 	 	 	 	 	 	 
	REGISTERED HOLDER
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Please print name and address of Registered Holder:
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

Name
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

Address
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	DTC Participant #:            
                    
                         
	 	 	 	 	 	 

B-12

 

ELECTION TO SETTLE EARLY/ MERGER EARLY SETTLEMENT

     The undersigned Holder of this Treasury HiMEDS Units Certificate hereby irrevocably exercises
the option to effect [Early Settlement] [Merger Early Settlement] in accordance with the terms of
the Purchase Contract and Pledge Agreement with respect to the Purchase Contracts underlying the
number of Treasury HiMEDS Units evidenced by this Treasury HiMEDS Units Certificate specified
below. The option to effect [Early Settlement] [Merger Early Settlement] may be exercised only
with respect to Purchase Contracts underlying Treasury HiMEDS Units in integral multiples of 20
Treasury HiMEDS Units. The undersigned Holder directs that a certificate for shares of Common
Stock or other securities deliverable upon such [Early Settlement] [Merger Early Settlement] be
registered in the name of, and delivered, together with a check in payment for any fractional share
and any Treasury HiMEDS Units Certificate representing any Treasury HiMEDS Units evidenced hereby
as to which [Early Settlement] [Merger Early Settlement] of the related Purchase Contracts is not
effected, to the undersigned at the address indicated below unless a different name and address
have been indicated below. Pledged Treasury Securities deliverable upon such [Early Settlement]
[Merger Early Settlement] will be transferred in accordance with the transfer instructions set
forth below. If shares are to be registered in the name of a Person other than the undersigned,
the undersigned will pay any transfer tax payable incident thereto.

	 	 	 	 	 	 	 	 	 	 	 
	Dated:
	 	 	 	 	 	 	 	 	 	 
	 	 	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature:	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature

Guarantee:	 	 	 	 
	 

	 	 	 	 	 	 	 	 

	 	 

     Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements
of the Security Registrar, which requirements include membership or participation in the Security
Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be
determined by the Security Registrar in addition to, or in substitution for, STAMP, all in
accordance with Securities Exchange Act of 1934, as amended.

	 	 	 	 	 
	DTC 
Participant #:
	 	 	 	 
	 

	 	 

	 	 

B-13

 

     Number of Treasury HiMEDS Units evidenced hereby as to which [Early Settlement] [Merger Early
Settlement] of the related Purchase Contracts is being elected:

	 	 	 	 	 	 	 	 	 
	If shares of Common Stock or Treasury
Units Certificates are to be
registered in the
name of and delivered to and Treasury
Securities, as the case may be,
are to be transferred to a Person
other than the Holder, please print
such Person’s name and address:	 	 	 	REGISTERED HOLDER

Please print name and address of
Registered Holder:	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Name

	 	 	 	Name	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Address

	 	 	 	Address	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Social Security or other 

Taxpayer Identification 

Number, if any

	 	 	 	DTC Participant #:
	 	 
	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 

     Transfer Instructions for Pledged Treasury Securities Transferable upon [Early Settlement]
[Merger Early Settlement] or a Termination Event:

B-14

 

[TO BE ATTACHED TO GLOBAL CERTIFICATES]

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL CERTIFICATE

The initial number of Treasury HiMEDS Units evidenced by this Global Certificate is 0. The
following increases or decreases in this Global Certificate have been made:

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Number of Treasury	 	 
	 	 	Amount of increase	 	Amount of decrease	 	HiMEDS Units	 	 
	 	 	in Number of	 	in Number of	 	evidenced by this	 	Signature of
	 	 	Treasury HiMEDS	 	Treasury HiMEDS	 	Global Certificate	 	authorized
	 	 	Units evidenced by	 	Units evidenced by	 	following such	 	signatory of
	 	 	the Global	 	the Global	 	decrease or	 	Purchase Contract
	Date	 	Certificate	 	Certificate	 	increase	 	Agent
	 

B-15

 

EXHIBIT C

INSTRUCTION TO PURCHASE CONTRACT AGENT FROM HOLDER

TO CREATE TREASURY HIMEDS UNITS OR CORPORATE HIMEDS UNITS

The Bank of New York Trust Company, N.A.,

as Purchase Contract Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	Re:  	 	[                    Corporate HiMEDS Units] [                    Treasury HiMEDS Units] of Avery Dennison Corporation, a Delaware corporation (the “Company”).

     The undersigned Holder hereby notifies you that it has delivered to                     , as
Securities Intermediary, for credit to the Collateral Account, $                     aggregate principal
amount of [Senior Notes] [Treasury Securities] in exchange for the [Pledged Senior Notes] [Pledged
Treasury Securities] held in the Collateral Account, in accordance with the Purchase Contract and
Pledge Agreement, dated as of November 20, 2007 (the “Agreement”; unless otherwise defined herein,
terms defined in the Agreement are used herein as defined therein), among you, as Purchase Contract
Agent and attorney-in-fact of the Holders from time to time, the Company, and you, as the
Collateral Agent, the Custodial Agent and the Securities Intermediary. The undersigned Holder has
paid all applicable fees and expenses relating to such exchange. The undersigned Holder hereby
instructs you to instruct the Collateral Agent to release to you on behalf of the undersigned
Holder the [Pledged Senior Notes] [Pledged Treasury Securities] related to such [Corporate HiMEDS
Units] [Treasury HiMEDS Units].

	 	 	 	 	 	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 	 	 	 	 
	 	 	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature:	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature

Guarantee:	 	 	 	 
	 

	 	 	 	 	 	 	 	 

	 	 

	 	 	 	 	 
	DTC Participant 
No.
	 	 	 	 
	 

	 	 

	 	 

C-1

 

Please print name and address of Registered Holder:

	 	 	 	 	 	 	 
	 

Name

	 	 	 	 

Social Security or other Taxpayer Identification Number, if any
	 	 
	 
	 	 	 	 	 	 
	Address
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 

C-2

 

EXHIBIT D

NOTICE FROM PURCHASE CONTRACT AGENT

TO HOLDERS UPON TERMINATION EVENT

(Transfer of Collateral upon Occurrence of a Termination Event)

	 	 	 
	[HOLDER]

	 	 
	 
	 	 
	 

	 	 
	 

	 	 
	Attention:
	 	 
	Telecopy:
	 	 

	 	Re:  	 	[                    Corporate HiMEDS Units] [                    Treasury HiMEDS Units] of Avery Dennison Corporation, a Delaware corporation (the “Company”)

     Please refer to the Purchase Contract and Pledge Agreement, dated as of November 20, 2007 (the
"Agreement”; unless otherwise defined herein, terms defined in the Agreement are used herein as
defined therein), among the Company, the undersigned, as Purchase Contract Agent and
attorney-in-fact of the Holders from time to time, and the undersigned, as Collateral Agent,
Custodial Agent and Securities Intermediary.

     We hereby notify you that a Termination Event has occurred and that [the Senior Notes] [the
Treasury Securities] compromising a portion of your ownership interest in                      [Corporate
HiMEDS Units] [Treasury HiMEDS Units] have been released and are being held by us for your account
pending receipt of transfer instructions with respect to such [Pledged Senior Notes] [Pledged
Treasury Securities] (the “Released Securities”).

     Pursuant to Section 3.15 of the Agreement, we hereby request written transfer instructions
with respect to the Released Securities. Upon receipt of your instructions and upon transfer to us
of your [Corporate HiMEDS Units] [Treasury HiMEDS Units] effected through book-entry or by delivery
to us of your [Corporate HiMEDS Units Certificate] [Treasury HiMEDS Units Certificate], we shall
transfer the Released Securities by book-entry transfer or other appropriate procedures, in
accordance with your instructions. In the event you fail to effect such transfer or delivery, the
Released Securities and any distributions thereon, shall be held in our name, or a nominee in trust
for your benefit, until such time as such [Corporate HiMEDS Units] [Treasury HiMEDS Units] are
transferred or your [Corporate HiMEDS Units Certificate] [Treasury HiMEDS Units Certificate] is
surrendered or satisfactory evidence is provided that such [Corporate HiMEDS Units Certificate]
[Treasury HiMEDS Units Certificate] has been destroyed, lost or stolen, together with any
indemnification that we or the Company may require.

D-1

 

	 	 	 	 	 	 	 
	Date:

	 	By:	 	THE BANK OF NEW YORK TRUST COMPANY, N.A.,
as the Purchase Contract Agent
	 	 

	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	   	 	 
	 

	 	Name:	 	 	 	 
	 

	 	Title:
	 	Authorized Signatory	 	 

D-2

 

EXHIBIT E

NOTICE TO SETTLE BY SEPARATE CASH

FROM HOLDER TO PURCHASE CONTRACT AGENT

The Bank of New York Trust Company, N.A.,

as Purchase Contract Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	 	 	Re: Corporate HiMEDS Units of Avery Dennison Corporation, a Delaware
corporation (the “Company”)

     The undersigned Holder hereby irrevocably notifies you in accordance with Section 5.02(a) of
the Purchase Contract and Pledge Agreement, dated as of November 20, 2007 (the “Agreement”; unless
otherwise defined herein, terms defined in the Agreement are used herein as defined therein), among
you, as Purchase Contract Agent and attorney-in-fact of the Holders from time to time, the Company,
and you, as Collateral Agent, Custodial Agent and Securities Intermediary, that such Holder has
elected to pay to the Securities Intermediary for deposit in the Collateral Account, on or prior to
4:00 p.m., New York City time, on the second Business Day immediately preceding the Remarketing
Date (in lawful money of the United States by certified or cashiers’ check or wire transfer, in
immediately available funds), $                             as the Purchase Price for the shares of Common Stock
issuable to such Holder by the Company with respect to                              Purchase Contracts on the
Purchase Contract Settlement Date. The undersigned Holder hereby instructs you to notify promptly
the Collateral Agent of the undersigned Holders’ election to make such Cash Settlement with respect
to the Purchase Contracts related to such Holder’s Corporate HiMEDS Units.

	 	 	 	 	 
	 	 	 
	Date:                              	
 	 
	 	Signature: 	 
	 
	 	Signature

Guarantee: 	 	 
	 

Please print name and address of Registered Holder:

                                                                    

                                                                    

DTC Participant

No.                                     

E-1

 

EXHIBIT F

RESERVED

F-1

 

EXHIBIT G

INSTRUCTION

FROM PURCHASE CONTRACT AGENT

TO COLLATERAL AGENT

REGARDING CREATION OF TREASURY HIMEDS UNITS

The Bank of New York Trust Company, N.A.,

as Purchase Contract Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	 	 	Re: Corporate HiMEDS Units of Avery Dennison Corporation (the “Company”)

     Please refer to the Purchase Contract and Pledge Agreement, dated as of November 20, 2007 (the
“Agreement”), among you, as Purchase Contract Agent and attorney-in-fact of the Holders from time
to time, the Company, and you, as Collateral Agent, Custodial Agent and Securities Intermediary.
Capitalized terms used herein but not defined shall have the meaning set forth in the Agreement.

     We hereby notify you in accordance with Section 3.13 of the Agreement that the holder of
securities named below (the “Holder”) has elected to substitute $                             Value of
Treasury Securities or security entitlements with respect thereto in exchange for an equal Value of
Pledged Senior Notes relating to                              Corporate HiMEDS Units and has delivered to the
undersigned a notice stating that the Holder has Transferred such Treasury Securities or security
entitlements with respect thereto to the Securities Intermediary, for credit to the Collateral
Account.

     We hereby request that you instruct the Securities Intermediary, upon confirmation that such
Treasury Securities or security entitlements thereto have been credited to the Collateral Account,
to release to the undersigned an equal Value of Pledged Senior Notes in accordance with Section
3.13 of the Agreement.

	 	 	 	 	 
	Date:

	 	THE BANK OF NEW YORK TRUST
 COMPANY, N.A., as

Purchase Contract Agent

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	Authorized Signatory 	 
	 

G-1

 

     Please print name and address of Holder electing to substitute Treasury Securities or security
entitlements with respect thereto for the Pledged Senior Notes:

	 	 	 
	 

	 	 
	Name:

	 	Social Security or other Taxpayer

Identification Number, if any
	 
	 	 
	Address
	 	 
	 
	 

	 	 
	 
	 

	 	 

G-2

 

EXHIBIT H

INSTRUCTION

FROM COLLATERAL AGENT

TO SECURITIES INTERMEDIARY

REGARDING CREATION OF TREASURY HIMEDS UNITS

The Bank of New York Trust Company, N.A.,

as Securities Intermediary

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	 	 	Re: HiMEDS Units of Avery Dennison Corporation (the “Company”)
	 
	 	 	 	The securities account of The Bank of New York Trust Company, N.A.,
as Collateral Agent, maintained by the Securities Intermediary and
designated “[                     ], as Collateral Agent of Avery
Dennison Corporation, as pledgee of The Bank of New York Trust
Company, N.A., as the Purchase Contract Agent on behalf of and as
attorney-in-fact for the Holders” (the “Collateral Account”)

     Please refer to the Purchase Contract and Pledge Agreement, dated as of November 20, 2007 (the
“Agreement”), among you, the Company, you, as Collateral Agent and Custodial Agent, and you, as
Purchase Contract Agent and attorney-in-fact for the Holders from time to time. Capitalized terms
used herein but not defined shall have the meaning set forth in the Agreement.

     When you have confirmed that $                                        Value of Treasury Securities or security
entitlements thereto has been credited to the Collateral Account by or for the benefit of
                                , as Holder of Corporate HiMEDS Units (the “Holder”), you are hereby
instructed to release from the Collateral Account an equal Value of Pledged Senior Notes or
security entitlements with respect thereto relating to
                                 Corporate HiMEDS Units of the
Holder by Transfer to the Purchase Contract Agent.

Dated:

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST
 COMPANY, N.A., as

Collateral Agent

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	Authorized Signatory 	 

H-1

 

	 	 	 	 	 

EXHIBIT I

INSTRUCTION

FROM PURCHASE CONTRACT AGENT

TO COLLATERAL AGENT

REGARDING RECREATION OF CORPORATE HIMEDS UNITS

The Bank of New York Trust Company, N.A.,

as Collateral Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	 	 	Re: Treasury HiMEDS Units of Avery Dennison Corporation (the “Company”)

     Please refer to the Purchase Contract and Pledge Agreement dated as of November 20, 2007 (the
“Agreement”), among you, the Company, you, as Custodial Agent and Securities Intermediary, and you,
as Purchase Contract Agent and attorney-in-fact of the Holders from time to time. Capitalized
terms used herein but not defined shall have the meaning set forth in the Agreement.

     We hereby notify you in accordance with Section 3.13 of the Agreement that the holder of
securities named below (the “Holder”) has elected to substitute $                                 Value of Senior
Notes or security entitlements with respect thereto in exchange for $                                 Value of Pledged
Treasury Securities relating to                                  Treasury HiMEDS Units and has delivered to the
undersigned a notice stating that the Holder has Transferred such Senior Notes or security
entitlements with respect thereto to the Securities Intermediary, for credit to the Collateral
Account.

     We hereby request that you instruct the Securities Intermediary, upon confirmation that such
Senior Notes or security entitlements with respect thereto have been credited to the Collateral
Account, to release to the undersigned an equal Value of Pledged Treasury Securities or security
entitlements with respect thereto in accordance with Section 3.13 of the Agreement.

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST
 COMPANY, N.A., as

Purchase Contract Agent

 	 
	Dated:                                  	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	Authorized Signatory 	 

I-1

 

	 	 	 	 	 

Please print name and address of Holder electing to substitute Senior Notes or security
entitlements with respect thereto for Pledged Treasury Securities:

	 	 	 
	 

	 	 
	Name:

	 	Social Security or other Taxpayer

Identification Number, if any
	 
	 	 
	Address
	 	 
	 
	 
	 	 
	 
	 	 
	 
	 	 
	 
	 	 
	 
	 	 
	DTC Participant
	 	 
	No.                                            
	 	 

I-2

 

EXHIBIT J

INSTRUCTION

FROM COLLATERAL AGENT

TO SECURITIES INTERMEDIARY

REGARDING RECREATION OF CORPORATE HIMEDS UNITS

The Bank of New York Trust Company, N.A.,

as Securities Intermediary

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

	 	 	 	Re: Treasury HiMEDS Units of Avery Dennison Corporation (the “Company”)
	 
	 	 	 	The securities account of The Bank of New York Trust Company, N.A., as
Collateral Agent, maintained by the Securities Intermediary and
designated “[                    ], as Collateral Agent of Avery
Dennison Corporation, as pledgee of The Bank of New York Trust Company,
N.A., as the Purchase Contract Agent on behalf of and as
attorney-in-fact for the Holders” (the “Collateral Account”)

     Please refer to the Purchase Contract and Pledge Agreement dated as of November 20, 2007 (the
“Agreement”), among you, the Company, you, as Collateral Agent and Custodial Agent and you, as
Purchase Contract Agent and attorney-in-fact of the Holders from time to time. Capitalized terms
used herein but no defined shall have the meaning set forth in the Agreement.

     When you have confirmed that $                            Value of Senior Notes or security entitlements
with respect thereto has been credited to the Collateral Account by or for the benefit of
                           , as Holder of Treasury HiMEDS Units (the “Holder”), you are hereby instructed
to release from the Collateral Account $                            Value of Treasury Securities or security
entitlements thereto by Transfer to the Purchase Contract Agent.

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST
 COMPANY, N.A., as

Collateral Agent

 	 
	Dated:                             	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	Authorized Signatory 	 
	 

J-1

 

EXHIBIT K

NOTICE OF SENIOR NOTES TO BE REMARKETED

FROM [COLLATERAL] [CUSTODIAL] AGENT TO

PURCHASE CONTRACT AGENT AND REMARKETING AGENT

The Bank of New York Trust Company, N.A.,

as Purchase Contract Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

[Remarketing Agent]

	 	 	 	Re: Corporate HiMEDS Units of Avery Dennison Corporation (the “Company”)

     Please refer to the Purchase Contract and Pledge Agreement dated as of November 20, 2007 (the
“Agreement”), among you, as Purchase Contract Agent and attorney-in-fact of the Holders from time
to time, the Company, and you, as Collateral Agent, Custodial Agent and Securities Intermediary.
Unless otherwise defined herein, terms defined in the Agreement are used herein as defined therein.

     [In accordance with Section 5.02(a)(iii) of the Agreement, we hereby notify you that as of
4:00 p.m., New York City time, on the second Business Day immediately preceding the Remarketing
Date, we have received (i) $                            in immediately available funds paid in an aggregate
amount equal to the Purchase Price due to the Company on the Purchase Contract Settlement Date with
respect to                             Corporate HiMEDS Units and (ii) based on the funds received set
forth in clause (i) above, an aggregate principal amount of $                            of Pledged Senior
Notes are to be tendered for purchase in the remarketing.]

     [In accordance with Section 5.02(b) of the Agreement, we hereby notify you that as of 4:00
p.m., New York City time, on the second Business Day immediately preceding the Remarketing Date, we
have received an aggregate principal amount of $                            of Separate Senior Notes tendered
for resale in the remarketing.]

	 	 	 	 	 
	 	THE BANK OF NEW YORK TRUST
 COMPANY, N.A., as

[Collateral Agent] [Custodial Agent]

 	 
	Dated:                             	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	Authorized Signatory 	 

K-1

 

EXHIBIT L

INSTRUCTION

FROM HOLDER OF SEPARATE SENIOR NOTES

TO CUSTODIAL AGENT

REGARDING REMARKETING

The Bank of New York Trust Company, N.A.,

as Custodial Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

			
	     Re:	 	Senior Notes Due 2020 of Avery Dennison Corporation (the “Company”)

     The undersigned hereby notifies you in accordance with of the Purchase Contract and Pledge
Agreement, dated as of November 20, 2007 (the “Agreement”), among you, the Company, you, as
Collateral Agent and Securities Intermediary, and you, as Purchase Contract Agent and
attorney-in-fact of the Holders from time to time, that the undersigned elects to deliver
$                                         aggregate principal amount of Separate Senior Notes for delivery to the Remarketing
Agent on or prior to 4:00 p.m., New York City time, on the second Business Day immediately
preceding the Remarketing Date for remarketing pursuant to Section 5.02(b) of the Agreement. The
undersigned will, upon request of the Remarketing Agent, execute and deliver any additional
documents deemed by the Remarketing Agent or by the Company to be necessary or desirable to
complete the sale, assignment and transfer of the Separate Senior Notes tendered hereby.
Capitalized terms used herein but not defined shall have the meaning set forth in the Agreement.

     The undersigned hereby instructs you, upon receipt of the Proceeds of such remarketing from
the Remarketing Agent, to deliver such Proceeds to the undersigned in accordance with the
instructions indicated herein under “A. Payment Instructions.” The undersigned hereby instructs
you, in the event of a Last Failed Remarketing, upon receipt of the Separate Senior Notes tendered
herewith from the Remarketing Agent, to deliver such Separate Senior Notes to the person(s) and the
address(es) indicated herein under “B. Delivery Instructions.”

     With this notice, the undersigned hereby:

     (i) represents and warrants that the undersigned has full power and authority to tender, sell,
assign and transfer the Separate Senior Notes tendered hereby and that the undersigned is the
record owner of any Senior Notes tendered herewith in physical form or a participant in The
Depository Trust Company (“DTC”) and the beneficial owner of any Senior Notes tendered herewith by
book-entry transfer to your account at DTC;

     (ii) agrees to be bound by the terms and conditions of Section 5.02(a)(ii) of the Agreement,
if applicable, and

L-1

 

     (iii) acknowledges and agrees that after 4:00 p.m., New York City time, on the second Business
Day immediately preceding the Remarketing Date, such election shall become an irrevocable election
to have such Separate Senior Notes remarketed in the remarketing, and that the Separate Senior
Notes tendered herewith will only be returned in the event of a Last Failed Remarketing.

	 	 	 	 	 	 	 	 	 
	Date:                                         

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	By:	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:	 	 
	 

	 	 	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature	 	 
	 

	 	 	 	 	 	Guarantee:	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

Name

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	Social Security or other Taxpayer

Identification

Number, if any

	 
	 	 	 	 	 	 	 	 
	 

Address

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	DTC Participant
	 	 	 	 	 	 	 	 
	No.
	 	 	 	 	 	 	 	 

	A.	 	PAYMENT INSTRUCTIONS

Proceeds of the remarketing should be paid by check in the name of the person(s) set forth below
and mailed to the address set forth below.

	 	 	 
	Name(s)
	 	 
	 

	 	 
	 

	 	(Please Print)
	Address
	 	 
	 
	 	 
	 
	 	(Please Print)
	 
	 
	 
	 
	 	(Zip Code)
	 
	 
	 
	 
	 	(Tax Identification or Social Security Number)

L-2

 

	B.	 	DELIVERY INSTRUCTIONS

In the event of a Last Failed Remarketing, Senior Notes which are in physical form should be
delivered to the person(s) set forth below and mailed to the address set forth below.

	 	 	 
	Name(s)
	 	 
	 

	 	 
	 

	 	(Please Print)
	Address
	 	 
	 
	 	 
	 
	 	(Please Print)
	 
	 
	 
	 
	 	(Zip Code)
	 
	 
	 
	 
	 	(Tax Identification or Social Security Number)

In the event of a Last Failed Remarketing, Senior Notes which are in book-entry form should be
credited to the account at The Depository Trust Company set forth below.

                                        

DTC Account Number

Name of Account

Party:                                                             

L-3

 

EXHIBIT M

INSTRUCTION

FROM HOLDER OF SEPARATE SENIOR NOTES

TO CUSTODIAL AGENT

REGARDING WITHDRAWAL FROM REMARKETING

The Bank of New York Trust Company, N.A.,

as Custodial Agent

601 Travis Street

18th Floor

Houston, Texas 77002

Telecopier No.: 713-483-7038

Attention: Corporate Trust Administration

			
	     Re:	 	Senior Notes Due 2020 of Avery Dennison Corporation (the “Company”)

     The undersigned hereby notifies you in accordance with Section 5.02(b) of the Purchase
Contract and Pledge Agreement, dated as of November 20, 2007 (the “Agreement”), among you, the
Company, you, as Collateral Agent and Securities Intermediary, and you, as Purchase Contract Agent
and attorney-in-fact of the Holders from time to time, that the undersigned elects to withdraw the
$                                         aggregate principal amount of Separate Senior Notes delivered to the Collateral
Agent for remarketing pursuant to Section 5.02(a)(ii) of the Agreement. The undersigned hereby
instructs you to return such Separate Senior Notes to the undersigned in accordance with the
undersigned’s instructions. With this notice, the Undersigned hereby agrees to be bound by the
terms and conditions of Section 5.02(a)(ii) of the Agreement. Capitalized terms used herein but
not defined shall have the meaning set forth in the Agreement.

	 	 	 	 	 	 	 	 	 
	Date:                                         

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	By:	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:	 	 
	 

	 	 	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature	 	 
	 

	 	 	 	 	 	Guarantee:	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

Name

	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	Social Security or other Taxpayer

Identification Number, if any
	 
	 	 	 	 	 	 	 	 
	 

Address

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	DTC
	 	 	 	 	 	 	 	 
	Participant No.
                                        
	 	 	 	 	 	 	 	 

M-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]